Name	MOA	Target	Phase
[sar9,met(o2)11]-substance-p	tachykinin antagonist	TACR1	Preclinical
A-1070722	glycogen synthase kinase inhibitor	GSK3A, GSK3B	Preclinical
A-1120	retinoid receptor ligand	RBP4	Preclinical
A-317491	purinergic receptor antagonist	P2RX3	Preclinical
A-33903			Phase 2
A-366	histone lysine methyltransferase inhibitor	EHMT1, EHMT2	Preclinical
A-412997	dopamine receptor agonist	DRD4	Preclinical
A-438079	purinergic receptor antagonist	P2RX7	Preclinical
A-582941	nicotinic receptor agonist	CHRNA7	Preclinical
A-61603	adrenergic receptor agonist	ADRA1A, ADRA1B, ADRA1D	Preclinical
A-674563	AKT inhibitor	AKT1, PKIA, PRKACA	Preclinical
A-7	calmodulin antagonist		Preclinical
A-769662	AMPK activator		Preclinical
A-784168	transient receptor potential channel antagonist	TRPV1	Preclinical
A-803467	sodium channel blocker	SCN10A	Preclinical
A-804598	purinergic receptor antagonist	P2RX7	Preclinical
A-839977	purinergic receptor antagonist	P2RX7	Preclinical
A-867744	acetylcholine receptor allosteric modulator	CHRNA3, CHRNA4, CHRNA7	Preclinical
A-887826	sodium channel blocker	SCN10A	Preclinical
A-922500	diacylglycerol O acyltransferase inhibitor	DGAT1	Preclinical
A-939572	stearoyl-CoA desaturase inhibitor	SCD	Preclinical
A-967079	transient receptor potential channel antagonist	TRPA1	Preclinical
A-987306	histamine receptor antagonist	ADORA1, AVPR1A, CCR1, CHRM1, CHRM2, CHRM3, CHRM4, DRD3, HTR1A, HTR1B, HTR2A, HTR2B, HTR3A, TACR2	Preclinical
AA-29504	GABA receptor positive allosteric modulator	GABRA1, GABRA4, GABRB3	Preclinical
abacavir	nucleoside reverse transcriptase inhibitor		Launched
abafungin	sterol methyltransferase inhibitor		Phase 3
abamectin	benzodiazepine receptor agonist	GABBR1, GABBR2	Launched
abametapir	metalloproteinase inhibitor	MMP9	Phase 3
ABC-294640	sphingosine kinase inhibitor	SPHK2	Phase 1/Phase 2
abemaciclib	CDK inhibitor	CDK4, CDK6	Launched
abiraterone	androgen biosynthesis inhibitor	CYP11B1, CYP17A1	Launched
abiraterone-acetate	androgen biosynthesis inhibitor	CYP17A1	Launched
ABT-202	acetylcholine receptor agonist		Phase 1
ABT-239	histamine receptor antagonist	HRH1, HRH2, HRH3	Phase 1
ABT-491	platelet activating factor receptor antagonist	PTAFR	Phase 1
ABT-639	calcium channel blocker	CACNA1G, CACNA1H, CACNA1I	Phase 2
ABT-702	adenosine kinase inhibitor	ADK	Preclinical
ABT-724	dopamine receptor agonist	DRD4	Phase 2
ABT-737	BCL inhibitor	BCL2, BCL2L1, BCL2L2	Phase 1/Phase 2
ABT-751	tubulin polymerization inhibitor	TUBB	Phase 2
AC-186	estrogen receptor agonist	ESR2	Preclinical
AC-261066	retinoid receptor agonist	RARB	Preclinical
AC-264613	PAR agonist	F2RL1	Preclinical
AC-55541	PARP inhibitor	PARP2	Preclinical
AC-55649	retinoid receptor agonist	RARA, RARB	Preclinical
AC-710	PDGFR tyrosine kinase receptor inhibitor	CSF1R, FLT3, KIT, PDGFRA, PDGFRB	Preclinical
AC-7954-(+/-)	urotensin receptor agonist	UTS2R	Preclinical
acadesine	AMPK activator		Phase 3
acalabrutinib	Bruton's tyrosine kinase (BTK) inhibitor	BTK	Phase 3
acalisib	PI3K inhibitor	PIK3CB, PIK3CD	Phase 1
acamprosate	glutamate receptor antagonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, GRM5	Launched
acarbose	glucosidase inhibitor	AMY2A, GAA, MGAM, SI	Launched
ACDPP	glutamate receptor antagonist	GRM5	Preclinical
acebutolol	adrenergic receptor antagonist	ADRB1, ADRB2	Launched
acecainide	polarization inhibitor	SCN5A	Phase 3
aceclidine	acetylcholine receptor agonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Launched
aceclofenac	prostanoid receptor antagonist	PTGS2	Launched
acedapsone			Launched
acedoben			Phase 2
acefylline	adenosine receptor agonist	ADORA1	Launched
aceglutamide			Launched
acemetacin	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
aceneuramic-acid		AZGP1, CES1, MBL2, REG1A, SELE, SELP, SIGLEC1	Phase 3
acenocoumarol	vitamin K antagonist	VKORC1	Launched
acepromazine	dopamine receptor antagonist	ADRA1A, ADRA1B, DRD1, DRD2, HTR1A, HTR2A	Launched
acesulfame-potassium			Phase 3
acetanilide	hydrogen peroxide decomposition inhibitor		Preclinical
acetarsol			Launched
acetazolamide	carbonic anhydrase inhibitor	AQP1, CA1, CA12, CA14, CA2, CA3, CA4, CA7	Launched
acetohexamide	ATP channel blocker	ABCC8, KCNJ1, KCNJ10, KCNJ11	Launched
acetohydroxamic-acid	urease inhibitor	MMP12	Launched
acetophenazine	dopamine receptor antagonist	DRD1, DRD2	Launched
acetriazoic-acid			Preclinical
acetyl-farnesyl-cysteine	methyltransferase inhibitor	PPARG	Launched
acetyl-l-leucine			Launched
acetyl-11-keto-beta-boswellic-acid	lipoxygenase inhibitor	HSD11B1, HSD11B2	Phase 2
acetylcholine	acetylcholine receptor agonist	ACHE, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2	Launched
acetylcysteine	mucolytic agent	ACY1, CHUK, GRIN1, GRIN2A, GRIN2B, GRIN2D, GRIN3A, GSS, IKBKB, RELA, SLC7A11	Launched
acetylsalicylsalicylic-acid	cyclooxygenase inhibitor		Preclinical
acexamic-acid	5 alpha reductase inhibitor	GAST	Launched
acifran	cholesterol inhibitor	HCAR2, HCAR3	Phase 3
acipimox	cholesterol inhibitor	HCAR2	Launched
acitazanolast	mediator release inhibitor		Launched
acitretin	retinoid receptor agonist	RARA, RARB, RARG, RBP1, RXRA, RXRB, RXRG, STAT3	Launched
acivicin	gamma glutamyltransferase Inhibitors	CTPS1	Phase 2
aclarubicin	topoisomerase inhibitor	TOP1, TOP2A	Launched
aclidinium	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Launched
ACPC	glutamate receptor antagonist		Phase 1
acriflavine	hypoxia inducible factor inhibitor	HIF1A	Launched
acriflavinium	hypoxia inducible factor inhibitor	HIF1A	Launched
acrisorcin	other antifungal		Launched
acrivastine	histamine receptor antagonist	HRH1	Launched
acrylate	mucus protecting agent		Phase 3
ACT-132577	endothelin receptor antagonist	EDNRA, EDNRB	Launched
ACT-462206	orexin receptor antagonist	HCRTR1, HCRTR2	Phase 1
actarit	interleukin receptor agonist		Launched
ACTB-1003	FGFR inhibitor, VEGFR inhibitor	KDR, TEK	Phase 1
actinomycin-d	RNA polymerase inhibitor		Launched
actinoquinol			Preclinical
ACY-1215	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC6, HDAC8	Phase 1/Phase 2
acyclovir	DNA polymerase inhibitor	PNP	Launched
AC1NDSS5			Phase 1
AD-5467	aldose reductase inhibitor	AKR1B1	Phase 2
adapalene	retinoid receptor agonist	RARA, RARB, RARG, RXRA, RXRB, RXRG	Launched
adaprev	TGF beta receptor inhibitor	IGF2R, M6PR	Phase 3
adaptavir	CC chemokine receptor antagonist	CCR5	Phase 2
adarotene	retinoid receptor agonist	RARB, RARG	Phase 1
adatanserin	serotonin receptor agonist, serotonin receptor antagonist	HTR1A, HTR2A	Phase 2
ADD-233089	benzodiazepine receptor agonist		Phase 1
adefovir	DNA polymerase inhibitor		Launched
adefovir-dipivoxil	DNA polymerase inhibitor		Launched
adelmidrol	anti-inflammatory agent		Phase 2/Phase 3
ademetionine	methyltransferase stimulant, phosphodiesterase inhibitor	AMD1, CBS, COMT, GNMT, MAT1A, MAT2A	Launched
adenine	protein synthesis stimulant	ACACB, ACP1, APRT, MTAP, PECR, SRPK2	Preclinical
adenosine	adenosine receptor agonist	ADORA1, ADORA2A, ADORA2B, ADORA3, PI4K2A, PI4K2B, TRPM4	Launched
adenosine-phosphate	adenosine receptor agonist	ACSL1, ACSS1, ACSS2, ADCY1, ADK, CREB1, FBP1, HINT1, PDE4B, PDE4D, PIM1, PRKAA1, PRKAB1, PRKAB2, PYGL, TRPM4	Launched
adenosine-triphosphate	adenosine receptor agonist	ABCA1, ABCB1, ABCB11, ABCC2, ABCC8, ABCC9, ABCG1, ABL1, ABL2, ACSL1, ACSS1, ACSS2, ACVR1, ACVR1B, ACVRL1, ADCY1, ADRBK1, ADRBK2, AFG3L2, AKT1, ALK, AMHR2, APAF1, ARAF, ASNA1, ASNS, ASS1, CDK15, GPR17, ITPR1, NAE1, NT5C2, P2RY1, P2RY11, P2RY13, P2RY2, P2RY4, PRKAA1, RYR1, RYR2, RYR3, SLC25A4, TNK2, TRPM4, TRPM7	Phase 2
adiphenine	acetylcholine receptor antagonist	CHRNA1	Launched
adipic-acid	solute carrier family member inhibitor	SLC22A6	Preclinical
adiporon	adiponectin receptor agonist	ADIPOR1, ADIPOR2	Preclinical
ADL5859	opioid receptor agonist	OPRD1	Phase 2
adoprazine	dopamine receptor antagonist, serotonin receptor agonist	DRD2, HTR1A	Phase 2
adrafinil	adrenergic receptor agonist		Launched
adrenalone	adrenergic receptor agonist	ADRA1A	Launched
adrenosterone	11-beta hydroxysteroid dehydrogenase inhibitor	HSD11B1, HSD11B2	Preclinical
ADX-10059	glutamate receptor negative allosteric modulator	GRM5	Phase 2
ADX-47273	glutamate receptor modulator	GRM5	Preclinical
AEE788	EGFR inhibitor, VEGFR inhibitor	EGFR, ERBB2, ERBB4, FGFR2, FGFR3, KDR	Phase 1/Phase 2
AEG3482	HSP inducer		Preclinical
afalanine	dopamine receptor agonist	DRD2	Phase 3
afatinib	EGFR inhibitor	EGFR, ERBB2, ERBB4	Launched
afimoxifene	estrogen receptor antagonist	ESR1, ESR2, ESRRG, PLD1, PRKCD, PRKCE, PRKCQ, PRKCZ	Phase 2
afloqualone	acetylcholine receptor antagonist		Launched
AFN-1252	FABI inhibitor		Phase 2
afobazole	anxiolytic		Launched
AF38469	sortilin inhibitor	SORT1	Preclinical
AG-1024	insulin growth factor receptor inhibitor	IGF1R	Preclinical
AG-14361	PARP inhibitor	PARP1	Preclinical
AG-490	EGFR inhibitor, JAK inhibitor	EGFR, JAK2, JAK3	Preclinical
AG-555	tyrosine kinase inhibitor	CDK2	Preclinical
AG-556	tyrosine kinase inhibitor		Preclinical
AGI-5198	isocitrate dehydrogenase inhibitor	IDH1	Preclinical
AGI-6780	isocitrate dehydrogenase inhibitor	IDH2	Preclinical
AGM-1470	cell cycle inhibitor	METAP2	Phase 2
agmatine	nitric oxide synthase inhibitor	ADRA2C, ASIC3, CACNA1B, CHRNA1, GRIN1, KCNJ1, NISCH	Phase 3
AGN-192403	imidazoline receptor ligand	NISCH	Preclinical
AGN-194310	retinoid receptor antagonist	RXRA, RXRB, RXRG	Phase 3
AGN-195183	retinoid receptor agonist	RARA	Phase 1/Phase 2
agomelatine	melatonin receptor agonist, serotonin receptor antagonist	HTR2A, HTR2B, HTR2C, MTNR1A, MTNR1B	Launched
AGP-103	membrane permeability inhibitor		Launched
AH-7614	free fatty acid receptor antagonist	FFAR4	Preclinical
AH11110	adrenergic receptor ligand	ADRA1B	Preclinical
AH6809	prostanoid receptor antagonist	PTGDR, PTGER1, PTGER2, PTGER3	Preclinical
AI-10-49	core binding factor inhibitor	CBFB	Preclinical
AIM-100	tyrosine kinase inhibitor	TNK2	Preclinical
ajmaline	sodium channel blocker	SCN5A	Launched
AJ76-(+)	dopamine receptor antagonist	DRD2, DRD3, DRD4	Preclinical
AK-7	SIRT inhibitor	SIRT2	Preclinical
AKBA	lipoxygenase inhibitor	ALOX5	Phase 3
aklomide			Launched
AL-8697	p38 MAPK inhibitor	MAPK14	Preclinical
alacepril	angiotensin converting enzyme inhibitor	ACE	Launched
alafosfalin	bacterial cell wall synthesis inhibitor		Phase 1
alagebrium	glycosylation inhibitor		Phase 2/Phase 3
alanine		AARS, AARS2, ABAT, AGXT, AGXT2, GPRC6A, GPT, GPT2, KYNU, NFS1, PHYKPL, SLC1A4, SLC36A1, SLC7A8	Launched
alantolactone	apoptosis stimulant, STAT inhibitor	STAT3	Preclinical
alaproclate	serotonin receptor antagonist	SLC6A4	Phase 2
alarelin	gonadotropin releasing factor hormone receptor antagonist	GNRH1	Launched
albendazole	tubulin polymerization inhibitor	TUBA1A, TUBB, TUBB4B	Launched
albendazole-oxide	anthelmintic agent		Launched
albuterol	adrenergic receptor agonist	ADRB1, ADRB2	Launched
alcaftadine	histamine receptor antagonist	HRH1	Launched
alclofenac	cyclooxygenase inhibitor	PTGS1	Launched
alclometasone-dipropionate	glucocorticoid receptor agonist	CYP3A4, NR3C1, SERPINA6	Launched
alcuronium	muscle relaxant	CHRM1, CHRM2, CHRM3, CHRM4, CHRNA7	Launched
alda-1	aldehyde dehydrogenase activator	ALDH2	Preclinical
aldoxorubicin	topoisomerase inhibitor	TOP2A	Phase 3
alectinib	ALK tyrosine kinase receptor inhibitor	ALK, MET	Launched
alendronate	bone resorption inhibitor	ATP6V1A, FDPS, PTPN4, PTPRE, PTPRS	Launched
alexidine	phosphatidylglycerophosphatase inhibitor	PTPMT1	Preclinical
alfacalcidol	vitamin D receptor agonist	CYP27B1, VDR	Launched
alfadolone-acetate	benzodiazepine receptor agonist		Phase 2
alfaxalone	chloride channel agonist, benzodiazepine receptor agonist	GABBR1	Launched
alfuzosin	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, KCNH2	Launched
algestone-acetophenide			Launched
alibendol	antispasmodic		Launched
alimemazine	histamine receptor agonist	HRH1	Launched
alisertib	Aurora kinase inhibitor	AURKA	Phase 3
aliskiren-hemifumarate	renin inhibitor	REN	Launched
alizapride	dopamine receptor antagonist	DRD2	Launched
alizarin			Preclinical
allantoin	cosmetic		Launched
allicin	cytokine production inhibitor	TRPA1, TRPV1	Phase 2
allopregnanolone	GABA receptor positive allosteric modulator	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB2, GABRG2	Phase 2
allopurinol	xanthine oxidase inhibitor	XDH	Launched
allopurinol-riboside	anti-leishmanial agent		Phase 2
allylestrenol	steroidal progestin	ESR1, PGR, SLC6A9	Launched
allylisothiocyanate	TRPV agonist	TRPA1	Preclinical
allylthiourea	nitrification inhibitor		Preclinical
almitrine	neurotransmitter agonist	ATP1A1	Launched
almorexant	orexin receptor antagonist	HCRTR1, HCRTR2	Phase 3
almotriptan	serotonin receptor agonist	HTR1B, HTR1D	Launched
aloe-emodin	anticancer agent	CASP8	Preclinical
alogliptin	dipeptidyl peptidase inhibitor	DPP4	Launched
aloin	angiogenesis inhibitor		Preclinical
aloperine			Preclinical
alosetron	serotonin receptor antagonist	HTR3A	Withdrawn
aloxistatin	protease inhibitor	CTSG	Phase 3
alpelisib	PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG	Phase 3
alpha-Asarone	cytochrome P450 inhibitor, HMGCR inhibitor	HMGCR	Preclinical
alpha-D-glucopyranose			Preclinical
alpha-linolenic-acid	omega 3 fatty acid stimulant	ELOVL4, FADS1, FADS2, FFAR1, FFAR4, PTGS2, SLC8A1, TRPV1	Phase 3
alpha-methylhistamine-dihydrobromide-(R)-(-)	histamine receptor agonist	HRH3	Preclinical
alpha-methylhistamine-dihydrobromide-(S)-(+)	histamine receptor agonist	HRH3	Preclinical
alpha-methylserotonin	serotonin receptor agonist	HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR4	Preclinical
alpha-tochopherol	antioxidant		Launched
alpha-tochopheryl-acetate	antioxidant		Launched
alpidem	benzodiazepine receptor agonist	GABRA1	Withdrawn
alprenolol	adrenergic receptor antagonist	ADRB1, ADRB2, HTR1A	Launched
alprostadil	prostanoid receptor agonist	CATSPER1, CATSPER2, CATSPER3, CATSPER4, PTGDR, PTGER1, PTGER2, PTGER4, PTGIR	Launched
alrestatin	aldose reductase inhibitor	AKR1B1	Preclinical
ALS-8176	RNA polymerase inhibitor		Phase 1
altanserin	serotonin receptor antagonist	HTR2A	Phase 2
althiazide	diuretic		Launched
altinicline	nicotinic receptor agonist	CHRNA4, CHRNB2	Phase 2
altiratinib	VEGFR inhibitor, MET inhibitor	KDR, MET, TEK	Phase 1
altrenogest	progestogen hormone	PGR	Launched
altretamine	DNA synthesis inhibitor		Launched
alverine	muscle relaxant	HTR1A	Launched
alvespimycin	HSP inhibitor	HSP90AA1	Phase 2
alvimopan	opioid receptor antagonist	OPRD1, OPRK1, OPRM1	Launched
alvocidib	CDK inhibitor	CDK1, CDK2, CDK4, CDK5, CDK6, CDK7, CDK8, CDK9, EGFR, PYGM	Phase 2
ALX-5407	Glycine transporter 1 inhibitor	SLC6A9	Phase 1
AM-1241	cannabinoid receptor agonist	CNR1, CNR2	Preclinical
AM-24	lipoxygenase inhibitor	ALOX5	Phase 2
AM-251	cannabinoid receptor antagonist	CNR1, GPR18, GPR55	Preclinical
AM-281	cannabinoid receptor antagonist	CNR1, CNR2, GPR55	Preclinical
AM-404	cyclooxygenase inhibitor, FAAH inhibitor, TRPV antagonist	CNR1, CNR2, FAAH, TRPV1	Preclinical
AM-580	retinoid receptor agonist	RARA	Preclinical
AM-630	cannabinoid receptor antagonist	CNR1, CNR2	Preclinical
AM-92016	potassium channel blocker	GRIN1	Preclinical
amantadine	glutamate receptor antagonist	DRD2, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A	Launched
ambazone	DNA damage inducer		Phase 1
ambenonium	cholinesterase inhibitor	ACHE	Launched
ambrisentan	endothelin receptor antagonist	EDNRA, EDNRB	Launched
ambroxol	sodium channel blocker	CYP3A4	Launched
amcinonide	glucocorticoid receptor agonist	ANXA1, NR3C1	Launched
AMD-3465	CC chemokine receptor antagonist	CXCR4	Preclinical
amdinocillin	bacterial cell wall synthesis inhibitor		Launched
AMD11070	CC chemokine receptor antagonist	CXCR4	Phase 1/Phase 2
ameltolide	anticonvulsant		Preclinical
amezinium	adrenergic receptor agonist	ADRB2	Launched
amfenac	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
amfepramone	adrenergic receptor agonist	SLC6A2, SLC6A3	Launched
amflutizole	xanthine oxidase inhibitor	XDH	Phase 2
AMG-PERK-44	PERK inhibitor	EIF2AK4	Preclinical
AMG-208	tyrosine kinase inhibitor	MET	Phase 1
AMG-232	MDM inhibitor	MDM2	Phase 1/Phase 2
AMG-319	PI3K inhibitor	PIK3CD	Phase 2
AMG-337	MET inhibitor	MET	Phase 2
AMG-487	CC chemokine receptor antagonist		Phase 2
AMG-487-(+/-)	CC chemokine receptor antagonist	CXCR3	Phase 2
AMG-517	TRPV antagonist	TRPV1	Phase 1
AMG-548	MAP kinase inhibitor	MAPK11, MAPK12, MAPK13, MAPK14	Phase 1
AMG-837	free fatty acid receptor agonist	FFAR1	Phase 1
AMG-925	CDK inhibitor, FLT3 inhibitor	CDK4, CDK6, FLT3	Phase 1
AMG-9810	TRPV antagonist	TRPV1	Preclinical
AMG319	PI3K inhibitor	PIK3CD	Phase 2
AMG458	MET inhibitor	MET	Preclinical
AMG900	Aurora kinase inhibitor	AURKA, AURKB, AURKC	Phase 1
AMI-1	protein arginine N-methyltransferase inhibitor	PRMT1	Preclinical
amibegron	adrenergic receptor agonist	ADRB3	Phase 3
amidopyrine	analgesic agent		Launched
amifampridine	potassium channel blocker		Launched
amiflamine	monoamine oxidase inhibitor	MAOA, SLC6A2	Phase 1
amifostine	reducing agent	ALPPL2, ENPP1	Launched
amikacin	bacterial 30S ribosomal subunit inhibitor		Launched
amiloride	sodium channel blocker	AOC1, ASIC1, ASIC2, ASIC3, PKD2, PKD2L1, PLAU, SCNN1A, SCNN1B, SCNN1D, SCNN1G, SLC9A1, TRPC7, TRPV2	Launched
amineptine	dopamine receptor agonist	SLC6A2, SLC6A4	Withdrawn
aminocaproic-acid	plasminogen activator inhibitor	LPA, PLAT, PLG	Launched
aminoglutethimide	glucocorticoid receptor antagonist	CYP11A1, CYP19A1	Launched
aminoguanidine	nitric oxide synthase inhibitor	NOS2	Phase 3
aminohydroxybutyric-acid			Launched
aminolevulinic-acid-benzyl-ester			Phase 1
aminomethyltransferase	nitric oxide synthase inhibitor	NOS2	Preclinical
aminopentamide	acetylcholine receptor antagonist	CHRM1	Launched
aminophylline	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3, HDAC2, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D	Launched
aminopterin	dihydrofolate reductase inhibitor	DHFR, SLC46A1	Phase 3
aminopurvalanol-a	CDK inhibitor, tyrosine kinase inhibitor	CDK1, CDK2, CDK5, CDK6	Preclinical
aminosalicylate	cyclooxygenase inhibitor	ALOX5, CHUK, PLA2G2E, PTGS1, PTGS2	Launched
aminothiadiazole	inosine monophosphate dehydrogenase inhibitor	ADORA3, IMPDH1	Phase 2
aminothiazole	cyclin D inhibitor	NOS2	Preclinical
amiodarone	potassium channel blocker	ADRB1, CACNA1H, CACNA2D2, KCNA7, KCNH2	Launched
amiprilose	CD antagonist		Phase 3
amisulpride	dopamine receptor antagonist	DRD2, DRD3, HTR2A, HTR7	Launched
amitifadine	serotonin transporter (SERT) inhibitor	SLC6A2, SLC6A3, SLC6A4	Phase 3
amitraz	adrenergic receptor agonist	ADRA1A, ADRA2A	Launched
amitriptyline	norepinephrine inhibitor, norepinephrine reuptake inhibitor, serotonin receptor antagonist, serotonin–norepinephrine reuptake inhibitor (SNRI)	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR2A, HTR2C, HTR6, HTR7, KCNA1, KCND2, KCND3, KCNQ2, KCNQ3, NTRK1, NTRK2, OPRD1, OPRK1, OPRM1, SIGMAR1, SLC6A2, SLC6A4	Launched
amlexanox	histamine receptor modulator	FGF1, IL3, PDE4A, PDE4B, PDE4C, PDE4D, S100A12, S100A13	Launched
amlodipine	calcium channel blocker	CA1, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNA2D1, CACNA2D3, CACNB1, CACNB2, SMPD1	Launched
ammonium-glycyrrhizinate	thrombin inhibitor	HSD11B1, HSD11B2, SLCO1B1, SLCO1B3	Launched
ammonium-lactate		HCAR1	Launched
ammonium-perfluorocaprylate	Pim kinase inhibitor	PIM1	Phase 1
AMN-082	glutamate receptor modulator	GRM7	Preclinical
amodiaquine	histamine receptor agonist	HNMT	Launched
amonafide	topoisomerase inhibitor	TOP2A, TOP2B	Phase 3
amorolfine	membrane integrity inhibitor		Launched
amoxapine	norepinephrine reputake inhibitor	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, HRH4, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR3A, HTR6, HTR7, SLC6A2, SLC6A3, SLC6A4	Launched
amoxicillin	penicillin binding protein inhibitor	CYP2C19, SLC15A1, SLC15A2, SLC22A6	Launched
AMPA-(RS)	glutamate receptor agonist	GRIN1	Preclinical
AMPA-(S)	glutamate receptor agonist	GRIN1	Preclinical
ampalex	glutamate receptor agonist	GRIA1, GRIA2, GRIA3, GRIA4	Phase 2
amperozide	dopamine receptor antagonist	FAAH, HTR2A	Launched
amphotericin-b	membrane permeability enhancer		Launched
ampicillin	bacterial cell wall synthesis inhibitor		Launched
ampiroxicam	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
amprenavir	HIV protease inhibitor		Launched
amprolium	thiamine uptake blocker		Launched
ampyrone	cyclooxygenase inhibitor		Preclinical
amrinone	phosphodiesterase inhibitor	PDE3A, PDE3B, PDE4B, TNF	Launched
amrubicin	topoisomerase inhibitor	TOP2A, TOP2B	Launched
amsacrine	topoisomerase inhibitor	KCNH2, TOP2A	Launched
amthamine	histamine receptor agonist	HRH2	Preclinical
amtolmetin-guacil	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
amuvatinib	FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RAD51 inhibitor, RET tyrosine kinase inhibitor	KIT, MET	Phase 2
amygdalin	caspase activator	CASP3	Phase 2
amyl-nitrite	atrial natriuretic peptide receptor agonist	NPR1	Preclinical
amyleine	local anesthetic		Preclinical
amylene-hydrate	local anesthetic		Preclinical
AMZ30	protein phosphatase inhibitor		Preclinical
AM679	cannabinoid receptor agonist, lipoxygenase inhibitor	ALOX5AP, CNR1, CNR2	Preclinical
ANA-12	tropomyosin receptor kinase inhibitor	NTRK2	Preclinical
anabasine	acetylcholine receptor agonist		Preclinical
anacetrapib	cholesteryl ester transfer protein inhibitor	CETP	Phase 3
anagliptin	dipeptidyl peptidase inhibitor	DPP4	Launched
anagrelide	phosphodiesterase inhibitor	PDE3A	Launched
anamorelin	growth hormone secretagogue receptor agonist	GHSR	Phase 3
anandamide	cannabinoid receptor agonist	CACNA1G, CACNA1H, CACNA1I, CNR1, CNR2, GLRA1, GPR18, GPR55, KCNA2, KCNK3, KCNK9, TRPM8, TRPV1	Phase 2
anastrozole	aromatase inhibitor	CYP19A1	Launched
andarine	androgen receptor modulator	AR	Phase 1
andrographolide	tumor necrosis factor production inhibitor	NFKB1	Phase 2
androstenone	steroid		Preclinical
androsterone	androgen receptor agonist		Preclinical
anecortave-acetate	angiogenesis inhibitor		Launched
anethole	glutathione transferase stimulant		Launched
anethole-trithione	glutathione transferase stimulant		Launched
anguidine	protein synthesis inhibitor	SLC5A1	Phase 2
anidulafungin	fungal 1,3-beta-D-glucan synthase inhibitor		Launched
aniracetam	glutamate receptor agonist	DRD2, GRIA1, GRIA2, GRIA3, GRIA4, HTR2A	Launched
anisindione	vitamin K antagonist	GGCX	Launched
anisodamine	lipid peroxidase inhibitor	ADRA1A	Phase 3
anisomycin	DNA synthesis inhibitor	NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1	Preclinical
anisotropine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3	Launched
anlotinib	VEGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor	KDR, PDGFRB	Phase 2/Phase 3
anpirtoline	serotonin receptor agonist	HTR1B	Phase 1
ANR-94	A1 adenosine receptor antagonist	ADORA2A	Preclinical
ansamitocin-p-3	apoptosis stimulant		Preclinical
antagonist-g	neuropeptide receptor antagonist	MAPK8	Phase 1
antalarmin	corticosteroid releasing factor receptor antagonist	CRHR1	Preclinical
antazoline	antihistamine	HRH1	Launched
anthralin	DNA synthesis inhibitor		Launched
anthranilic-acid			Preclinical
anthraquinone	CDC inhibitor	CDC25B	Preclinical
antimony-potassium			Phase 2
antimonyl			Phase 1
antimycin-a	ATP synthase inhibitor	CYCS	Preclinical
antioxine			Launched
AN2718	leucyl-tRNA synthetase inhibitor		Phase 1
AP-18	transient receptor potential channel antagonist	TRPA1	Preclinical
apabetalone	apolipoprotein expression enhancer	BRD3	Phase 3
apafant	platelet activating factor receptor antagonist	PTAFR	Phase 3
apalutamide	androgen receptor antagonist		Launched
apatinib	RET tyrosine kinase inhibitor	CSK, KDR, KIT, RET	Phase 3
APC-100	anti-inflammatory agent, androgen receptor antagonist	AR	Phase 1/Phase 2
APcK-110	KIT inhibitor	KIT, STAT3	Preclinical
APD597	glucose dependent insulinotropic receptor agonist	GPR119	Phase 1
APD668	glucose dependent insulinotropic receptor agonist	GPR119	Phase 1
aphidicolin	RNA synthesis inhibitor		Phase 1
API-001	sigma receptor antagonist	SIGMAR1	Phase 2
API-1	AKT inhibitor	AKT1, AKT2, AKT3	Preclinical
apigenin	casein kinase inhibitor, cell proliferation inhibitor	AKR1B1, AR, CDK6, CFTR, CYP19A1, CYP1B1, HSD17B1	Preclinical
apixaban	coagulation factor inhibitor	F10	Launched
apocynin	NADPH oxidase inhibitor	NOX4	Phase 1
apoptosis-activator-II	carboxylesterase inhibitor	BCHE, CES1	Preclinical
APR-246	p53 activator	TP53	Phase 1/Phase 2
apraclonidine	adrenergic receptor agonist	ADRA1A, ADRA2A, ADRA2B, ADRA2C	Launched
apramycin	bacterial 30S ribosomal subunit inhibitor		Launched
apratastat	matrix metalloprotease inhibitor, tumor necrosis factor production inhibitor	ADAM17, MMP1, MMP13, MMP9	Phase 2
apremilast	phosphodiesterase inhibitor	PDE4A, PDE4B, PDE4C, PDE4D	Launched
aprepitant	tachykinin antagonist	TACR1	Launched
apricitabine	nucleoside reverse transcriptase inhibitor		Phase 3
aprindine	voltage-gated sodium channel blocker	CALM1, SCN5A	Launched
aptiganel	glutamate receptor antagonist	GRIN1	Phase 3
APTO-253	krüppel-like factor expression enhancer	KLF4	Phase 1
APY-29	serine/threonine kinase inhibitor	ERN1	Preclinical
APY0201	phosphoinositide dependent kinase inhibitor	IL12A, IL12B, PIKFYVE	Preclinical
AP1903			Phase 1/Phase 2
AP26113	ALK tyrosine kinase receptor inhibitor	ALK, EGFR	Phase 2
AQ-RA741	acetylcholine receptor antagonist	CHRM2	Preclinical
AR-A014418	glycogen synthase kinase inhibitor	GSK3B	Preclinical
AR-C155858	monocarboxylate transporter inhibitor	SLC16A1, SLC16A7	Preclinical
AR-12	phosphoinositide dependent kinase inhibitor	PDPK1	Phase 1
AR-42	HDAC inhibitor	HDAC1	Phase 1
arachidonic-acid	cytochrome P450 inhibitor	CLCN2, KCNJ4, KCNK10, KCNK18, KCNK2, PRKCZ, PTGS1, TRPC6, TRPM2	Phase 1
arbidol	cytochrome P450 inhibitor	CYP3A4	Launched
arbutin	melanin inhibitor	TYR	Phase 2/Phase 3
ARC-239	adrenergic receptor antagonist	ADRA2A, ADRA2B, ADRA2C	Preclinical
arctigenin	MEK inhibitor	CHUK, MAP2K1	Preclinical
arcyriaflavin-a	CDK inhibitor	CCND1, CDK4	Preclinical
ardeparin	thrombin inhibitor	SERPINC1, SERPIND1	Withdrawn
arecaidine-but-2-ynyl-ester	acetylcholine receptor agonist	CHRM2	Preclinical
arecaidine-propargyl-ester	acetylcholine receptor agonist	CHRM1, CHRM2, CHRM3, CHRM4	Preclinical
arecoline	acetylcholine receptor agonist	CHRM1, CHRM2, CHRM3, CHRM4	Phase 1
argatroban	thrombin inhibitor	F2	Launched
arglabin	farnesyltransferase inhibitor	FNTA, NFKB1	Launched
aripiprazole	serotonin receptor agonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR6, HTR7	Launched
armodafinil	adrenergic receptor agonist	SLC6A3	Launched
arofylline	phosphodiesterase inhibitor	PDE4A	Phase 3
arotinolol	adrenergic receptor antagonist	ADRB3	Launched
ARQ-092	AKT inhibitor	AKT2	Phase 1
ARQ-621	kinesin-like spindle protein inhibitor	KIF11	Phase 1
ARRY-334543	EGFR inhibitor	ERBB2	Phase 2
arsanilic-acid		LYZ	Phase 1
arsenic-trioxide	apoptosis stimulant	AKT1, CCND1, IKBKB, JUN, MAPK1, MAPK3, TXNRD1	Launched
artemether	antimalarial agent	ATP1A1	Launched
artemisinin	DNA synthesis inhibitor	CYP2B6	Launched
artemotil			Launched
artesunate	DNA synthesis inhibitor		Launched
articaine	local anesthetic		Launched
arundic-acid	astrocyte modulating agent	PTGS2, S100B	Phase 2/Phase 3
ARV-825	bromodomain inhibitor	BRD4	Preclinical
AS-1269574	glucose dependent insulinotropic receptor agonist	GPR119	Preclinical
AS-1892802	rho associated kinase inhibitor	ROCK1	Preclinical
AS-1949490	SHIP2 phosphatase inhibitor	INPP5D	Preclinical
AS-2034178	free fatty acid receptor agonist	FFAR1	Preclinical
AS-2444697	interleukin inhibitor	IRAK4	Preclinical
AS-252424	PI3K inhibitor	PIK3CG	Preclinical
AS-604850	PI3K inhibitor	PIK3CA, PIK3CG	Preclinical
AS-703026	MEK inhibitor	MAP2K1, MAP2K2	Phase 2
AS-77	potassium channel blocker	KCNA3, KCNA5, KCNN4	Preclinical
ASA-404	angiogenesis inhibitor		Phase 3
asaraldehyde	cyclooxygenase inhibitor	PTGS2	Preclinical
ASC-J9	androgen receptor enhancer	AR	Phase 2
ascomycin	calcineurin inhibitor	FKBP1A	Preclinical
ascorbic-acid	antioxidant	ALKBH2, ALKBH3, BBOX1, DBH, EGLN1, EGLN2, EGLN3, KDM5D, LCT, OGFOD1, OGFOD2, P3H1, P3H2, P3H3, P4HA1, P4HTM, PAM, PHYH, PLOD1, PLOD2, PLOD3, SLC23A1, SLC23A2, TMLHE	Launched
asenapine	dopamine receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD4, HRH1, HRH2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7	Launched
asiatic-acid	apoptosis stimulant	PYGM	Preclinical
ASP-2535	glycine transporter inhibitor	SLC6A9	Phase 1
aspartame		TAS1R2, TRPV1	Launched
aspirin	cyclooxygenase inhibitor	AKR1C1, ASIC3, EDNRA, HSPA5, IKBKB, NFKB1, NFKB2, NFKBIA, PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKAG1, PRKAG2, PRKAG3, PTGS1, PTGS2, RPS6KA3, TP53	Launched
ASP3026	ALK tyrosine kinase receptor inhibitor	ALK	Phase 1
AST-1306	EGFR inhibitor	EGFR, ERBB2	Phase 1
astaxanthin	antioxidant		Launched
astemizole	histamine receptor antagonist	HRH1, KCNH1, KCNH2	Withdrawn
astragaloside-a	antiinflammatory agent		Preclinical
asunaprevir	HCV inhibitor		Phase 3
asymmetrical-dimethylarginine	nitric oxide synthase inhibitor	NOS2, NOS3	Phase 1
AT-1015	serotonin receptor antagonist	HTR2A	Preclinical
AT-7519	CDK inhibitor	CDK1, CDK2, CDK4, CDK5, CDK6, CDK9	Phase 2
AT-9283	Aurora kinase inhibitor, JAK inhibitor	AURKA, AURKB, JAK2, JAK3, RPS6KA6, STK17A	Phase 2
ataluren	CFTR channel agonist, dystrophin stimulant	DMD	Launched
atazanavir	HIV protease inhibitor		Launched
ATB-346	cyclooxygenase inhibitor	PTGER2	Phase 2
atenolol-(+)	adrenergic receptor antagonist		Preclinical
atenolol-(+/-)	adrenergic receptor antagonist	ADRB1, ADRB2	Launched
atenolol-(-)	adrenergic receptor antagonist		Phase 2
atglistatin	adipose triglyceride lipase inhibitor		Preclinical
atipamezole	adrenergic receptor antagonist		Launched
atiprimod	JAK inhibitor, STAT inhibitor	JAK2, STAT3	Phase 2
atizoram	phosphodiesterase inhibitor	PDE4A, PDE4B, PDE4C, PDE4D	Phase 2
ATN-161	integrin antagonist	ITGA5, ITGAV, ITGB1, ITGB3	Phase 2
atomoxetine	norepinephrine transporter inhibitor	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, SLC6A2, SLC6A3, SLC6A4	Launched
atorvastatin	HMGCR inhibitor	AHR, DPP4, HMGCR	Launched
atosiban	oxytocin receptor antagonist	AVPR1A, AVPR1B, AVPR2, OXTR	Launched
atovaquone	mitochondrial electron transport inhibitor	DHODH	Launched
ATPA	glutamate receptor agonist	GRIA2, GRIK1	Preclinical
atracurium	acetylcholine receptor antagonist	CHRNA2	Launched
atrasentan	endothelin receptor antagonist	EDNRA	Phase 3
atropine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Launched
atropine-oxide	acetylcholine receptor antagonist		Preclinical
AT13148	protein kinase inhibitor	AKT1, AKT2, AKT3, ROCK1, ROCK2, SGK3	Phase 1
AT13387	HSP antagonist	HSP90AA1	Phase 2
AT7867	AKT inhibitor	AKT2, GSK3B, PKIA, PRKACA	Preclinical
auranofin	NFkB pathway inhibitor	IKBKB, PRDX5, TRPA1	Launched
aurora-a-inhibitor-i	Aurora kinase inhibitor	AURKA	Preclinical
aurothioglucose	PKC inhibitor	PRKCI	Launched
autotaxin-modulator-1	autotaxin inhibitor	ENPP2	Preclinical
AV-412	protein tyrosine kinase inhibitor	EGFR, ERBB2	Phase 1
AV-608	tachykinin antagonist	TACR1	Phase 2
avagacestat	gamma secretase inhibitor	PSEN1	Phase 2
avanafil	phosphodiesterase inhibitor	PDE5A	Launched
avasimibe	ACAT inhibitor	CES1	Phase 3
avatrombopag	thrombopoietin receptor agonist	MPL	Launched
AVE-0991	angiotensin receptor agonist	MRGPRX1	Preclinical
avibactam	beta lactamase inhibitor		Launched
AVL-292	Bruton's tyrosine kinase (BTK) inhibitor	BTK, YES1	Phase 2
AVN-944	inosine monophosphate dehydrogenase inhibitor	IMPDH1, IMPDH2	Phase 2
avobenzone	UV blocker	TYR	Launched
avridine	immunostimulant		Preclinical
axitinib	PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	CSF1, FLT1, FLT4, KDR, PLK4	Launched
AY-9944	hedgehog pathway modulator		Preclinical
AZ-10417808	caspase inhibitor	CASP3	Preclinical
AZ-10606120	purinergic receptor antagonist	P2RX7	Preclinical
AZ-12080282	hedgehog pathway inhibitor	DHH	Preclinical
AZ-628	RAF inhibitor	BRAF, RAF1	Preclinical
azacitidine	DNA methyltransferase inhibitor	DNMT1, DNMT3A	Launched
azacyclonol	histamine receptor antagonist	HRH1	Preclinical
azaguanine-8	purine antagonist	PNP	Preclinical
azalomycin-b	bacterial 50S ribosomal subunit inhibitor		Preclinical
azaperone	dopamine receptor antagonist	DRD2, DRD3	Launched
azapropazone	cyclooxygenase inhibitor	PTGS2	Withdrawn
azaserine	purine antagonist		Preclinical
azasetron	serotonin receptor antagonist	HTR3A, HTR3B	Launched
azatadine	histamine receptor antagonist	HRH1	Launched
azathioprine	dehydrogenase inhibitor	HPRT1, IMPDH1, PPAT	Launched
AZD1080	glycogen synthase kinase inhibitor	GSK3A, GSK3B	Phase 1
AZD1208	Pim kinase inhibitor	PIM1, PIM2, PIM3	Phase 1
AZD1283	purinergic receptor antagonist	P2RY12	Preclinical
AZD1446	acetylcholine receptor agonist	CHRNA4, CHRNB2	Phase 2
AZD1480	JAK inhibitor	JAK1, JAK2, JAK3	Phase 1
AZD1981	CRTH receptor antagonist	PTGDR2	Phase 2
AZD2014	mTOR inhibitor	MTOR	Phase 2
AZD2461	PARP inhibitor		Phase 1
AZD2858	glycogen synthase kinase inhibitor	GSK3B	Preclinical
AZD3264	IKK inhibitor	IKBKB	Preclinical
AZD3463	ALK tyrosine kinase receptor inhibitor, insulin growth factor receptor inhibitor	ALK, IGF1R	Preclinical
AZD3514	androgen receptor modulator	AR	Phase 1
AZD3759	EGFR inhibitor	EGFR	Phase 1
AZD3839	beta-secretase inhibitor	BACE1	Phase 1
AZD3965	monocarboxylate transporter inhibitor	SLC16A1	Phase 1
AZD3988	diacylglycerol kinase inhibitor	DGAT1	Preclinical
AZD4282	glutamate receptor antagonist	AGXT, AGXT2, ALAS1, ALAS2, BAAT, GARS, GATM, GCAT, GCSH, GLDC, GLRA1, GLRA2, GLRA3, GLRB, GLYAT, GLYATL1, GLYATL2, GNMT, GPR18, GPRC6A, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3B, GSS, PIPOX, SHMT1, SHMT2, SLC32A1, SLC36A1, SLC6A5, SLC6A9	Phase 1
AZD4547	FGFR inhibitor	FGFR1, FGFR2, FGFR3, FGFR4, IGF1R, KDR	Phase 2/Phase 3
AZD5069	CC chemokine receptor antagonist	CXCR2	Phase 2
AZD5363	AKT inhibitor	AKT1, AKT2, AKT3	Phase 2
AZD5438	CDK inhibitor	KCNH2	Phase 1
AZD5582	XIAP inhibitor	BIRC2, BIRC3, XIAP	Preclinical
AZD6482	PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG	Phase 1
AZD6738	ATR kinase inhibitor	ATR	Phase 1/Phase 2
AZD6765	glutamate receptor antagonist	GRIN1	Phase 2
AZD7545	pyruvate dehydrogenase kinase inhibitor	PDK1	Phase 1
AZD7687	diacylglycerol O acyltransferase inhibitor	DGAT1	Phase 1
AZD7762	CHK inhibitor	CHEK1, CHEK2	Phase 1
AZD8055	mTOR inhibitor	MTOR	Phase 1
AZD8186	PI3K inhibitor	PIK3CB, PIK3CD	Phase 1
AZD8330	MEK inhibitor		Phase 1
AZD8835	PI3K inhibitor	PIK3CA, PIK3CD	Phase 1
AZD8931	EGFR inhibitor	EGFR, ERBB2, ERBB3	Phase 2
AZD9272	glutamate receptor antagonist	GRM5	Preclinical
AZD9496	estrogen receptor agonist	ESR1	Phase 1
AZD9668	elastase inhibitor	ELANE	Phase 2
azelaic-acid	tyrosinase inhibitor	AKR1D1, SRD5A2, TYR	Launched
azelastine	histamine receptor antagonist	HRH1	Launched
azeliragon	RAGE receptor antagonist	AGER	Phase 3
azelnidipine	calcium channel blocker	CACNA1C	Launched
azilsartan	angiotensin receptor antagonist	AGTR1, AGTR2	Launched
azilsartan-medoxomil	angiotensin receptor antagonist	AGTR1, AGTR2	Launched
azimilide	potassium channel blocker	KCNA5, KCNE1, KCNH2, KCNQ1	Phase 3
azithromycin	bacterial 50S ribosomal subunit inhibitor	MLNR	Launched
azlocillin	bacterial cell wall synthesis inhibitor		Launched
AZM-475271	src inhibitor	SRC	Preclinical
azodicarbonamide	DNA synthesis inhibitor		Phase 2
azomycin-(2-nitroimidazole)	protein synthesis inhibitor		Preclinical
azosemide	electrolyte reabsorption inhibitor	SLC12A1, SLC12A2	Launched
aztreonam	bacterial cell wall synthesis inhibitor		Launched
AZ191	DYRK inhibitor	DYRK1B	Preclinical
AZ20	ATR kinase inhibitor	ATR, MTOR	Preclinical
AZ3146	monopolar spindle 1 kinase inhibitor		Preclinical
AZ505	histone lysine methyltransferase inhibitor	SMYD2	Preclinical
AZ5104	EGFR inhibitor	EGFR	Preclinical
AZ960	JAK inhibitor	JAK2	Preclinical
A0001			Phase 2
A12B4C3	polynucleotide kinase/phosphatase inhibitor	PNKP	Preclinical
A205804	ICAM1 expression inhibitor	ICAM1, SELE	Preclinical
A61603	adrenergic receptor agonist	ADRA1A	Preclinical
A66	PI3K inhibitor	PIK3CA	Preclinical
A740003	purinergic receptor antagonist	P2RX7	Preclinical
A77636	dopamine receptor agonist	CALY	Preclinical
A922500	diacylglycerol O acyltransferase inhibitor	DGAT1	Preclinical
bacampicillin	bacterial cell wall synthesis inhibitor		Launched
bacitracin	bacterial cell wall synthesis inhibitor	A2M, IDE	Launched
bacitracin-zinc	bacterial cell wall synthesis inhibitor		Launched
baclofen	benzodiazepine receptor agonist	GABBR1, GABBR2, KCTD12, KCTD16, KCTD8	Launched
baclofen-(R)	benzodiazepine receptor agonist	GABBR1, GABBR2	Preclinical
BADGE	PPAR receptor antagonist	PPARG	Preclinical
bafetinib	Bcr-Abl kinase inhibitor, LYN tyrosine kinase inhibitor	ABL1, BCR, LYN	Phase 2
BAG-956	phosphoinositide dependent kinase inhibitor	PIK3CG	Preclinical
baicalein	lipoxygenase inhibitor	ALOX5, GLO1, PREP, SELL, SELP, TNF, XDH	Preclinical
baicalin	beta glucuronidase inhibitor	PREP	Launched
bakuchiol	DNA polymerase inhibitor	HIF1A	Phase 2
balaglitazone	insulin sensitizer, PPAR receptor partial agonist	PPARG	Phase 3
balapiravir	RNA polymerase inhibitor		Phase 2
balicatib	cathepsin inhibitor	CTSK	Phase 2
balofloxacin	bacterial DNA gyrase inhibitor		Launched
balsalazide	cyclooxygenase inhibitor	ALOX5, PPARG, PTGS1, PTGS2	Launched
bambuterol	adrenergic receptor agonist	ADRB2, BCHE	Launched
BAM7	BAX activator	BAX	Preclinical
BAN-ORL-24	nociceptin/orphanin FQ receptor antagonist	OPRL1	Preclinical
barasertib	Aurora kinase inhibitor	AURKA, AURKB	Phase 2/Phase 3
barasertib-HQPA	Aurora kinase inhibitor	AURKB	Phase 2/Phase 3
barbital	sedative	CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GRIA2, GRIK2	Launched
bardoxolone	nuclear factor erythroid derived, like (NRF2) activator	NOS2, PPARG	Phase 1
bardoxolone-methyl	nuclear factor erythroid derived, like (NRF2) activator	PPARG, STAT3	Phase 3
baricitinib	JAK inhibitor	JAK1, JAK2	Phase 3
barium-6-O-phosphonato-D-glucose		GPI	Preclinical
barnidipine	calcium channel blocker		Launched
basic-fuchsin			Preclinical
basimglurant	glutamate receptor antagonist	GRM5	Phase 2
batimastat	matrix metalloprotease inhibitor	ADAM28, ADAMTS5, MMP12, MMP16, MMP2, MMP8	Phase 3
bavisant	histamine receptor antagonist	HRH3	Phase 2
BAX-channel-blocker	cytochrome C release inhibitor	BAX	Preclinical
BAY-K-8644-(+/-)	L-type calcium channel activator		Preclinical
BAY-K-8644-(s)-(-)	L-type calcium channel activator	CACNA1C	Preclinical
bay-w-9798	antioxidant		Phase 2
BAY-11-7082	NFkB pathway inhibitor	RELA	Preclinical
BAY-11-7085	NFkB pathway inhibitor	NFKBIA	Preclinical
BAY-41-2272	guanylyl cyclase activator	GUCY1A3, GUCY1B3	Preclinical
BAY-60-6583	adenosine receptor agonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Preclinical
bay-60-7550	phosphodiesterase inhibitor	PDE2A	Preclinical
BAY-61-3606	syk inhibitor	SYK	Preclinical
BAY-85-8050			Phase 1
BAY-87-2243	hypoxia inducible factor inhibitor	HIF1A	Phase 1
bazedoxifene	selective estrogen receptor modulator (SERM)	ESR1, ESR2	Launched
BAZ2-ICR	bromodomain inhibitor	ZNF215	Preclinical
BC-11	urokinase inhibitor	PLAU	Preclinical
BCI-540	glutamate receptor agonist		Phase 2
BCTC	TRPV antagonist	TRPV1	Preclinical
BCX-1470	serine protease inhibitor, complement inhibitor	CFD	Phase 1
BD-1008	sigma receptor antagonist		Preclinical
BD-1047	adrenergic receptor antagonist	SIGMAR1	Preclinical
BD-1063	sigma receptor antagonist	SIGMAR1	Preclinical
BE-2254	adrenergic receptor antagonist	ADRA1A	Phase 2
beclamide	anticonvulsant		Launched
beclomethasone	glucocorticoid receptor agonist	NR3C1, SERPINA6	Launched
beclomethasone-dipropionate	glucocorticoid receptor agonist	GPR97, NR3C1	Launched
bedaquiline	ATPase inhibitor		Launched
befuraline			Phase 2
begacestat	gamma secretase inhibitor	PSEN1	Phase 1
bekanamycin	bacterial 30S ribosomal subunit inhibitor		Launched
belinostat	HDAC inhibitor	HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9	Launched
bemegride	chemoreceptor agonist	GABRA1	Launched
bemesetron	serotonin receptor antagonist	HTR3A, HTR3B	Phase 3
bemotrizinol			Launched
benaxibine			Phase 1
benazepril	angiotensin converting enzyme inhibitor	ACE	Launched
bendamustine	DNA inhibitor		Launched
bendazac	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
bendroflumethiazide	sodium/potassium/chloride transporter inhibitor	CA1, CA2, CA4, KCNMA1, SLC12A1, SLC12A3	Launched
benethamine			Preclinical
benfluorex	gluconeogenesis inhibitor	HMGCR	Withdrawn
benfluralin		CYP1A1, CYP1A2, CYP2B6, CYP3A4, ESR1, MMP1, SULT2A1, UGT1A1	Phase 3
benfotiamine	antioxidant	AGER	Launched
benidipine	calcium channel blocker	CACNA1C, CACNA1G	Launched
benperidol	dopamine receptor antagonist	DRD2	Launched
benproperine	antitussive	SCN5A	Launched
benserazide	DOPA decarboxylase inhibitor	DDC	Launched
bentazepam	benzodiazepine receptor agonist		Launched
bentiromide		HPN	Launched
benurestat	urease inhibitor		Phase 1
benzalkonium	Cationic surfactant		Launched
benzamil	sodium channel blocker	ASIC1, PKD2L1, SCNN1A, SCNN1B, SCNN1D, SCNN1G, SLC8A1	Phase 2
benzbromarone	chloride channel blocker	ABCC1	Launched
benzenemethanol,-2,5-dimethyl-[[(1-methylethyl)amino]methyl]			Preclinical
benzethonium	sodium channel blocker	SCN10A	Launched
benznidazole	DNA synthesis inhibitor		Launched
benzo[d]thiazole-2(3h)-thione			Phase 1
benzocaine	sodium channel blocker	SCN10A	Launched
benzoclidine			Preclinical
benzofenac			Phase 1
benzoic-acid	food preservative	DAO, HRSP12, PRDX5, RAB9A	Launched
benzoin		CES1	Preclinical
benzonatate	local anesthetic	SCN5A	Launched
benzoquinonium-dibromide	cholinergic receptor antagonist	CHRNA1	Preclinical
benzotript	CCK receptor antagonist	CCKAR, CCKBR	Phase 1
benzoxiquine	antiinfective drug		Preclinical
benzoyl-peroxide	oxidizing agent		Launched
benzoylpas			Preclinical
benzthiazide	carbonic anhydrase inhibitor	CA1, CA12, CA2, CA4, CA9, SLC12A3	Launched
benztropine-mesylate	acetylcholine receptor antagonist	CHRM1, HRH1, SLC6A3	Launched
benzydamine	prostanoid receptor antagonist		Launched
benzyl-alcohol	local anesthetic		Launched
benzyl-benzoate	lipase inhibitor	LIPE	Launched
benzyl-isothiocyanate	methylazoxymethanol acetate inhibitor		Preclinical
benzyldimethylhexadecylammonium	cationic surfactant		Preclinical
benzyldimethyloctylammonium			Preclinical
benzylpenicillin	penicillin binding protein inhibitor		Launched
bephenium-hydroxynaphthoate	anthelmintic agent		Launched
bepotastine	histamine receptor antagonist	HRH1	Launched
bepridil	calcium channel blocker	ATP1A1, CACNA1A, CACNA1H, CACNA2D2, CALM1, KCNQ1, KCNQ4, PDE1A, PDE1B, TNNC1	Launched
berberine	LDL receptor activator	LDLR	Phase 2/Phase 3
bergapten			Preclinical
bergenin	interleukin inhibitor	IL1B, TNF	Preclinical
besifloxacin	bacterial DNA gyrase inhibitor		Launched
BET-BAY-002	bromodomain inhibitor		Preclinical
beta-amyloid-synthesis-inhibitor	beta amyloid synthesis inhibitor	APP	Preclinical
beta-carotene			Launched
beta-CCB	benzodiazepine receptor ligand	GABRA1, GABRG2	Launched
beta-elemene	apoptosis stimulant	MMP2, MMP9	Launched
beta-funaltrexamine	opioid receptor antagonist	OPRD1, OPRK1, OPRM1	Preclinical
beta-glycerophosphoric-acid			Preclinical
beta-hydroxy-beta-methylbutyrate	protein synthesis stimulant	MTOR	Phase 2/Phase 3
beta-Hydroxybutyrate		HCAR2	Phase 1
beta-lapachone	topoisomerase inhibitor	TOP1	Phase 2
beta-naphthol			Preclinical
betahistine	histamine receptor agonist, histamine receptor antagonist	HRH1, HRH3	Launched
betaine	nitric oxide donor		Launched
betamethasone	glucocorticoid receptor agonist	NR3C1	Launched
betamethasone-acetate	glucocorticoid receptor agonist	NR3C1	Launched
betamethasone-dipropionate	anti-inflammatory agent		Launched
betamethasone-valerate	glucocorticoid receptor agonist	NR3C1	Launched
betamipron	panipenem uptake inhibitor		Launched
betaxolol	adrenergic receptor antagonist	ADRB1, ADRB2	Launched
betazole	histamine receptor agonist	HRH2	Launched
bethanechol	acetylcholine receptor agonist	CHRM1, CHRM2, CHRM3, CHRM4	Launched
BETP	glucagon-like peptide receptor positive allosteric modulator	GLP1R	Preclinical
betrixaban	coagulation factor inhibitor	KCNH2	Launched
betulinic-acid	apoptosis stimulant, NFkB pathway inhibitor	GPBAR1	Phase 1/Phase 2
bevantolol	adrenergic receptor antagonist	ADRA1A, ADRB1, ADRB2	Launched
bevirimat-dimeglumine	HIV capsid assembly inhibitor		Phase 2
bexarotene	retinoid receptor agonist	RXRA, RXRB, RXRG	Launched
bezafibrate	PPAR receptor agonist	PPARA, PPARD, PPARG	Launched
BF2.649	histamine receptor antagonist	HRH3	Phase 3
BGT226	PI3K inhibitor	MTOR, PIK3CA, PIK3CB, PIK3CG	Phase 1/Phase 2
BHQ	ATPase inhibitor	ATP2A1	Preclinical
BI-D1870	ribosomal protein inhibitor	RPS6KA1, RPS6KA2, RPS6KA3, RPS6KA6	Preclinical
BI-224436	HIV integrase inhibitor		Phase 1
BI-2536	PLK inhibitor	BRD4, PLK1, PLK2, PLK3	Phase 2
BI-78D3	JNK inhibitor	MAPK8	Preclinical
BI-847325	MEK inhibitor, Aurora kinase inhibitor	AURKA, AURKB, AURKC, MAP2K1, MAP2K2	Phase 1
biapenem	bacterial cell wall synthesis inhibitor		Launched
BIBN4096	calcitonin antagonist	CALCA, CALCRL, RAMP1	Phase 2
BIBR-1532	telomerase inhibitor	TERT	Preclinical
BIBU-1361	EGFR inhibitor	EGFR	Preclinical
BIBX-1382	EGFR inhibitor	EGFR, ERBB2	Phase 1
bicalutamide	androgen receptor antagonist	AR	Launched
bicifadine	serotonin receptor antagonist, dopamine reuptake inhibitor	DRD2, SLC6A2, SLC6A4	Phase 3
bicuculline-(+)	GABA receptor antagonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, KCNN1	Preclinical
bicuculline-methochloride-(-)	GABA receptor antagonist		Preclinical
bicyclol	NFkB pathway inhibitor	HSPA1A, HSPB1	Launched
bifemelane	acetylcholine release enhancer	MAOA, MAOB	Launched
bifendate			Launched
bifonazole	sterol demethylase inhibitor	CYP2B6	Launched
BIIB021	HSP inhibitor	HSP90AA1	Phase 2
bilastine	histamine receptor antagonist	HRH1	Launched
bilobalide	GABA receptor modulator	GLRA1, GLRA2, GLRB, HTR3A, HTR3B	Preclinical
bimatoprost	prostanoid receptor agonist	AKR1C3, PTGER1, PTGER3, PTGFR	Launched
BIMU-8	serotonin receptor agonist	HTR4	Preclinical
BINA	glutamate receptor positive allosteric modulator	GRM2	Preclinical
bindarit	NFkB pathway inhibitor	CCL2, CCL7, CCL8	Phase 2
BIO-1211	integrin antagonist	ITGA4, ITGB1	Phase 2
BIO-5192	integrin inhibitor	ITGA4, ITGB1	Preclinical
biotin	vitamin B	ACACA, ACACB, HLCS, MCCC1, MCCC2, PC, PCCA, PCCB, SLC5A6	Launched
bipenamol	dipeptidyl peptidase inhibitor	CTSC	Phase 2
biperiden	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2	Launched
birinapant	XIAP inhibitor	BIRC2, XIAP	Phase 2
BIRT-377	lymphocyte function-associated antigen negative modulator	ICAM1	Preclinical
bis(maltolato)oxovanadium(IV)	tyrosine phosphatase inhibitor	PTPN1	Phase 2
bisacodyl	laxative		Launched
bisindolylmaleimide-ix	PKC inhibitor	AKT1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SIRT1	Preclinical
bismuth(iii)-trifluoromethanesulfonate	direct substitution catalyst		Preclinical
bismuth-oxalate			Preclinical
bismuth-subcitrate-potassium			Launched
bismuth-subgallate	nitric oxide synthase inhibitor	NOS1	Launched
bismuth-subsalicylate	antacid		Launched
bisoctrizole			Phase 2
bisoprolol	adrenergic receptor antagonist	ADRB1, ADRB2	Launched
bisphenol-a	synthetic estrogen	AR, ESR1, ESR2, ESRRG, PPARG	Phase 1
bithionol	autotaxin inhibitor	ESR1, ESR2, MCL1	Withdrawn
bitopertin	glycine transporter inhibitor, GlyT-1 inhibitor	SLC6A5, SLC6A9	Phase 3
bitoscanate	anthelmintic agent		Preclinical
bivalirudin	thrombin inhibitor	F2	Launched
BIX-01294	histone lysine methyltransferase inhibitor	EHMT1, EHMT2	Preclinical
BIX-02188	MEK inhibitor	MAP2K5	Preclinical
BIX-02189	MEK inhibitor	MAP2K5, MAPK7	Preclinical
BL-5583	hypercalcaemic agent		Preclinical
blebbistatin-(+/-)	ATPase inhibitor	MYH2	Preclinical
blebbistatin-(-)	ATPase inhibitor		Preclinical
bleomycetin	EGFR expression inhibitor		Phase 2
bleomycin	DNA synthesis inhibitor	LIG1, LIG3	Launched
blonanserin	dopamine receptor antagonist, serotonin receptor antagonist	DRD2, HTR2A	Launched
BLU9931	FGFR inhibitor	FGFR4	Preclinical
BML-190	cannabinoid receptor inverse agonist	CNR2	Preclinical
BML-284	WNT agonist		Preclinical
BMS-CCR2-22	CC chemokine receptor antagonist	CCR2	Preclinical
BMS-182874	endothelin receptor antagonist	EDNRA	Phase 2
BMS-191011	potassium channel activator	KCNMA1	Preclinical
BMS-191095	KATP activator, potassium channel agonist		Phase 1
BMS-265246	CDK inhibitor	CDK1, CDK2	Preclinical
BMS-299897	gamma secretase inhibitor		Phase 1
BMS-309403	fatty acid binding protein inhibitor	FABP4	Preclinical
BMS-345541	IKK inhibitor	CHUK, IKBKB	Preclinical
BMS-387032	CDK inhibitor, cell cycle inhibitor, MCL1 inhibitor	CDK2, CDK7, CDK9	Phase 1
BMS-470539	melanocortin receptor agonist	MC1R	Preclinical
BMS-536924	IGF-1 inhibitor	AKT1, CCNE1, CDK2, CYP3A4, ERBB2, IGF1R, KDR, LCK, MAPK1, MET, PDGFRA, PDGFRB	Preclinical
BMS-566419	inosine monophosphate dehydrogenase inhibitor	IMPDH1, IMPDH2	Preclinical
BMS-587101	integrin antagonist	ITGAL, ITGB2	Phase 2
BMS-599626	EGFR inhibitor, protein tyrosine kinase inhibitor	EGFR, ERBB2, ERBB4	Phase 1
BMS-626529	HIV attachment inhibitor		Phase 3
BMS-649	retinoid receptor agonist	RXRA	Preclinical
BMS-688521	leukocyte function-associated antigen receptor antagonist, ICAM1 antagonist	ICAM1	Preclinical
BMS-690514	EGFR inhibitor, VEGFR inhibitor	EGFR, ERBB2, FLT3, KDR	Phase 2
BMS-707035	HIV integrase inhibitor		Phase 2
BMS-754807	IGF-1 inhibitor	AKT1, IGF1R	Phase 2
BMS-777607	AXL kinase inhibitor, c-Met inhibitor, FLT3 inhibitor, hepatocyte growth factor receptor inhibitor, macrophage migration inhibiting factor inhibitor, tyrosine kinase inhibitor	AXL, MERTK, MET, MST1R, TYRO3	Phase 1/Phase 2
BMS-806	HIV attachment inhibitor		Phase 1
BMS-817378	c-Met inhibitor, VEGFR inhibitor	KDR, MET	Phase 1
BMS-833923	smoothened receptor antagonist	SMO	Phase 2
BMS-863233	CDC inhibitor	CDC7, PIM1	Phase 1/Phase 2
BMS-927711	calcitonin antagonist	CALCA	Phase 2
BMS-983970	notch signaling inhibitor		Phase 1
BMS-986020	lysophosphatidic acid receptor antagonist	LPAR1	Phase 2
BMY-14802	sigma receptor antagonist	HTR1A	Phase 2
BMY-45778	IP1 prostacyclin receptor agonist	PTGIR	Preclinical
BMY-7378	adrenergic receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA1D, HTR1A	Preclinical
BNC105	tubulin polymerization inhibitor		Phase 2
BNTX	opioid receptor antagonist	OPRD1, OPRK1, OPRM1	Preclinical
boceprevir	HCV inhibitor	CMA1, CTSA, CTSF, CTSK, CTSL, CTSS	Launched
bonaphthone			Phase 3
bopindolol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3, HTR1A, HTR1B	Launched
bornyl-acetate			Preclinical
boronophenylalanine			Phase 2
bortezomib	NFkB pathway inhibitor, proteasome inhibitor	PSMA1, PSMA2, PSMA3, PSMA4, PSMA5, PSMA6, PSMA7, PSMA8, PSMB1, PSMB10, PSMB11, PSMB2, PSMB3, PSMB4, PSMB5, PSMB6, PSMB7, PSMB8, PSMB9, PSMD1, PSMD2, RELA	Launched
bosentan	endothelin receptor antagonist	EDNRA, EDNRB	Launched
bosutinib	Abl kinase inhibitor, Bcr-Abl kinase inhibitor, src inhibitor	ABL1, BCR, CAMK1D, CAMK2G, CDK2, FRK, FYN, HCK, LYN, MAP2K1, MAP2K2, MAP3K2, MAP4K5, SRC, STK10, STK24, STK4, TNK2, TXK	Launched
BP-554	serotonin receptor agonist	HTR1A	Preclinical
BP-897	dopamine receptor agonist	ADRA1A, ADRA1D, ADRA2A, DRD1, DRD2, DRD3, DRD4, HTR1A, HTR2B	Phase 2
BQ-123	endothelin receptor antagonist	EDNRA	Phase 2
BQ-788	endothelin receptor antagonist	EDNRB	Phase 1
BQU57	Ras GTPase inhibitor	RALA, RALB	Preclinical
BRD-7389	ribosomal protein inhibitor	RPS6KA1, RPS6KA2, RPS6KA3	Preclinical
BRD-9876	kinesin inhibitor	KIF11	Preclinical
BRD4770	histone lysine methyltransferase inhibitor	EHMT2	Preclinical
brefeldin-a	protein synthesis inhibitor	ARF1, CYTH2	Preclinical
bremelanotide	melanocortin receptor agonist	MC1R, MC2R, MC3R, MC4R, MC5R	Phase 3
brequinar	dihydroorotate dehydrogenase inhibitor	DHODH	Phase 2
bretazenil	GABA benzodiazepine site receptor partial agonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6	Phase 2
bretylium	norepinephrine inhibitor	ATP1A1	Launched
brexpiprazole	dopamine receptor partial agonist	DRD2	Launched
briciclib	cyclin D inhibitor	CCND1	Phase 1
brigatinib	ALK tyrosine kinase receptor inhibitor, EGFR inhibitor	ALK, EGFR	Launched
brilliant-green			Launched
brimonidine	adrenergic receptor agonist	ADRA2A, ADRA2B, ADRA2C	Launched
brinzolamide	carbonic anhydrase inhibitor	CA1, CA12, CA14, CA2, CA4, CA5A, CA7	Launched
brivanib	FGFR inhibitor, VEGFR inhibitor	CYP3A4, FGFR1, FLT1, KCNH2, KDR	Phase 3
brivanib-alaninate	FGFR inhibitor, VEGFR inhibitor	FGFR3	Phase 3
brivaracetam	voltage-gated sodium channel blocker	SV2A	Launched
brivudine	DNA directed DNA polymerase inhibitor		Launched
BRL-15572	serotonin receptor antagonist	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR6	Preclinical
BRL-26314	cholesterol inhibitor	LPL	Phase 1
BRL-37344	adrenergic receptor agonist	ADRB1, ADRB2, ADRB3	Phase 2
BRL-44408	adrenergic receptor antagonist	ADRA2A, ADRA2B, ADRA2C	Preclinical
BRL-50481	phosphodiesterase inhibitor	PDE7A, PDE7B	Preclinical
BRL-52537	opioid receptor agonist	OPRK1	Preclinical
BRL-54443	serotonin receptor agonist	HTR1E, HTR1F	Preclinical
brolitene	muscle relaxant	RYR1	Launched
bromantan	dopamine reuptake inhibitor, serotonin reuptake inhibitor		Launched
bromebric-acid	purine antagonist, DNA synthesis inhibitor		Preclinical
bromfenac	cyclooxygenase inhibitor	PTGS1, PTGS2	Withdrawn
bromhexine	mucolytic agent		Launched
bromindione	anticoagulant		Phase 2
bromocriptine	dopamine receptor agonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR6, HTR7	Launched
bromopride	dopamine receptor antagonist	DRD2	Launched
bromosporine	bromodomain inhibitor		Preclinical
bromperidol	dopamine receptor antagonist	DRD2	Launched
brompheniramine	histamine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1	Launched
bronopol			Launched
bropirimine	interferon inducer		Phase 3
broxaldine			Preclinical
broxaterol	adrenergic receptor agonist	ADRB2	Phase 3
broxuridine	antimetabolite		Phase 2
broxyquinoline	antiprotozoal agent		Phase 1
bruceantin	protein synthesis inhibitor		Phase 2
brucine	glycine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Preclinical
bryostatin-1	protein kinase C inhibitor	PRKCE	Phase 2
BS-181	CDK inhibitor	CDK7	Preclinical
BTB06584	ATPase inhibitor	ATP5F1	Preclinical
BTB1	mitotic kinesin inhibitor	KIF18A	Preclinical
BTS			Preclinical
BTS-54505	dopamine reuptake inhibitor	SLC6A2, SLC6A3, SLC6A4	Withdrawn
BTS-72664	GABA receptor antagonist	GABBR1	Phase 1
BTT-3033	integrin inhibitor	ITGA2, ITGB1	Preclinical
BTZ043-racemate	DPRE1 inhibitor		Preclinical
BU-224	imidazoline receptor ligand	MAOA, MAOB	Preclinical
BU-239	imidazoline receptor ligand, imidazoline receptor agonist		Preclinical
bucetin	analgesic agent		Withdrawn
bucillamine	immunosuppressant		Launched
bucladesine	adenosine receptor agonist, cAMP stimulant	PRKACA	Launched
buclizine	histamine receptor antagonist	CHRM1, HRH1	Launched
budesonide	glucocorticoid receptor agonist	NR3C1	Launched
budipine	glutamate receptor antagonist	GRIN1	Launched
bufexamac	cyclooxygenase inhibitor	HDAC10, HDAC6	Withdrawn
buflomedil	adrenergic receptor antagonist, calcium channel blocker	ADRA1A	Launched
bumetanide	solute carrier family member inhibitor	CFTR, GPR35, SLC12A1, SLC12A2, SLC12A4, SLC12A5	Launched
bunazosin	adrenergic receptor antagonist	ADRA1A	Launched
buparlisib	PI3K inhibitor	PIK3CA, PIK3CG	Phase 3
buparvaquone	antiprotozoal agent		Launched
buphenine	adrenergic receptor agonist	ADRB2	Launched
bupicomide	adrenergic receptor antagonist	ADRB1	Phase 1
bupivacaine	sodium channel blocker	KCNA5, PTGER1, SCN10A, SCN4A	Launched
bupranolol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3	Launched
bupropion	dopamine uptake inhibitor	CHRNA3, SLC6A2, SLC6A3	Launched
buramate	antiepileptic		Preclinical
buspirone	serotonin receptor agonist	DRD2, HTR1A	Launched
busulfan	DNA inhibitor		Launched
butabindide	tripeptidyl peptidase inhibitor	TPP2	Preclinical
butacaine	local anesthetic		Launched
butaclamol	dopamine receptor antagonist	DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR2A	Phase 2
butalbital	GABA receptor antagonist	CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2	Launched
butamben	sodium channel blocker		Withdrawn
butein	EGFR inhibitor, src inhibitor	ACE	Preclinical
butenafine	fungal squalene epoxidase inhibitor	SQLE	Launched
buthionine-sulfoximine	glutathione transferase inhibitor	GCLM	Phase 1
butibufen	cyclooxygenase inhibitor		Withdrawn
butoconazole	bacterial cell wall synthesis inhibitor		Launched
butofilolol	adrenergic receptor antagonist		Phase 2
butorphanol-(+)-tartrate	opioid receptor agonist, opioid receptor antagonist	OPRD1, OPRK1, OPRM1	Launched
butyl-paraben	DNA synthesis inhibitor		Preclinical
butylated-hydroxyanisole	antioxidant		Preclinical
butylated-hydroxytoluene	carbonic anhydrase inhibitor	CA2	Phase 1
butylphthalide	potassium channel antagonist	KCNK2	Launched
butylscopolamine-bromide	cholinergic receptor antagonist		Launched
BU226	imidazoline receptor ligand		Preclinical
BVD-523	MAP kinase inhibitor		Phase 1/Phase 2
BVT-2733	11-beta hydroxysteroid dehydrogenase inhibitor	HSD17B1	Preclinical
BVT-948	tyrosine phosphatase inhibitor	PTPN1, PTPN11, PTPN2	Preclinical
BW-A4C	lipoxygenase inhibitor	ALOX5	Phase 1
BW-B70C	lipoxygenase inhibitor	ALOX5	Preclinical
BW-180C	opioid receptor agonist	OPRD1, OPRM1	Phase 2
BW-373U86	opioid receptor agonist	OPRD1	Preclinical
BW-616U	monoamine oxidase inhibitor	MAOA	Preclinical
BW-723C86	serotonin receptor agonist	HTR2A, HTR2B, HTR2C	Preclinical
BX-795	IKK inhibitor	CDK2, CHEK1, GSK3B, KDR, PDK1, PDPK1	Preclinical
BX-912	pyruvate dehydrogenase kinase inhibitor	CDK2, CHEK1, GSK3B, KDR, PDK1, PDPK1	Preclinical
BYK-204165	PARP inhibitor	PARP1	Preclinical
C-021	CC chemokine receptor antagonist	CCR4	Preclinical
C-1	protein kinase inhibitor	PRKCA	Preclinical
C-751			Preclinical
cabagin			Launched
cabaletta	pharmacological chaperone		Phase 2
cabazitaxel	microtubule inhibitor	TUBA4A, TUBB, TUBB1	Launched
cabergoline	dopamine receptor agonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR7	Launched
cabotegravir	HIV integrase inhibitor		Phase 2/Phase 3
cabozantinib	RET tyrosine kinase inhibitor, VEGFR inhibitor	KDR, MET	Launched
CaCCinh-A01	calcium-activated chloride channel inhibitor	CLCA1	Preclinical
cadralazine	adrenergic receptor antagonist		Launched
cafestol	pregnane X receptor agonist		Launched
caffeic-acid	HIV integrase inhibitor, lipoxygenase inhibitor, nitric oxide production inhibitor, tumor necrosis factor production inhibitor	ALOX5, MIF	Preclinical
caffeic-acid-phenethyl-ester	HIV integrase inhibitor	RELA	Preclinical
caffeine	adenosine receptor antagonist, phosphodiesterase inhibitor	ADORA1, ADORA2A, ADORA2B, ADORA3, ATM, ITPR1, ITPR2, ITPR3, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, PIK3CA, PIK3CB, PIK3CD, PRKDC, RYR1, RYR2, RYR3	Launched
calcifediol	vitamin D receptor agonist	VDR	Launched
calcipotriol	vitamin D receptor agonist	VDR	Launched
calcitriol	vitamin D receptor agonist	VDR	Launched
calcium-gluceptate			Launched
calcium-levofolinate			Launched
Calhex-231	calcium sensing receptor negative allosteric modulator	CASR	Preclinical
calpeptin	calpain inhibitor		Preclinical
camicinal	motilin receptor agonist	MLNR	Phase 2
CaMKII-IN-1	calcium/calmodulin dependent protein kinase inhibitor	AKT1, CAMK2A, CAMK4, MYLK	Preclinical
camostat-mesilate	protease inhibitor	PRSS1	Launched
camphor-(+)		TRPV1	Phase 2
camphor-(1r)	TRPV activator		Phase 1
camptothecin	topoisomerase inhibitor	TOP1	Phase 3
camylofine-chlorhydrate			Launched
canagliflozin	sodium/glucose cotransporter inhibitor	SLC5A1, SLC5A2	Launched
candesartan	angiotensin receptor antagonist	AGTR1	Launched
candesartan-cilextil	angiotensin receptor antagonist	AGTR1, AGTR2	Launched
candicidin	fungal ergosterol inhibitor		Launched
canertinib	EGFR inhibitor	AKT1, EGFR, ERBB2, ERBB4	Phase 3
canrenone	mineralocorticoid receptor antagonist	NR3C2	Withdrawn
cantharidin	protein phosphatase inhibitor		Launched
capadenoson	adenosine receptor agonist	ADORA1	Phase 2
capecitabine	DNA synthesis inhibitor, thymidylate synthase inhibitor	TYMS	Launched
capobenic-acid			Preclinical
capreomycin	protein synthesis inhibitor		Launched
caprylic-acid			Launched
capsaicin	TRPV agonist	CFTR, TRPV1	Launched
capsazepine	TRPV agonist	TRPV1, TRPV4	Preclinical
captamine			Preclinical
captan			Phase 1
captopril	angiotensin converting enzyme inhibitor	ACE, LTA4H, MMP2, MMP9	Launched
caracemide	ribonucleotide reductase inhibitor	RRM1	Phase 2
caramiphen	cholinergic receptor antagonist	CHRM1, CHRM2	Launched
carazolol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3	Launched
carbachol	cholinergic receptor agonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2	Launched
carbadox	other antibiotic		Launched
carbamazepine	carboxamide antiepileptic	SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	Launched
carbaril	acetylcholinesterase inhibitor		Launched
carbarsone	antiprotozoal agent		Launched
carbazochrome			Launched
carbendazim	microtubule inhibitor, tubulin polymerization inhibitor	TP53, TUBB	Launched
carbenicillin	bacterial cell wall synthesis inhibitor		Launched
carbenoxolone	11-beta hydroxysteroid dehydrogenase inhibitor	GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, HSD11B1, PANX1, PANX2, PANX3	Launched
carbetapentane	acetylcholine receptor antagonist	CHRM2	Launched
carbetocin	oxytocin receptor agonist	OXTR	Launched
carbidopa	aromatic L-amino acid decarboxylase inhibitor	DDC	Launched
carbimazole	antithyroid agent	TPO	Launched
carbinoxamine	histamine receptor antagonist	HRH1	Launched
carboplatin	DNA alkylating agent, DNA inhibitor		Launched
carboxyamidotriazole	calcium channel blocker	CXCL8	Phase 3
carboxylosartan	angiotensin antagonist	AGTR1	Phase 1
carboxypyridine-disulfide			Phase 2
cardiogenol-c	cardiomyogenesis inducer		Preclinical
cardionogen-1	WNT signaling inhibitor	CTNNB1	Preclinical
carebastine	histamine receptor antagonist	HRH1	Phase 1
carfilzomib	proteasome inhibitor	PSMA1, PSMA2, PSMA3, PSMA4, PSMA5, PSMA6, PSMA7, PSMA8, PSMB1, PSMB10, PSMB11, PSMB2, PSMB3, PSMB4, PSMB5, PSMB6, PSMB7, PSMB8, PSMB9	Launched
carglumic-acid	carbamoyl phosphate synthase activator	CPS1	Launched
caricotamide	NADPH quinone oxidoreductase inhibitor	NQO2	Phase 2
cariporide	sodium/hydrogen exchanger inhibitor	SLC9A1	Phase 3
cariprazine	dopamine receptor antagonist	DRD2, DRD3	Launched
carisoprodol	acetylcholine receptor antagonist	CYP2C19	Launched
carmofur	thymidylate synthase inhibitor	TYMS	Launched
carmoterol	adrenergic receptor agonist	ADRB2	Phase 2
carmoxirole	dopamine receptor agonist	DRD2	Phase 2
carmustine	DNA alkylating agent, DNA inhibitor	GSR	Launched
carnitine-(D/L)			Phase 3
carnosine	antiglycating agent		Phase 2
caroverine	glutamate receptor antagonist, calcium channel blocker		Launched
caroxazone	monoamine oxidase inhibitor	MAOA, MAOB	Withdrawn
carprofen	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
carsalam	analgesic agent		Preclinical
carteolol	adrenergic receptor antagonist	ADRB1, ADRB2	Launched
carumonam	bacterial cell wall synthesis inhibitor		Launched
carvedilol	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, GJA1, HIF1A, KCNH2, NDUFC2, NPPB, SELE, VCAM1, VEGFA	Launched
carzenide		CA1, CA12, CA14, CA2, CA6, CA9	Preclinical
casanthranol-variant			Launched
casin	GTPase inhibitor	CDC42	Preclinical
caspofungin	fungal 1,3-beta-D-glucan synthase inhibitor, bacterial cell wall synthesis inhibitor		Launched
caspofungin-acetate	fungal 1,3-beta-D-glucan synthase inhibitor		Launched
castanospermine	glucosidase inhibitor	GAA, GBA	Phase 2
catharanthine	tubulin polymerization inhibitor		Preclinical
cathepsin-inhibitor-1	cathepsin inhibitor	CTSB, CTSL, CTSV	Preclinical
CAY10505	PI3K inhibitor	PIK3CG	Preclinical
CB-03-01	androgen receptor antagonist	AR	Phase 3
CB-10-277	DNA synthesis inhibitor		Phase 1
CB-5083	valosin-containing protein inhibitor	VCP	Phase 1
CB-839	glutaminase inhibitor	GLS	Phase 1/Phase 2
CBiPES	glutamate receptor positive allosteric modulator	GRM2	Preclinical
CBS,-N-Cyclohexyl-2-benzothiazolesulfenamide			Preclinical
CBS-1114	lipoxygenase inhibitor	ALOX5	Phase 1
CC-115	mTOR inhibitor, DNA protein kinase inhibitor	MTOR	Phase 1
CC-223	mTOR inhibitor	MTOR	Phase 1/Phase 2
CC-401	JNK inhibitor	MAPK8	Phase 1
CC-930	JNK inhibitor		Phase 2
CCG-1423	apoptosis stimulant	RHOC, SRF	Preclinical
CCG-50014	G protein signaling inhibitor	RGS4, RGS8	Preclinical
CCG-63802	G protein signaling inhibitor	RGS4	Preclinical
CCG-63808	G protein signaling inhibitor	RGS4	Preclinical
CCMI	acetylcholine receptor allosteric modulator	CHRNA7	Preclinical
CCMQ	homoquinolinic acid binding inhibitor		Preclinical
CCT-031374	WNT signaling inhibitor	CTNNB1	Preclinical
CCT018159	HSP inhibitor	HSP90AA1, HSP90AB1	Preclinical
CCT128930	AKT inhibitor	PKIA, PRKACA	Preclinical
CCT129202	Aurora kinase inhibitor	AURKA, AURKB, AURKC	Preclinical
CCT137690	Aurora kinase inhibitor	AURKA, AURKB, AURKC	Preclinical
CC4	nicotinic receptor agonist	CHRNB2	Preclinical
CD-1530	retinoid receptor agonist	RARG	Preclinical
CD-437	retinoid receptor agonist	RARG	Preclinical
CDBA			Phase 3
CDK1-5-inhibitor	CDK inhibitor, glycogen synthase kinase inhibitor	CDK1, CDK5, GSK3B	Preclinical
CDK9-IN-6	CDK inhibitor	CDK9	Preclinical
CDPPB	glutamate receptor positive allosteric modulator	GRM5	Preclinical
cebranopadol	opioid receptor agonist	OPRL1, OPRM1	Phase 3
cediranib	KIT inhibitor, VEGFR inhibitor	CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB	Phase 3
cedrol			Phase 2
cedrol-(+)	sedative		Phase 2
cefaclor	bacterial cell wall synthesis inhibitor		Launched
cefadroxil	bacterial cell wall synthesis inhibitor	SLC15A1, SLC15A2, SLC22A6, SLC22A8	Launched
cefalonium	bacterial cell wall synthesis inhibitor		Launched
cefamandole	bacterial cell wall synthesis inhibitor		Launched
cefamandole-nafate	bacterial cell wall synthesis inhibitor		Launched
cefathiamidine	bacterial cell wall synthesis inhibitor		Launched
cefazolin	bacterial cell wall synthesis inhibitor	PON1	Launched
cefcapene-pivoxil	bacterial cell wall synthesis inhibitor		Launched
cefdinir	bacterial cell wall synthesis inhibitor	MPO	Launched
cefditoren-pivoxil	bacterial cell wall synthesis inhibitor		Launched
cefepime	bacterial cell wall synthesis inhibitor		Launched
cefetamet	bacterial cell wall synthesis inhibitor		Launched
cefetamet-pivoxil	bacterial cell wall synthesis inhibitor		Launched
cefixime	bacterial cell wall synthesis inhibitor		Launched
cefmenoxime	bacterial cell wall synthesis inhibitor		Launched
cefmetazole	bacterial cell wall synthesis inhibitor		Launched
cefminox	bacterial cell wall synthesis inhibitor		Launched
cefodizime	bacterial cell wall synthesis inhibitor		Launched
cefonicid	bacterial cell wall synthesis inhibitor		Launched
cefoperazone	bacterial cell wall synthesis inhibitor		Launched
ceforanide	penicillin binding protein inhibitor		Launched
cefoselis	bacterial cell wall synthesis inhibitor		Launched
cefotaxime	bacterial cell wall synthesis inhibitor		Launched
cefotetan	bacterial cell wall synthesis inhibitor		Launched
cefotiam	bacterial cell wall synthesis inhibitor		Launched
cefotiam-cilexetil	bacterial cell wall synthesis inhibitor		Launched
cefoxitin	bacterial cell wall synthesis inhibitor		Launched
cefozopran	bacterial cell wall synthesis inhibitor		Launched
cefpiramide	bacterial cell wall synthesis inhibitor		Launched
cefpirome	bacterial cell wall synthesis inhibitor		Launched
cefpodoxime	bacterial cell wall synthesis inhibitor		Launched
cefprozil	bacterial cell wall synthesis inhibitor		Launched
cefradine	bacterial cell wall synthesis inhibitor	CYP3A4	Launched
cefsulodin	bacterial cell wall synthesis inhibitor		Launched
ceftaroline-fosamil	bacterial cell wall synthesis inhibitor		Launched
ceftazidime	bacterial cell wall synthesis inhibitor		Launched
ceftibuten	bacterial cell wall synthesis inhibitor		Launched
ceftiofur	bacterial cell wall synthesis inhibitor		Launched
ceftizoxim	bacterial cell wall synthesis inhibitor		Launched
ceftriaxone	bacterial cell wall synthesis inhibitor		Launched
cefuroxime	bacterial cell wall synthesis inhibitor		Launched
cefuroxime-axetil	bacterial cell wall synthesis inhibitor		Launched
celecoxib	cyclooxygenase inhibitor	CA12, PDPK1, PTGS2	Launched
celiprolol	adrenergic receptor antagonist	ADRA2A, ADRB1, ADRB2	Launched
centazolone	monoamine oxidase inhibitor		Phase 1
centpropazine	inositol monophosphatase inhibitor		Phase 3
CEP-32496	RAF inhibitor	BRAF, RAF1	Phase 1/Phase 2
CEP-33779	JAK inhibitor	JAK2	Preclinical
CEP-37440	ALK tyrosine kinase receptor inhibitor	ALK	Phase 1
cephalexin	bacterial cell wall synthesis inhibitor		Launched
cephalomannine	DNA polymerase inhibitor		Preclinical
cephalosporin-c-zn	bacterial cell wall synthesis inhibitor		Preclinical
cephalothin	bacterial cell wall synthesis inhibitor		Launched
cephapirin	bacterial cell wall synthesis inhibitor		Launched
cepharanthine	NFkB pathway inhibitor		Phase 2
cephradine	bacterial cell wall synthesis inhibitor		Launched
ceramide	phosphoenolpyruvate carboxylase activator, serine/threonine protein phosphatase activator		Launched
ceritinib	ALK tyrosine kinase receptor inhibitor	ALK, FLT3, IGF1R, INSR, TSSK1B	Launched
cerulenin	fatty acid synthase inhibitor	FASN	Launched
cetaben	cholesterol inhibitor, ACAT inhibitor	PPARA	Phase 2
cetilistat	triacylglycerol lipase inhibitor	PNLIP	Phase 3
cetirizine	histamine receptor antagonist	HRH1	Launched
cetrimonium			Launched
cetrorelix	gonadotropin releasing factor hormone receptor antagonist	GNRHR, LHCGR	Launched
cetylpyridinium			Launched
cevimeline	acetylcholine receptor agonist	CHRM1, CHRM3	Launched
cevipabulin	microtubule stimulant, tubulin polymerization inhibitor	TUBB	Phase 1
CE3F4	rap guanine nucleotide exchange factor inhibitor	RAPGEF3	Preclinical
CFM-1571	guanylate cyclase activator		Preclinical
CFM-2	glutamate receptor antagonist		Preclinical
CFTRinh-172	chloride channel blocker	CFTR	Preclinical
CF102	adenosine receptor agonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Phase 2
CG-400549	FABI inhibitor		Phase 2
CGH2466	adenosine receptor antagonist	ADORA1, ADORA2B, ADORA3	Preclinical
CGK-733	ATM kinase inhibitor, ATR kinase inhibitor	ATM, ATR	Preclinical
CGM097	MDM inhibitor	MDM2	Phase 1
CGP-12177	adrenergic receptor agonist	ADRB1, ADRB2, ADRB3	Phase 1
CGP-13501	GABA receptor modulator	GABBR1	Preclinical
CGP-20712A	adrenergic receptor antagonist	ADRB1, ADRB3	Preclinical
CGP-37157	mitochondrial Na+/Ca2+ exchanger antagonist, sodium/calcium exchange inhibitor	SLC8A1	Preclinical
CGP-37849	glutamate receptor antagonist	GRIN2A, GRIN2B, GRIN2C, GRIN2D	Phase 1
CGP-52411	EGFR inhibitor	EGFR	Preclinical
CGP-53353	EGFR inhibitor, PKC inhibitor	EGFR, PRKCB	Preclinical
CGP-54626	GABA receptor antagonist	GABBR1, GABBR2, KCTD12, KCTD16, KCTD8	Preclinical
CGP-55845	GABA receptor antagonist	GABBR1, GABBR2, KCTD12, KCTD16, KCTD8	Preclinical
CGP-57380	MAP kinase inhibitor	AURKB, LCK, MKNK1, MKNK2, SGK1	Preclinical
CGP-60474	CDK inhibitor	CDK1, CDK2	Preclinical
CGP-71683	neuropeptide receptor antagonist	NPY5R	Preclinical
CGP-74514	CDK inhibitor	CDK1	Preclinical
CGP-78608	glutamate receptor antagonist		Preclinical
CGP-7930	GABA receptor modulator	GABBR1	Preclinical
CGS-15943	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Preclinical
CGS-20625	benzodiazepine receptor agonist, GABA benzodiazepine site receptor partial agonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6	Phase 1
CGS-21680	adenosine receptor agonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Preclinical
CGS-9896	GABA receptor antagonist	GABRA1, GABRB2, GABRG2	Preclinical
CH-170			Phase 1
CH-5183284	fibroblast growth factor inhibitor	FGFR1, FGFR2, FGFR3	Phase 1
CHC	monocarboxylate transporter inhibitor	SLC16A1	Preclinical
chenodeoxycholic-acid	11-beta hydroxysteroid dehydrogenase inhibitor, FXR agonist	HSD11B1, NR1H4	Launched
CHF5074	gamma secretase modulator	PSEN1	Phase 2
chicago-sky-blue-6b	glutamate inhibitor, macrophage migration inhibiting factor inhibitor	MIF	Preclinical
chidamide	HDAC inhibitor	HDAC10, HDAC3	Launched
chiniofon	antiprotozoal agent		Launched
CHIR-124	CHK inhibitor	CHEK1	Preclinical
CHIR-98014	glycogen synthase kinase inhibitor	GSK3A, GSK3B	Preclinical
CHIR-99021	glycogen synthase kinase inhibitor	CDK1, GSK3A, GSK3B, MAPK1	Preclinical
chloralose			Preclinical
chlorambucil	DNA inhibitor		Launched
chloramine-t			Launched
chloramphenicol	bacterial 50S ribosomal subunit inhibitor	CD55	Launched
chloramphenicol-palmitate	protein synthesis inhibitor		Launched
chloramphenicol-sodium-succinate	protein synthesis inhibitor		Launched
chlorazanil			Preclinical
chlorcyclizine	histamine receptor antagonist	HRH1	Launched
chlorfenson	other antifungal		Phase 2
chlorhexidine	membrane integrity inhibitor		Launched
chlorindanol			Preclinical
chlorindione			Preclinical
chlorisondamine-diiodide	acetylcholine receptor antagonist	CHRNA1	Preclinical
chlormadinone-acetate	5 alpha reductase inhibitor	PGR	Launched
chlormezanone	GABA receptor modulator	GABRA1, TSPO	Withdrawn
chlormidazole	fungal lanosterol demethylase inhibitor		Launched
chlorobutanol			Launched
chlorocresol	ryanodine receptor activator		Launched
chlorogenic-acid	antioxidant	SLC37A4	Launched
chlorophyllide-cu-complex-na-salt			Preclinical
chlorophyllin			Preclinical
chlorophyllin-copper	cytochrome P450 inhibitor		Phase 1
chloroprocaine	sodium channel blocker	ATP1A1, CHRNA10, GRIN3A, HTR3A, SCN10A, SLC6A3	Launched
chloropyramine	histamine receptor antagonist	HRH1	Launched
chloroquine	antimalarial agent	GSTA2, MRGPRX1, TLR9, TNF	Launched
chlorothiazide	diuretic	CA1, CA2, CA4, SLC12A3	Launched
chlorothymol			Launched
chlorotrianisene	estrogenic hormone	ESR1, ESR2	Launched
chloroxine	opioid receptor antagonist	OPRK1	Launched
chloroxoquinoline			Launched
chloroxylenol	ATP synthase inhibitor		Launched
chlorphenamine	histamine receptor antagonist	HRH1, SLC6A2, SLC6A3, SLC6A4	Launched
chlorphenesin	muscle relaxant		Launched
chlorphensin-carbamate	muscle relaxant		Preclinical
chlorproguanil	dihydrofolate reductase inhibitor	DHFR	Launched
chlorpromazine	dopamine receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CALM1, CHRM1, CHRM3, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HRH4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, HTR7, KCNH2, ORM1, ORM2, SMPD1, TRPC5	Launched
chlorpropamide	ATP channel blocker	ABCC8, KCNJ10, KCNJ11	Launched
chlorpropham	antiviral		Phase 1
chlorprothixene	dopamine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, HRH1, HTR2A, HTR2B, HTR2C	Launched
chlorpyrifos	acetylcholinesterase inhibitor	ACHE	Launched
chlorquinaldol	other antibiotic		Launched
chlortetracycline	protein synthesis inhibitor		Launched
chlorthalidone	carbonic anhydrase inhibitor	CA1, CA12, CA14, CA4, CA7, SLC12A1, SLC12A3	Launched
chlorzoxazone	bacterial 30S ribosomal subunit inhibitor	KCNMA1, KCNN4	Launched
cholecalciferol		VDR	Launched
cholesterol		RORA	Preclinical
cholic-acid	bile acid	ADH1C, CES1, COX4I1, COX5A, COX5B, COX6A2, COX6B1, COX6C, COX7A1, COX7B, COX7C, COX8A, ESRRG, FABP6, FECH, GPBAR1, MT-CO1, MT-CO2, MT-CO3, PLA2G1B	Launched
choline	acetylcholine precursor	ACHE, BCHE, CHRNA2, PCYT1A, PCYT1B, PHOSPHO1, PLD1, PLD2	Phase 3
choline-alfoscerate	acetylcholine precursor	GM2A	Launched
CHPG	glutamate receptor agonist	GRM5	Preclinical
CHR-6494	serine/threonine kinase inhibitor	GSG2	Preclinical
chromanol-(+/-)	potassium channel blocker		Preclinical
chromanol-293B-(-)-[3R,4S]	potassium channel blocker		Preclinical
chromocarb	antispasmodic		Launched
chrysin	breast cancer resistance protein inhibitor	AKR1B1, CDK6, CYP19A1, CYP1B1	Phase 1
chrysophanic-acid	EGFR inhibitor	EGFR, MTOR	Preclinical
chuanxiongzine			Phase 2
CH223191	aryl hydrocarbon receptor antagonist	AHR	Preclinical
CH5132799	PI3K inhibitor	MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG	Phase 1
CH55	retinoid receptor binder	RARA, RARB	Preclinical
CI-844			Phase 2
CI-923	acetylcholine receptor antagonist		Phase 1
CI-966	GAT inhibitor	SLC6A1	Phase 1
CI-976	ACAT inhibitor	ACAT1, CES1	Phase 1
ciaftalan-zinc	reactive oxygen species stimulant		Phase 1
cianidanol	fatty acid synthase inhibitor	PTGS1	Withdrawn
cibenzoline	sodium channel blocker		Launched
ciclesonide	glucocorticoid receptor agonist	NR3C1, SERPINA6	Launched
ciclopirox	membrane integrity inhibitor	ATP1A1	Launched
cicloprofen	cyclooxygenase inhibitor	PTGS1, PTGS2	Preclinical
CID-16020046	G protein-coupled receptor antagonist	GPR55	Preclinical
CID-2011756	protein kinase inhibitor	PKD1	Preclinical
CID-2745687	G protein-coupled receptor antagonist	GPR35	Preclinical
CID-5458317	MAP kinase phosphatase inhibitor	MAPK3	Preclinical
cidofovir	DNA polymerase inhibitor		Launched
ciglitazone	PPAR receptor agonist	PPARG	Phase 2
cilastatin	dehydropeptidase inhibitor	DPEP1	Launched
cilazapril	angiotensin converting enzyme inhibitor	ACE	Launched
cilengitide	integrin antagonist	ITGAV, ITGB3	Phase 3
cilnidipine	calcium channel blocker	CACNA1B	Launched
cilomilast	phosphodiesterase inhibitor	PDE4A, PDE4B, PDE4D	Phase 3
cilostamide	phosphodiesterase inhibitor	PDE3A, PDE3B	Preclinical
cilostazol	phosphodiesterase inhibitor	PDE3A, PDE3B	Launched
CIM-0216	transient receptor potential channel agonist	TRPM3	Preclinical
cimaterol	adrenergic receptor agonist	ADRB1, ADRB2, ADRB3	Preclinical
cimetidine	histamine receptor antagonist	HRH2, SLC29A4, SLC47A1, SLC47A2	Launched
cimetropium	acetylcholine receptor antagonist	CHRM1	Launched
cinacalcet	calcium channel activator	CASR	Launched
cinaciguat	guanylate cyclase activator	GUCY1A3, GUCY1B3	Phase 2
cinalukast	leukotriene receptor antagonist	CYSLTR1	Phase 2
cinanserin	serotonin receptor antagonist	HTR2A	Preclinical
cinchocaine	sodium channel blocker	CALM1, SCN10A, SCN5A	Launched
cinchonidine	P glycoprotein inhibitor		Phase 1
cinchonine	P glycoprotein inhibitor	CYP2D6	Preclinical
cinchophen	analgesic agent		Launched
cinepazet	vasodilator		Launched
cinepazide	calcium channel activator		Withdrawn
cinflumide	muscle relaxant		Phase 2
cinnamaldehyde	aldose reductase inhibitor, TRPV agonist	TRPA1	Preclinical
cinnarazine	calcium channel blocker		Launched
cinoctramide			Preclinical
cinoxacin	topoisomerase inhibitor		Launched
cinoxate			Launched
CINPA-1	CAR antagonist	NR1H4, NR1I3, PPARG	Preclinical
cinromide			Phase 3
cintriamide			Preclinical
cipemastat	metalloproteinase inhibitor	ADAM17, MMP1, MMP13, MMP2, MMP3, MMP8, MMP9	Phase 3
ciprofibrate	PPAR receptor agonist	PPARA	Launched
ciprofloxacin	bacterial DNA gyrase inhibitor	TOP2A	Launched
ciproxifan	histamine receptor antagonist	ADRA2A, ADRA2C, HRH3, HRH4, HTR3A	Preclinical
CIQ	glutamate receptor potentiator	GRIN2C, GRIN2D	Preclinical
cirazoline	adrenergic receptor agonist	ADRA1A	Preclinical
cis-aconitic-acid		ACO2	Preclinical
cis-ACPD	glutamate receptor agonist	GRM2, GRM3, GRM6, GRM7, GRM8	Preclinical
cis-exo-camphanediol-2,3	nitric oxide stimulant	NOS3	Phase 1
cis-urocanic acid	serotonin receptor agonist	HTR2A	Phase 2
cis-urocanic-acid	serotonin receptor agonist	HTR2A	Phase 2
cis-9,trans-11-Conjugated-linoleic-acid			Launched
cisapride	serotonin receptor agonist	HTR2A, HTR3A, HTR4, KCNH2	Withdrawn
cisatracurium	acetylcholine receptor antagonist	CHRNA2	Launched
cisplatin	DNA alkylating agent, DNA synthesis inhibitor	XIAP	Launched
citalopram	selective serotonin reuptake inhibitor (SSRI)	SLC6A2, SLC6A4	Launched
CITCO	constitutive androstane receptor (CAR) agonist	NR1I3	Preclinical
citicoline	membrane permeability enhancer, glutathione transferase stimulant	ACHE, SLC1A2	Launched
citiolone	lipotropic, mucolytic agent		Preclinical
citric-acid	coagulation factor inhibitor	AKR1B1, ANG, APRT, BHMT, C8G, CA4, CPB1, CS, CTDSP1, GNMT, HGS, HS3ST3A1, IL4I1, ITPA, LSM6, MDH2, MIF, PDE5A, PKD2L1, PLEKHA1, RNASE1, RNASE3, SRC, TNFSF13B, UCK2	Preclinical
CJ-033466	serotonin receptor agonist	HTR4	Preclinical
CK-636	actin related protein inhibitor	ACTR2, ACTR3, ARPC1B, ARPC2, ARPC3, ARPC4, ARPC5	Preclinical
CKD-712	NFkB pathway inhibitor	JAK2, STAT1	Phase 1
CKI-7	casein kinase inhibitor	CSNK1G2	Preclinical
CL-218872	benzodiazepine receptor agonist	GABRA1, GABRA2, GABRA3, GABRA5, GABRB2, GABRG2	Phase 1
CL-225385			Phase 2
cladribine	adenosine deaminase inhibitor, ribonucleotide reductase inhibitor	ADA, PNP, POLA1, POLE, POLE2, POLE3, POLE4, RRM1, RRM2, RRM2B	Launched
clarithromycin	bacterial 50S ribosomal subunit inhibitor	CYP3A4	Launched
clavulanate	beta lactamase inhibitor		Launched
clebopride	dopamine receptor antagonist	ACHE, DRD2	Launched
clemastine	histamine receptor antagonist	HRH1	Launched
clemizole	HCV inhibitor		Launched
clenbuterol	adrenergic receptor agonist	ADRB1, ADRB2, ADRB3, NGF, TNF	Launched
cleviprex	calcium channel blocker	CACNA1C, CACNA1D, CACNA1F, CACNA1S	Launched
clevudine	DNA polymerase inhibitor		Launched
clidinium	acetylcholine receptor antagonist	CHRM1, CHRM3	Launched
climbazole	enzyme inducer		Launched
clinafloxacin	bacterial DNA gyrase inhibitor		Phase 3
clindamycin	protein synthesis inhibitor		Launched
clindamycin-palmitate	bacterial 50S ribosomal subunit inhibitor		Launched
clindamycin-phosphate	protein synthesis inhibitor		Launched
clinofibrate	lipase clearing factor inhibitor	LPL	Launched
clioquinol	chelating agent	OPRK1	Withdrawn
clobazam	GABA benzodiazepine site receptor agonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ	Launched
clobenpropit	histamine receptor antagonist	HRH1, HRH2, HRH3, HRH4	Preclinical
clobetasol-propionate	glucocorticoid receptor agonist	NR3C1, PLA2G1B	Launched
clobetasone-butyrate	corticosteroid agonist	NR3C1	Launched
clobutinol	antitussive		Withdrawn
clocortolone-pivalate	steroid	NR3C1, PLA2G1B	Launched
clodronic-acid	bone resorption inhibitor	SLC25A4, SLC25A5, SLC25A6	Launched
clofarabine	ribonucleotide reductase inhibitor	POLA1, POLD1, POLE, RRM1, RRM2, RRM2B	Launched
clofazimine	GK0582 inhibitor		Launched
clofedanol	histamine receptor antagonist	HRH1	Launched
clofibrate	PPAR receptor agonist	LPL, PPARA	Launched
clofibric-acid	PPAR receptor agonist	PPARA	Launched
clofilium	potassium channel blocker	KCNA5, KCNH1	Phase 2
clofoctol	protein synthesis inhibitor		Launched
clomesone	DNA inhibitor		Phase 1
clomethiazole	GABA receptor antagonist, GABA receptor modulator	GABRA1	Launched
clomifene	estrogen receptor antagonist	ESR1	Launched
clomipramine	serotonin transporter (SERT) inhibitor	GSTP1, HTR2A, HTR2B, HTR2C, SLC6A2, SLC6A3, SLC6A4	Launched
clonazepam	GABA benzodiazepine site receptor agonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, TSPO	Launched
clonidine	adrenergic receptor agonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C	Launched
clonixin-lysinate	cyclooxygenase inhibitor		Launched
clopamide	sodium/chloride cotransporter inhibitor		Launched
cloperastine	antitussive		Launched
clopidogrel	purinergic receptor antagonist	P2RY12	Launched
clopidol			Launched
cloprostenol-(+/-)	prostaglandin receptor agonist	PTGDR, PTGER1, PTGER3, PTGFR, TBXA2R	Launched
cloranolol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3	Launched
clorgiline	monoamine oxidase inhibitor	MAOA	Phase 2
clorotepine	dopamine receptor antagonist, adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, DRD2, HRH1, HTR2C, HTR6	Launched
clorprenaline	adrenergic receptor agonist	ADRB1, ADRB2	Launched
clorsulon	glycolysis inhibitor		Launched
closantel	chitinase inhibitor, NFkB pathway inhibitor		Launched
clotiapine			Launched
clotrimazole	cytochrome P450 inhibitor, imidazoline receptor ligand	CYP3A4, KCNN4, NR1I2, NR1I3, TRPM2, TRPM4, TRPM8	Launched
cloxacillin	bacterial cell wall synthesis inhibitor		Launched
cloxyquin	potassium channel activator	KCNK18	Preclinical
clozapine	dopamine receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CALY, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR3A, HTR5A, HTR6, HTR7	Launched
CL316243	adrenergic receptor agonist	ADRB3, UCP1, UCP2, UCP3	Phase 2
CMPD-1	p38 MAPK inhibitor	GNRHR, MAPK14	Preclinical
CNQX	glutamate receptor antagonist	GRIA1, GRIA2, GRIA3, GRIA4	Phase 1
CNX-2006	EGFR inhibitor	EGFR	Preclinical
CNX-774	Bruton's tyrosine kinase (BTK) inhibitor	BTK	Preclinical
CO-101244	glutamate receptor antagonist	GRIN2B	Preclinical
co-102862		SCN4A, SCN9A	Phase 1
cobicistat	cytochrome P450 inhibitor	CYP3A4, CYP3A43, CYP3A5, CYP3A7	Launched
cobimetinib	MEK inhibitor		Launched
coenzyme-a		ACAT2, CRAT, CS, DBI, HMGCR, KAT2A, KAT2B, KAT5	Launched
coenzyme-i		AASS, ACADS, ADH1A, ADH1B, ADH1C, ADH4, ADH5, ADH7, AKR1B1, AKR1C1, AKR1C2, AKR1C3, AKR1C4, ALDH1A1, ALDH1A2, ALDH1A3, ALDH1B1, ALDH2, ALDH3A1, ALDH3A2, ALDH3B1, ALDH3B2, ALDH4A1, ALDH5A1, ALDH6A1, ALDH7A1, ALDH9A1, AMT, BDH1, BLVRA, BLVRB, CDO1, CYB5R3, CYP17A1, CYP4A11, DHCR7, DHFR, DLAT, DLD, EHHADH, GAPDH, GAPDHS, GLUD1, GLUD2, GPD1, GSR, H6PD, HADH, HADHA, HIBADH, HMGCR, HMOX1, HMOX2, HPGD, HSD11B1, HSD11B2, HSD17B1, HSD17B10, HSD17B2, HSD17B3, HSD17B4, HSD17B7, HSD17B8, HSD3B1, HSD3B2, IDH3A, IDH3B, IDH3G, IMPDH1, IMPDH2, LDHA, LDHAL6A, LDHAL6B, LDHB, LDHC, MDH1, MDH2, ME1, ME2, ME3, MSMO1, MT-ND1, MT-ND2, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-ND6, MTHFD1, MTHFD2, NDUFA1, NDUFA10, NDUFA11, NDUFA12, NDUFA13, NDUFA2, NDUFA3, NDUFA4, NDUFA4L2, NDUFA5, NDUFA6, NDUFA7, NDUFA8, NDUFA9, NDUFAB1, NDUFB1, NDUFB10, NDUFB2, NDUFB3, NDUFB4, NDUFB5, NDUFB6, NDUFB7, NDUFB8, NDUFB9, NDUFC1, NDUFC2, NDUFS1, NDUFS2, NDUFS3, NDUFS4, NDUFS5, NDUFS6, NDUFS7, NDUFS8, NDUFV1, NDUFV2, NDUFV3, NNT, NQO2, NSDHL, OGDH, PDHA1, PDHA2, PDHB, PHGDH, PYCR1, PYCR2, QDPR, RDH5, SORD, TSTA3, TYR, UGDH	Phase 2
coenzyme-q10			Launched
colchicine	microtubule inhibitor	GLRA1, GLRA2, TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8	Launched
colesevalam			Preclinical
colforsin	adenylyl cyclase activator	ADCY2, ADCY5	Phase 2
colforsin-daproate	adenylyl cyclase activator		Launched
colfosceril-palmitate	pulmonary surfactant		Launched
colistimethate	bacterial permeability inducer		Launched
colistin	bacterial permeability inducer		Launched
colistin-b-sulfate	bacterial permeability inducer		Launched
colistin-sulfate	bacterial permeability inducer		Launched
combretastatin-A-4	tubulin polymerization inhibitor		Phase 2
compound-w	beta-secretase inhibitor	BACE1	Preclinical
compound-401	DNA dependent protein kinase inhibitor	MTOR, PRKDC	Preclinical
compound-58112			Preclinical
conivaptan	vasopressin receptor antagonist	AVPR1A, AVPR2	Launched
copanlisib	PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG	Launched
copper-histidine		HAL, HARS, HDC, SLC15A3, SLC15A4, SLC38A3, SLC38A5	Phase 3
COR-170	cannabinoid receptor inverse agonist	CNR2	Preclinical
cordycepin	DNA inhibitor		Phase 1/Phase 2
corosolic-acid	PKC inhibitor, protein tyrosine kinase inhibitor	HSD11B1, PTPN1	Phase 2
corticosterone	mineralocorticoid receptor agonist	HSD11B1, NCOA1, NR3C2	Preclinical
cortisone	glucocorticoid receptor agonist	NR3C1	Launched
cortisone-acetate	glucocorticoid receptor agonist	NR3C1	Launched
cortodoxone	androgen receptor antagonist	AR	Phase 3
costunolide	telomerase inhibitor		Preclinical
cot-inhibitor-1	MAPK-interacting kinase inhibitor	MAP3K8	Preclinical
cot-inhibitor-2	MAPK-interacting kinase inhibitor	MAP3K8	Preclinical
cotinine	nicotine metabolite		Phase 2
coumarin	vitamin K antagonist	CA1, CA12, CA14, CA2, CA4, CA6, CA9, CYP2A6	Launched
coumophos	cholinesterase inhibitor		Preclinical
CP-316819	glycogen phosphorylase inhibitor	PYGL	Preclinical
CP-339818	potassium channel blocker	KCNA3	Preclinical
CP-376395	corticosteroid releasing factor receptor antagonist	CRHR1	Phase 1
CP-471474	matrix metalloprotease inhibitor	MMP1, MMP13, MMP2, MMP3, MMP9	Preclinical
CP-532623	cholesteryl ester transfer protein inhibitor	CETP	Phase 1
CP-640186	acetyl-CoA carboxylase inhibitor	ACACA, ACACB	Preclinical
CP-673451	PDGFR tyrosine kinase receptor inhibitor	KIT, PDGFRA, PDGFRB	Preclinical
CP-724714	EGFR inhibitor, protein tyrosine kinase inhibitor	ERBB2	Phase 2
CP-775146	PPAR receptor agonist	PPARA	Preclinical
CP-91149	glycogen phosphorylase inhibitor	PYGL	Preclinical
CP-93129	serotonin receptor agonist	HTR1A	Preclinical
CP-94253	serotonin receptor agonist	HTR1B	Preclinical
CP-945,598	cannabinoid receptor antagonist	CNR1	Phase 3
CP-99994	tachykinin antagonist	TACR1	Phase 2
CPA-inhibitor	carboxypeptidase inhibitor	CPA1, CPA2	Preclinical
CPCCOEt	glutamate receptor antagonist	GRM1	Preclinical
CPI-0610	bromodomain inhibitor	BRD4	Phase 1
CPI-1189	tumor necrosis factor release inhibitor	TNF	Phase 2
CPI-169	histone lysine methyltransferase inhibitor	EZH2	Preclinical
CPI-203	bromodomain inhibitor	BRD4	Preclinical
CPI-360	histone lysine methyltransferase inhibitor	EZH2	Preclinical
CPI-613	pyruvate dehydrogenase inhibitor	PDHA1	Phase 2
CPP	glutamate receptor antagonist	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D	Phase 2
CPSI-1306-(+/-)	macrophage migration inhibiting factor inhibitor	MIF	Preclinical
creatine		CKB, CKM, CKMT1A, CKMT2, GAMT, SLC6A8	Launched
creatinine			Preclinical
creatinol-phosphate			Launched
crenolanib	PDGFR tyrosine kinase receptor inhibitor	CSF1R, FLT3, KIT, PDGFRA, PDGFRB	Phase 2
cresol			Launched
cresopirine			Preclinical
cridanimod	progesterone receptor agonist	PGR	Launched
crisaborole	phosphodiesterase inhibitor	PDE4B	Phase 3
crizotinib	ALK tyrosine kinase receptor inhibitor	ALK, MET	Launched
crizotinib-(S)	MTH1 inhibitor	NUDT1	Preclinical
croconazole	bacterial cell wall synthesis inhibitor		Launched
cromakalim		KCNJ8	Phase 2
cromoglicic-acid	immunosuppressant	KCNMA1, S100P	Launched
crotamiton	antipruritic		Launched
CRT0044876			Preclinical
cryptotanshinone	acetylcholinesterase inhibitor, STAT inhibitor	STAT3	Preclinical
crystal-violet	other antibiotic		Launched
CR8-(R)	CDK inhibitor	CCNA2	Preclinical
CS-110266	dopamine receptor agonist	SLC6A3	Preclinical
CS-917	fructose biphosphate inhibitor	FBP1	Phase 2
CT-7758	integrin antagonist	ITGA4	Phase 2
CTEP	glutamate receptor antagonist	GRM5	Preclinical
CTS-1027	metalloproteinase inhibitor	MMP1, MMP13, MMP2, MMP3, MMP9	Phase 2
CTS21166	beta-secretase inhibitor	BACE1	Phase 1
CU-CPT-4a	toll-like receptor inhibitor	TLR3	Preclinical
CU-T12-9	toll-like receptor agonist	TLR1, TLR2	Preclinical
CUDC-101	EGFR inhibitor	EGFR, ERBB2	Phase 1
CUDC-427	apoptosis inhibitor	XIAP	Phase 1
CUDC-907	PI3K inhibitor	HDAC2, PIK3R1	Phase 2
CUR-61414	smoothened receptor antagonist	DHH, IHH, SMO	Phase 1
curcumin	cyclooxygenase inhibitor, histone acetyltransferase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor	APP, CA1, CA12, CA14, CA2, CA4, CA6, CA9, CYP3A4, DNMT3B, EP300, MMP13, MMP9, NOS2, PTGS1, PTGS2, XDH	Launched
curcumol	JAK inhibitor	JAK1, JAK2, JAK3	Phase 1
cutamesine	sigma receptor agonist	SIGMAR1	Phase 2
CV-1808	adenosine receptor agonist	ADORA2A	Preclinical
CVT-10216	aldehyde dehydrogenase inhibitor	ALDH2	Phase 1
CW-008	PKA activator	PRKACA	Preclinical
CX-4945	casein kinase inhibitor	CSNK2A1, CSNK2A2, DAPK3, HIPK3	Phase 1/Phase 2
CX-516	glutamate receptor modulator		Phase 2/Phase 3
CX-5461	RNA polymerase inhibitor		Phase 1
cyacetacide			Preclinical
cyamemazine	serotonin receptor antagonist	HTR1A, HTR2A, HTR2C, HTR7	Launched
cyanocobalamin	methylmalonyl CoA mutase stimulant, vitamin B	MMAA, MMACHC, MTHFR, MTR, MTRR, MUT	Launched
cyanopindolol	adrenergic receptor antagonist	ADRB1, HTR1A, HTR1D	Phase 2
cyclamic-acid			Preclinical
cyclandelate	calcium channel blocker	CACNA2D1, CES1	Launched
cyclic-AMP		CNGA3, HCN2, PRKAR1A, PRKAR2B, TRPM7	Preclinical
cyclizine	histamine receptor modulator	HRH1, SULT1E1	Launched
cyclobenzaprine	adrenergic receptor agonist, serotonin receptor agonist	HTR2A	Launched
cyclocreatine	creatine kinase substrate		Phase 1
cyclocytidine	DNA synthesis inhibitor, RNA synthesis inhibitor		Preclinical
cycloheximide	protein synthesis inhibitor	RPL3	Preclinical
cyclopenthiazide	thiazide diuretic		Launched
cyclopentolate	acetylcholine receptor antagonist	CHRM1	Launched
cyclophosphamide	DNA alkylating agent	CYP2A6, CYP2B6, CYP2C18, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP3A4, CYP3A5, CYP3A7	Launched
cyclopiazonic-acid	ATPase inhibitor	ATP2A1	Preclinical
cycloserine-(d)	bacterial cell wall synthesis inhibitor	GRIN1	Launched
cyclosporin-a	calcineurin inhibitor	PPP3CA	Launched
cyclosporine	calcineurin inhibitor	ABCB11, CAMLG, FPR1, PPIA, PPIF, PPP3R2, SLC10A1, SLCO1B1, SLCO1B3	Launched
cyclothiazide	glutamate receptor modulator	CA1, CA2, CA4, FXYD2, GRIA1, GRIA2, GRIA3, GRIA4, SLC12A3	Launched
cyclovalone	breast cancer resistance protein inhibitor	ABCG2	Launched
cyclovirobuxin-d	calcium channel modulator		Preclinical
CYC116	Aurora kinase inhibitor	AURKA, AURKB, KDR	Phase 1
CYM-50260	sphingosine 1 phosphate receptor agonist	S1PR4	Preclinical
CYM-50358	sphingosine 1-phosphate receptor antagonist	S1PR4	Preclinical
CYM-50769	neuropeptide receptor antagonist	NPBWR1	Preclinical
CYM-5442	sphingosine 1 phosphate receptor agonist	S1PR1	Preclinical
CYM-5520	sphingosine 1 phosphate receptor agonist	S1PR2	Preclinical
CYM-5541	sphingosine 1 phosphate receptor agonist	S1PR3	Preclinical
cypermethrin			Launched
cyproheptadine	histamine receptor antagonist	ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, HRH1, HTR2A, HTR2C, HTR6, HTR7	Launched
cyproterone	androgen receptor antagonist	AR	Launched
cyproterone-acetate	androgen receptor antagonist	ADORA1, AR	Launched
cyromazine			Launched
cysteamine	tissue transglutaminase inhibitor	NPY2R, SST	Launched
CYT-997	tubulin polymerization inhibitor	TUBB	Phase 2
cytarabine	ribonucleotide reductase inhibitor	POLA1, POLB, POLD1, POLE	Launched
cytisine	acetylcholine receptor agonist	CHRNA2, CHRNA3, CHRNA4, CHRNA6, CHRNA7, CHRNB2, CHRNB4	Launched
cytochalasin-b	microtubule inhibitor	ACTB	Phase 2
cytochlor			Phase 1
cyt387		JAK1, JAK2, JAK3	Phase 3
CY208-243	dopamine receptor agonist	CALY	Phase 2
CZC-54252	leucine rich repeat kinase inhibitor	LRRK2	Preclinical
CZC24832	PI3K inhibitor	PIK3CG	Preclinical
C106			Phase 3
C11-Acetate		ABAT, ACE, AKR1C3, CA2, CELA1, ESR2, FFAR2, FFAR3, HPRT1, LTA4H, MMP12, NOS1, NOS3, PLA2G1B, PTPN1, SOD1, TXN	Phase 3
C34	toll-like receptor inhibitor	TLR4	Preclinical
C646	histone acetyltransferase inhibitor	EP300	Preclinical
D-(+)-maltose		AMY2B, MGAM	Preclinical
D-alpha-tocopheryl-succinate			Launched
D-delta-Tocopherol			Launched
D-limonene			Phase 1
D-Phenylalanine	enkephalinase inhibitor	CCBL1, CRH, HCAR3	Preclinical
D-Serine	glutamate receptor agonist	GLRA1, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SERPINB3	Launched
D-4476	TGF beta receptor inhibitor	CSNK1A1, CSNK1D, TGFB1	Preclinical
D-64131	microtubule inhibitor	TUBB	Preclinical
D-7193			Phase 2
DAA-1106	benzodiazepine receptor agonist	TSPO	Preclinical
dabigatran	thrombin inhibitor	F2	Launched
dabigatran-etexilate	thrombin inhibitor	F2	Launched
dabrafenib	RAF inhibitor	BRAF, LIMK1, NEK11, RAF1, SIK1	Launched
dacarbazine	DNA alkylating agent	PGD, POLA2	Launched
dacinostat	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9	Phase 1
daclatasvir	HCV inhibitor		Launched
dacomitinib	EGFR inhibitor	EGFR, ERBB2, ERBB4	Phase 3
dactinomycin	RNA polymerase inhibitor	POLR2A	Launched
daidzein	estrogen receptor agonist	ESRRA, ESRRB, ESRRG, TRPC5	Phase 2
dalargin	opioid receptor agonist	OPRM1	Phase 2
dalbavancin	bacterial cell wall synthesis inhibitor	PNLIP	Launched
dalcetrapib	cholesteryl ester transfer protein inhibitor	CETP	Phase 3
dalfampridine	potassium channel blocker	KCNA1, KCNA10, KCNA2, KCNA3, KCNA4, KCNA5, KCNA6, KCNA7, KCNB1, KCNB2, KCNC1, KCNC2, KCNC3, KCNC4, KCND1, KCND2, KCND3, KCNF1, KCNG1, KCNG2, KCNG3, KCNG4, KCNH1, KCNH2, KCNH3, KCNH4, KCNH5, KCNH6, KCNH7, KCNH8, KCNJ13, KCNJ5, KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5, KCNS1, KCNS2, KCNS3, KCNV1, KCNV2	Launched
daltroban	thromboxane receptor antagonist	TBXA2R	Phase 3
daminozide	KDM2A inhibitor	KDM2A, KDM7A, PHF8	Preclinical
danazol	estrogen receptor antagonist, progesterone receptor agonist	AR, CCL2, ESR1, GNRHR, GNRHR2, PGR	Launched
danegaptide	gap junction modulator		Phase 2
danirixin	CC chemokine receptor antagonist	CXCR2	Phase 2
danofloxacin	bacterial DNA gyrase inhibitor		Launched
danoprevir	HCV inhibitor		Phase 2
dantrolene	calcium channel blocker	RYR1, RYR3	Launched
dantron	laxative		Withdrawn
danusertib	Aurora kinase inhibitor, growth factor receptor inhibitor	AURKA, AURKB, AURKC, FGFR1, NTRK1, RET, SLK	Phase 2
dapagliflozin	sodium/glucose cotransporter inhibitor	SLC5A1, SLC5A2	Launched
daphnetin	protein kinase inhibitor		Preclinical
dapiprazole	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D	Launched
dapivirine	non-nucleoside reverse transcriptase inhibitor	CYP3A4, CYP3A5	Phase 3
dapoxetine	selective serotonin reuptake inhibitor (SSRI)	HTR1A, HTR1B, HTR2C, SLC6A4	Launched
daprodustat	hypoxia inducible factor inhibitor	EGLN1	Phase 3
dapsone	bacterial antifolate	DHFR	Launched
DAPT	gamma secretase inhibitor		Preclinical
daptomycin	bacterial cell wall synthesis inhibitor		Launched
darapladib	phospholipase inhibitor	PLA2G7	Phase 3
darglitazone	PPAR receptor antagonist	PPARG	Phase 2
darifenacin	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Launched
darunavir	HIV protease inhibitor	CYP3A4	Launched
darusentan	endothelin receptor antagonist	EDNRA	Phase 3
dasabuvir	HCV inhibitor		Launched
dasatinib	Bcr-Abl kinase inhibitor, ephrin inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor, tyrosine kinase inhibitor	ABL1, ABL2, BLK, EPHA2, FGR, FRK, FYN, HCK, KIT, LCK, LYN, PDGFRB, SRC, SRMS, STAT5B, YES1	Launched
DAU-5884	acetylcholine receptor antagonist	CHRM3	Preclinical
daucosterol	apoptosis stimulant		Phase 2
daunorubicin	RNA synthesis inhibitor, topoisomerase inhibitor	TOP2A, TOP2B	Launched
dazmegrel	thromboxane synthase inhibitor	TBXAS1	Phase 2
dazoxiben	thromboxane synthase inhibitor	TBXAS1	Phase 2
DBeQ	ATPase inhibitor	CASP3	Preclinical
DBPR108	dipeptidyl peptidase inhibitor	DPP4	Phase 1
DC-260126	free fatty acid receptor antagonist	FFAR1	Preclinical
DCC-2618	PDGFR tyrosine kinase receptor inhibitor, KIT inhibitor	KIT, PDGFRA	Phase 1
DCEBIO	potassium channel activator	KCNN2, KCNN3, KCNN4	Preclinical
DCPIB	chloride channel blocker, gap junction modulator, glutamate inhibitor	SLC1A2	Preclinical
DDR1-IN-1	discoidin domain receptor inhibitor	DDR1, DDR2	Preclinical
debrisoquin	adrenergic neuron blocker	SLC6A2	Launched
decamethonium	acetylcholine receptor agonist	ACHE, CHRNA2	Launched
decamethoxine	antiseptic		Phase 2
decernotinib	JAK inhibitor	JAK3	Phase 2/Phase 3
decitabine	DNA methyltransferase inhibitor	DNMT1, DNMT3A	Launched
decoquinate	antiprotozoal agent		Launched
defactinib	focal adhesion kinase inhibitor	PTK2	Phase 2
deferasirox	chelating agent	CYP3A4	Launched
deferiprone	chelating agent	UGT1A6	Launched
deferoxamine-mesylate	chelating agent		Launched
deflazacort	glucocorticoid receptor agonist	NR3C1	Launched
deforolimus	mTOR inhibitor	MTOR	Phase 3
degarelix	gonadotropin releasing factor hormone receptor antagonist	GNRHR	Launched
dehydroacetic-acid			Preclinical
dehydrocholate			Preclinical
dehydrocholate-acid			Preclinical
dehydrocorydaline	acetylcholinesterase inhibitor	ACHE	Phase 3
dehydroepiandrosterone	protein synthesis stimulant	ESR1, ESR2, G6PD, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, HSD17B1, NR1I2, NR1I3, PPARA, SIGMAR1, SULT2A1, SULT2B1	Launched
dehydroepiandrosterone-sulfate	androgen receptor agonist, estrogen receptor agonist	AR, ESR1, ESR2	Launched
delamanid	bacterial cell wall synthesis inhibitor		Launched
delanzomib	proteasome inhibitor	CMA1, CTSG, CYP3A4, ELANE	Phase 1/Phase 2
delapril	angiotensin converting enzyme inhibitor	ACE	Launched
delavirdine	non-nucleoside reverse transcriptase inhibitor	CYP3A4	Launched
delivert	angiotensin receptor agonist	AGTR1, AGTR2	Launched
delphinidin	membrane permeability inhibitor	GLO1	Phase 2
delta-Tocotrienol	HMGCR inhibitor	HMGCR	Phase 1
deltarasin	phosphodiesterase inhibitor	KRAS	Preclinical
demecarium	acetylcholinesterase inhibitor	ACHE, BCHE	Launched
demeclocycline	bacterial 30S ribosomal subunit inhibitor		Launched
denatonium-benzoate			Preclinical
denotivir	antiviral		Launched
deoxyarbutin	tyrosinase inhibitor		Preclinical
deoxycholic-acid	biliverdin reductase A activator, G protein-coupled receptor agonist	EFTUD1, FPR1, GPBAR1	Launched
deoxycorticosterone-acetate	progestogen hormone	NR3C2	Preclinical
deoxyepinephrine	adrenergic receptor agonist, dopamine receptor agonist	ADRA1A, DRD1, DRD2	Preclinical
deptropine	histamine receptor antagonist	HRH1	Preclinical
dequalinium	PKC inhibitor	KCNN1, KCNN3	Launched
deracoxib	cyclooxygenase inhibitor	PTGS2	Launched
deserpidine	angiotensin converting enzyme inhibitor	ACE, SLC18A2	Launched
desipramine	tricyclic antidepressant	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR1A, HTR2A, HTR2C, SLC6A2, SLC6A4, SMPD1	Launched
deslanoside	Na/K-ATPase inhibitor	ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP1B1, ATP1B2, ATP1B3, FXYD2	Launched
desloratadine	histamine receptor antagonist	HRH1	Launched
desmethylclozapine	acetylcholine receptor agonist	HTR2C	Phase 2
desmopressin-acetate	vasopressin receptor agonist	AVPR1A, AVPR1B, AVPR2, OXTR	Launched
desogestrel	progesterone receptor agonist	ESR1, PGR	Launched
desonide	glucocorticoid receptor agonist	NR3C1, PLA2G1B	Launched
desoximetasone	glucocorticoid receptor agonist	NR3C1, PLA2G1B	Launched
desoxycorticosterone-pivalate	corticosteroid agonist	NR3C2	Launched
desoxycortone	mineralocorticoid receptor agonist	NR3C1, NR3C2	Preclinical
desoxypeganine	acetylcholinesterase inhibitor, monoamine oxidase inhibitor	ACHE	Phase 1
desvenlafaxine	serotonin–norepinephrine reuptake inhibitor (SNRI)	SLC6A2, SLC6A3, SLC6A4	Launched
detomidine	adrenergic receptor agonist	ADRA2A	Launched
dexamethasone	glucocorticoid receptor agonist	ANXA1, NOS2, NR0B1, NR3C1, NR3C2	Launched
dexamethasone-acetate	glucocorticoid receptor agonist		Launched
dexamethasone-sodium-phosphate	glucocorticoid receptor agonist	NR3C1	Launched
dexchlorpheniramine	histamine receptor antagonist		Launched
dexfenfluramine	serotonin receptor agonist	HTR2C, SLC6A4	Withdrawn
dexfosfoserine	membrane integrity inhibitor	CFTR, GRM4, GRM6, GRM7, GRM8, KCNC4, PDPK1, PIM1, PRKACA, PRKCQ, PYGL, PYGM, REG1A, RHO, SERPINB3, SMAD2, TAOK2	Preclinical
dexlansoprazole	ATPase inhibitor	ATP4A, ATP4B	Launched
dexloxiglumide	CCK receptor antagonist	CCKAR	Phase 3
dexmedetomidine	adrenergic receptor agonist	ADRA2A, ADRA2B, ADRA2C	Launched
dexniguldipine	calmodulin antagonist	ADORA3	Phase 2
dexpanthenol			Launched
dexrazoxane	chelating agent, topoisomerase inhibitor	TOP2A, TOP2B	Launched
dextran			Launched
dextroamphetamine	monoamine oxidase inhibitor	ADRA1A, ADRA1B, SLC18A2, SLC6A2, SLC6A3, TAAR1	Launched
dextromethorphan	glutamate receptor antagonist, sigma receptor agonist	CHRNA2, CHRNA3, CHRNA4, CHRNA7, CHRNB2, CHRNB4, CYBA, CYBB, GRIN3A, NCF1, NCF2, NCF4, OPRD1, OPRK1, OPRM1, PGRMC1, RAC1, RAC2, SIGMAR1, SLC6A2, SLC6A4	Launched
dextrose			Launched
DFB	glutamate receptor agonist	GRM5	Preclinical
DG-172	PPAR receptor inverse agonist	PPARD	Preclinical
DH-97	melatonin receptor antagonist	MTNR1B	Preclinical
DHBP	ryanodine receptor blocker		Preclinical
diacerein	interleukin inhibitor	IL1B	Launched
diacetamate			Preclinical
diadenosine-tetraphosphate	adenosine kinase inhibitor	P2RY13, P2RY2	Phase 1
dianhydrogalactitol	DNA alkylating agent		Phase 1
diarylpropionitrile	estrogen receptor agonist	ESR2	Preclinical
diatrizoic-acid			Launched
diaveridine	dihydrofolate reductase inhibitor		Launched
diazepam	benzodiazepine receptor agonist	ADRA1A, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, TSPO	Launched
diazooxonorleucine	glutamate receptor antagonist		Phase 2
diazoxide	potassium channel activator	ATP1A1, CA1, CA2, KCNJ11, KCNJ8, KCNMA1, SLC12A3	Launched
dibekacin	bacterial 30S ribosomal subunit inhibitor		Launched
dibenzepine	norepinephrine reputake inhibitor		Preclinical
dibenzothiophene			Preclinical
dibutyl-phthalate		TRPA1	Preclinical
dichlorisone-acetate			Phase 2
dichloroacetate	pyruvate dehydrogenase kinase inhibitor	PDK1	Phase 3
dichlorophen	anticestodal agent		Launched
dichlorvos	acetylcholinesterase inhibitor		Launched
diclazuril	antiprotozoal agent		Launched
diclofenac	cyclooxygenase inhibitor	AKR1C3, ALOX5, ASIC1, ASIC3, KCNQ2, KCNQ3, PLA2G2A, PPARG, PTGS1, PTGS2, SCN4A	Launched
diclofenamide	carbonic anhydrase inhibitor	CA1, CA12, CA2, CA4, CA7	Launched
diclofensine	dopamine reuptake inhibitor	DRD1, MAOA, MAOB	Phase 3
dicloralurea			Preclinical
dicloxacillin	bacterial cell wall synthesis inhibitor		Launched
dicoumarol	NADPH inhibitor	CRYZ, NQO1, VKORC1	Launched
dicyclohexylamine			Preclinical
dicycloverine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3	Launched
didanosine	nucleoside reverse transcriptase inhibitor	PNP	Launched
dideoxyadenosine	nucleoside reverse transcriptase inhibitor		Phase 1
didox	ribonucleotide reductase inhibitor	RRM1	Launched
dienestrol	estrogen receptor agonist	ESR1	Launched
dienogest	progesterone receptor agonist	PGR	Launched
diethylcarbamazine	lipoxygenase inhibitor	ALOX5, PTGS1	Launched
diethylstilbestrol	estrogen receptor agonist	ESR1, ESR2, ESRRB, ESRRG	Withdrawn
diethyltoluamide	ionotropic receptor IR40a activator		Launched
difenpiramide	cyclooxygenase inhibitor, prostaglandin inhibitor		Launched
diflorasone-diacetate	glucocorticoid receptor agonist	NR3C1	Launched
difloxacin	bacterial DNA gyrase inhibitor		Launched
diflunisal	prostanoid receptor antagonist	PTGS1, PTGS2	Launched
difluprednate	glucocorticoid receptor agonist	NR3C1	Launched
diftalone	cyclooxygenase inhibitor		Launched
digitoxigenin	ATPase inhibitor	ATP1A1	Preclinical
digitoxin	ATPase inhibitor	ATP1A1	Launched
digoxigenin	steroid		Preclinical
digoxin	ATPase inhibitor	ATP1A1	Launched
dihomo-gamma-linolenic-acid	prostanoid receptor agonist	PTGS1, PTGS2	Phase 2
dihydrexidine	dopamine receptor agonist	DRD1, DRD2, DRD3, DRD4, DRD5	Phase 2
dihydroartemisinin	antimalarial agent		Launched
dihydroergocristine	adrenergic receptor antagonist, prolactin inhibitor	ADRA1A, ADRB1, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR2A, HTR3A, HTR4, HTR5A, HTR6, HTR7	Launched
dihydroergotamine	serotonin receptor agonist	ADRA2A, DRD2, HTR1B, HTR1D, HTR1E, HTR1F, HTR2B, HTR7	Launched
dihydromyricetin			Preclinical
dihydrostreptomycin	bacterial 30S ribosomal subunit inhibitor		Withdrawn
dihydrotachysterol	vitamin analog	VDR	Launched
dihydrotestosterone	androgen receptor agonist	AR, HSD17B1	Launched
dihydroxyacetone			Launched
dihydroxyphenylglycine	glutamate receptor agonist	GRM1, GRM5	Preclinical
diiodothyropropionic-acid	thyroid hormone stimulant		Phase 2
dilazep	adenosine reuptake inhibitor	SLC29A1	Launched
diloxanide	protein synthesis inhibitor		Launched
diltiazem	calcium channel blocker	CACNA1C, CACNA1S, CACNA2D1, CACNG1, HTR3A, KCNA5	Launched
dimaprit	histamine receptor agonist	HRH2, HRH3, HRH4	Preclinical
dimemorfan	sigma receptor agonist	SIGMAR1	Launched
dimenhydrinate	histamine receptor antagonist	HRH1	Launched
dimercaprol	chelating agent		Launched
dimercaptosuccinic-acid	chelating agent	DNMT1	Launched
dimesna	tubulin polymerization inhibitor		Phase 3
dimethadione	oxazolidine antiepileptic		Preclinical
dimethicone			Launched
dimethindene-(S)-(+)	acetylcholine receptor antagonist	HRH1	Preclinical
dimethisoquin	local anesthetic		Launched
dimethyl-fumarate	nuclear factor erythroid derived, like (NRF2) activator	KEAP1	Launched
dimethyl-isosorbide	cosmetic moisturizer		Preclinical
dimetindene	histamine receptor antagonist, cholinergic receptor antagonist	CHRM2, HRH1	Launched
dimetridazole	bacterial DNA inhibitor		Launched
diminazene-aceturate	angiotensin converting enzyme activator	AOC1, PRDX5, PRSS1	Phase 3
dimpylate	acetylcholinesterase inhibitor	ACHE	Launched
dinaciclib	CDK inhibitor	CDK1, CDK2, CDK5, CDK9	Phase 3
dinitolmide			Launched
dinoprost	prostacyclin analog	PTGDR, PTGDR2, PTGER1, PTGER2, PTGER3, PTGER4, PTGFR, PTGIR, TBXA2R	Launched
dinoprostone	prostanoid receptor agonist	CATSPER1, CATSPER2, CATSPER3, CATSPER4, PTGDR, PTGDR2, PTGER1, PTGER2, PTGER3, PTGER4, PTGFR, TBXA2R	Withdrawn
dioscin	apoptosis stimulant	CXCR3	Preclinical
diosgenin	steroid		Preclinical
diosmetin	aryl hydrocarbon receptor agonist	CYP1B1	Launched
diosmin	aryl hydrocarbon receptor agonist, capillary stabilizing agent	AHR	Launched
dioxybenzone	topical sunscreen agent		Preclinical
dipeptamin			Launched
diperodon	local anesthetic		Preclinical
diphemanil	acetylcholine receptor antagonist	CHRM3	Launched
diphencyprone	immunostimulant		Phase 2
diphenhydramine	histamine receptor antagonist	HRH1	Launched
diphenidol	acetylcholine receptor agonist	CHRM1, CHRM2, CHRM3, CHRM4	Launched
diphenyleneiodonium	nitric oxide synthase inhibitor	NOS2, NOS3	Preclinical
diphenylguanidine			Preclinical
diphenylpyraline	dopamine uptake inhibitor	HRH1, SLC6A3	Launched
dipivefrine	adrenergic receptor agonist	ACHE, ADRA1A, ADRA2A, ADRB2, BCHE	Launched
dipraglurant	glutamate receptor negative allosteric modulator	GRM5	Phase 2
DIPT	dopamine reuptake inhibitor, serotonin reuptake inhibitor	HTR1A, HTR2A, HTR2C	Launched
dipyridamole	phosphodiesterase inhibitor	ADA, PDE10A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE6D, PDE6G, PDE6H, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, SLC29A1	Launched
dipyrocetyl	chelating agent		Launched
dirithromycin	bacterial 50S ribosomal subunit inhibitor		Launched
diroximel-fumarate	anti-inflammatory agent		Phase 3
disodium sebacate		HBA1, HBB	Phase 1
disopyramide	sodium channel blocker	CHRM1, CHRM2, CHRM3, KCND2, KCND3, KCNH2, SCN5A	Launched
disulfiram	aldehyde dehydrogenase inhibitor, DNA methyltransferase inhibitor, TRPV agonist	ALDH2, DBH	Launched
dithranol	DNA synthesis inhibitor		Launched
ditiocarb-sodium-trihydrate	immunostimulant	CA1, CA2, CA4	Phase 3
ditolylguanidine	sigma receptor agonist	GRIN1, GRIN2A, GRIN2B, SIGMAR1	Preclinical
divalproex-sodium	benzodiazepine receptor agonist	ALDH5A1	Launched
dixanthogen			Preclinical
dizocilpine-(+)	glutamate receptor antagonist	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D	Preclinical
dizocilpine-(-)	glutamate receptor antagonist		Phase 1
DMAB-anabaseine	adrenergic receptor agonist	CHRNA7	Preclinical
DMeOB		GRM5	Preclinical
DMH1	ALK tyrosine kinase receptor inhibitor	ACVR1	Preclinical
DMH4	VEGFR inhibitor	KDR	Preclinical
DMNB	DNA dependent protein kinase inhibitor		Preclinical
DMP-543	acetylcholine release enhancer		Phase 2
DMP-777	elastase inhibitor	MPO	Phase 2
DMPS	chelating agent		Phase 1
DMSO	control vehicle		Preclinical
DNQX	glutamate receptor antagonist	GRIA1, GRIA2, GRIK1, GRIN1, GRIN2A, GRIN2B	Preclinical
dobutamine	adrenergic receptor agonist	ADRB1, ADRB2	Launched
docebenone	lipoxygenase inhibitor	ALOX5	Phase 2
docetaxel	tubulin polymerization inhibitor	BCL2, MAP2, MAP4, MAPT, NR1I2, TUBB, TUBB1	Launched
doconexent	PPAR receptor agonist	FFAR1, PTGS1, PTGS2	Launched
doconexent-ethyl-ester	omega 3 fatty acid stimulant		Launched
docosanol	lipase clearing factor inhibitor	TLR7	Launched
docusate	laxative		Launched
dodecyl-sulfate		LYZ	Preclinical
dofequidar	MRP inhibitor, P glycoprotein inhibitor	ABCB1	Phase 3
dofetilide	potassium channel blocker	KCNH1, KCNH2, KCNJ12, KCNK2	Withdrawn
dolasetron	serotonin receptor antagonist	HTR3A	Launched
dolastatin-10	tubulin polymerization inhibitor	TUBB	Phase 2
dolutegravir	HIV integrase inhibitor	CYP3A4, CYP3A5, CYP3A7, POU2F2, UGT1A1	Launched
domiphen			Preclinical
domperidone	dopamine receptor antagonist	DRD2, DRD3	Launched
donepezil	acetylcholinesterase inhibitor	ACHE, HTR2A	Launched
donitriptan	serotonin receptor agonist	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR5A, HTR6	Phase 2
dopamine	dopamine receptor agonist	DBH, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR7, SLC6A2, SLC6A3, SLC6A4	Launched
doramapimod	p38 MAPK inhibitor	MAPK11, MAPK12, MAPK13, MAPK14	Phase 2
doramectin			Launched
doripenem	bacterial cell wall synthesis inhibitor	DPEP1	Launched
dorsomorphin	AMPK inhibitor	ACVR1, BMPR1A, BMPR1B, EPHA2, FKBP1A, FLT1, FLT3, KDR, LCK, MKNK1, PRKAA1, RPS6KA1, SRC	Preclinical
dorzolamide	carbonic anhydrase inhibitor	CA1, CA12, CA14, CA2, CA4, CA7	Launched
dosulepin	norepinephrine reuptake inhibitor, serotonin–norepinephrine reuptake inhibitor (SNRI), tricyclic antidepressant	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, SLC6A2, SLC6A4	Launched
dovitinib	EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	CSF1R, EGFR, FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, INSR, KDR, KIT, PDGFRA, PDGFRB	Phase 3
doxapram	potassium channel blocker	KCNK3, KCNK9	Launched
doxazosin	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, KCNH2, KCNH6, KCNH7	Launched
doxepin	histamine receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HRH2, HRH4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, KCNH2, SLC6A2, SLC6A4	Launched
doxercalciferol	vitamin D receptor agonist	VDR	Launched
doxifluridine	thymidylate synthase inhibitor	TYMS	Launched
doxofylline	adenosine receptor antagonist	ADORA1, PDE4A, PDE4B, PDE4C, PDE4D	Launched
doxorubicin	topoisomerase inhibitor	TOP2A	Launched
doxycycline	metalloproteinase inhibitor	MMP8	Launched
doxycycline-hyclate	bacterial 30S ribosomal subunit inhibitor		Launched
doxylamine	histamine receptor antagonist	CHRM1, HRH1	Launched
DPC-681	HIV protease inhibitor		Phase 1
DPCPX	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Phase 1
DPI-201106	sodium channel activator	ADRB2	Phase 2
DPO-1	potassium channel blocker	KCNA5	Preclinical
DPPE	histamine receptor antagonist	ABCB1, HRH1	Phase 3
DQP-1105	glutamate receptor antagonist	GRIN2C, GRIN2D	Preclinical
DR-2313	PARP inhibitor	PARP1, PARP3	Preclinical
DR-4485	serotonin receptor antagonist	HTR7	Preclinical
DRF053-(R)	CDK inhibitor	CSNK1A1	Preclinical
drofenine			Launched
droloxifene	selective estrogen receptor modulator (SERM)	ESR1	Phase 3
dromostanolone-propionate	androgen receptor modulator	AR	Launched
dronedarone	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, KCNA5, KCNH2, KCNK2, SCN1A	Launched
droperidol	dopamine receptor antagonist	ADRA1A, DRD2, DRD3, DRD4, HTR2A	Launched
dropropizine	antitussive		Launched
drospirenone	mineralocorticoid receptor antagonist	AR, NR3C2, PGR	Launched
drotaverine	phosphodiesterase inhibitor	CACNA1C, PDE4A	Launched
droxicam	cyclooxygenase inhibitor	PTGS1	Launched
droxidopa	norepinephrine precursor	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, PAH	Launched
droxinostat	HDAC inhibitor	HDAC6, HDAC8	Preclinical
DSR-6434	toll-like receptor agonist	TLR7	Preclinical
DS2-(806622)			Preclinical
DU-728	structural glycoprotein antagonist	ITGA2B, ITGB3	Phase 1
duloxetine	norepinephrine reuptake inhibitor, serotonin–norepinephrine reuptake inhibitor (SNRI)	HTR2A, HTR2C, HTR6, SLC6A2, SLC6A3, SLC6A4	Launched
DUP-697	cyclooxygenase inhibitor	PTGS2	Phase 1
dutasteride	5 alpha reductase inhibitor	SRD5A1, SRD5A2	Launched
DVD-111			Phase 2
dyclonine	sodium channel blocker	SCN10A, SCN5A	Launched
dydrogesterone	progesterone receptor agonist	PGR	Launched
dynasore	dynamin inhibitor	DNM1, DNM1L, DNM2	Preclinical
dynole-34-2	dynamin inhibitor	DNM1	Preclinical
dyphylline	adenosine receptor antagonist, phosphodiesterase inhibitor	ADORA1, ADORA2A, PDE3A, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B	Launched
DY131	estrogen-related receptor agonist	ESRRB, ESRRG	Preclinical
D609	phospholipase inhibitor		Preclinical
E-2012	gamma secretase modulator	APH1A, APH1B, PSENEN	Phase 1
E-4031	potassium channel blocker	KCNH1, KCNH2	Phase 1
E-64	cysteine protease inhibitor, calpain inhibitor	CTSS	Preclinical
eact	calcium-activated chloride channel inhibitor	ANO1	Preclinical
EB-47	PARP inhibitor	PARP1	Preclinical
ebastine	histamine receptor antagonist	CYP3A4, HRH1	Launched
EBPC	aldose reductase inhibitor	AKR1B1	Preclinical
ebrotidine	histamine receptor antagonist	HRH2	Withdrawn
ebselen	cyclooxygenase inhibitor, glutathione peroxidase agonist, H+/K+-ATPase inhibitor, nitric oxide synthase inhibitor	ALB	Phase 2/Phase 3
EC-144	HSP inhibitor	HSP90AA1, HSP90AB1	Preclinical
EC-23	retinoid receptor agonist	RARA, RARB, RARG	Preclinical
ecabapide			Phase 3
ecabet	gastrin inhibitor, urease inhibitor	NOXO1	Launched
ecamsule-triethanolamine			Launched
echinomycin	DNA intercalating agent		Phase 2
econazole	lanosterol demethylase inhibitor, sterol demethylase inhibitor	CYP51A1, NPY1R, NPY2R, TRPM2, TRPV5	Launched
ectoine-zwitterion			Preclinical
edaglitazone	PPAR receptor agonist	PPARG	Phase 2
edaravone	nootropic agent	BCL2	Launched
edelfosine	phospholipase inhibitor		Phase 2
editol			Preclinical
edoxaban	coagulation factor inhibitor	F10	Launched
edoxudine	DNA directed DNA polymerase inhibitor		Launched
edrophonium	acetylcholinesterase inhibitor	ACHE, BCHE	Launched
EDTMP	chelating agent		Preclinical
EED226	polycomb protein inhibitor	EED	Preclinical
efaproxiral	haemoglobin oxygen release stimulant	HBA1, HBB	Phase 3
efaroxan	adrenergic receptor antagonist	ADORA2A	Phase 2
efatutazone	PPAR receptor agonist	PPARG	Phase 2
efavirenz	HIV protease inhibitor	CYP1A2, CYP2B6, CYP2C19, CYP2C9, CYP2D6, CYP3A4	Launched
efinaconazole	lanosterol demethylase inhibitor	CYP51A1	Launched
eflornithine	ornithine decarboxylase inhibitor	ARG2, ODC1	Launched
efloxate	vasodilator		Preclinical
efonidipine-monoethanolate	L-type calcium channel blocker, T-type calcium channel blocker	CACNA1C, CACNA1G	Launched
EGF816	EGFR inhibitor	EGFR	Phase 2
eglumetad	glutamate receptor agonist	GRM2, GRM3, GRM6, GRM8	Phase 2
EG00229	neuropilin receptor antagonist	NRP1	Preclinical
EHop-016	Ras GTPase inhibitor	RAC1, RAC3	Preclinical
EIPA	transient receptor potential polycystic inhibitor, sodium/hydrogen exchanger inhibitor	ADRA2A, ASIC1, PKD2L1	Preclinical
EIT-hydrobromide	nitric oxide synthase inhibitor	NOS2, NOS3	Preclinical
EI1	histone lysine methyltransferase inhibitor	EZH2	Preclinical
elacridar	P glycoprotein inhibitor	ABCB1	Phase 1
elactocin	exportin antagonist	XPO1	Phase 1
elafibranor	PPAR receptor agonist	PPARA, PPARD	Phase 3
elagolix	gonadotropin releasing factor hormone receptor antagonist	GNRHR	Phase 3
elbasvir	HCV inhibitor		Launched
elemene	VEGFR inhibitor		Phase 2
elesclomol	oxidative stress inducer	HSPA1A	Phase 3
eletriptan	serotonin receptor agonist	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2B, HTR7	Launched
eliglustat	Glycosyl transferase inhibitor	UGCG	Launched
elinogrel	purinergic receptor antagonist	P2RY12	Phase 2
eliprodil	glutamate receptor antagonist	GRIN1, GRIN2B	Phase 3
ellagic-acid	glutathione transferase inhibitor, non-nucleoside reverse transcriptase inhibitor	CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, GSK3B, PRKACA, PRKCA, PRKCB, SQLE, SYK	Phase 2
ELN-441958	bradykinin receptor antagonist	BDKRB1	Preclinical
eltanolone	membrane integrity inhibitor	GABRA1, GABRB2, GABRG2	Phase 3
eltoprazine	serotonin receptor agonist	HTR1A, HTR1B	Phase 2
eltrombopag	thrombopoietin receptor agonist	MPL	Launched
eluxadoline	opioid receptor modulator	OPRD1, OPRK1, OPRM1	Launched
elvitegravir	HIV integrase inhibitor		Launched
embelin	HCV inhibitor, XIAP inhibitor	XIAP	Preclinical
EMD-1214063	hepatocyte growth factor receptor inhibitor	MET	Phase 1
EMD-386088	serotonin receptor agonist	HTR6	Preclinical
EMD-53998	phosphodiesterase inhibitor	TNNC1	Phase 1
EMD-66684	angiotensin receptor antagonist	AGTR1	Preclinical
emedastine	histamine receptor antagonist	HRH1	Launched
emetine	protein synthesis inhibitor	RPS2	Phase 2
emodin	11-beta hydroxysteroid dehydrogenase inhibitor	CSNK2A1	Preclinical
emorfazone	antiinflammatory agent, cyclooxygenase inhibitor		Launched
emoxipin			Phase 2
empagliflozin	sodium/glucose cotransporter inhibitor	SLC5A1, SLC5A2	Launched
emtricitabine	nucleoside reverse transcriptase inhibitor		Launched
enalapril	angiotensin converting enzyme inhibitor	ACE	Launched
enalaprilat	angiotensin converting enzyme inhibitor	ACE	Launched
enasidenib	isocitrate dehydrogenase inhibitor	IDH1	Launched
enbucrilate			Launched
enciprazine	GABA receptor modulator	GABRA1	Phase 3
endo-IWR-1	PARP inhibitor	TNKS, TNKS2	Preclinical
endoxifen	estrogen receptor antagonist	ESR1	Phase 2
enflurane	membrane permeability inhibitor	ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, KCNK10, KCNK18, KCNK2, KCNK3, KCNK9, KCNN4	Launched
enilconazole	sterol demethylase inhibitor	CYP19A1, CYP1A2, CYP2B6, CYP2C9, CYP2J2, CYP3A4, CYP3A5, NR1I2, PPARA, PTGER2	Launched
eniluracil	dihydropyrimidine dehydrogenase inhibitor	AOX1, DPYD, XDH	Phase 3
enisamium-iodide			Launched
ENMD-2076	Aurora kinase inhibitor, FLT3 inhibitor, VEGFR inhibitor	AURKA, FLT3, KDR, PDGFRA, PTK2, SRC	Phase 2
enocitabine	DNA synthesis inhibitor	CMPK1, RRM1, TYMS	Launched
enoxacin	topoisomerase inhibitor	TOP2A	Launched
enoximone	phosphodiesterase inhibitor	PDE3A	Launched
enoxolone	gap junction modulator	HSD11B1	Launched
enprofylline	phosphodiesterase inhibitor	ADORA1, ADORA2A, ADORA2B, ADORA3, PDE4A, PDE4B	Phase 3
enrofloxacin	bacterial DNA gyrase inhibitor		Launched
entacapone	catechol O methyltransferase inhibitor	COMT	Launched
entecavir	DNA replication inhibitor, nucleoside reverse transcriptase inhibitor		Launched
entinostat	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC9	Phase 3
entrectinib	ALK tyrosine kinase receptor inhibitor, proto-oncogene tyrosine protein kinase inhibitor	ALK, NTRK1, NTRK2, NTRK3, ROS1	Phase 2
enzalutamide	androgen receptor antagonist	AR	Launched
enzastaurin	PKC inhibitor	AKT1, GSK3B, PRKCA, PRKCB, PRKCD, PRKCG	Phase 3
EN460	endoplasmic reticulum oxidation inhibitor	ERO1A	Preclinical
EO-1428	p38 MAPK inhibitor	MAPK11, MAPK14	Preclinical
epacadostat	indoleamine 2,3-dioxygenase inhibitor	IDO1	Phase 3
epalrestat	aldose reductase inhibitor	AKR1B1	Launched
eperezolid	bacterial 30S ribosomal subunit inhibitor		Phase 1
eperisone	acetylcholine receptor antagonist	CYP2J2	Launched
ephedrine	adrenergic receptor agonist	ACHE, ADRA1A, ADRB2, SLC18A2, SLC6A2	Launched
ephedrine-(racemic)	adrenergic receptor agonist	ADRA1A, ADRA2A	Launched
epiandrosterone	steroid	G6PD	Preclinical
epicatechin-gallate-(-)	bacterial DNA gyrase inhibitor	BACE1, FASN	Phase 2
epigallocatechin-gallate-(-)	bacterial DNA gyrase inhibitor	ELANE, EP300, FASN, KAT2B, MMP14, MMP2	Phase 2/Phase 3
epinastine	histamine receptor antagonist	ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7	Launched
epinephrine	adrenergic receptor agonist, neurotransmitter	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, PAH, TNF	Launched
epinephrine-(racemic)	carbonic anhydrase activator		Launched
epirizole	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
epirubicin	topoisomerase inhibitor	CHD1, TOP2A	Launched
epitiostanol	androgen receptor agonist	AR	Launched
eplerenone	cytochrome P450 inhibitor	NR3C2	Launched
epomediol	cholesterol inhibitor	CYP7A1	Launched
epoprostenol	prostacyclin analog	P2RY12, PTGER1, PTGER4, PTGIR, PTGIS	Launched
epothilone-a	microtubule stabilizing agent		Preclinical
epothilone-b	microtubule stabilizing agent, tubulin polymerization inhibitor	TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA4A, TUBA8, TUBB, TUBB1, TUBB3, TUBB4A, TUBB4B	Phase 3
epothilone-d	microtubule stabilizing agent, tubulin polymerization inhibitor	TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA4A, TUBA8, TUBB, TUBB1, TUBB3, TUBB4A, TUBB4B	Phase 2
EPPTB	trace amine associated receptor antagonist	TAAR1	Preclinical
eprazinone	mucolytic agent		Launched
eprinomectin	benzodiazepine receptor agonist		Launched
eprobemide	monoamine oxidase inhibitor	MAOA	Launched
eprodisate	antiamyloidogenic agent, amyloid protein inhibitor	SAA1	Phase 3
eprosartan	angiotensin receptor antagonist	AGTR1	Launched
eptifibatide	platelet aggregation inhibitor	ITGA2B, ITGB3	Launched
EPZ-5676	histone lysine methyltransferase inhibitor	DOT1L	Phase 1
EPZ004777	histone lysine methyltransferase inhibitor	DOT1L	Preclinical
EPZ005687	histone lysine methyltransferase inhibitor	EZH2	Preclinical
EPZ011989	histone lysine methyltransferase inhibitor	EZH2	Preclinical
EPZ015666	protein arginine N-methyltransferase inhibitor	PRMT5	Preclinical
EPZ020411	protein arginine N-methyltransferase inhibitor	PRMT6	Preclinical
equilin	estrogen receptor agonist	HSD17B1	Preclinical
equol	estrogen receptor agonist	ESR1, ESR2	Launched
ER-27319	mediator release inhibitor, SYK inhibitor	SYK	Preclinical
ER-50891	retinoid receptor antagonist	RARA	Preclinical
erastin	ion channel antagonist	VDAC2	Preclinical
erbstatin-analog	EGFR inhibitor, tyrosine kinase inhibitor	EGFR	Preclinical
ercalcitriol	vitamin D receptor agonist	VDR	Phase 1
erdafitinib	FGFR inhibitor	FGFR1, FGFR2, FGFR3, FGFR4	Phase 2
erdosteine	mucolytic agent		Launched
ergocalciferol	vitamin analog	VDR	Launched
ergonovine	adrenergic receptor agonist, serotonin receptor agonist	ADRA1A, HTR1E	Launched
ergosterol	vitamin D precursor		Preclinical
ergotamine	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, DRD1, DRD2, DRD5, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, SLC6A2	Launched
ERK5-IN-1	MAP kinase inhibitor	MAPK7	Preclinical
erlotinib	EGFR inhibitor	EGFR, NR1I2	Launched
ertapenem	bacterial cell wall synthesis inhibitor		Launched
erteberel	estrogen receptor agonist	ESR1, ESR2	Phase 2
ertugliflozin	sodium/glucose cotransporter inhibitor	SLC5A2	Launched
erythritol			Launched
erythromycin	NFkB pathway inhibitor	MLNR	Launched
erythromycin-estolate	bacterial 50S ribosomal subunit inhibitor	ABCB1, ALB, CYP3A4, CYP51A1, KCNH2, MLNR, SLC47A1	Launched
erythromycin-ethylsuccinate	cytochrome P450 inhibitor, protein synthesis inhibitor	ABCB1, ALB, CYP3A4, CYP51A1, KCNH2, MLNR, SLC47A1	Launched
erythrosine	coloring agent		Preclinical
esaprazole			Phase 2
escin	nitric oxide synthase stimulant		Launched
escitalopram	selective serotonin reuptake inhibitor (SSRI)	ADRA1A, CHRM1, HRH1, SLC6A2, SLC6A3, SLC6A4	Launched
esculin	antioxidant		Phase 1
eseroline-(-)	acetylcholinesterase inhibitor	OPRD1, OPRM1	Preclinical
ESI-09	EPAC inhibitor	RAPGEF3, RAPGEF4	Preclinical
eslicarbazepine-acetate	sodium channel blocker	SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	Launched
esmolol	adrenergic receptor antagonist	ADRB1	Launched
esomeprazole	ATPase inhibitor	ATP4A	Launched
estetrol	selective estrogen receptor modulator (SERM)	ESR1	Phase 3
estradiol	estrogen receptor agonist	ESR1, ESR2, GPER1, KCNMA1, NR1I2	Launched
estradiol-acetate	estrogen receptor agonist	ESR1	Launched
estradiol-benzoate	contraceptive agent	ESR1	Preclinical
estradiol-cypionate	estrogen receptor agonist	ESR1	Launched
estradiol-valerate	estrogen receptor agonist	ESR1	Launched
estramustine	DNA alkylating agent	ESR1, ESR2, MAP1A, MAP2	Launched
estramustine-phosphate	DNA synthesis inhibitor, microtubule inhibitor	ESR1, ESR2, MAP1A, MAP2	Launched
estriol	estrogen receptor agonist	ESR1, ESR2	Launched
estrone	estrogen receptor agonist, estrogenic hormone	ESR1, ESR2	Launched
estropipate	estrogen receptor agonist	ESR1, ESR2	Launched
eszopiclone	benzodiazepine receptor agonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, TSPO	Launched
etacrynic-acid	sodium/potassium/chloride transporter inhibitor	ATP1A1, SLC12A1	Launched
etafenone	calcium channel blocker		Launched
etamsylate	haemostatic agent		Launched
etanidazole	bacterial cell wall synthesis inhibitor		Phase 3
etazolate	phosphodiesterase inhibitor	GABRB3, PDE4A	Phase 2
ETC-1002	AMPK inhibitor	ACLY	Phase 3
ETC-159	porcupine inhibitor, beta catenin inhibitor	PORCN	Phase 1
etebenecid	uricosuric blocker		Preclinical
eterobarb	anticonvulsant		Phase 2
ethacizin	anticonvulsant		Launched
ethacridine-lactate-monohydrate	DNA intercalating agent		Preclinical
ethambutol	bacterial cell wall synthesis inhibitor		Launched
ethamivan	respiratory stimulant		Preclinical
ethanolamine-oleate	immunostimulant	F12, FABP4, FFAR1, FFAR4, PLD2	Launched
ethaverine	calcium channel blocker		Launched
ethenzamide	analgesic agent		Launched
ethimizol			Phase 1
ethinyl-estradiol	estrogen receptor agonist, estrogenic hormone	ESR1, ESR2, NR1I2	Launched
ethionamide	mycolic synthesis inhibitor		Launched
ethisterone	progestogen hormone	TYR	Launched
ethopabate	antiprotozoal agent		Launched
ethosuximide	succinimide antiepileptic	CACNA1G, CACNA1H, CACNA1I	Launched
ethotoin	hydantoin antiepileptic	SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	Launched
ethoxyquin	antioxidant		Preclinical
ethoxzolamide	carbonic anhydrase inhibitor	CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9	Launched
ethyl-paraben			Preclinical
ethyl-pyruvate	tumor necrosis factor production inhibitor	HMGB1, TNF	Phase 2
ethyl-vanillin			Preclinical
ethyl-2-(carbamoyloxy)benzoate			Phase 1
ethylenediaminetetraacetic-acid	PKC inhibitor		Launched
ethylnorepinephrine	bronchodilator		Preclinical
ethynodiol-diacetate		ESR1, PGR	Launched
eticlopride	dopamine receptor antagonist	DRD2, DRD3, DRD4	Preclinical
etidronic-acid	bone resorption inhibitor	ATP6V1A, PTPRS	Launched
etifenin	renal function diagnostic agent		Preclinical
etifoxine	GABA receptor modulator	GABRA1, GABRA2, GABRA3, GABRA5	Launched
etilefrine	adrenergic receptor agonist	ADRA1A, ADRB1	Launched
etilevodopa	dopamine receptor agonist	DRD3	Phase 3
etizolam	benzodiazepine receptor agonist	GABRA1	Launched
etodolac	cyclooxygenase inhibitor	PTGS1, PTGS2, RXRA	Launched
etofenamate	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
etofibrate	PPAR receptor agonist	PPARA	Launched
etofylline	adenosine receptor antagonist	ADORA1	Launched
etofylline-clofibrate	platelet aggregation inhibitor	PPARA	Launched
etomidate	GABA receptor modulator	ADRA2B, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ	Launched
etomoxir	carnitine palmitoyltransferase inhibitor	CPT1A	Phase 2
etonogestrel	progesterone receptor agonist	ESR1, PGR	Launched
etoposide	topoisomerase inhibitor	TOP2A, TOP2B	Launched
etoposide-phosphate	topoisomerase inhibitor	TOP2A	Launched
etoricoxib	cyclooxygenase inhibitor	PTGS2	Launched
etosalamide	anti-inflammatory agent		Preclinical
etoxybamide			Phase 2
ETP-45658	PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG	Preclinical
ETP-46464	ATR kinase inhibitor		Preclinical
etravirine	non-nucleoside reverse transcriptase inhibitor	CYP2C19, CYP2C9, CYP3A4	Launched
etretinate	protein synthesis inhibitor	RARA, RARB, RARG, RXRA, RXRB, RXRG	Withdrawn
eucalyptol	acetylcholinesterase inhibitor	ACHE	Launched
eucatropine	acetylcholine receptor antagonist		Preclinical
eugenol	androgen receptor antagonist	AR	Launched
EUK-134	catalase stimulant	APP, SOD2	Preclinical
eupatilin	mucus protecting agent		Launched
evacetrapib	cholesteryl ester transfer protein inhibitor	CETP	Phase 3
evans-blue	glutamate receptor negative allosteric modulator	GRIA1, PTPN1	Launched
evatanepag	prostaglandin inhibitor	PTGER2, PTGER4	Phase 2
everolimus	mTOR inhibitor	MTOR	Launched
evodiamine	ATPase inhibitor, TRPV agonist	TRPV1	Preclinical
EVP-6124	acetylcholine receptor agonist	CHRNA7	Phase 3
EVP4593	NFkB pathway inhibitor		Preclinical
EW-7197	TGF beta receptor inhibitor	ACVR1B, TGFBR1	Phase 1
EX-527	SIRT inhibitor	SIRT1	Phase 2
exalamide	membrane permeability inhibitor		Launched
examorelin	growth hormone releasing factor agonist	GHRHR, GHSR	Phase 2
exatecan-mesylate	topoisomerase inhibitor	TOP1	Phase 3
exemestane	aromatase inhibitor	CYP19A1	Launched
exenatide	GLP receptor agonist	GLP1R	Launched
exherin	cadherin antagonist	CDH2	Phase 2
exifone	nootropic agent	TYR	Withdrawn
exisulind	phosphodiesterase inhibitor	PDE5A	Phase 3
exo-IWR-1	WNT signaling inhibitor negative control	TNKS	Preclinical
EXO-1	ARF inhibitor		Preclinical
ezatiostat	glutathione transferase inhibitor	GSTP1	Phase 2
ezetimibe	cholesterol inhibitor, Niemann-Pick C1-like 1 protein antagonist	ANPEP, NPC1L1, SOAT1	Launched
ezutromid	utrophin enhancer	UTRN	Phase 2
E7449	PARP inhibitor	PARP1, PARP2, TNKS, TNKS2	Phase 1/Phase 2
F-11440	serotonin receptor agonist	HTR1A	Phase 2
fadrozole	aromatase inhibitor	CYP11B1, CYP19A1	Launched
fagomine	glucosidase inhibitor	GLB1	Phase 2
falecalcitriol	vitamin D receptor agonist	VDR	Launched
famciclovir	DNA polymerase inhibitor		Launched
famotidine	histamine receptor antagonist	HRH2	Launched
famprofazone	cyclooxygenase inhibitor		Preclinical
fananserin	dopamine receptor antagonist, serotonin receptor antagonist	HTR2A	Phase 2
fanetizole	neutrophil superoxide production		Phase 3
farnesyl-thiosalicylic-acid-amide	Ras GTPase inhibitor	HRAS	Phase 1
faropenem	lactamase inhibitor		Launched
faropenem-medoxomil	lactamase inhibitor		Launched
fasudil	rho associated kinase inhibitor	PKIA, PRKACA, ROCK1, ROCK2	Launched
favipiravir	RNA polymerase inhibitor		Phase 3
FCE-22250	DNA directed DNA polymerase inhibitor		Phase 1
fdcyd	DNA methyltransferase inhibitor		Phase 2
febuxostat	xanthine oxidase inhibitor	XDH	Launched
felbamate	glutamate receptor antagonist	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B	Launched
felbinac	cyclooxygenase inhibitor	CTSL	Launched
felbinac-ethyl	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
felodipine	calcium channel blocker	CACNA1C, CACNA1D, CACNA1F, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2, CALM1, CFTR, NR3C2, PDE1A, PDE1B, TNNC1, TNNC2	Launched
fenaclon			Preclinical
fenbendazole	tubulin polymerization inhibitor	TUBB	Launched
fenbufen	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
fenclonine-(+/-)	tryptophan hydroxylase inhibitor	PAH, TPH1, TPH2	Preclinical
fendiline	calcium channel blocker	HTR2B	Preclinical
fenigam	benzodiazepine receptor agonist	GABBR1, GABBR2	Launched
fenipentol	choleretic agent		Launched
fenobam	glutamate receptor antagonist	GRM5	Phase 2
fenofibrate	PPAR receptor agonist	MMP25, PPARA	Launched
fenofibric-acid	cytochrome P450 inhibitor	CLCN1, PPARA	Launched
fenoldopam	dopamine receptor agonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD4, DRD5	Launched
fenoprofen	prostaglandin inhibitor	PTGS1, PTGS2, SLC5A8	Launched
fenoterol	adrenergic receptor agonist	ADRB1, ADRB2, ADRB3	Withdrawn
fenoverine	acetylcholine receptor antagonist		Launched
fenoxaprop-p-ethyl		NOS2, NOS3	Preclinical
fenretinide	apoptosis stimulant, retinoid receptor agonist	RARA	Phase 3
fenspiride	bronchodilator		Launched
fenthion	cholinesterase inhibitor		Launched
fentiazac	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
fenticonazole	bacterial cell wall synthesis inhibitor		Launched
FERb-033	EGFR inhibitor	ERBB2	Preclinical
ferrostatin-1	ferroptosis inhibitor		Preclinical
ferulic-acid	antioxidant	CA1, CA12, CA14, CA2, CA4, CA6, CA9	Phase 2
fesoterodine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Launched
fexaramine	FXR agonist	NR1H4	Preclinical
fexinidazole			Phase 2/Phase 3
fexofenadine	histamine receptor antagonist	HRH1	Launched
FG-2216	hypoxia inducible factor prolyl hydroxylase inhibitor	EGLN1, EGLN2, HIF1A	Phase 2
FG-4592	hypoxia inducible factor prolyl hydroxylase inhibitor	EGLN2	Phase 3
FG-7142	GABA benzodiazepine site receptor inverse agonist		Preclinical
FGIN-1-27	inositol monophosphatase inhibitor	TSPO	Preclinical
FGIN-1-43	benzodiazepine receptor agonist	TSPO	Preclinical
FH-535	PPAR receptor antagonist, WNT signaling inhibitor	PPARD, PPARG	Preclinical
FH1	hepatocyte function enhancer		Preclinical
fiacitabine	DNA synthesis inhibitor		Phase 2
fidarestat	aldose reductase inhibitor	AKR1B1	Phase 3
fidaxomicin	RNA polymerase inhibitor		Launched
filanesib	kinesin inhibitor, kinesin-like spindle protein inhibitor	KIF11	Phase 3
filgotinib	JAK inhibitor	JAK1, JAK2, JAK3, TYK2	Phase 2
fimasartan	angiotensin receptor antagonist	AGTR1	Launched
finafloxacin	bacterial DNA gyrase inhibitor		Launched
finasteride	5 alpha reductase inhibitor	AKR1D1, SRD5A1, SRD5A2	Launched
fingolimod	immunosuppressant, sphingosine phosphate receptor agonist	S1PR1, S1PR5	Launched
fipexide	psychoactive drug		Withdrawn
FIPI	phospholipase inhibitor	PLD1, PLD2	Preclinical
fipronil	chloride channel blocker, GABA gated chloride channel blocker		Launched
firategrast	integrin antagonist	ITGA4	Phase 2
firocoxib	cyclooxygenase inhibitor	PTGS2	Launched
fisetin	Aurora kinase inhibitor	CDK6, FASN	Preclinical
FIT	opioid receptor agonist	OPRD1	Preclinical
FK-33-824	opioid receptor agonist	OPRM1	Phase 2
FK-3311	cyclooxygenase inhibitor	PTGS2	Phase 2
FK-866	niacinamide phosphoribosyltransferase inhibitor	NAMPT	Phase 2
FK-888	tachykinin antagonist	TACR1, TACR2	Phase 2
FK-962	somatostatin receptor agonist		Phase 2
flavin-adenine-dinucleotide		ACAD8, ACADM, ACADS, ACOX1, AIFM1, CYB5R1, CYB5R3, DAO, DLD, DPYD, ERO1LB, FDXR, GCDH, GFER, GSR, IL4I1, IVD, MAOA, MAOB, NOS1, NQO1, NQO2, POR, TXNRD1, XDH	Preclinical
flavoxate	acetylcholine receptor antagonist	CHRM1, CHRM2	Launched
flecainide	sodium channel blocker	KCNA5, KCNA7, SCN4A, SCN5A	Launched
fleroxacin	topoisomerase inhibitor		Launched
FLI-06	notch signaling inhibitor		Preclinical
flibanserin	serotonin receptor agonist	DRD4, HTR1A, HTR2A	Launched
flindokalner	potassium channel agonist	KCNMA1, KCNN4, KCNQ2, KCNQ4, KCNQ5	Phase 3
floctafenine	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
flopropione	serotonin receptor antagonist	HTR1A	Launched
florfenicol	protein synthesis inhibitor		Launched
flosequinan	phosphodiesterase inhibitor		Withdrawn
floxuridine	DNA synthesis inhibitor	TYMS	Launched
flubendazole	tubulin polymerization inhibitor	TUBB	Launched
flucloxacillin	bacterial cell wall synthesis inhibitor		Launched
fluconazole	sterol demethylase inhibitor	CYP51A1	Launched
flucytosine	other antifungal	DNMT1	Launched
fludarabine	ribonucleotide reductase inhibitor	ADA, RRM1, RRM2	Launched
fludarabine-phosphate	ribonucleotide reductase inhibitor	DCK, POLA1, POLD1, POLE, RRM1, RRM2, RRM2B	Launched
fludrocortisone-acetate		AR, NR3C1, NR3C2	Launched
fludroxycortide	glucocorticoid receptor agonist	NR3C1, SERPINA6	Launched
flufenamic-acid	chloride channel blocker	AKR1C3, ANO1, AR, GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, PANX1, PANX2, PANX3, PKD2L1, PTGS1, PTGS2, TRPC5, TRPM2, TRPM5	Preclinical
flumatinib	Bcr-Abl kinase inhibitor	ABL1, PDGFRB	Phase 3
flumazenil	benzodiazepine receptor antagonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ	Launched
flumecinol			Launched
flumequine	topoisomerase inhibitor		Launched
flumethasone	glucocorticoid receptor agonist	NR3C1, PLA2G1B	Launched
flumethasone-pivalate	glucocorticoid receptor agonist	NR3C1, SERPINA6	Launched
flumexadol			Preclinical
flunarizine	calcium channel blocker	CACNA1G, CACNA1H, CACNA1I, CALM1, HRH1	Launched
flunisolide	cytochrome P450 inhibitor	NR3C1	Launched
flunixin-meglumin	prostanoid receptor antagonist		Launched
fluocinolone-acetonide	glucocorticoid receptor agonist	NR3C1, SERPINA6	Launched
fluocinonide	glucocorticoid receptor agonist	NR3C1, SERPINA6, SMO	Launched
fluorescein		SLC22A6	Launched
fluorometholone	glucocorticoid receptor agonist	NR3C1	Launched
fluorometholone-acetate		NR3C1	Launched
fluoromethylcholine			Launched
fluoxetine	selective serotonin reuptake inhibitor (SSRI)	ANO1, HTR2B, SLC6A4	Launched
fluoxymesterone	androgen receptor modulator	AR, ESR1, NR3C1, PRLR	Launched
flupentixol	dopamine receptor antagonist	ADRA1A, CHRM1, DRD1, DRD2, DRD3, DRD5, HTR2A	Launched
fluphenazine	dopamine receptor antagonist	CALM1, DRD1, DRD2, DRD5, HRH1, HTR2A, HTR6, HTR7	Launched
fluphenazine-decanoate	dopamine receptor antagonist	DRD2, HTR1B, HTR4	Launched
flupirtine	glutamate receptor antagonist	ADRA2A, KCNQ1, KCNQ2	Launched
fluprazine	serotonin receptor agonist	HTR1A, HTR1B	Phase 1
flurbiprofen-(+/-)	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
flurbiprofen-(S)-(+)	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
flurizan	gamma secretase inhibitor	APH1B, BACE1, IKBKG, PSEN1, PSEN2, PTGS1, PTGS2	Phase 3
flurofamide	urease inhibitor		Preclinical
flurothyl			Preclinical
fluroxene	local anesthetic		Preclinical
fluspirilene	dopamine receptor antagonist	CACNG1, DRD2, HRH1, HTR1A, HTR1D, HTR1E, HTR2A	Launched
flutamide	androgen receptor antagonist	AHR, AR	Launched
fluticasone-propionate	glucocorticoid receptor agonist	NR3C1, NR3C2, PGR, PLA2G4A	Launched
flutrimazole	sterol demethylase inhibitor		Launched
fluvastatin	HMGCR inhibitor	HMGCR	Launched
fluvoxamine	selective serotonin reuptake inhibitor (SSRI)	SLC6A4	Launched
fmoc-l-leucine	PPAR receptor agonist		Phase 2
folic-acid	folate receptor ligand	FOLR2, FOLR3, SLC19A1, SLC46A1	Launched
fomepizole	alcohol dehydrogenase inhibitor	ADH1A, ADH1B, ADH1C, AKR1A1, CAT	Launched
fomocaine	voltage-gated sodium channel modulator		Launched
foretinib	VEGFR inhibitor	FLT1, FLT4, KDR, MET	Phase 2
formestane	aromatase inhibitor	CYP19A1	Launched
formononetin	alcohol dehydrogenase inhibitor	ADH1C, SLC5A2	Preclinical
formoterol	adrenergic receptor agonist	ADRB2	Launched
forodesine	purinergic receptor antagonist	PNP	Phase 2
foropafant	platelet activating factor receptor antagonist	PTAFR	Phase 3
forskolin	adenylyl cyclase activator	ADCY2, ADCY5, GNAS	Launched
fosamprenavir	HIV protease inhibitor		Launched
fosaprepitant-dimeglumine	tachykinin antagonist	TACR1	Launched
fosbretabulin	tubulin polymerization inhibitor, VE-cadherin antagonist	CDH5	Phase 3
foscarnet	DNA polymerase inhibitor		Launched
fosfestrol	synthetic estrogen	ESR1, ESR2	Launched
fosfomycin	bacterial cell wall synthesis inhibitor		Launched
fosfosal	phosphodiesterase inhibitor	PTGS1, PTGS2	Launched
fosfructose	fructose diphosphate stimulant	PKLR	Phase 3
fosinopril	angiotensin converting enzyme inhibitor	ACE	Launched
fosinoprilat	angiotensin converting enzyme inhibitor	ACE	Launched
fosphenytoin	sodium channel blocker	SCN5A	Launched
fostamatinib	SYK inhibitor	SYK	Launched
fotemustine	thioredoxin inhibitor	TXNRD1	Launched
foxy-5	WNT5a peptide mimetic	WNT5A	Phase 1
FPA-124	AKT inhibitor		Preclinical
FPH1-(BRD-6125)	hepatocyte function enhancer		Preclinical
FPL-12495	glutamate receptor antagonist		Phase 1
FPL-55712	leukotriene receptor antagonist		Phase 1
FPL-62064	cyclooxygenase inhibitor, lipoxygenase inhibitor		Phase 2
FPL-64176	calcium channel activator	CACNA1C, CACNA1S	Preclinical
FPS-ZM1	RAGE receptor antagonist	AGER	Preclinical
FR-122047	cyclooxygenase inhibitor		Preclinical
FR-139317	endothelin receptor antagonist	EDNRA	Phase 1
FR-180204	MAP kinase inhibitor	MAPK1, MAPK3	Preclinical
FRAX486	serine/threonine kinase inhibitor	PAK1, PAK2, PAK3, PAK4	Preclinical
frentizole	immunosuppressant		Phase 1
frovatriptan	serotonin receptor agonist	HTR1A, HTR1B, HTR1D	Launched
fruquintinib	VEGFR inhibitor	KDR	Phase 3
ftaxilide			Preclinical
ftorafur	thymidylate synthase inhibitor	TYMS	Launched
fudosteine	mucolytic agent		Launched
fulvestrant	estrogen receptor antagonist	ESR1, ESR2, GPER1	Launched
fumagillin	methionine aminopeptidase inhibitor	METAP2	Launched
furaltadone	bacterial DNA inhibitor		Launched
furamidine	protein arginine N-methyltransferase inhibitor	PRMT1	Preclinical
furazolidone	bacterial DNA inhibitor		Launched
furegrelate	thromboxane synthase inhibitor	TBXAS1	Phase 1
furosemide	diuretic	CA2, GPR35, SLC12A1, SLC12A2	Launched
fursultiamine	vitamin B		Launched
fusidic-acid	bacterial 30S ribosomal subunit inhibitor		Launched
F351	TGF beta receptor inhibitor	TGFB1	Phase 2
g-caryophyllene	acetylcholinesterase inhibitor	ACHE	Preclinical
G-1	G protein-coupled receptor agonist	GPER1	Preclinical
G-15	estrogen receptor antagonist	GPER1	Preclinical
GABA-linoleamide	benzodiazepine receptor agonist		Phase 2
gabapentin	calcium channel blocker	ADORA1, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1E, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CACNG2, CACNG3, CACNG4, CACNG5, CACNG6, CACNG7, CACNG8, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B	Launched
gabapentin-enacarbil	adrenergic receptor agonist	CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1E, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CACNG2, CACNG3, CACNG4, CACNG5, CACNG6, CACNG7, CACNG8	Launched
gabazine	GABA receptor antagonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRG2	Preclinical
gabexate	serine protease inhibitor	PRSS1, TPSAB1	Launched
gaboxadol	benzodiazepine receptor agonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRD, GABRR1, GABRR2, GABRR3	Phase 3
gadobutrol	radiopaque medium		Launched
gadodiamide	radiopaque medium		Launched
gadopentetic-acid	contrast agent		Launched
gadoterate-meglumine	radiopaque medium		Launched
gadoteridol	radiopaque medium		Launched
galantamine	acetylcholinesterase inhibitor	ACHE, BCHE, CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG	Launched
galeterone	androgen receptor modulator	AR, CYP17A1	Phase 3
gallamine-triethiodide	acetylcholine receptor antagonist	ACHE, CHRM2, CHRNA1, CHRNA2	Launched
gallic-acid	beta amyloid protein neurotoxicity inhibitor, PPAR receptor agonist	CA1, CA12, CA14, CA2, CA4, CA6, CA9, SELP	Preclinical
gallium-triquinolin-8-olate			Phase 1
gallopamil	L-type calcium channel blocker	ATP2A2	Launched
gambogic-acid	caspase activator	BCL2	Phase 2
gamma-aminobutyric-acid	benzodiazepine receptor agonist	GABBR1, GABBR2, GABRA1, GABRA2, GABRA3, GABRA5, GABRB2, GABRG2, GATM, KCTD12, KCTD16, KCTD8, SLC6A1	Preclinical
gamma-linolenic-acid	cyclooxygenase inhibitor, prostanoid receptor agonist	PTGS1, PTGS2	Phase 2
ganaxolone	GABA receptor modulator	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6	Phase 3
ganciclovir	DNA polymerase inhibitor		Launched
ganetespib	HSP inhibitor	HSP90AA1	Phase 3
ganglioside-gm1			Phase 2
GANT-58	GLI antagonist	GLI1	Preclinical
GANT-61	GLI antagonist	GLI1, GLI2	Preclinical
garenoxacin	topoisomerase inhibitor	TOP2A	Launched
gastrodin			Phase 2
gatifloxacin	bacterial DNA gyrase inhibitor		Withdrawn
gavestinel	glutamate receptor antagonist	GLRB	Phase 3
GBR-12783	dopamine uptake inhibitor		Preclinical
GBR-12935	dopamine uptake inhibitor	AGTR1, SLC6A3	Preclinical
GBR-13069	dopamine uptake inhibitor	SLC6A3	Preclinical
GDC-0068	AKT inhibitor	AKT1, AKT2, AKT3, PRKG1	Phase 2
GDC-0152	XIAP inhibitor	BIRC2, BIRC3, BIRC7, XIAP	Phase 1
GDC-0349	Pim kinase inhibitor	PIK3CA	Phase 1
GDC-0623	MEK inhibitor		Phase 1
GDC-0810	selective estrogen receptor destabilizer	ESR1	Phase 2
GDC-0834	Bruton's tyrosine kinase (BTK) inhibitor	BTK	Phase 1
GDC-0879	RAF inhibitor	BRAF	Preclinical
GDC-0941	PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG	Phase 2
GDC-0980	mTOR inhibitor, PI3K inhibitor	FGR, MAP3K9, MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, SYK	Phase 2
GDC-0994	MAP kinase inhibitor	MAPK1, MAPK3	Phase 1
gedunin	HSP inhibitor	HSP90AA1	Preclinical
gefitinib	EGFR inhibitor	EGFR	Launched
geldanamycin	HSP inhibitor	HSP90AA1, HSP90AB1	Preclinical
gemcadiol	antilipemic		Phase 2
gemcitabine	ribonucleotide reductase inhibitor	CMPK1, RRM1, RRM2, TYMS	Launched
gemcitabine-elaidate	DNA synthesis inhibitor, apoptosis inhibitor	CMPK1, RRM1, TYMS	Phase 1
gemfibrozil	lipoprotein lipase activator	LPL, PPARA, SLCO1B1, SLCO1B3, SLCO2B1	Launched
gemifloxacin	bacterial DNA gyrase inhibitor		Launched
genipin	choleretic agent		Preclinical
geniposide	GLP receptor agonist	GLP1R	Preclinical
geniposidic-acid	cyclooxygenase inhibitor		Preclinical
genistein	tyrosine kinase inhibitor	CFTR, ESR1, ESR2, ESRRA, ESRRB, ESRRG, NCOA1, NCOA2, PPARG, PTK2B, TOP2A, TRPC5	Phase 2/Phase 3
gentamycin	bacterial 50S ribosomal subunit inhibitor	HSPA8, LRP2	Launched
gentiopicrin	glutamate receptor downregulator	GRIN2B	Phase 3
genz-123346	glucosylceramidase inhibitor	UGCG	Preclinical
genz-644282	topoisomerase inhibitor	TOP1	Phase 1
gepefrine	adrenergic receptor agonist		Launched
gepon			Phase 1
geranyl-farnesylacetate	mucin production enhancer		Phase 2
gestodene	contraceptive agent		Launched
gestrinone	progesterone receptor antagonist	AR, ESR1, PGR	Launched
GF109203X	PKC inhibitor	PDPK1, PIM1, PRKCI, PRKCZ	Preclinical
GGsTop	gamma glutamyltransferase Inhibitors	GGT1	Preclinical
GGTI-298	GGTase inhibitor	CDKN1A	Preclinical
gidazepam	GABA benzodiazepine site receptor agonist		Launched
gilteritinib	FLT3 inhibitor	FLT3	Phase 3
gimeracil	dihydropyrimidine dehydrogenase inhibitor	DPYD	Launched
ginkgolide-a	GABA receptor antagonist	GLRA1, GLRB	Preclinical
ginkgolide-b	platelet activating factor receptor antagonist	GLRA1, GLRA2, GLRA3, GLRB, HTR3A, HTR3B	Phase 3
ginsenoside-c-k	NFkB pathway inhibitor, nitric oxide synthase inhibitor	PTGS2	Preclinical
ginsenoside-rd	calcium channel blocker		Phase 3
ginsenoside-rg3	angiogenesis inhibitor, apoptosis stimulant	KCNH2	Launched
givinostat	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9	Phase 2
GKA-50	glucokinase activator	GCK	Preclinical
GKT137831	NADPH oxidase inhibitor	NOX1, NOX4	Phase 2
GK921	transglutaminase inhibitor	TGM2	Preclinical
glafenine	DeltaF508-CFTR Correctors	CFTR	Withdrawn
glasdegib	hedgehog pathway inhibitor	SMO	Phase 2
gliclazide	ATP channel blocker, insulin secretagogue	ABCC8, VEGFA	Launched
glimepiride	insulin secretagogue	ABCC8, KCNJ1, KCNJ11	Launched
glipizide	sulfonylurea	ABCC8, KCNJ10, KCNJ11, PPARG	Launched
gliquidone	sulfonylurea	ABCC8, KCNJ10, KCNJ8	Launched
GLPG0492	androgen receptor modulator	AR	Phase 1
GLPG0492-R-enantiomer	androgen receptor modulator	AR	Phase 1
glucaric-acid			Phase 1
gluconolactone		LCT	Launched
glucosamine	glycosylated protein precursor	IFNG, IL1B, MMP9, NFKB2, TNF	Launched
glutamine-(l)		CTPS1, GLUL, GPRC6A, PPAT	Launched
glutathione	antioxidant	ESD, GGT1, GLO1, GLRX, GLRX2, GPX1, GPX2, GPX3, GPX4, GPX5, GPX6, GPX7, GPX8, GSR, GSS, GSTA1, GSTA2, GSTA3, GSTA4, GSTA5, GSTK1, GSTM1, GSTM2, GSTM3, GSTM4, GSTM5, GSTO1, GSTO2, GSTP1, GSTT1, GSTZ1, HAGH, HPGDS, LTC4S, MGST1, MGST2, MGST3, TXNDC12	Phase 3
glutathione-monoisopropyl-ester	lipid peroxidase inhibitor		Phase 2
gly-gln			Phase 2
glyburide	ATP channel blocker, insulin secretagogue, sulfonylurea	ABCA1, ABCB11, ABCC8, ABCC9, CFTR, CPT1A, KCNJ1, KCNJ11, KCNJ5, KCNJ8, SLCO2B1	Launched
glycerol-monolaurate	beta lactamase inhibitor		Launched
glycitein	tumor necrosis factor release inhibitor	TNF	Phase 3
glycopyrrolate	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Launched
GMX1778	NAMPT inhibitor	NAMPT	Phase 1/Phase 2
GNF-2	Bcr-Abl kinase inhibitor	ABL1, BCR	Preclinical
GNF-5	Bcr-Abl kinase inhibitor	ABL1, BCR	Preclinical
GNF-5837	growth factor receptor inhibitor	NTRK1, NTRK2, NTRK3	Preclinical
GNF-7	protein kinase inhibitor, glucokinase inhibitor	GCK, TNK2	Preclinical
GNTI	opioid receptor antagonist	OPRK1, OPRM1	Preclinical
go-6983	protein kinase inhibitor	PRKCA, PRKCB, PRKCD, PRKCG, PRKCZ	Preclinical
golgicide-a	ARF inhibitor	GBF1	Preclinical
golvatinib	VEGFR inhibitor	KDR, MET	Phase 2
gonadorelin	gonadotropin releasing factor hormone receptor agonist	GNRHR, GNRHR2	Launched
goserelin-acetate	gonadotropin releasing factor hormone receptor agonist	GNRHR, LHCGR	Launched
gossypol	BCL inhibitor, MCL1 inhibitor	BCL2	Phase 2
GPBAR-A	G protein coupled receptor agonist	GPBAR1	Preclinical
GPI-1046	FKBP inhibitor	FKBP1A	Preclinical
GPi-688	glycogen phosphorylase inhibitor		Preclinical
GPP-78	NAMPT inhibitor	NAMPT	Preclinical
GPR120-modulator-1	G protein-coupled receptor modulator	FFAR4	Preclinical
GP1a	cannabinoid receptor agonist	CNR2	Preclinical
GP2a	cannabinoid receptor agonist	CNR2	Preclinical
GR-103691	dopamine receptor antagonist	DRD3	Preclinical
GR-113808	serotonin receptor antagonist	HTR4	Preclinical
GR-127935	serotonin receptor antagonist	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR6	Preclinical
GR-135531	melatonin receptor agonist		Preclinical
GR-144053	integrin antagonist	ITGA2B, ITGB3	Preclinical
GR-159897	tachykinin antagonist	TAC1, TACR2	Preclinical
GR-235	estrogen receptor agonist, FXR antagonist, progesterone receptor agonist	NR1H4	Launched
GR-79236	adenosine receptor agonist	ADORA1, ADORA2A	Phase 1
gramicidin	bacterial permeability inducer		Launched
gramine	norepinephrine reputake inhibitor		Preclinical
granisetron	serotonin receptor antagonist	HTR3A	Launched
grapiprant	prostaglandin inhibitor	PTGER4	Launched
grazoprevir	HCV inhibitor		Launched
griseofulvin	tubulin polymerization inhibitor	KRT12	Launched
GR125487	serotonin receptor antagonist	HTR4	Preclinical
GR46611	serotonin receptor agonist	HTR1D	Preclinical
GS-143	ubiquitin ligase inhibitor	BTRC, NFKBIA	Preclinical
GS-39783	GABA receptor modulator	GABBR1	Preclinical
GS-6201	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Phase 1
GS-9620	toll-like receptor agonist	TLR7	Phase 2
GS-9973	syk inhibitor	SYK	Phase 2
GSK-J1	histone demethylase inhibitor	KDM6B	Preclinical
GSK-J2	histone demethylase inhibitor		Preclinical
GSK-J4	histone lysine demethylase inhibitor	KDM6A, KDM6B	Preclinical
GSK-J5	histone demethylase control		Preclinical
GSK-LSD-1	histone lysine demethylase inhibitor	KDM1A	Preclinical
GSK-0660	PPAR receptor antagonist	PPARD	Preclinical
GSK-1562590	urotensin receptor antagonist	UTS2R	Preclinical
GSK-2193874	transient receptor potential channel antagonist	TRPV4	Preclinical
GSK-2837808A	lactate dehydrogenase inhibitor	LDHA	Preclinical
GSK-3-inhibitor-IX	glycogen synthase kinase inhibitor, lipoxygenase inhibitor	GSK3A, GSK3B	Preclinical
GSK-37647	free fatty acid receptor agonist	FFAR4	Preclinical
GSK1059615	PI3K inhibitor	PIK3CG	Phase 1
GSK1070916	Aurora kinase inhibitor	AURKA, AURKB, AURKC, CYP2D6, CYP3A4	Phase 1
GSK1292263	glucose dependent insulinotropic receptor agonist	GRPR	Phase 2
GSK163090	serotonin receptor antagonist	HTR1A, HTR1B, HTR1D	Phase 2
GSK1838705A	insulin growth factor receptor inhibitor	ALK, IGF1R, INSR, RPS6KA1	Preclinical
GSK1904529A	IGF-1 inhibitor, insulin growth factor receptor inhibitor, insulin receptor ligand	IGF1R, INSR	Preclinical
GSK2110183	AKT inhibitor	AKT1, AKT2, AKT3	Phase 2
GSK2126458	mTOR inhibitor, PI3K inhibitor	MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG	Phase 1
GSK2190915	lipoxygenase inhibitor	ALOX5AP	Phase 2
GSK2194069	fatty acid synthase inhibitor	FASN	Preclinical
GSK2256294A	epoxide hydolase inhibitor	EPHX2	Phase 1
GSK2330672	bile acid transporter inhibitor	SLC10A2	Phase 2
GSK2334470	phosphoinositide dependent kinase inhibitor	AURKA, AURKB, PDPK1	Preclinical
GSK256066	phosphodiesterase inhibitor	PDE4A	Phase 2
GSK2578215A	leucine rich repeat kinase inhibitor	LRRK2	Preclinical
GSK2606414	protein kinase inhibitor	EIF2AK3, MYLK2	Preclinical
GSK2636771	PI3K inhibitor	PIK3CB	Phase 2
GSK2656157	PERK inhibitor		Preclinical
GSK269962	rho associated kinase inhibitor	ROCK1, ROCK2	Preclinical
GSK2801	bromodomain inhibitor	BAZ2A, BAZ2B	Preclinical
GSK2816126	histone lysine methyltransferase inhibitor	EZH2	Phase 1
GSK2830371	protein phosphatase inhibitor	PPM1D	Preclinical
GSK2838232	HIV gag inhibitor		Phase 1
GSK2879552	histone lysine demethylase inhibitor	KDM1A	Phase 1
GSK3787	PPAR receptor antagonist	PPARD	Preclinical
GSK429286A	rho associated kinase inhibitor	ROCK1	Preclinical
GSK461364	PLK inhibitor	PLK1	Phase 1
GSK503	histone lysine methyltransferase inhibitor	EZH2	Preclinical
GSK650394	serum/glucocorticoid regulated kinase inhibitor	SGK1, SGK2	Preclinical
GSK690693	AKT inhibitor	AKT1, AKT2, AKT3, PAK4, PAK6, PAK7, PRKCQ, PRKG1, PRKX	Phase 1
GSK9027	glucocorticoid receptor agonist	NR3C1	Preclinical
GSK923295	centromere associated protein inhibitor	CENPE	Phase 1
GTP-14564	FLT3 inhibitor, tyrosine kinase inhibitor	CSF1R, FLT3, KIT, PDGFRB	Preclinical
GTS21	cholinergic receptor agonist	CHRNA7	Phase 1/Phase 2
guacetisal	immunosuppressant		Launched
guaiacol	local anesthetic	CA2	Launched
guaifenesin	expectorant		Launched
guanaben-acetate	adrenergic receptor agonist	ADRA2A, ADRA2B, ADRA2C	Launched
guanadrel	adrenergic inhibitor	SLC6A2	Launched
guanethidine	adrenergic inhibitor	SLC6A2	Launched
guanfacine	adrenergic receptor agonist	ADRA2A, ADRA2B, ADRA2C	Launched
guanidine	HSP inhibitor	ALDH2, DLG4, GAMT, RNASE1	Launched
guanidinoethyldisulfide-bicarbonate	nitric oxide synthase inhibitor	NOS2	Phase 2
guanidinopropionic-acid	creatine kinase inhibitor	CKM	Phase 2
guanosine		PNP	Preclinical
Gue-1654	oxoeicosanoid receptor modulator	OXER1	Preclinical
guvacine	GABA uptake inhibitor	SLC6A1, SLC6A11, SLC6A12, SLC6A13	Preclinical
GW-0742	PPAR receptor agonist	PPARD	Preclinical
GW-1100	G protein-coupled receptor agonist	FFAR1	Preclinical
GW-1929	PPAR receptor agonist	PPARG	Preclinical
GW-2580	cFMS kinase inhibitor	CSF1R	Preclinical
GW-311616	leukocyte elastase inhibitor, elastase inhibitor	ELANE	Phase 1
GW-3965	LXR agonist	NR1H2, NR1H3	Preclinical
GW-405833	cannabinoid receptor agonist	CNR2	Preclinical
GW-4064	FXR agonist	NR1H4	Preclinical
GW-438014A	neuropeptide receptor antagonist	NPY5R	Preclinical
GW-441756	growth factor receptor inhibitor	NTRK1	Preclinical
GW-501516	PPAR receptor agonist	PPARA, PPARD	Phase 2
GW-5074	RAF inhibitor, leucine rich repeat kinase inhibitor	NTRK1, RAF1	Preclinical
GW-542573X	calcium channel activator	KCNN1	Preclinical
GW-583340	EGFR inhibitor	EGFR, ERBB2	Preclinical
GW-627368	prostanoid receptor antagonist	PTGER4	Preclinical
GW-6471	PPAR receptor antagonist	PPARA	Preclinical
GW-7647	PPAR receptor agonist	PPARA	Preclinical
GW-788388	ALK tyrosine kinase receptor inhibitor	LCK, MAPK14, TGFBR1	Preclinical
GW-803430	melanin inhibitor	KCNH2, MCHR1	Phase 1
GW-842166	cannabinoid receptor agonist	CNR2	Phase 2
GW-843682X	PLK inhibitor	PLK1, PLK3	Preclinical
GW-9508	free fatty acid receptor agonist, G protein-coupled receptor agonist	FFAR1, FFAR4	Preclinical
GW-9662	PPAR receptor antagonist	NCOA2, PPARG, RXRA	Preclinical
GYKI-52466	glutamate receptor antagonist	GRIA1, GRIA2, GRIA3, GRIA4	Preclinical
gynostemma-extract	calcium channel modulator		Preclinical
GZD824	Bcr-Abl kinase inhibitor	ABL1, BCR	Preclinical
G007-LK	tankyrase inhibitor	TNKS, TNKS2	Preclinical
H-89	PKA inhibitor	GSG2, PKIA, PRKACA	Preclinical
HA-1004	calcium channel blocker		Phase 2
HA-130	autotaxin inhibitor	ENPP2	Preclinical
HA-14-1	BCL inhibitor	BCL2	Preclinical
HA-966-(R)-(+)	glutamate receptor agonist	GRIA1	Preclinical
HA-966-(S)-(-)	glutamate receptor antagonist	GRIA1	Preclinical
halazone			Launched
halcinonide	glucocorticoid receptor agonist	NR3C1	Launched
halobetasol-propionate	glucocorticoid receptor agonist	NR3C1, PLA2G1B	Launched
halofantrine	antimalarial agent	KCNH2, KCNN4	Launched
halofuginone	collagenase inhibitor	COL1A1, MMP2	Launched
halopemide	phospholipase inhibitor	PLD1, PLD2	Phase 2
haloperidol	dopamine receptor antagonist	DRD1, DRD2, DRD3, DRD4, DRD5, GRIN2B, HRH1, HTR1A, HTR1D, HTR2A, HTR2B, HTR7, KCNH1	Launched
haloperidol-decanoate	psychoactive drug	DRD2, DRD3, DRD4, HTR2A	Launched
haloprogin	other antifungal		Launched
halothane	glutamate receptor antagonist	ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GNG2, GRIN2A, GRIN3A, GRIN3B, KCNJ3, KCNJ6, KCNK10, KCNK12, KCNK13, KCNK15, KCNK18, KCNK2, KCNK3, KCNK9, KCNMA1, KCNN4, MT-ND1, NPSR1, RHO	Launched
harmane	monoamine oxidase inhibitor	MAOA, MAOB	Preclinical
harringtonine	protein synthesis inhibitor		Phase 3
HA14-1	BCL inhibitor	BCL2	Preclinical
HC-030031	TRPA1 channel blocker	TRPA1	Phase 1
HC-067047	transient receptor potential channel antagonist	TRPV4	Preclinical
heclin	ubiquitin ligase inhibitor	NEDD4, SMURF2, WWP1	Preclinical
HEMADO		ADORA1, ADORA2A, ADORA2B, ADORA3	Preclinical
hematoporphyrin			Launched
hematoxylin			Preclinical
hemin	enzyme inducer		Launched
hemoglobin-modulators-1	hemoglobin modulator		Phase 3
hemomex-s		PPARG	Launched
heptaminol	vasoconstrictor		Launched
HER2-Inhibitor-1	EGFR inhibitor		Preclinical
hesperadin	Aurora kinase inhibitor	AURKB	Preclinical
hesperetin	ACAT inhibitor	DGAT1, MTTP, SOAT1, SOAT2	Launched
hesperidin	flavanone glycoside	CACNA1B	Launched
hetacillin	bacterial cell wall synthesis inhibitor		Launched
hexachlorophene	potassium channel activator	GLUD1, SDHD	Launched
hexamethonium	cholinergic receptor antagonist	CHRNA2, CHRNA3, CHRNA4, CHRNA6	Preclinical
hexamethylenebisacetamide	AKT inhibitor, differentiation inducer, NFKB pathway inhibitor	AKT1	Phase 2
hexaminolevulinate			Launched
hexasodium-phytate			Phase 2
hexestrol	synthetic estrogen	AKR1C1, ESR1, ESR2	Launched
hexetidine	local anesthetic		Launched
hexonic-acid			Preclinical
hexoprenaline	adrenergic receptor agonist	ADRB2	Launched
hexylcaine	sodium channel blocker	SCN10A, SCN5A	Launched
hexylene-glycol		AKR1C3, CTPS1, DLG4, HSP90AA1, NOS3, PGF, PLA2G1B, PTPN1, SELP	Preclinical
hexylresorcinol	local anesthetic	TYR	Launched
higenamine	adrenergic receptor agonist	ADRB2	Phase 1
hippuric-acid			Preclinical
histamine	histamine receptor agonist	HRH1, HRH2, HRH3, HRH4	Launched
HJC-0350	GTPase inhibitor	RAPGEF4	Preclinical
HKI-357	EGFR inhibitor	EGFR	Phase 1
HLCL-61	protein arginine N-methyltransferase inhibitor	PRMT5	Preclinical
HMN-214	PLK inhibitor	PLK1	Phase 1
homatropine	acetylcholine receptor antagonist	CES1, CHRM1	Launched
homatropine-methylbromide	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Launched
homidium			Preclinical
homochlorcyclizine	antihistamine	HRH1	Launched
homoharringtonine	protein synthesis inhibitor	RPL3	Launched
homoquinolinic-acid	glutamate receptor agonist	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D	Preclinical
homosalate	HSP inducer		Preclinical
homoveratrylamine	dopamine analog		Preclinical
honokiol	AKT inhibitor	ALOX5, PTGS1, PTGS2	Phase 3
hordenine			Preclinical
HQK-1001			Phase 2
HTH-01-015	protein kinase inhibitor	NUAK1	Preclinical
HTMT	histamine receptor agonist	HRH4	Preclinical
huperzine-a	acetylcholinesterase inhibitor	ACHE	Phase 2
hyaluronic-acid		C1QBP, CD44, HABP2, HAPLN1, HAPLN3, HAPLN4, HMMR, ICAM1, NCAN, VCAN	Launched
hycanthone	RNA synthesis inhibitor		Launched
hydralazine	vasodilator	AOC3, P4HA1	Launched
hydrastine-(1r,-9s)	tyrosine hydroxylase inhibitor		Preclinical
hydrastinine	haemostatic agent		Preclinical
hydrochlorothiazide	thiazide diuretic	CA1, CA12, CA2, CA4, CA9, KCNMA1, SLC12A3	Launched
hydrocortisone	glucocorticoid receptor agonist		Launched
hydrocortisone-acetate	glucocorticoid receptor agonist	NR3C1, NR3C2	Launched
hydrocortisone-butyrate	glucocorticoid receptor agonist	NR3C1	Launched
hydrocortisone-hemisuccinate			Phase 2/Phase 3
hydrocortisone-phosphate		ANXA1, NOS2, NR3C1	Launched
hydrocortisone-valerate	glucocorticoid receptor agonist		Launched
hydroflumethiazide	sodium/potassium/chloride transporter inhibitor	ATP1A1, CA1, CA12, CA2, CA4, CA9, KCNMA1, SLC12A1, SLC12A3	Launched
hydroquinidine	antiarrhythmic		Launched
hydroquinone	melanin inhibitor	TYR	Launched
hydroxyamphetamine	trace amine associated receptor agonist	TAAR1	Launched
hydroxychloroquine	antimalarial agent	TLR7, TLR9	Launched
hydroxyfasudil	rho associated kinase inhibitor	PKIA, PRKACA, ROCK1	Preclinical
hydroxyprogesterone	progesterone receptor agonist	PGR	Launched
hydroxyprogesterone-acetate	progesterone receptor agonist	PGR	Launched
hydroxypropyl-beta-cyclodextrin			Phase 2
hydroxystilbamidine			Launched
hydroxytacrine-maleate-(r,s)	cholinesterase inhibitor	ACHE	Preclinical
hydroxytoluic-acid			Preclinical
hydroxyurea	ribonucleotide reductase inhibitor	RRM1, RRM2, RRM2B	Launched
hydroxyzine	antihistamine	HRH1	Launched
hygromycin-b	polypeptide synthesis inhibitor		Preclinical
hymecromone	monoamine oxidase inhibitor	MAOA, MAOB	Phase 2
hyodeoxycholic-acid	atherosclerosis formation inhibitor		Phase 1
hyoscyamine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4	Launched
hypericin	tyrosine kinase inhibitor		Phase 2
hyperin	aldose reductase inhibitor	ACE, AKR1B1	Preclinical
hypoestoxide	IKK inhibitor	IKBKB, IL1B, TNF	Phase 1
hypoxanthine	PARP inhibitor	PNP	Preclinical
H2L-5765834	lysophosphatidic acid receptor antagonist	LPAR1, LPAR3	Preclinical
I-BET-762	bromodomain inhibitor	BRD2, BRD3, BRD4	Phase 2
I-BET151	bromodomain inhibitor	BRD2, BRD3, BRD4	Preclinical
I-BRD9	bromodomain inhibitor	BRD9	Preclinical
I-BZA			Phase 2
I-BZA2			Phase 3
I-CBP-112	bromodomain inhibitor	CREBBP, EP300	Preclinical
IB-MECA	adenosine receptor agonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Phase 3
ibandronate	bone resorption inhibitor	FDPS	Launched
IBC-293	hydroxycarboxylic acid receptor agonist	HCAR3	Preclinical
IBMX	phosphodiesterase inhibitor	ADORA1, PDE2A, PDE3B, PDE4D, PDE5A, PDE6G, PDE7A, PDE8A, PDE9A	Preclinical
ibotenic-acid	glutamate receptor agonist	GRIN1	Phase 1
ibrolipim	lipoprotein lipase activator	LPL	Phase 2
ibrutinib	Bruton's tyrosine kinase (BTK) inhibitor	BLK, BMX, BTK	Launched
ibudilast	leukotriene receptor antagonist, phosphodiesterase inhibitor	IL1B, IL6, PDE3A, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A	Launched
ibuprofen	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
ibuprofen-(s)	cyclooxygenase inhibitor	ASIC1, BCL2, CFTR, FABP2, PLAT, PPARG, PTGS1, PTGS2, SLC5A8, THBD	Preclinical
ibuprofen-lysine	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
ibuprofen-piconol	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
ibuproxam	cyclooxygenase inhibitor, prostaglandin inhibitor	ALOX5	Launched
ibutamoren	growth hormone secretagogue receptor agonist	GHR, GHSR	Phase 2
ibutilide	potassium channel blocker	CACNA1C, CACNA2D1, CACNB1, CACNG1, KCNH2, KCNH6, KCNH7, KCNJ11, KCNK1, KCNK6	Launched
ICA-069673	voltage-gated potassium channel activator	KCNQ2, KCNQ3	Preclinical
ICA-110381	voltage-gated potassium channel activator	KCNQ2	Preclinical
ICA-121431	sodium channel blocker	SCN1A, SCN3A	Preclinical
icariin	phosphodiesterase inhibitor	PDE5A	Phase 3
icaritin	PPAR receptor antagonist	PDE5A	Phase 2
icatibant-acetate	bradykinin receptor antagonist	ANPEP, BDKRB2	Launched
ICG-001	beta-catenin inhibitor	CTNNB1	Preclinical
ICI-118,551	adrenergic receptor antagonist	ADRB2, ADRB3	Phase 2
ICI-162846	histamine receptor antagonist	HRH2	Phase 1
ICI-185,282	thromboxane receptor antagonist		Phase 1
ICI-192605	thromboxane receptor antagonist	TBXA2R	Phase 2
ICI-199441	opioid receptor agonist	CYP2D6, OPRD1, OPRK1, OPRM1, UTS2R	Preclinical
ICI-215,001	adrenergic receptor agonist	ADRB3	Preclinical
ICI-63197	phosphodiesterase inhibitor		Preclinical
ICI-89406	adrenergic receptor antagonist	ADRB1, ADRB2	Phase 1
icilin	TRPV agonist	TRPA1, TRPM8	Phase 1
icomucret	mucin production enhancer	LTB4R2	Phase 3
icosapent	platelet aggregation inhibitor	ACSL3, ACSL4, FADS1, FFAR1, PPARD, PPARG, PTGS1, PTGS2, SLC8A1, TRPV1	Launched
icotinib	EGFR inhibitor	EGFR	Launched
iCRT-14	WNT signaling inhibitor, beta catenin inhibitor	CTNNB1, TCF4	Preclinical
IC261	casein kinase inhibitor	CSNK1A1, CSNK1D, CSNK1E, CSNK1G2	Preclinical
ID-1101	insulin sensitizer	INS	Phase 1
ID-8			Preclinical
idalopirdine	serotonin receptor antagonist	HTR6	Phase 3
idarubicin	topoisomerase inhibitor	TOP2A	Launched
idasanutlin	MDM inhibitor	MDM2, TP53	Phase 3
idazoxan	adrenergic receptor antagonist	ADRA2A	Phase 3
idazoxane	adrenergic receptor antagonist	ADRA2A, ADRA2B, ADRA2C	Preclinical
idebenone	calcium channel modulator		Launched
idelalisib	PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG	Launched
idoxuridine	DNA directed DNA polymerase inhibitor		Launched
IDO5L	indoleamine 2,3-dioxygenase inhibitor	IDO1	Preclinical
IDRA-21	glutamate receptor positive allosteric modulator	GRIA1, GRIA2, GRIA3, GRIA4	Preclinical
idramantone			Preclinical
idronoxil	XIAP inhibitor	ENOX2, SPHK1	Phase 3
IEM1460	glutamate receptor antagonist	GRIA2	Preclinical
IEM1754	glutamate receptor antagonist	GRIA1	Preclinical
ifenprodil	adrenergic receptor antagonist, glutamate receptor antagonist	GRIN1, GRIN2B	Launched
ifosfamide	DNA alkylating agent	CYP2A6, CYP2B6, CYP2C18, CYP2C19, CYP2C8, CYP2C9, CYP3A4, CYP3A5, CYP3A7, PTGS1	Launched
igmesine	sigma receptor agonist	SIGMAR1	Phase 2
iguratimod	cyclooxygenase inhibitor, NFkB pathway inhibitor	PTGS2	Launched
IKK-16	IKK inhibitor	IKBKB	Preclinical
IKK-2-inhibitor	IKK inhibitor, SYK inhibitor	IKBKB	Preclinical
IKK-2-inhibitor-V	IKK inhibitor, NFkB pathway inhibitor	IKBKB	Phase 1
ilepcimide	anticonvulsant		Phase 3
ilomastat	matrix metalloprotease inhibitor	ACAN, ADAM28, MMP1, MMP12, MMP13, MMP14, MMP2, MMP3, MMP8, MMP9	Phase 3
iloperidone	dopamine receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA2C, DRD1, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR2A, HTR6, HTR7	Launched
iloprost	platelet aggregation inhibitor, prostanoid receptor agonist	PDE4A, PDE4B, PDE4C, PDE4D, PLAT, PTGDR, PTGER1, PTGER2, PTGER3, PTGER4, PTGFR, PTGIR, TBXA2R	Launched
imatinib	Bcr-Abl kinase inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor	ABL1, CSF1R, DDR1, KIT, NTRK1, PDGFRA, PDGFRB, RET	Launched
imeglimin	gluconeogenesis inhibitor		Phase 2
imetit	histamine receptor agonist	HRH3, HRH4	Preclinical
imexon	apoptosis stimulant, ribonucleotide reductase inhibitor	RRM1, RRM2	Phase 2
imidacloprid	acetylcholine receptor antagonist	CHRFAM7A	Launched
imidafenacin	acetylcholine receptor antagonist	CHRM1, CHRM3	Launched
imidapril	angiotensin converting enzyme inhibitor	ACE	Launched
imidurea	other antibiotic		Preclinical
imiloxan	adrenergic receptor antagonist	ADRA2A, ADRA2B	Phase 1
imipenem	bacterial cell wall synthesis inhibitor		Launched
imipramine	norepinephrine reputake inhibitor, serotonin reuptake inhibitor	ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD5, HRH1, HTR1A, HTR2A, HTR2C, HTR6, HTR7, KCND2, KCND3, KCNH1, KCNH2, SLC6A2, SLC6A3, SLC6A4	Launched
imiquimod	interferon inducer, toll-like receptor agonist	TLR7, TLR8	Launched
immepip	histamine receptor agonist	HRH3, HRH4	Preclinical
immethridine	histamine receptor agonist	HRH3	Phase 1
impentamine	histamine receptor antagonist	HRH3	Preclinical
IMREG-1			Phase 3
INC-280	c-Met inhibitor	MET	Phase 2
INCA-6	calcineurin inhibitor	NFATC1	Preclinical
INCB-003284	CC chemokine receptor antagonist		Phase 2
INCB-024360	indoleamine 2,3-dioxygenase inhibitor	IDO1	Phase 2
INCB-3284	CC chemokine receptor antagonist	CCR2	Phase 2
indacaterol	adrenergic receptor agonist	ADRB1, ADRB2	Launched
indalpine	selective serotonin reuptake inhibitor (SSRI)	SLC6A4	Withdrawn
indapamide	thiazide diuretic	KCNE1, KCNQ1, SLC12A3	Launched
indatraline	norepinephrine transporter inhibitor	MAOA, MAOB	Preclinical
indeloxazine	norepinephrine reuptake inhibitor, serotonin reuptake inhibitor		Withdrawn
indibulin	tubulin polymerization inhibitor		Phase 1/Phase 2
indinavir	HIV protease inhibitor	CYP3A4, CYP3A5, CYP3A7	Launched
indiplon	benzodiazepine receptor agonist	GABRA1	Phase 3
indirubin	CDK inhibitor, glycogen synthase kinase inhibitor	CDK1, CDK5, GSK3A	Phase 2/Phase 3
indirubin-3-monoxime	CDK inhibitor, glycogen synthase kinase inhibitor	CDK1, CDK2, CDK5, CDK5R1, GSK3B	Preclinical
indisulam	CDK inhibitor	CA1, CA12, CA14, CA2, CA6, CA7, CA9	Phase 2
indium(iii)-isopropoxide			Preclinical
indium-tri(2-propanolate)			Preclinical
indobufen	cyclooxygenase inhibitor, platelet aggregation inhibitor	PTGS1, PTGS2	Launched
indocyanine-green	contrast agent	SLCO1B1	Launched
indole-3-carbinol	aryl hydrocarbon receptor agonist, indoleamine 2,3-dioxygenase inhibitor	AHR	Phase 2/Phase 3
indole-3-pyrubate	melatonin receptor agonist		Phase 2
indomethacin	cyclooxygenase inhibitor	GLO1, PLA2G2A, PPARA, PPARG, PTGDR2, PTGR2, PTGS1, PTGS2, SLC46A1	Launched
indoprofen	cyclooxygenase inhibitor, prostanoid receptor antagonist	CXCR1, CXCR2, PTGS1, PTGS2	Withdrawn
indoramin	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2B, ADRA2C	Launched
indoximod	indoleamine 2,3-dioxygenase inhibitor	IDO1	Phase 2
ingenol-mebutate	PKC activator	PRKCA, PRKCB, PRKCD, PRKCE, PRKCG	Launched
INH1	Hec1 inhibitor	NDC80	Preclinical
inimur	other antifungal		Launched
iniparib	PARP inhibitor	PARP1	Phase 3
inosine	neurotrophic agent	PARP1, PNP	Launched
inositol	insulin sensitizer	CDIPT, GBA	Launched
inositol-hexanicotinate			Launched
INS316	purinergic receptor antagonist		Phase 2
INT-747	FXR agonist		Phase 3
INT-767	FXR agonist	GPBAR1	Phase 1
integrin-antagonist-1	integrin antagonist	ITGAV, ITGB6	Phase 1
iobenguane	antineoplastic agent		Launched
iocetamic-acid	radiopaque medium		Launched
iodipamide	radiopaque medium	ALB	Launched
iodixanol	radiopaque medium		Launched
iodoantipyrine			Preclinical
iododexetimide	acetylcholine receptor antagonist		Phase 2
iodophenpropit	histamine receptor antagonist	HRH3, HRH4	Preclinical
iodoquinol	antiseptic		Launched
iohexol	radiopaque medium		Launched
iopamidol	radiopaque medium		Launched
iopanic-acid	thyroid hormone inhibitor		Preclinical
iopodic-acid			Launched
iopromide	radiopaque medium		Launched
iothalamic-acid-d3	radiopaque medium		Preclinical
ioversol	radiopaque medium		Launched
IOWH032	CFTR channel antagonist	CFTR	Phase 2
ioxaglic-acid	radiopaque medium		Launched
ioxilan	radiopaque medium		Launched
IOX1	histone demethylase inhibitor	EGLN1, KDM3A, KDM4C, KDM6B	Preclinical
IOX2	hypoxia inducible factor inhibitor	EGLN1, KDM2A, KDM5C	Preclinical
IPA-3	p21 activated kinase inhibitor	PAK1	Preclinical
IPAG			Preclinical
IPI-145	PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG	Phase 3
ipidacrine	acetylcholinesterase inhibitor	ACHE	Phase 3
ipragliflozin-l-proline	sodium/glucose cotransporter inhibitor	SLC5A2	Launched
ipratropium	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Launched
ipriflavone	bone resorption inhibitor		Launched
iproniazid	monoamine oxidase inhibitor	MAOA, MAOB	Withdrawn
ipsapirone	serotonin receptor agonist	HTR1A	Phase 3
irbesartan	angiotensin receptor antagonist	AGTR1, JUN, SLC10A1	Launched
irinotecan	topoisomerase inhibitor	TOP1, TOP1MT	Launched
IRL-2500	endothelin receptor antagonist	EDNRB	Preclinical
irosustat	steroid sulfatase inhibitor	CA2, STS	Phase 2
irsogladine	phosphodiesterase inhibitor	PDE4A	Launched
isamoltane	adrenergic receptor antagonist	HTR1A, HTR1B	Phase 1
isavuconazole	cytochrome P450 inhibitor	CYP3A4	Phase 3
isaxonine	nerve growth factor agonist		Withdrawn
isbufylline	phosphodiesterase inhibitor		Phase 2
isepamicin	protein synthesis inhibitor		Launched
ISO-1	macrophage migration inhibiting factor inhibitor	MIF	Preclinical
isobutamben	local anesthetic		Preclinical
isobutyramide	gene expression stimulant	HBE1, HBG1	Phase 2
isocarboxazid	monoamine oxidase inhibitor	MAOA, MAOB	Launched
isoconazole	fungal lanosterol demethylase inhibitor	CYP17A1	Launched
isodibut	aldehyde reductase inhibitor		Phase 2
isoetharine	adrenergic receptor agonist	ADRB1, ADRB2	Launched
isofloxythepin	dopamine receptor antagonist		Phase 2
isoflupredone-acetate		NR3C1	Preclinical
isoflurane	inhaled anaesthetic	ATP2C1, ATP5D, CALM1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, KCNK10, KCNK18, KCNK2, KCNK3, KCNK9	Launched
isoflurophate	cholinesterase inhibitor	ACHE, BCHE	Launched
isoguvacine	benzodiazepine receptor agonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRR1, GABRR2, GABRR3	Preclinical
isoleucine		ACADSB, BCAT1, BCAT2, IARS, IARS2	Launched
isoliquiritigenin	guanylate cyclase activator	GABBR1	Preclinical
isometheptene-mucate		ADRA1A, SLC18A2	Launched
isoniazid	FABI inhibitor	CYP1A2, CYP2C19, CYP2C8, CYP2E1, CYP3A4	Launched
isopentyl-4-methoxycinnamate			Launched
isoprenaline	adrenergic receptor agonist	ADRB1, ADRB2, ADRB3, MAPK1, PIK3R1, PIK3R2, PIK3R3	Launched
isopropamide-iodide	acetylcholine receptor antagonist	CHRM3, CHRM4	Launched
isopropyl-myristate			Launched
isopropyl-palmitate	cosmetic moisturizer		Launched
isoquinoline,-6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro,			Preclinical
isosorbide	nitric oxide stimulant		Launched
isosorbide-dinitrate	nitric oxide stimulant	GUCY1A2, GUCY1A3, GUCY1B2, GUCY1B3, NPR1	Launched
isosorbide-mononitrate	nitric oxide stimulant	GUCY1A2, GUCY1A3, GUCY1B2, GUCY1B3	Launched
isosteviol			Phase 2
isotiquimide			Phase 1
isotretinoin	retinoid receptor agonist	RARA, RARB, RARG	Launched
isovaleramide	alcohol dehydrogenase inhibitor		Phase 2
isoxepac	anti-inflammatory agent		Phase 2
isoxicam	cyclooxygenase inhibitor	PTGS1, PTGS2	Withdrawn
isoxsuprine	adrenergic receptor agonist	ADRB2	Launched
ispinesib	kinesin inhibitor	KIF11	Phase 2
isradipine	calcium channel blocker	CACNA1C, CACNA1D, CACNA1F, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2	Launched
ISRIB	eukaryotic translation initiation factor inhibitor, PERK inhibitor	EIF2A, EIF2AK3	Preclinical
istaroxime	ATPase inhibitor	ATP1A1	Phase 2
istradefylline	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Launched
ISX-9	neural stem cell inducer	NEUROD1	Preclinical
itacitinib	JAK inhibitor	JAK1	Phase 2
ITD-1	TGF beta receptor inhibitor	TGFBR2	Preclinical
ITE	aryl hydrocarbon receptor agonist	AHR	Preclinical
ITI214	phosphodiesterase inhibitor	PDE1A	Phase 1
itopride	dopamine receptor antagonist	CHRM3, DRD2	Launched
itraconazole	cytochrome P450 inhibitor	CYP51A1	Launched
ITX3	GEF inhibitor	TRIO	Preclinical
IT1t	CC chemokine receptor antagonist	CXCR4	Preclinical
IU1	ubiquitin C-terminal hydrolase inhibitor	USP14	Preclinical
ivabradine	HCN channel antagonist, potassium channel blocker, sodium channel blocker	HCN1, HCN3, HCN4	Launched
ivacaftor	CFTR channel potentiator	CFTR	Launched
ivermectin	benzodiazepine receptor agonist	CHRNA7, GABRB3, GLRA3, P2RX7	Launched
ivosidenib	isocitrate dehydrogenase inhibitor	IDH1	Launched
IWP-L6	porcupine inhibitor	PORCN	Preclinical
ixabepilone	microtubule stabilizing agent	TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8	Launched
ixazomib	proteasome inhibitor		Launched
ixazomib-citrate	proteasome inhibitor		Launched
JAK3-inhibitor-V	JAK inhibitor	JAK3	Preclinical
JDTic	opioid receptor antagonist	OPRK1	Phase 1
JHW-007	dopamine uptake inhibitor	SLC6A3	Preclinical
JIB04	histone lysine demethylase inhibitor	KDM4E	Preclinical
JK-184	hedgehog pathway inhibitor		Preclinical
JLK-6	gamma secretase inhibitor	PSEN1	Preclinical
JNJ-10191584	histamine receptor antagonist	HRH4	Preclinical
JNJ-10397049	orexin receptor antagonist	HCRTR1, HCRTR2	Preclinical
JNJ-16259685	glutamate receptor antagonist	GRM1	Preclinical
JNJ-1661010	FAAH inhibitor	FAAH	Preclinical
JNJ-17203212	TRPV antagonist	TRPV1	Preclinical
JNJ-26481585	HDAC inhibitor	HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9, MDM2	Phase 2
JNJ-26990990	anticonvulsant		Phase 2
JNJ-27141491	CC chemokine receptor antagonist	CCR2	Preclinical
JNJ-37822681	dopamine receptor antagonist	DRD2	Phase 2
JNJ-38877605	tyrosine kinase inhibitor	MET	Phase 1
JNJ-40411813	glutamate receptor positive allosteric modulator	GRM2	Phase 2
JNJ-42041935	hypoxia inducible factor prolyl hydroxylase inhibitor	PDK2	Preclinical
JNJ-42165279	FAAH inhibitor	FAAH	Phase 2
JNJ-47965567	purinergic receptor antagonist	P2RX7	Preclinical
JNJ-63533054	G protein-coupled receptor agonist	GPR139	Preclinical
JNJ-7706621	CDK inhibitor	AURKA, AURKB, CDK1, CDK2	Preclinical
JNJ-7777120	histamine receptor antagonist	HRH4	Preclinical
josamycin	bacterial 50S ribosomal subunit inhibitor		Launched
JQ1-(+)	bromodomain inhibitor	BRD4, BRDT	Preclinical
JTC-801	opioid receptor antagonist	OPRL1	Phase 2
JTE-013	lysophospholipid receptor antagonist	P2RY10, S1PR2	Preclinical
JTE-607	cytokine production inhibitor	IL10, IL1B, IL6, TNF	Phase 2
JTE-907	cannabinoid receptor inverse agonist	CNR2	Phase 1
JW-55	tankyrase inhibitor	TNKS, TNKS2	Preclinical
JW-642	monoacylglycerol lipase inhibitor	MGLL	Preclinical
JW-67	Wnt pathway inhibitor	APC, AXIN1, GSK3B	Preclinical
JW-74	WNT signaling inhibitor, tankyrase inhibitor	TNKS, TNKS2	Preclinical
JX-401	p38 MAPK inhibitor	MAPK14	Preclinical
JZL-184	monoacylglucerol lipase inhibitor	MGLL	Preclinical
JZL-195	FAAH inhibitor, monoacylglycerol lipase inhibitor	FAAH, MGLL	Preclinical
K-MAP			Phase 2
K-Ras(G12C)-inhibitor-12	K-ras inhibitor	KRAS	Preclinical
K-Ras(G12C)-inhibitor-6	K-ras inhibitor		Preclinical
k-strophanthidin	ATPase inhibitor	ATP1A1	Phase 2
K-247			Phase 1
K-858	kinesin-like spindle protein inhibitor	KIF11	Preclinical
kaempferol	bone resorption inhibitor, estrogen-related receptor inverse agonist	AKR1B1, ALOX15B, ALOX5, AR, CYP1B1, GLO1, HSD17B1, UGT3A1	Preclinical
kainic-acid	kainate receptor agonist	GRIA1, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5	Preclinical
kakonein	GABA receptor antagonist, serotonin receptor antagonist		Phase 2
kanamycin	bacterial 30S ribosomal subunit inhibitor		Launched
kartogenin	chondrocyte differentiation stimulator	FLNA	Preclinical
KB-R7943	sodium/calcium exchange inhibitor	SLC8A1, TRPC3, TRPC5, TRPC6	Preclinical
KB-SRC-4	src inhibitor	SRC	Preclinical
KBG	neprilysin inhibitor	MME	Phase 2
KD-023	ACAT inhibitor	ACACA, ACACB	Phase 2
KD025	rho associated kinase inhibitor	ROCK2	Phase 2
kenpaullone	CDK inhibitor, glycogen synthase kinase inhibitor	CCNB1, CDK1, CDK5, GSK3B	Preclinical
ketanserin	serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA1D, DRD1, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, SLC18A1, SLC18A2	Launched
ketoconazole	sterol demethylase inhibitor	AR, CYP19A1, CYP21A2, KCNA10	Launched
ketoprofen	cyclooxygenase inhibitor	CXCR1, PTGS1, PTGS2, SLC5A8	Launched
ketorolac	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
ketotifen	histamine receptor agonist, leukotriene receptor antagonist, phosphodiesterase inhibitor	HRH1, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B, PGD	Launched
kevetrin	p53 activator		Phase 1
KF-38789	P selectin inhibitor	SELP	Preclinical
KG-5	RAF inhibitor	BRAF, FLT3, KIT, PDGFRB	Preclinical
KH-CB19	CDC inhibitor	CLK1, CLK3, DYRK1A	Preclinical
khellin	vasodilator		Phase 2
KHK-IN-1	hexokinase inhibitor	KHK	Preclinical
KHS-101	neural stem cell inducer	TACC3	Preclinical
KI-16425	lysophosphatidic acid receptor antagonist	LPAR1, LPAR3	Preclinical
KI-20227	c-Fms inhibitor	CSF1R, KDR, KIT, PDGFRB	Preclinical
KI-8751	KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	KDR	Preclinical
kifunensine	mannosidase inhibitor	MAN1B1, MAN2A1	Phase 1
kinetin	cell division inducer		Launched
ki16198	lipoprotein antagonist	LPA	Preclinical
KL-001	proteasome inhibitor	CRY1, CRY2	Preclinical
KML29	monoacylglucerol lipase inhibitor	MGLL	Preclinical
KN-62	calcium/calmodulin dependent protein kinase inhibitor, purinergic receptor antagonist	AKT1, CAMK2A, CHEK1, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, P2RX7, PRKCA, ROCK1, RPS6KB1, SGK1	Preclinical
KN-93	calcium/calmodulin dependent protein kinase inhibitor	CAMK2A	Preclinical
Ko143	BCRP inhibitor	ABCB1, ABCC1	Preclinical
KP-1212			Phase 2
KPT-185	exportin antagonist	XPO1	Preclinical
KPT-276	exportin antagonist	XPO1	Preclinical
KRCA-0008	ALK inihibitor	ALK	Preclinical
KRN-633	VEGFR inhibitor	FLT1, FLT4, KDR	Preclinical
KS-176	BCRP inhibitor	ABCG2	Preclinical
KT-433	uricosuric agent		Phase 2
ku-0063794	mTOR inhibitor	MTOR	Preclinical
KU-55933	ATM kinase inhibitor	ATM, PRKDC	Preclinical
KU-60019	ATM kinase inhibitor	ATM	Preclinical
kuromanin	ribosyl cyclase inhibitor	CD38	Preclinical
KU14R	imidazoline receptor antagonist		Preclinical
KW-2449	Abl kinase inhibitor, Aurora kinase inhibitor, FLT3 inhibitor	ABL1, AURKA, AURKB, FLT3	Phase 1
KW-2478	HSP inhibitor		Phase 1/Phase 2
KW-3902	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Phase 3
KX2-391	src inhibitor, tubulin polymerization inhibitor	SRC	Phase 2
kynurenic-acid	glutamate receptor antagonist	GPR35, GRIN1, GRIN2A, GRIN2B	Preclinical
KY02111	Wnt pathway inhibitor	DKK1	Preclinical
K02288	bone morphogenic protein inhibitor	BMP1	Preclinical
K145	sphingosine kinase inhibitor	SPHK2	Preclinical
L-(+)-Rhamnose-Monohydrate			Preclinical
L-alanine			Launched
L-Arginine	nitric oxide precursor	ARG2, ASL, ASS1, AZIN2, GPRC6A, NOS2, NOS3, SLC7A1, SLC7A3, SLC7A4	Launched
L-Ascorbyl-6-palmitate			Preclinical
L-asparagine		ASNS, ASRGL1, NARS, NARS2, SLC1A5, SLC38A3	Phase 3
L-asparagine-n-hydroxy			Preclinical
L-Aspartic-Acid	metallic radical formation stimulant	ACY1, ACY3, ADSS, ADSSL1, ASNS, ASPA, ASPH, ASRGL1, ASS1, CAD, DARS, DARS2, GOT1, GOT2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, LYZ, PAICS, RNASE1, SLC1A1, SLC25A12, SLC25A13	Launched
L-Citrulline	nitric oxide stimulant	ASS1, DDAH1, DDAH2, GPRC6A, NOS1, NOS2, NOS3, OTC, PADI1, PADI2, PADI3, PADI4, PADI6	Launched
L-cysteine		CARS, CARS2, CBS, CDO-1, CDO1, CSAD, CTH, GCLC, GCLM, GOT1, GSS, MGMT, NFS1, SLC19A3	Launched
L-Cysteinesulfinic-acid	glutamate receptor agonist	GRM1, GRM5, GSR, HMGCS2, PAPOLA, PRDX2	Preclinical
L-Cystine		CTNS, SLC3A1, SLC7A11, SLC7A9	Launched
L-ergothioneine	free radical scavenger		Phase 2
L-glutamic-acid	glutamate receptor agonist	AADAT, AASS, ABAT, ALDH18A1, ASNS, BCAT1, BCAT2, CCBL2, DNPEP, EARS2, ENPEP, EPRS, FOLH1, FPGS, FTCD, GAD1, GAD2, GATB, GCLC, GCLM, GGCX, GLS, GLS2, GLUD1, GLUD2, GLUL, GMPS, GOT1, GOT2, GPT, GPT2, GRIA1, GRIA2, GRIA3, GRIA4, GRID1, GRID2, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, GRM1, GRM2, GRM3, GRM4, GRM6, GRM7, GRM8, LGSN, NADSYN1, NAGS, OPLAH, PFAS, PGCP, PSAT1, SLC1A1, SLC1A2, SLC1A3, SLC1A6, SLC1A7, SLC25A18, SLC25A22, SLC7A11, TAT	Launched
L-Hydroxyproline			Launched
L-leucine		BCAT1, BCAT2, LARS, LARS2, LCMT1, LCMT2	Phase 3
L-lysine	serotonin receptor agonist	GPRC6A, KARS, SLC7A1, SLC7A2, SLC7A3, SLC7A4	Phase 2
L-methionine	voltage-gated calcium channel ligand		Launched
L-mimosine	dopamine beta hydroxylase inhibitor, eukaryotic translation initiation factor inhibitor	DBH, EIF5A	Preclinical
L-monomethylarginine	nitric oxide synthase inhibitor	NOS1, NOS2	Phase 3
L-NAME	nitric oxide synthase inhibitor	NOS3	Phase 2/Phase 3
L-NIL	nitric oxide synthase inhibitor	NOS1, NOS2, NOS3	Preclinical
L-proline	glutamate receptor agonist	EPRS, L3HYPDH, P3H1, P3H2, P3H3, P4HA1, P4HA2, PARS2, PPIA, PPIB, PPIC, PPIF, PPIG, PPIH, PRODH, PROSC, PYCR1, PYCR2, PYCRL, SLC6A14, SLC6A7	Launched
L-Quisqualic-acid	glutamate receptor agonist	FOLH1, GRIA2, GRIK1, GRIK2, GRM1, GRM2, GRM3, GRM5, GRM7, GRM8	Preclinical
L-Theanine	glutamate receptor antagonist		Launched
L-threonine		TARS, TARS2, THNSL1	Phase 2
L-152804	neuropeptide receptor antagonist	NPY5R	Preclinical
L-161982	prostanoid receptor antagonist	PTGER4	Preclinical
L-165041	PPAR receptor agonist	PPARD	Preclinical
L-168049	glucagon receptor antagonist	GCGR	Preclinical
L-365260	CCK receptor antagonist	CCKAR, CCKBR, KCNQ1	Phase 2
L-368899	oxytocin receptor antagonist	AVPR1A, AVPR2, OXTR	Phase 1
L-655,708	GABA receptor inverse agonist	GABRA1, GABRA2, GABRA3, GABRA5, GABRG2	Preclinical
L-655240	thromboxane receptor antagonist	PTGES	Phase 1
L-670596	prostanoid receptor antagonist		Preclinical
L-689560	glutamate receptor antagonist	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D	Preclinical
L-690330	inositol monophosphatase inhibitor	IMPA1	Preclinical
L-693403	sigma receptor agonist, sigma receptor antagonist	DRD2, SIGMAR1	Preclinical
L-694247	serotonin receptor agonist	HTR1A, HTR1B, HTR1D	Preclinical
L-701252	glutamate receptor antagonist	GRIN1	Preclinical
L-701324	glutamate receptor antagonist	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D	Preclinical
L-732,138	tachykinin antagonist	TACR1, TACR2	Preclinical
L-733060	tachykinin antagonist	TACR1	Preclinical
L-741742	dopamine receptor antagonist	DRD3, DRD4, SCN1A, SCN3A	Preclinical
L-745870	dopamine receptor antagonist	DRD1, DRD2, DRD3, DRD4, HTR1A, HTR2A, HTR6, HTR7	Preclinical
L-755507	adrenergic receptor agonist	ADRB1, ADRB2, ADRB3	Preclinical
L-760735	tachykinin antagonist	TACR1	Preclinical
L-778123	farnesyltransferase inhibitor	FNTA, FNTB, PGGT1B	Phase 1
L-798,106	prostanoid receptor antagonist	PTGER3	Preclinical
L-838417	GABA receptor partial agonist	GABRA1, GABRA2, GABRA3, GABRA5	Preclinical
labetalol	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2	Launched
lacidipine	calcium channel blocker	CACNA1C	Launched
lacitol	osmosis stimulant		Launched
lacosamide	collapsin response mediator protein inhibitor, collapsin response mediator protein stimulant, sodium channel blocker	SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	Launched
lactulose	laxative		Launched
lafutidine	histamine receptor antagonist	HRH2	Launched
lamivudine	nucleoside reverse transcriptase inhibitor		Launched
lamotrigine	serotonin receptor antagonist, sodium channel blocker	SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	Launched
lanatoside-c	cardiac glycoside		Preclinical
landiolol	adrenergic receptor antagonist	ADRB1	Launched
lanoconazole	sterol demethylase inhibitor		Launched
lansoprazole	ATPase inhibitor	ATP4A, ATP4B	Launched
lapatinib	EGFR inhibitor	EGFR, ERBB2	Launched
lappaconite	sodium channel blocker		Phase 2
laquinimod	immunosuppressant	CXCL2	Phase 3
laropiprant	prostanoid receptor antagonist	PTGDR, PTGDR2, PTGER1, PTGER2, PTGER3, PTGFR, PTGIR, TBXA2R	Launched
lasalocid	bacterial permeability inducer		Launched
lasofoxifene	selective estrogen receptor modulator (SERM)	ESR1, ESR2	Launched
latanoprost	prostanoid receptor agonist	PTGFR	Launched
latrepirdine	glutamate receptor antagonist	HRH1, HTR6	Phase 3
latrunculin-b	actin polymerization inhibitor	ACTA1, MKL1, SPIRE2	Phase 1
lauric-acid	bacterial permeability inducer	GPR84, HNF4A, LTF, LY96, PLA2G2A, TLR4	Phase 3
lauric-diethanolamide			Preclinical
laurocapram			Phase 3
lazabemide	monoamine oxidase inhibitor	MAOB	Phase 3
LB-100	protein phosphatase inhibitor		Phase 1
LB42708	farnesyltransferase inhibitor		Preclinical
LCL-161	XIAP inhibitor	BIRC2, XIAP	Phase 2
LCQ908	diacylglycerol O acyltransferase inhibitor	DGAT1	Phase 3
LCZ696	angiotensin receptor antagonist		Launched
LDC1267	protein tyrosine kinase inhibitor	AXL, MERTK, TYRO3	Preclinical
LDN-209929	haspin kinase inhibitor	GSG2	Preclinical
LDN-212854	bone morphogenic protein inhibitor	ABL1, ACVR1, RIPK2	Preclinical
LDN-27219	tissue transglutaminase inhibitor	TGM2	Preclinical
LDN-57444	ubiquitin C-terminal hydrolase inhibitor		Preclinical
LDN193189	bone morphogenic protein inhibitor	ACVR1, BMPR1A	Preclinical
LE-135	retinoid receptor agonist	RARB	Preclinical
ledipasvir	HCV inhibitor		Launched
leflunomide	dihydroorotate dehydrogenase inhibitor, PDGFR tyrosine kinase receptor inhibitor	AHR, DHODH, PTK2B	Launched
lemborexant	orexin receptor antagonist	HCRTR1, HCRTR2	Phase 3
lenalidomide	anticancer agent	CDH5, CRBN, PTGS2, TNF, TNFSF11	Launched
lenvatinib	FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	FLT4, KDR	Launched
lercanidipine	calcium channel blocker	CACNA2D1, CACNG1	Launched
lerisetron	serotonin receptor antagonist	HTR3A	Phase 3
lersivirine	non-nucleoside reverse transcriptase inhibitor		Phase 2
lesinurad	uric acid diuretic	SLC22A12	Launched
lestaurtinib	FLT3 inhibitor, growth factor receptor inhibitor, JAK inhibitor	FLT3, NTRK1	Phase 3
leteprinim	nerve growth factor agonist		Phase 2
letermovir	CMV terminase inhibitor		Phase 3
letosteine	mucolytic agent		Launched
letrozole	aromatase inhibitor	CYP19A1	Launched
leucomethylene-blue	nitric oxide production inhibitor, tau aggregation inhibitor	MAPT	Phase 3
leucovorin	folate receptor ligand	TYMS	Launched
leucylleucine-methyl-ester			Phase 2
leuprolide	gonadotropin releasing factor hormone receptor agonist	GNRHR	Launched
levalbuterol	adrenergic receptor agonist	ADRB2	Launched
levallorphan	opioid antagonist	CHRNA2, OPRM1	Launched
levamisole	acetylcholine receptor agonist	ALPL, ALPPL2, CHRNA3	Withdrawn
levcromakalim	potassium channel activator	KCNJ5	Phase 3
levetiracetam	calcium channel blocker	CACNA1B, SCN1A, SV2A	Launched
levo-phencynonate	acetylcholine receptor antagonist	CHRM1	Launched
levobetaxolol	adrenergic receptor antagonist	ADRB1, ADRB2	Launched
levobunolol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3	Launched
levobunolol-(+)	adrenergic receptor antagonist		Preclinical
levobunolol-(+/-)	adrenergic receptor antagonist		Preclinical
levocabastine	histamine receptor antagonist	HRH1, NTSR2	Launched
levocarnitine			Launched
levocarnitine-propionate	carnitine palmitoyltransferase inhibitor	CRAT	Launched
levocetirizine	histamine receptor antagonist	HRH1	Launched
levodopa	dopamine precursor	DRD1, DRD2, DRD3, DRD4, DRD5, GPR143	Launched
levodropropizine	antitussive		Launched
levofloxacin	bacterial DNA gyrase inhibitor	TOP2A	Launched
levomenol			Launched
levomenthol		OPRK1, TRPA1, TRPM8, TRPV3	Launched
levomepromazine	dopamine receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR2A, HTR2C	Launched
levomequitazine	histamine receptor antagonist	HRH1	Phase 2
levonordefrin	vasodilator	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, SLC6A2	Launched
levonorgestrel	estrogen receptor agonist, glucocorticoid receptor antagonist, progesterone receptor agonist, progesterone receptor antagonist	AR, ESR1, PGR, SRD5A1	Launched
levopropoxyphene	antitussive	OPRD1, OPRK1, OPRM1	Launched
levosimendan	calcium sensitizer	KCNJ11, KCNJ8, PDE3A, TNNC1	Launched
levosulpiride	dopamine receptor antagonist	CA1, CA12, CA7, DRD2, DRD3	Launched
levothyroxine	thyroid hormone stimulant	THRA, THRB	Launched
LFM-A13	Bruton's tyrosine kinase (BTK) inhibitor	BTK	Preclinical
LGK-974	porcupine inhibitor	PORCN	Phase 2
LGX818	RAF inhibitor	BRAF	Phase 3
LH846	casein kinase inhibitor	CSNK1D	Preclinical
liarozole	cytochrome P450 inhibitor	CYP19A1, CYP26A1	Phase 2/Phase 3
licarbazepine	voltage-gated sodium channel blocker	SCN5A	Phase 3
licochalcone-a	topoisomerase inhibitor	PTPN1	Phase 3
licofelone	cyclooxygenase inhibitor, lipoxygenase inhibitor	ALOX5, PLA2G2E, PTGS2	Phase 3
lidamidine	adrenergic receptor agonist		Launched
lidocaine	histamine receptor agonist	EGFR, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	Launched
lidoflazine	calcium channel blocker	SCN1A, SCN3A, SLC29A1	Launched
ligustilide	tumor necrosis factor production inhibitor	TNF	Preclinical
limaprost-alfadex	prostanoid receptor agonist	PTGER1	Launched
LIMKi-3	LIM kinase inhibitor	LIMK1	Preclinical
limonin	HIV protease inhibitor		Preclinical
linaclotide	guanylate cyclase activator	GUCY2C	Launched
linagliptin	dipeptidyl peptidase inhibitor	DPP4	Launched
linalool	anticonvulsant		Phase 1
lincomycin	bacterial 30S ribosomal subunit inhibitor		Launched
lindane		GABRB1, GLRA1, GLRA2, GLRA3, GLRB	Launched
linezolid	bacterial 50S ribosomal subunit inhibitor	MAOA, MAOB	Launched
linifanib	PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	CSF1, CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRB, RET, TEK	Phase 3
linoleic-acid	oxidative stress inducer	FABP4, FFAR1, FFAR4, HNF4A, KCNB1, PPARG, TRPM8	Phase 3
linopirdine	potassium channel blocker	KCNQ2, KCNQ3, KCNQ4, KCNQ5	Phase 3
linsidomine	nitric oxide donor		Launched
linsitinib	IGF-1 inhibitor	IGF1R, INSR, INSRR	Phase 3
liothyronine	thyroid hormone stimulant	THRA, THRB	Launched
liothyronine-(isomer)			Preclinical
lipoamide			Preclinical
liraglutide	GLP receptor agonist	GLP1R	Launched
liranaftate	fungal squalene epoxidase inhibitor		Launched
lirimilast	phosphodiesterase inhibitor		Phase 2
lisadimate	topical sunscreen agent		Launched
lisinopril	angiotensin converting enzyme inhibitor	ACE, ACE2	Launched
lisofylline	interleukin receptor antagonist, STAT inhibitor		Phase 2
lisuride	dopamine receptor agonist	ADRA1A, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR6	Launched
lithium-acetoacetate			Preclinical
lithium-citrate			Launched
lithocholic-acid	FXR antagonist, vitamin D receptor agonist	GPBAR1, NR1H4, NR1I2, VDR	Preclinical
litronesib	kinesin-like spindle protein inhibitor	KIF11	Phase 2
lixivaptan	vasopressin receptor antagonist	AVPR2	Phase 3
LM-22A4	tropomyosin receptor kinase inhibitor	NTRK2	Preclinical
LMI070	survival motor neuron protein modulator	SMN1	Phase 1/Phase 2
LMK-235	HDAC inhibitor	HDAC4, HDAC5	Preclinical
LM11A-31	neurotrophic agent	NGFR	Phase 1
lobeline	acetylcholine receptor antagonist	CHRNA10, CHRNA9, SLC18A2	Launched
lobendazole	anthelmintic agent		Preclinical
lobenzarit	immunosuppressant		Launched
lodoxamide	histamine receptor antagonist		Launched
lofemizole	cyclooxygenase inhibitor		Phase 3
lofepramine	norepinephrine reuptake inhibitor, serotonin–norepinephrine reuptake inhibitor (SNRI)	HTR1A, SLC6A2, SLC6A4	Launched
lofexidine	adrenergic receptor agonist	ADRA2A	Launched
lomefloxacin	bacterial DNA gyrase inhibitor	TOP2A	Launched
lomeguatrib	O6-alkylguanine-DNA alkyltransferase inhibitor	MGMT	Phase 2
lomerizine	calcium channel blocker	CACNA1B, SCN5A	Launched
lometrexol	glycinamide ribonucleotide formyltransferase inhibitor	GART, MTHFD1	Phase 2
lomitapide	microsomal trigylceride transfer protein inhibitor	MTTP	Launched
lomustine	DNA synthesis inhibitor	STMN4	Launched
lonafarnib	farnesyltransferase inhibitor	FNTA, HRAS, KRAS, NRAS	Phase 3
lonidamine	glucokinase inhibitor	GCK	Launched
loperamide	opioid receptor agonist	CACNA1A, CALM1, OPRD1, OPRK1, OPRM1, POMC	Launched
lopinavir	HIV protease inhibitor		Launched
loracarbef	bacterial cell wall synthesis inhibitor		Launched
loratadine	histamine receptor antagonist	HRH1	Launched
lorazepam	benzodiazepine receptor agonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, TSPO	Launched
lorcaserin	serotonin receptor agonist	HTR2A, HTR2B, HTR2C	Launched
loreclezole	benzodiazepine receptor agonist	GABRB2, GABRB3	Phase 2
lorediplon	GABA receptor modulator	GABRA1	Phase 2
lorglumide	CCK receptor antagonist	CCKAR, CCKBR	Phase 1
lorlatinib	ALK tyrosine kinase receptor inhibitor	ALK	Phase 2
lornoxicam	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
losartan	angiotensin receptor antagonist	AGTR1	Launched
losmapimod	p38 MAPK inhibitor	MAPK14	Phase 3
loteprednol	glucocorticoid receptor agonist, phospholipase inhibitor	NR3C1	Launched
lovastatin	HMGCR inhibitor	HDAC2, HMGCR, ITGAL, NR1I2	Launched
loxapine	dopamine receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, ADRB1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR5A, HTR6, HTR7, SLC6A2, SLC6A3, SLC6A4	Launched
loxistatin-acid	cysteine peptidase inhibitor	CTSB	Preclinical
LOXO-101	tropomyosin receptor kinase inhibitor	NTRK1, NTRK2, NTRK3	Phase 2
loxoprofen	cyclooxygenase inhibitor, prostanoid receptor antagonist	PTGS2	Launched
LPA2-antagonist-1	lysophosphatidic acid receptor antagonist	LPAR2	Preclinical
LRRK2-IN-1	leucine rich repeat kinase inhibitor	LRRK2	Preclinical
LSN-2463359	glutamate receptor positive allosteric modulator	GRM5	Preclinical
LTA			Phase 2
LTB4	leukocyte activator	LTB4R, LTB4R2	Phase 2
Lu-AA-47070	adenosine receptor antagonist	ADORA2A	Phase 2
lubiprostone	chloride channel activator	CLCN2	Launched
lucitanib	FGFR inhibitor, VEGFR inhibitor	FGFR1, FLT1, KDR, KIT, PDGFRA, PDGFRB, RET	Phase 2
LUF-5834	adenosine receptor agonist	ADORA2A, ADORA2B	Preclinical
lufenuron	chitin inhibitor		Launched
luliconazole	sterol demethylase inhibitor		Launched
lumacaftor	CFTR channel agonist	CFTR	Launched
lumateperone	serotonin receptor antagonist, dopamine receptor modulator	DRD2, HTR2A	Phase 3
lumefantrine	antimalarial agent	ATP1A1	Launched
lumiracoxib	cyclooxygenase inhibitor	PTGS1, PTGS2	Withdrawn
lupanine	sodium channel blocker	INS	Phase 1
lurasidone	dopamine receptor antagonist, serotonin receptor antagonist	ADRA2A, ADRA2C, DRD2, HTR1A, HTR2A, HTR7	Launched
lutein	antioxidant		Launched
luteolin	glucosidase inhibitor	TOP1	Phase 2
luzindole	melatonin receptor antagonist	MTNR1A, MTNR1B	Preclinical
LXR-623	LXR agonist	AR, NR1H2, NR1H3, NR1I2, NR3C1	Phase 1
LX1031	tryptophan hydroxylase inhibitor	TPH1	Phase 2
LX7101	LIM kinase inhibitor, rho associated kinase inhibitor	LIMK2, ROCK1, ROCK2	Phase 1/Phase 2
LY-404187	glutamate receptor positive allosteric modulator	GRIA1, GRIA2, GRIA3, GRIA4	Preclinical
lycopene	free radical scavenger		Phase 3
lylamine	cannabinoid receptor agonist	CNR1	Preclinical
lymecycline	bacterial 50S ribosomal subunit inhibitor		Launched
lynestrenol	progestogen hormone		Launched
lypressin	vasopressin receptor agonist	AVPR1A, AVPR1B, AVPR2	Launched
LY2090314	glycogen synthase kinase inhibitor	GSK3B	Phase 2
LY2109761	TGF beta receptor inhibitor	TGFBR1, TGFBR2	Preclinical
LY2140023	glutamate receptor agonist	GRM3	Phase 3
LY215490	glutamate receptor antagonist	GRIA1, GRIA2, GRIA3, GRIA4, GRIK1	Phase 1
LY2157299	TGF beta receptor inhibitor	TGFBR1	Phase 2/Phase 3
LY2183240	FAAH inhibitor, FAAH reuptake inhibitor	FAAH	Preclinical
LY2228820	p38 MAPK inhibitor	MAPK14	Phase 2
LY223982	leukotriene receptor antagonist	LTB4R	Phase 2
LY225910	CCK receptor antagonist	CCKBR	Preclinical
LY231617	lipid peroxidase inhibitor		Preclinical
LY2334737	antitumor agent, ribonucleotide reductase inhibitor		Phase 1
LY2365109	Glycine transporter 1 inhibitor	SLC6A9	Preclinical
LY2452473	androgen receptor modulator	AR	Phase 2
LY255283	leukotriene receptor antagonist	LTB4R, LTB4R2	Preclinical
LY2584702	ribosomal protein inhibitor	RPS6KB1	Phase 1
LY2603618	CHK inhibitor	CHEK1	Phase 2
LY2606368	CHK inhibitor	CHEK1	Phase 2
LY2608204	glucokinase activator	GCK	Phase 2
LY266097	serotonin receptor antagonist	HTR2B	Preclinical
LY2784544	JAK inhibitor	JAK2, JAK3	Phase 2
LY2801653	MET inhibitor	MET	Phase 2
LY2811376	beta-secretase inhibitor	BACE1	Phase 1
LY2857785	CDK inhibitor	CDK9	Preclinical
LY2874455	FGFR antagonist	FGFR1, FGFR2, FGFR3, FGFR4, KDR	Phase 1
LY288513	CCK receptor antagonist	CCKBR	Preclinical
LY2886721	beta-secretase inhibitor	BACE1	Phase 1/Phase 2
LY294002	mTOR inhibitor, PI3K inhibitor, DNA dependent protein kinase inhibitor, phosphodiesterase inhibitor, PLK inhibitor	AKT1, CHEK1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PLK1, PRKCA, PRKDC, ROCK1, RPS6KB1, SGK1	Preclinical
LY2979165	glutamate receptor agonist	GRM2	Phase 1
LY3000328	cathepsin inhibitor	CTSS	Phase 1
LY3009120	RAF inhibitor	BRAF, RAF1	Phase 1
LY3023414	PI3K inhibitor, mTOR inhibitor	MTOR	Phase 2
LY303511	casein kinase inhibitor, mTOR inhibitor, PI3K inhibitor	BRD2, BRD3, BRD4	Preclinical
LY310762	serotonin receptor antagonist	HTR1D	Preclinical
LY320135	cannabinoid receptor antagonist	CNR1	Preclinical
LY344864	serotonin receptor agonist	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR7	Preclinical
LY364947	TGF beta receptor inhibitor, p38 MAPK inhibitor	TGFBR1	Preclinical
LY393558	serotonin receptor antagonist	HTR1B, HTR1D, HTR2A, HTR2B	Preclinical
LY411575	gamma secretase inhibitor		Preclinical
LY450108	glutamate receptor modulator		Phase 1
LY456236	glutamate receptor antagonist	GRM1	Preclinical
m-Chlorophenylbiguanide		HTR3A, HTR3B	Preclinical
m-THP			Phase 1
M-14157	ATP-sensitive potassium channel antagonist	KCNQ1	Phase 2
M-25	smoothened receptor antagonist	DHH, IHH, SMO	Preclinical
m-3M3FBS		PLCB2, PLCB3, PLCD1, PLCG1, PLCG2	Preclinical
M-344	HDAC inhibitor		Preclinical
mabuprofen	cyclooxygenase inhibitor		Launched
mabuterol	adrenergic receptor agonist	ADRB2	Launched
macelignan	antioxidant, antiinflammatory agent		Preclinical
macitentan	endothelin receptor antagonist	EDNRA, EDNRB	Launched
madrasin	cell splicing inhibitor		Preclinical
mafenide	carbonic anhydrase inhibitor	CA12, CA14, CA2, CA4, CA6, CA9	Launched
magnolol	PPAR receptor agonist	GABRA1, PPARG	Preclinical
malathion	cholinesterase inhibitor	ACHE, BCHE	Launched
malic-acid		CS, ME2, PKD2L1	Launched
malotilate	protein synthesis stimulant		Launched
maltobionic-acid	matrix metalloprotease inhibitor		Launched
mandelic-acid			Launched
mangafodipir	contrast agent		Launched
manidipine	calcium channel blocker	CACNA1C, CACNA1D	Launched
mannitol-D	diuretic		Launched
maprotiline	norepinephrine reputake inhibitor, tricyclic antidepressant	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A, HTR2C, HTR7, SLC6A2	Launched
maraviroc	CC chemokine receptor antagonist	CCR5	Launched
marbofloxacin	bacterial DNA gyrase inhibitor		Launched
maribavir	cytomegalovirus inhibitor, protein kinase inhibitor	PYGM	Phase 3
marimastat	matrix metalloprotease inhibitor	MMP1, MMP10, MMP11, MMP12, MMP13, MMP14, MMP15, MMP16, MMP17, MMP19, MMP2, MMP20, MMP21, MMP23A, MMP24, MMP25, MMP26, MMP27, MMP28, MMP3, MMP7, MMP8, MMP9	Phase 3
maropitant	neurokinin receptor antagonist	TACR1	Launched
masitinib	KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor	FGFR3, KIT, PDGFRA, PDGFRB	Launched
masoprocol	lipoxygenase inhibitor	ALOX5	Launched
matrine	opioid receptor agonist	OPRK1	Phase 2
mavoglurant	glutamate receptor antagonist	GRM5	Phase 2
maxacalcitol	vitamin D receptor agonist	VDR	Launched
maytansinol-isobutyrate			Preclinical
mazindol	dopamine reuptake inhibitor, selective serotonin reuptake inhibitor (SSRI)	SLC6A2, SLC6A3, SLC6A4	Launched
MBX-2982	glucose dependent insulinotropic receptor agonist	GPR119	Phase 2
MC-1		AADAT, ABAT, AGXT, AGXT2, ALAS1, AZIN2, BCAT1, BCAT2, CBS, CCBL1, CCBL2, CSAD, CTH, DDC, FTCD, GAD1, GAD2, GADL1, GCAT, GLDC, GOT1, GOT2, GPT, GPT2, HDC, IGSF10, KYNU, MOCOS, NFS1, OAT, ODC1, PDXDC1, PDXP, PHYKPL, PNPO, PROSC, PSAT1, PYGB, PYGL, PYGM, SCLY, SDS, SDSL, SEPSECS, SGPL1, SHMT1, SHMT2, SPTLC1, SPTLC2, SPTLC3, SRR, TAT, THNSL1	Phase 3
MCC950	NOD like receptor inhibitor	NLRP3	Preclinical
McN-5652-(+/-)	selective serotonin reuptake inhibitor (SSRI)		Preclinical
MCOPPB	nociceptin/orphanin FQ (NOP) receptor agonist	OPRL1	Preclinical
mCPP	serotonin receptor agonist	HTR1A, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR6	Phase 2
MC1568	HDAC inhibitor	HDAC2	Preclinical
MD-920	NFkB pathway inhibitor	AADACL2	Phase 1
mdivi-1	dynamin inhibitor	DNM1	Preclinical
MDL-11939	serotonin receptor antagonist	HTR2A, HTR2B, HTR2C	Phase 2
MDL-27531	glycine receptor agonist		Preclinical
MDL-29951	glutamate receptor antagonist	FBP1	Preclinical
MDL-72832	serotonin receptor agonist	HTR1A	Preclinical
MDL-73005EF	serotonin receptor antagonist	HTR1A	Phase 1
MDMS	DNA inhibitor		Phase 2
ME-0328	PPAR receptor antagonist	PARP3	Preclinical
mebendazole	tubulin polymerization inhibitor	TUBA1A, TUBB, TUBB4B	Launched
mebeverine	acetylcholine receptor antagonist	CHRM1	Launched
mebhydrolin	antihistamine		Launched
mebhydroline-1,5-naphtalenedisulfonate			Preclinical
mebicar	anxiolytic		Launched
mebrofenin			Launched
mecamylamine	acetylcholine receptor antagonist	CHRNA1, CHRNA2, CHRNA3, CHRNA4, CHRNA6, CHRNA7	Launched
mecarbinate			Preclinical
mechlorethamine	DNA inhibitor		Launched
meclinertant	neurotensin receptor antagonist	NTSR1, NTSR2	Phase 2/Phase 3
meclizine	constitutive androstane receptor (CAR) agonist	HRH1, NR1I3	Launched
meclocycline-sulfosalicylate	bacterial 50S ribosomal subunit inhibitor		Launched
meclofenamic-acid	cyclooxygenase inhibitor, prostanoid receptor antagonist	ALOX5, CNR1, KCNQ2, KCNQ3, PTGS1, PTGS2	Launched
meclofenoxate	nootropic agent		Launched
mecysteine	analgesic agent		Launched
medetomidine	adrenergic receptor agonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C	Launched
medica-16	ATP citrase lyase inhibitor	FFAR1	Phase 2
medorinone			Phase 1
medronic-acid	bone resorption inhibitor		Launched
medroxyprogesterone	progesterone receptor agonist	ESR1, PGR	Launched
medroxyprogesterone-acetate	progesterone receptor agonist		Launched
medrysone	glucocorticoid receptor agonist	NR3C1	Launched
mefenamic-acid	cyclooxygenase inhibitor	KCNQ1, PTGS1, PTGS2, TRPM3	Launched
mefexamide	psychoactive drug		Preclinical
mefloquine	adenosine receptor antagonist, hemoglobin antagonist	ADORA2A, HBA1	Launched
megestrol-acetate	progesterone receptor agonist	NR3C1, PGR	Launched
meglitinide	potassium channel blocker	CCR2	Phase 2
meglumine	excipient		Launched
meglutol	HMGCR inhibitor	HMGCR	Launched
meisoindigo	STAT inhibitor	STAT3	Phase 3
MEK1-2-inhibitor	MEK inhibitor	MAP2K2	Preclinical
MEK162	MEK inhibitor	MAP2K1, MAP2K2	Phase 3
melatonin	melatonin receptor agonist, nitric oxide synthase inhibitor	ASMT, CALM1, CALR, EPX, ESR1, HTR2B, MPO, MTNR1A, MTNR1B, NQO2, RORB	Launched
meldonium	gamma butyrobetaine hydroxylase inhibitor	BBOX1	Launched
melengestrol-acetate	progesterone receptor agonist		Preclinical
melevodopa	dopamine precursor, dopamine receptor agonist	DDC	Launched
meloxicam	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
melperone	dopamine receptor antagonist, serotonin receptor antagonist	DRD2, HTR2A	Launched
melphalan	DNA alkylating agent, DNA inhibitor		Launched
melphalan-n-oxide	hypoxia inducible factor inhibitor	HIF1A	Phase 1
meluadrine			Preclinical
memantine	glutamate receptor antagonist	CHRFAM7A, DRD2, GRIN1, GRIN2A, GRIN2B, GRIN3A, HTR3A	Launched
menadione	mitochondrial DNA polymerase inhibitor, phosphatase inhibitor	AOX1, BGLAP, F10, F2, F7, F9, GGCX, NQO1, NQO2, PROC, PROS1, PROZ, VKORC1, VKORC1L1	Launched
menadione-bisulfite	vitamin K	GGCX, VKORC1, VKORC1L1	Phase 2
menatetrenone	bone resorption inhibitor		Launched
menbutone			Launched
mepacrine	cytokine production inhibitor, NFkB pathway inhibitor, TP53 activator	PLA2G1B, PLA2G4A, PLA2G6, PLCL1	Launched
meparfylon			Preclinical
mepazine	MALT1 inhibitor (JH)	MALT1	Phase 2
mepenzolate	acetylcholine receptor antagonist	CHRM1, CHRM3	Launched
mephenesin	muscle relaxant		Launched
mephentermine	adrenergic receptor agonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3	Launched
mephenytoin	hydantoin antiepileptic	SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	Launched
mepiroxol			Preclinical
mepivacaine	potassium channel blocker, sodium channel blocker	SCN10A	Launched
meprednisone		NR3C1	Launched
meprobamate		GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ	Launched
meprylcaine	local anesthetic		Preclinical
meptazinol	opioid receptor agonist	BCHE	Launched
mepyramine	histamine receptor antagonist	HRH1	Launched
mequinol		TYR	Launched
merbarone	topoisomerase inhibitor	TOP2A	Phase 2
merbromin	antiseptic		Launched
mercaptopurine	immunosuppressant, protein synthesis inhibitor, purine antagonist	HPRT1, IMPDH1, IMPDH2, PPAT	Launched
mercaptosuccinic-acid			Launched
mericitabine	HCV inhibitor		Phase 2
merimepodib	inosine monophosphate dehydrogenase inhibitor	IMPDH1	Phase 2
meropenem	bacterial cell wall synthesis inhibitor		Launched
mesalazine	cyclooxygenase inhibitor, lipoxygenase inhibitor, prostanoid receptor antagonist	ALOX5, CHUK, IKBKB, MPO, PPARG, PTGS1, PTGS2	Launched
mesna	antioxidant		Launched
mesoridazine	dopamine receptor antagonist	DRD2, HTR2A	Launched
mestinon	cholinesterase inhibitor	ACHE, BCHE	Launched
mestranol	estrogen receptor agonist	ESR1	Launched
mesulergine	dopamine receptor agonist	HTR2A, HTR2B, HTR2C, HTR3A, HTR3B, HTR6, HTR7	Phase 2
meta-cresyl-acetate			Preclinical
metacetamol	analgesic agent		Preclinical
metacresol		INS	Launched
metafolin		AMT	Launched
metamizole	cyclooxygenase inhibitor, opioid receptor agonist	PTGS1	Withdrawn
metaphit	phencyclidine receptor acylator		Preclinical
metaproterenol	adrenergic receptor agonist	ADRB2	Launched
metaraminol	adrenergic receptor agonist	ADRA1A	Launched
metatinib	Bcr-Abl kinase inhibitor	ABL1, BCR	Phase 1
metaxalone	muscle relaxant		Launched
metazosin	adrenergic receptor antagonist	ADRA1A	Phase 2
metenkephalin	immunostimulant	OPRD1	Phase 2
metergoline	dopamine receptor agonist, serotonin receptor antagonist	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7	Launched
metformin	insulin sensitizer	ACACB, PRKAB1	Launched
methacholine	acetylcholine receptor agonist	CHRM2, CHRM3, CHRM4	Launched
methacycline	protein synthesis inhibitor		Launched
methanesulfonyl-fluoride	acetylcholinesterase inhibitor	ACHE	Phase 2
methantheline	acetylcholine receptor antagonist	CHRM1, HRH2	Launched
methapyrilene	histamine receptor antagonist	HRH1	Withdrawn
metharbital	GABA receptor modulator	CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2	Launched
methazolamide	carbonic anhydrase inhibitor	CA1, CA12, CA14, CA2, CA4, CA7	Launched
methenamine	bacterial DNA inhibitor		Launched
methiazole	anthelmintic agent		Preclinical
methicillin	bacterial cell wall synthesis inhibitor		Launched
methimazole	antithyroid agent	TPO	Launched
methionine		BHMT, BHMT2, METAP2, MTR, MTRR	Launched
methiopril	angiotensin converting enzyme inhibitor	ACE	Phase 2
methocarbamol	muscle relaxant	CA1	Launched
methoprene-(s)			Preclinical
methotrexate	dihydrofolate reductase inhibitor	DHFR	Launched
methoxamine	adrenergic receptor agonist	ADRA1A, ADRA1B, ADRA1D	Launched
methoxsalen	DNA synthesis inhibitor	CYP1A1, CYP1A2, CYP2A13, CYP2A6, CYP3A4	Launched
methoxyamine	DNA repair enzyme inhibitor	APEX1	Phase 2
methoxyflurane	membrane permeability inhibitor	ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, MT-ND1	Launched
methoxyphenamine	adrenergic receptor agonist		Launched
methscopolamine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3	Launched
methsuximide	T-type calcium channel binder	CACNA1G, CACNA1H, CACNA1I	Launched
methyclothiazide	chloride reabsorption inhibitor	CA1, CA2, CA4, SLC12A1, SLC12A3	Launched
methyl-aminolevulinate	oxidizing agent	FCGR1A, FECH	Launched
methyl-nicotinate			Phase 2
methyl-salicylate			Launched
methylatropine-nitrate	acetylcholine receptor antagonist	CHRM1	Preclinical
methylbenzethonium-chloride	other antibiotic		Preclinical
methyldopa	adrenergic receptor agonist	ADRA2A, ADRA2B, ADRA2C, DDC	Launched
methyldopate			Launched
methylene-blue	guanylyl cyclase inhibitor, nitric oxide production inhibitor	ACHE	Launched
methylergometrine	dopamine receptor antagonist, serotonin receptor antagonist	DRD1, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C	Launched
methyllycaconitine	acetylcholine receptor antagonist	CHRNA7	Preclinical
methylnaltrexone	opioid receptor antagonist	OPRD1, OPRK1, OPRM1	Launched
methylparaben	other antifungal		Launched
methylphenidate	dopamine-norepinephrine reuptake inhibitor	SLC6A2, SLC6A3, SLC6A4	Launched
methylprednisolone	glucocorticoid receptor agonist	NR3C1	Launched
methylprednisolone-aceponate	anti-inflammatory agent, glucocorticoid receptor agonist	NR3C1	Launched
methylprednisolone-sodium-succinate	glucocorticoid receptor agonist		Launched
methylthiouracil			Launched
methysergide	serotonin receptor antagonist	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7	Launched
meticrane	diuretic		Launched
metipranolol	adrenergic receptor antagonist	ADRB1, ADRB2	Withdrawn
metirosine	tyrosine hydroxylase inhibitor	TH	Launched
metitepine	anti-HCVE2	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7	Preclinical
metixene	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Launched
metoclopramide	dopamine receptor antagonist, serotonin receptor antagonist	CHRM1, DRD2, HTR3A, HTR3B, HTR4	Launched
metocurine	acetylcholine receptor antagonist	CHRM2, CHRNA2	Launched
metolazone	carbonic anhydrase inhibitor	SLC12A3	Launched
metoprolol	adrenergic receptor antagonist	ADRB1, ADRB2	Launched
metoxibutropate	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
metrifonate	acetylcholinesterase inhibitor	ACHE	Phase 3
metrizamide	radiopaque medium		Launched
metrizoic-acid	radiopaque medium		Launched
metronidazole	DNA inhibitor	CYP2C9, CYP3A4	Launched
metyrapone	cytochrome P450 inhibitor	CYP11B1	Launched
mevalonic-d,-l-acid-lactone			Preclinical
mevastatin	HMGCR inhibitor	HMGCR	Preclinical
mexeneone			Preclinical
mexiletine	sodium channel blocker	AHR, SCN4A, SCN5A	Launched
mezlocillin	bacterial cell wall synthesis inhibitor		Launched
ME0328	PARP inhibitor	PARP3	Preclinical
MF-101	estrogen receptor agonist	CYP19A1, XDH	Phase 3
MG-132	proteasome inhibitor	PSMB1	Preclinical
MG-624	acetylcholine receptor antagonist	CHRNA7	Preclinical
MGCD-265	VEGFR inhibitor	AXL, MET	Preclinical
MI-14	PI4K inhibitor	PI4KB	Preclinical
mianserin	serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD5, HRH1, HRH2, HRH4, HTR1A, HTR1F, HTR2A, HTR2B, HTR2C, HTR6, HTR7, OPRK1, SLC6A2, SLC6A3, SLC6A4	Launched
mibampator	glutamate receptor modulator	GRIA1	Phase 2
mibefradil	T-type calcium channel blocker	ANO1, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CATSPER1, CATSPER2, CATSPER3, CATSPER4	Withdrawn
micafungin	fungal 1,3-beta-D-glucan synthase inhibitor		Launched
miconazole	bacterial cell wall synthesis inhibitor	KCNH2, KCNH6, KCNH7, KCNMA1, KCNMB1, KCNMB2, KCNMB3, KCNMB4, KCNN1, KCNN2, KCNN3, KCNN4, NOS2, NOS3, TRPM2, TRPV5	Launched
micronomicin	protein synthesis inhibitor		Launched
midafotel	glutamate receptor antagonist	GRIN2A, GRIN2B, GRIN2C, GRIN2D	Phase 3
midecamycin	protein synthesis inhibitor		Launched
midodrine	adrenergic receptor agonist	ADRA1A, ADRA1B, ADRA1D	Launched
midostaurin	FLT3 inhibitor, KIT inhibitor, PKC inhibitor	FLT3, PRKCG	Launched
mifepristone	glucocorticoid receptor antagonist, progesterone receptor antagonist	AR, NR1I2, NR3C1, PGR	Launched
mifobate	PPAR receptor antagonist	PPARG	Phase 2
miglitol	glucosidase inhibitor	GAA, GANAB, GANC, MGAM	Launched
miglustat	Glycosyl transferase inhibitor	UGCG	Launched
milacemide	monoamine oxidase inhibitor	MAOB	Phase 3
milnacipran	serotonin–norepinephrine reuptake inhibitor (SNRI)	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, SLC6A2, SLC6A4	Launched
milrinone	phosphodiesterase inhibitor	PDE2A, PDE3A, PDE3B, PDE5A	Launched
miltefosine	membrane integrity inhibitor	PLA2G1B	Launched
mimosine	DNA replication inhibitor	CCL2, SHMT1, SHMT2, TYR	Preclinical
minaprine	serotonin reuptake inhibitor	ACHE, CHRM1, DRD1, DRD2, HTR2A, HTR2B, HTR2C, MAOA, SLC6A4	Withdrawn
minerval	FAAH inhibitor		Phase 1/Phase 2
minocycline	bacterial 30S ribosomal subunit inhibitor	ALOX5, CASP1, CASP3, CYCS, IL1B, MMP9, VEGFA	Launched
minodronic-acid	bone resorption inhibitor	FDPS, GGPS1	Launched
minoxidil	KATP activator, Kir6 channel (KATP) activator, vasodilator	ABCC9, KCNJ1, KCNJ10, KCNJ11, KCNJ8, PTGS1	Launched
miocamycin	other antibiotic		Launched
MIRA-1	apoptosis stimulant		Preclinical
mirabegron	adrenergic receptor agonist	ADRB1, ADRB2, ADRB3	Launched
mirin	MRE11A exonuclease inhibitor	MRE11A	Preclinical
miriplatin	DNA synthesis inhibitor		Launched
mirodenafil	phosphodiesterase inhibitor	PDE5A	Launched
mirtazapine	adrenergic receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD5, HRH1, HRH3, HTR2A, HTR2B, HTR2C, HTR3A, HTR7, OPRK1, SLC6A2, SLC6A3, SLC6A4	Launched
misonidazole			Phase 3
misoprostol	prostanoid receptor agonist	PTGER2, PTGER3, PTGER4, PTGIR	Launched
mitiglinide	insulin secretagogue	ABCC8, KCNJ10, PPARG	Launched
mitoflaxone	antitumor agent	VWF	Phase 2
mitomycin-c	DNA alkylating agent, DNA synthesis inhibitor		Launched
mitotane	antineoplastic agent	CYP11A1, CYP11B1, ESR1, FDX1	Launched
mitoxantrone	topoisomerase inhibitor	TOP2A	Launched
mivacurium	acetylcholine receptor antagonist	BCHE, CHRM2, CHRM3, CHRNA2	Launched
mivobulin	microtubule inhibitor		Preclinical
mizolastine	histamine receptor antagonist	HRH1	Launched
mizoribine	immunosuppressant, inosine monophosphate dehydrogenase inhibitor	IMPDH1	Launched
MJ-15	cannabinoid receptor antagonist	CNR1	Preclinical
MK-0354	niacin receptor agonist	HCAR2, HCAR3	Phase 2
MK-0752	gamma secretase inhibitor		Phase 1/Phase 2
MK-0773	androgen receptor modulator	AR	Phase 2
MK-0812	CC chemokine receptor antagonist	CCR2	Phase 2
MK-0893	glucagon receptor antagonist	GCGR	Phase 2
MK-1775	WEE1 kinase inhibitor	WEE1	Phase 2
MK-2048	HIV integrase inhibitor		Preclinical
MK-2206	AKT inhibitor	AKT1, AKT2, AKT3	Phase 2
MK-2295	TRPV antagonist	TRPV1	Phase 2
MK-2461	FGFR inhibitor, VEGFR inhibitor	FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, KDR, MERTK, MET, MST1R, NTRK1, NTRK2, PDGFRB	Phase 1/Phase 2
MK-2894	prostaglandin inhibitor	PTGER4	Preclinical
MK-3207	calcitonin antagonist	CALCA	Phase 2
MK-3697	orexin receptor antagonist	HCRTR2	Phase 2
MK-5046	bombesin receptor agonist	BRS3, GRPR, NMBR	Preclinical
MK-5108	Aurora kinase inhibitor	AURKA, AURKB, AURKC	Phase 1
MK-571	leukotriene receptor antagonist	ABCC2, CYSLTR1	Phase 2
MK-6096	orexin receptor antagonist	HCRTR1, HCRTR2	Phase 2
MK-8033	c-Met inhibitor	MET	Phase 1
MK-8245	stearoyl-CoA desaturase inhibitor	SCD	Phase 2
MK-8745	Aurora kinase inhibitor	AURKA	Preclinical
MKT-077	HSP inhibitor		Phase 1
MK2-IN-1	MAP kinase inhibitor	MAPKAPK2	Preclinical
ML-10302	serotonin receptor partial agonist	HTR3A, HTR3B, HTR4	Preclinical
ML-141	GTPase inhibitor	CDC42	Preclinical
ML-179	liver receptor homolog inverse agonist	NR5A2	Preclinical
ML-193	G protein-coupled receptor antagonist	GPR55	Preclinical
ML-213	potassium channel activator	KCNQ4	Preclinical
ML-218	T-type calcium channel binder	CACNA1G, CACNA1H, CACNA1I	Preclinical
ML-228	hypoxia inducible factor activator	HIF1A	Preclinical
ML-277	potassium channel activator	KCNQ1	Preclinical
ML-281	serine/threonine kinase inhibitor	STK33	Preclinical
ML-297	inward rectifier potassium channel activator	KCNJ3	Preclinical
ML-298	phospholipase inhibitor	PLD2	Preclinical
ML-323	ubiquitin specific protease inhibitor	USP1	Preclinical
ML-3403	MAP kinase inhibitor	CYP3A4, MAPK11, MAPK12, MAPK14	Preclinical
ML-348	lysophospholipase inhibitor	LYPLA1	Preclinical
ML-365	potassium channel blocker	KCNK3, KCNK9	Preclinical
ML-786	RAF inhibitor	BRAF, RAF1	Preclinical
ML-9	myosin light chain kinase inhibitor	TRPC6	Preclinical
MLN-8054	Aurora kinase inhibitor	AURKA	Phase 1
MLN0128	mTOR inhibitor	MTOR, PIK3CA, PIK3CD, PIK3CG	Phase 2
MLN1117	PI3K inhibitor	PIK3CA	Phase 1/Phase 2
MLN2480	RAF inhibitor		Phase 1
MLN9708	proteasome inhibitor		Phase 3
ML130	NOD1 inhibitor		Preclinical
ML133	potassium channel blocker		Preclinical
ML161	protease-activated receptor inhibitor		Preclinical
ML167	CLK inhibitor, DYRK inhibitor	CLK4, DYRK1B	Preclinical
ML204	transient receptor potential channel antagonist	TRPC4, TRPC5	Preclinical
ML314	neurotensin agonist	NTSR1	Preclinical
ML324	histone lysine demethylase inhibitor	KDM4A	Preclinical
ML347	ALK tyrosine kinase receptor inhibitor	ACVR1, ACVRL1, BMPR1A	Preclinical
MM-102	WDR5/MLL interaction inhibitor		Preclinical
MM-11253	retinoid receptor antagonist	RARG	Preclinical
MMPX	phosphodiesterase inhibitor		Preclinical
MM77	serotonin receptor antagonist	HTR1A	Preclinical
MN-64	tankyrase inhibitor	TNKS	Preclinical
MNITMT	lymphocyte inhibitor		Preclinical
MNS-(3,4-Methylenedioxy-nitrostyrene)	src inhibitor, syk inhibitor	SRC, SYK	Preclinical
mocetinostat	HDAC inhibitor	HDAC1, HDAC11, HDAC2, HDAC3	Phase 2
moclobemide	monoamine oxidase inhibitor	MAOA, MAOB	Launched
modafinil	adrenergic receptor agonist	ADRA1B, SLC6A3	Launched
modaline			Preclinical
moexipril	angiotensin converting enzyme inhibitor	ACE, ACE2	Launched
mofegiline	monoamine oxidase inhibitor	MAOA, MAOB	Phase 1
mofezolac	cyclooxygenase inhibitor	PTGS1	Launched
moguisteine	ATP-sensitive potassium channel inhibitor		Phase 2
molidustat	hypoxia inducible factor inhibitor	EGLN2	Phase 2
molindone	dopamine receptor antagonist	CHRM1, DRD2, HRH1, HTR1A, HTR2A	Launched
molsidomine	guanylate cyclase stimulant	GUCY1A3	Launched
mometasone	glucocorticoid receptor agonist	NR3C1	Launched
mometasone-furoate	glucocorticoid receptor agonist	NR3C1	Launched
monastrol	kinesin inhibitor	KIF11	Preclinical
monensin	bacterial permeability inducer		Launched
monobenzone	melanin inhibitor	TYR	Launched
monoctanoin			Launched
monosodium-alpha-luminol			Launched
monostearin			Preclinical
montelukast	leukotriene receptor antagonist	ALOX5, CYSLTR1	Launched
moprolol	adrenergic receptor antagonist		Launched
moracizine	sodium channel blocker	SCN5A	Launched
morantel	acetylcholine receptor agonist		Launched
morin	cytochrome P450 inhibitor	ADORA2A, ESR2, FASN, MCL1, SLC22A12	Preclinical
morinidazole	other antibiotic	CYP51A1	Launched
morniflumate	anti-inflammatory agent		Launched
moroxydine	antiviral		Launched
mosapride	serotonin receptor agonist	HTR4	Launched
motesanib	KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	FLT1, FLT4, KDR, KIT	Phase 3
motolimod	toll-like receptor agonist	TLR8	Phase 1/Phase 2
moxalactam	bacterial cell wall synthesis inhibitor		Launched
moxaverine	phosphodiesterase inhibitor		Launched
moxidectin	chloride channel antagonist		Launched
moxifloxacin	bacterial DNA gyrase inhibitor	TOP2A	Launched
moxisylyte	adrenergic receptor antagonist		Withdrawn
moxonidine	imidazoline receptor agonist	ADRA2A, ADRA2B, ADRA2C	Launched
mozavaptan	vasopressin receptor antagonist	AVPR1A, AVPR1B, AVPR2	Launched
MPEP	glutamate receptor antagonist	GRM1, GRM4, GRM5	Preclinical
MPI-0479605	mitotic kinase inhibitor	TTK	Preclinical
Mps-BAY-2a	monopolar spindle 1 kinase inhibitor	TTK	Preclinical
Mps1-IN-1	monopolar spindle 1 kinase inhibitor	TTK	Preclinical
Mps1-IN-5	protein kinase inhibitor		Preclinical
MR-16728	acetylcholine release enhancer		Preclinical
MR-948	thromboxane synthase inhibitor	TBXAS1	Phase 1
MRK-016	GABA receptor inverse agonist	GABRA1, GABRA2, GABRA3, GABRA5	Phase 1
MRK-409	benzodiazepine receptor agonist		Phase 1
MRK-560	gamma secretase inhibitor	APP	Preclinical
MRS-1220	adenosine receptor antagonist	ADORA2B, ADORA3	Preclinical
MRS-3777	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Preclinical
MRS1334	adenosine receptor antagonist	ADORA3	Preclinical
MRS1845	calcium channel blocker		Preclinical
MRS2578	purinergic receptor antagonist	P2RY6	Preclinical
MRS3777	adenosine receptor antagonist	ADORA2A	Preclinical
MSX-122	CC chemokine receptor antagonist	CXCR4	Phase 1
MTPG	glutamate receptor antagonist	GRM2, GRM3	Preclinical
mubritinib	protein tyrosine kinase inhibitor	EGFR, ERBB2	Phase 1
mupirocin	isoleucyl-tRNA synthetase inhibitor		Launched
muscimol	benzodiazepine receptor agonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRR1, GABRR2, GABRR3	Phase 1
MUT056399	FABI inhibitor		Phase 1
MY-5445	phosphodiesterase inhibitor, platelet aggregation inhibitor	PDE5A	Preclinical
mycophenolate-mofetil	dehydrogenase inhibitor, inositol monophosphatase inhibitor	IMPDH1, IMPDH2	Launched
mycophenolic-acid	dehydrogenase inhibitor, inositol monophosphatase inhibitor	IMPDH1, IMPDH2	Launched
myricetin	androgen receptor agonist, cytochrome P450 inhibitor	PIK3CG	Preclinical
myricitrin	PKC inhibitor	NOS1, PRKCA	Preclinical
myristyl-nicotinate	topical sunscreen agent		Phase 1
M8-B	transient receptor potential channel antagonist	TRPM8	Preclinical
N-(2-chlorophenyl)-2-({(2E)-2-[1-(2-pyridinyl)ethylidene]hydrazino}carbothioyl)hydrazinecarbothioamide			Preclinical
N-[2-(Piperidinylamino)ethyl]-4-iodobenzamide	sigma receptor ligand		Preclinical
N-acetyl-D-glucosamine		B4GALT1, B4GALT2, B4GALT3, B4GALT4, NAGK, NAGLU, NAGPA, RENBP	Phase 2/Phase 3
N-acetyl-tyrosine			Launched
N-acetylcarnosine			Phase 2
N-acetylglycyl-D-glutamic-acid	glutamate receptor agonist		Preclinical
N-acetylmannosamine		CHIT1	Phase 1
N-acetyltryptamine	melatonin receptor agonist		Preclinical
N-alpha-Methylhistamine-dihydrochloride	histamine receptor agonist	HRH4	Phase 3
N-benzylnaltrindole	opioid receptor antagonist		Preclinical
N-cyanopyrrolidine		CTSK	Preclinical
N-demethylantipyrine			Preclinical
N-hydroxynicotinamide			Preclinical
N-methyl-(-)ephedrine-[1r,2s]			Preclinical
N-methylformamide			Phase 2
N-methyllidocaine-iodide	antiarrhythmic medication		Preclinical
N-methylpyrrolidone			Phase 1
N-methylquipazine	serotonin receptor agonist	HTR1A, HTR1D, HTR2A, HTR2B, HTR2C, HTR3A, HTR3B, HTR6, SLC6A4	Preclinical
N-MPPP	opioid receptor agonist		Preclinical
N-oxydiethylenebenzothiazole-2-sulfenamide			Preclinical
N-salicoylaminophenol	ribonucleotide reductase inhibitor		Preclinical
NAB-2	ubiquitin ligase transport promoter	NEDD4	Preclinical
nabumetone	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
nadide	electron acceptor	AHCY, AKR1A1, ALDH2, BLVRA, DHPS, DLD, GALE, HMGCR, HSD17B1, HSD17B4, IMPDH2, MGAM, P2RY11, SORD, TRPM2	Launched
nadifloxacin	bacterial DNA gyrase inhibitor		Launched
nadolol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3	Launched
NADPH		AASS, DPYD, GHSR, TXNRD1	Preclinical
nafadotride	dopamine receptor antagonist	DRD2, DRD3, HTR1A	Preclinical
nafamostat	serine protease inhibitor	ASIC1, ASIC2, ASIC3, C1R, PRSS1, TPSAB1, TRPM7	Launched
nafcillin	bacterial cell wall synthesis inhibitor	CYP1A2, CYP3A4, SLC22A6	Launched
naftidrofuryl	adrenergic receptor antagonist		Launched
naftifine	fungal squalene epoxidase inhibitor	SQLE	Launched
naftopidil	adrenergic receptor antagonist	ADRA1A	Launched
nalbuphine	opioid receptor agonist, opioid receptor antagonist	OPRD1, OPRK1, OPRM1	Launched
nalfurafine	opioid receptor agonist	OPRK1, OPRM1	Launched
nalidixic-acid	bacterial DNA gyrase inhibitor		Launched
nalmefene	opioid receptor antagonist	OPRD1, OPRK1, OPRM1	Launched
naloxegol	opioid receptor antagonist	OPRM1	Launched
naloxone	opioid receptor antagonist	CREB1, ESR1, OPRD1, OPRK1, OPRM1, TLR4	Launched
naloxone-benzoylhydrazone	opioid receptor antagonist	OPRK1, OPRM1	Preclinical
naltrexone	opioid receptor antagonist	OPRD1, OPRK1, OPRM1, SIGMAR1	Launched
naltriben	opioid receptor antagonist	OPRD1, OPRK1, OPRM1	Preclinical
naltrindole	opioid receptor antagonist	OPRD1, OPRK1, OPRM1	Preclinical
Nampt-IN-1			Preclinical
NAN-190	serotonin receptor agonist	ADRA1A, ADRA1B, ADRA1D, HTR1A, HTR1F	Preclinical
nanchangmycin	other antibiotic		Preclinical
nandrolone	imidazoline receptor agonist	AR, CYP19A1, MAOA, MAOB	Launched
nandrolone-decanoate	androgenic steroid	AR	Phase 1
napabucasin	STAT inhibitor	STAT3	Phase 3
naphazoline	adrenergic receptor agonist	ADRA1A, ADRA2A	Launched
naphthoquine-phosphate	antimalarial agent		Launched
napirimus	immunosuppressant		Phase 1
naproxen	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
narasin	antiprotozoal agent		Launched
naratriptan	serotonin receptor agonist	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F	Launched
naringenin	aromatase inhibitor, TRPV antagonist	CYP19A1, CYP1B1, ESR2, GLO1, HSD17B1	Phase 1
naringeninic-acid		HCAR2, PTGR1	Phase 1
naringin	cytochrome P450 inhibitor	SLCO1A2	Preclinical
naringin-dihydrochalcone	cytochrome P450 inhibitor		Preclinical
narlaprevir	HCV inhibitor		Phase 2/Phase 3
nastorazepide	CCK receptor antagonist	CCKBR	Phase 2
natamycin	fungal ergosterol inhibitor		Launched
nateglinide	insulin secretagogue	ABCC8, KCNJ10, KCNJ11, PPARG	Launched
NAV-26	voltage-gated sodium channel blocker	SCN9A	Preclinical
navarixin	CC chemokine receptor antagonist	CXCR1, CXCR2	Phase 2
navitoclax	BCL inhibitor	BCL2, BCL2L1, BCL2L2	Phase 2
NBI-27914	corticosteroid releasing factor receptor antagonist	CRHR1	Preclinical
NBI-74330-(+/-)	CC chemokine receptor antagonist	CXCR3	Preclinical
NBQX	glutamate receptor antagonist	GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIN1, GRIN2A, GRIN2B	Preclinical
NCS-382	GABA receptor antagonist	GABBR1, GABBR2, SLC52A2	Preclinical
NDT-9513727	complement antagonist	C5AR1	Preclinical
NE-100	sigma receptor antagonist	SIGMAR1	Phase 2
nebivolol	adrenergic receptor antagonist	ADRB1, ADRB2	Launched
nebracetam	acetylcholine receptor agonist	CHRM1	Phase 3
NECA	adenosine receptor agonist	ADORA1, ADORA2A, ADORA2B, ADORA3, HSP90B1	Launched
necrostatin-1	RIPK inhibitor	RIPK1	Preclinical
necrostatin-2	necroptosis inhibitor, RIPK inhibitor	RIPK2	Preclinical
nedaplatin	DNA inhibitor		Launched
nedocromil	histamine receptor antagonist	CYSLTR1, CYSLTR2, FPR1, HSP90AA1, PTGDR	Launched
nefazodone	adrenergic inhibitor, norepinephrine reuptake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor	ADRA1A, ADRA1B, ADRA2A, CYP3A4, HTR1A, HTR2A, HTR2C, SLC6A2, SLC6A3, SLC6A4	Withdrawn
nefiracetam	acetylcholine receptor agonist, benzodiazepine receptor agonist	CHRM1	Phase 3
nefopam	cyclooxygenase inhibitor		Launched
nelarabine	DNA synthesis inhibitor, T cell inhibitor	POLA1	Launched
nelfinavir	HIV protease inhibitor	CYP1A2, CYP2B6, CYP2C19, CYP2C9, CYP2D6, CYP3A4, CYP3A7	Launched
nemonapride	dopamine receptor antagonist	DRD2, DRD3, DRD4	Launched
nemorubicin	topoisomerase inhibitor	TOP1, TOP2A	Phase 2
neo-gilurytmal			Launched
neohesperidin			Preclinical
neohesperidin-dihydrochalcone			Preclinical
neomycin	bacterial 30S ribosomal subunit inhibitor	CXCR4	Launched
neomycin-sulfate	bacterial 30S ribosomal subunit inhibitor		Launched
neostigmine	acetylcholinesterase inhibitor	ACHE	Launched
nepafenac	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
nepicastat	dopamine beta hydroxylase inhibitor	DBH	Phase 2
neratinib	EGFR inhibitor	EGFR, ERBB2, KDR	Phase 3
nerbacadol	cyclooxygenase inhibitor		Phase 3
neridronic-acid	bone resorption inhibitor	FDPS	Launched
nesbuvir	RNA polymerase inhibitor		Phase 2
netilmicin	protein synthesis inhibitor		Launched
netupitant	tachykinin antagonist	TACR1	Launched
neurodazine	neurogenesis of non-pluripotent C2C12 myoblast inducer		Preclinical
neuropathiazol	neural stem cell inducer	BMP2, LIF	Preclinical
nevirapine	non-nucleoside reverse transcriptase inhibitor	CYP1A2, CYP2A6, CYP2B6, CYP2C9, CYP2D6, CYP3A4, CYP3A5	Launched
nexturastat-a	HDAC inhibitor	HDAC1, HDAC6	Preclinical
NFKB-activation-inhibitor-II	NFkB pathway inhibitor	RELA	Preclinical
NG-nitro-arginine	nitric oxide synthase inhibitor	NOS1, NOS2, NOS3	Phase 1
NGB-2904	dopamine receptor antagonist	DRD3	Preclinical
NGD-94-1	dopamine receptor antagonist	DRD4	Phase 1
NGD-98-2	corticosteroid releasing factor receptor antagonist	CRHR1	Preclinical
NHI-2	lactate dehydrogenase inhibitor	LDHA	Preclinical
NH125	eukaryotic translation elongation factor 2 inhibitor		Preclinical
NI-57	bromodomain inhibitor	BRD1, BRPF1, BRPF3	Preclinical
niacin	NAD precursor, vitamin B	DGAT2, HCAR1, HCAR2, HCAR3, NNMT, QPRT	Launched
nialamide	monoamine oxidase inhibitor	COMT, MAOA, MAOB	Withdrawn
nibentan	potassium channel blocker		Phase 2
nicaraven	free radical scavenger		Phase 3
nicardipine	calcium channel blocker	ADORA3, ADRA1A, ADRA1B, ADRA1D, CACNA1C, CACNA1D, CACNA2D1, CACNB2, CALM1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, PDE1A, PDE1B	Launched
nicergoline	adrenergic receptor antagonist	ADRA1A	Launched
niceritrol	NAD precursor		Launched
niclosamide	DNA replication inhibitor, STAT inhibitor	STAT3	Launched
nicorandil	nitric oxide donor, potassium channel activator	KCNJ11	Launched
nicotinamide	protein synthesis stimulant	BST1, LDHA, PARP1, SIRT5	Launched
nicotine	acetylcholine receptor agonist	CHAT, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB2, CHRNB3, CHRNB4, CYP19A1, TBXAS1, TRPA1	Launched
nicotinyl-alcohol-tartrate			Launched
NIDA-41020	cannabinoid receptor antagonist	CNR1	Preclinical
nifedipine	calcium channel blocker	CACNA1C, CACNA1D, CACNA1F, CACNA1H, CACNA1S, CACNA2D1, CACNB2, CALM1, GLRA1, GLRA3, GLRB, KCNA1, KCNA5, NR1I2, TRPM3	Launched
nifekalant	potassium channel blocker		Launched
nifenalol	adrenergic receptor antagonist	ADRB1, ADRB2	Launched
nifenazone	analgesic agent		Launched
niflumic-acid	cyclooxygenase inhibitor	ANO1, CLCN1, CLCNKA, CLCNKB, KCNQ1, PLA2G1B, PLA2G4A, PTGS1, PTGS2, UGT1A9	Launched
nifuroxazide	bacterial DNA inhibitor		Launched
nifursol	bacterial DNA inhibitor		Launched
nifurtimox	DNA inhibitor		Launched
niguldipine-(S)-(+)	adrenergic receptor antagonist	ADRA1A	Preclinical
nikethamide	immunostimulant		Withdrawn
nilotinib	Abl kinase inhibitor, Bcr-Abl kinase inhibitor	ABL1, KIT	Launched
nilutamide	androgen receptor antagonist	AR	Launched
nilvadipine	calcium channel blocker	CACNA1C, CACNA1D, CACNA1S, CACNA2D1, CACNA2D3, CACNB2	Launched
nimesulide	cyclooxygenase inhibitor	LTF, PLA2G2E, PTGS1, PTGS2	Launched
nimodipine	calcium channel blocker	AHR, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CFTR, NR3C2	Launched
nimorazole	bacterial DNA inhibitor		Launched
nimustine	DNA alkylating agent		Launched
nintedanib	FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB	Launched
niraparib	PARP inhibitor	PARP1	Launched
niridazole	phosphofructokinase inhibitor		Launched
nisin	bacterial cell wall synthesis inhibitor		Phase 1
nisoldipine	calcium channel blocker	CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNA2D1, CACNB2	Launched
nisoxetine	norepinephrine reuptake inhibitor	SLC6A2, SLC6A3, SLC6A4	Phase 1
nitarsone			Launched
nitazoxanide	pyruvate ferredoxin oxidoreductase inhibitor		Launched
nitecapone	catechol O methyltransferase inhibitor	COMT	Phase 2
nitenpyram			Launched
nithiamide	bacterial DNA inhibitor		Preclinical
nitisinone	hydroxyphenylpyruvate dioxygenase inhibitor	HPD	Launched
nitrendipine	calcium channel blocker	CACNA1C, CACNA1D, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2, CACNG1, KCNN4	Launched
nitrocaramiphen	cholinergic receptor antagonist	CHRM1	Preclinical
nitrofurantoin	DNA inhibitor		Launched
nitrofurazone	bacterial DNA inhibitor		Launched
nitromide			Launched
nitrosodimethylurea	DNA synthesis inhibitor		Preclinical
nitroxoline	cathepsin inhibitor	METAP2	Launched
nizatidine	histamine receptor antagonist	HRH2	Launched
nizofenone	ion channel antagonist		Launched
NK-252	NRF2 activator	NFE2L2	Preclinical
NKP-1339	HSP inhibitor		Phase 1
NKY-80	adenylyl cyclase inhibitor	ADCY5	Preclinical
NLG919	indoleamine 2,3-dioxygenase inhibitor	IDO1	Phase 1
NMDA	glutamate receptor agonist	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D	Preclinical
NMS-E973	HSP inhibitor		Preclinical
NMS-P715	protein kinase inhibitor		Preclinical
NMS-1286937	PLK inhibitor	FLT3, PLK1, PLK2, PLK3	Phase 1
NMS-873	ATPase inhibitor	VCP	Preclinical
NM107	RNA polymerase inhibitor		Phase 2
NNC-05-2090	GABA uptake inhibitor, GAT inhibitor	SLC6A12	Preclinical
NNC-55-0396	T-type calcium channel blocker	CATSPER1, CATSPER2, CATSPER3, CATSPER4	Preclinical
NNC-63-0532	opioid receptor agonist	OPRL1	Preclinical
NNC-711	GABA uptake inhibitor	SIGMAR1, SLC6A1	Preclinical
NO-ASA	cyclooxygenase inhibitor	PTGS2	Phase 2
nobiletin	MEK inhibitor	MAP2K1	Preclinical
nocodazole	tubulin polymerization inhibitor	HPGDS	Preclinical
nolatrexed	thymidylate synthase inhibitor	TYMS	Phase 3
nomegestrol-acetate	progesterone receptor agonist	PGR	Launched
nomifensine	dopamine uptake inhibitor, noradrenaline uptake inhibitor	DRD2, MAOA, MAOB, MPO, SLC6A2, SLC6A3	Withdrawn
nonivamide	TRPV agonist	TRPV1	Launched
nonoxynol-9	membrane integrity inhibitor		Launched
nor-Binaltorphimine-dihydrochloride	opioid receptor antagonist	OPRD1, OPRK1, OPRM1	Preclinical
norcyclobenzaprine	adrenergic receptor agonist, serotonin receptor antagonist		Preclinical
norelgestromin		PGR	Launched
norepinephrine	adrenergic receptor agonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, PAH, SLC18A1, SLC18A2	Launched
norethindrone	progesterone receptor agonist	PGR	Launched
norethindrone-acetate	progesterone receptor agonist		Launched
norethisterone-enanthate	contraceptive agent		Launched
noretynodrel	progestogen hormone	PGR	Launched
norfloxacin	bacterial DNA gyrase inhibitor	TOP2A	Launched
norfluoxetine	selective serotonin reuptake inhibitor (SSRI)	HTR2B	Phase 1
norgestimate	progesterone receptor agonist	ESR1, PGR	Launched
norgestrel	progesterone receptor agonist	PGR	Launched
nornicotine	acetylcholine receptor agonist		Preclinical
nortriptyline	tricyclic antidepressant	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR1A, HTR2A, HTR2C, HTR6, KCNJ10, PGRMC1, SIGMAR1, SLC6A2, SLC6A4	Launched
norvancomycin			Preclinical
noscapine	bradykinin receptor antagonist, tubulin polymerization inhibitor	SIGMAR1	Launched
NOV-002		GSR, GSTM2	Phase 3
novobiocin	bacterial DNA gyrase inhibitor		Launched
NPC-01	steroid		Phase 3
NPC-15199	ICAM1 antagonist	PPARG	Phase 2
NPPB	chloride channel blocker	ANO1, CLCN2, CLCN7, TRPA1	Preclinical
NPS-2143	calcium receptor antagonist	CASR	Preclinical
NPY-5RA972	neuropeptide receptor antagonist	NPY5R	Preclinical
NQDI-1	caspase inhibitor	CASP3	Preclinical
NS-018	JAK inhibitor	JAK1, JAK2, JAK3, TYK2	Phase 1/Phase 2
NS-11021	calcium-activated potassium channel activator	KCNMA1	Preclinical
NS-1643	voltage-gated potassium channel activator	KCNH2, KCNH6, KCNMA1	Preclinical
NS-19504	calcium-activated potassium channel activator	KCNMA1	Preclinical
NS-309	calcium-activated potassium channel activator	KCNN1, KCNN2, KCNN3, KCNN4	Preclinical
NS-3623	voltage-gated potassium channel activator	KCNH2	Preclinical
NS-3861	acetylcholine receptor agonist	CHRNA3, CHRNB4	Preclinical
NS-5806	voltage-gated potassium channel activator	KCND3	Preclinical
NS-8	potassium channel agonist	KCNMA1	Phase 2
NS-8593	calcium-activated potassium channel modulator	KCNN1, KCNN2, KCNN3	Preclinical
NS-9283	acetylcholine receptor allosteric modulator	CHRNA4	Preclinical
NSC-23766	Ras GTPase inhibitor		Preclinical
NSC-319726	p53 activator		Preclinical
NSC-3852	HDAC inhibitor	HDAC1	Preclinical
NSC-405020	matrix metalloprotease inhibitor	MMP1	Preclinical
NSC-4644	ACAT inhibitor, sterol regulatory element binding protein (SREBP) inhibitor	PYGM	Phase 2
NSC-625987	CDK inhibitor	CDK2, CDK4	Preclinical
NSC-632839	ubiquitin specific protease inhibitor	SENP2, USP1, USP2, USP7	Preclinical
NSC-663284	CDC inhibitor	CDC25A, CDC25B, CDC25C	Preclinical
NSC-697923	ubiquitin-conjugating enzyme inhibitor	UBE2N	Preclinical
NSC-95397	CDC inhibitor	CDC25A, CDC25B	Preclinical
NSC-9965	acetylcholine receptor antagonist	CHRNA4, CHRNB2	Preclinical
NSC5844	CC chemokine receptor agonist	CCR1	Preclinical
NSC636819	histone demethylase inhibitor	KDM4A, KDM4B	Preclinical
NSI-189	neurotrophic agent		Phase 2
NTNCB	neuropeptide receptor antagonist	NPY5R	Preclinical
NTRC-824	neurotensin receptor antagonist	NTSR2	Preclinical
nTZDpa	PPAR receptor agonist	PPARG	Preclinical
NT157	IGF-1 inhibitor	IGF1R	Preclinical
NU-1025	PARP inhibitor	PARP1	Preclinical
NU-2058	cyclin D inhibitor	CCNA2, CDK2	Preclinical
NU-7026	DNA dependent protein kinase inhibitor, mTOR inhibitor, PI3K inhibitor	PRKDC	Preclinical
NU-7441	DNA dependent protein kinase inhibitor	PRKDC	Preclinical
nuclomedone	immunosuppressant		Phase 3
nutlin-3	MDM inhibitor	MDM2, TP53	Preclinical
NU6027	CDK inhibitor	CCNA2, CDK2	Preclinical
NVP-ADW742	insulin growth factor receptor inhibitor	IGF1R	Preclinical
NVP-AEW541	IGF-1 inhibitor	IGF1R, INSR	Preclinical
NVP-AUY922	HSP inhibitor	HSP90AA1, HSP90AB1	Phase 2
NVP-BEZ235	mTOR inhibitor, PI3K inhibitor	ATR, MTOR, PIK3CA, PIK3CD, PIK3CG	Phase 2
NVP-BGJ398	FGFR inhibitor	FGFR1, FGFR2, FGFR3, FGFR4, KDR	Phase 2
NVP-BHG712	ephrin inhibitor	EPHB4	Preclinical
NVP-BSK805	JAK inhibitor	JAK2	Preclinical
NVP-BVU972	MET inhibitor	MET	Preclinical
NVP-DPP728	dipeptidyl peptidase inhibitor	DPP4	Phase 2
NVP-HSP990	HSP inhibitor	HSP90AA1, HSP90AB1	Phase 1
NVP-TAE226	protein tyrosine kinase inhibitor	PTK2	Preclinical
NVP-TAE684	ALK tyrosine kinase receptor inhibitor	ALK, INSR	Preclinical
NVP-TNKS656	tankyrase inhibitor	TNKS2	Preclinical
NVP-231	ceramidase inhibitor	CERK	Preclinical
NVS-PAK1-1	p21 activated kinase inhibitor	PAK1	Preclinical
NXY-059	free radical scavenger		Phase 3
nystatin	fungal ergosterol inhibitor		Launched
N20C	glutamate receptor antagonist		Preclinical
N6-cyclopentyladenosine	adenosine receptor agonist	ADORA1, ADORA2A, ADORA2B, ADORA3, SLC29A1	Preclinical
N6-methyladenosine			Preclinical
N6022	alcohol dehydrogenase inhibitor	ADH5	Phase 1/Phase 2
o-acetyl-L-serine		PTGS1	Preclinical
o-mercapto-benzoic-acid			Preclinical
O-1918	cannabinoid receptor antagonist		Preclinical
o-3M3FBS	phospholipase activator		Preclinical
OAC1	Oct activator		Preclinical
OAC2	Oct activator	POU5F1	Preclinical
obatoclax	BCL inhibitor	BCL2	Phase 3
obeticholic-acid	FXR agonist	NR1H4	Launched
obidoxime	cholinesterase reactivator	ACHE	Launched
ochromycinone	STAT inhibitor	STAT3	Phase 1
ocinaplon	GABA receptor modulator	GABRA1, GABRA2, GABRA3, GABRA5	Phase 3
OCO-1112	cholesterol inhibitor		Phase 2
octadecan-1-ol			Preclinical
octamethyltrisiloxane			Preclinical
octenidine	membrane integrity inhibitor		Launched
octinoxate			Launched
octisalate			Launched
octocrylene			Launched
octodrine	antitumor agent		Preclinical
octopamine	trace amine associated receptor agonist	F10, TAAR1	Preclinical
octreotide	somatostatin receptor agonist	SSTR1, SSTR2, SSTR3, SSTR5	Launched
OC000459	CRTH receptor antagonist	PTGDR2	Phase 2
odanacatib	cathepsin inhibitor	CTSK	Phase 3
ODM-201	androgen receptor antagonist	AR	Phase 3
ODQ	guanylyl cyclase inhibitor	GUCY1A2, GUCY1A3, GUCY1B3	Preclinical
OF-1	bromodomain inhibitor	BRD1	Preclinical
ofloxacin	bacterial DNA gyrase inhibitor	TOP2A	Launched
OG-L002	histone lysine demethylase inhibitor	KDM1A	Preclinical
oglemilast	phosphodiesterase inhibitor		Phase 2
OICR-9429	WDR5/MLL interaction inhibitor	WDR5	Preclinical
olanzapine	dopamine receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR3A, HTR5A, HTR6, HTR7	Launched
olaparib	PARP inhibitor	PARP1, PARP2	Launched
OLDA	TRPV agonist	GPR119	Preclinical
oleamide	cannabinoid receptor agonist	HTR7, PLA2G2A	Preclinical
oleandrin	Na/K-ATPase inhibitor		Phase 1
oleanolic-acid	G protein-coupled receptor agonist	GPBAR1	Preclinical
oleoylethanolamide	cannabinoid receptor agonist, glucose dependent insulinotropic receptor agonist, potassium channel blocker, PPAR receptor agonist	CNR1, GPR119, GPR55, PPARA	Preclinical
olesoxime	apoptosis stimulant		Phase 2/Phase 3
oleuropein	estrogen receptor agonist	GPER1	Phase 2
oligomycin-a	ATP synthase inhibitor, ATPase inhibitor	ATP5A1	Preclinical
olmesartan	angiotensin receptor antagonist	AGTR1	Launched
olmesartan-medoxomil	angiotensin receptor antagonist	AGTR1	Launched
olmutinib	EGFR inhibitor, Bruton's tyrosine kinase (BTK) inhibitor	BTK, EGFR	Launched
olomoucine	CDK inhibitor	CDK1, CDK2, CDK5, MAPK1	Preclinical
olopatadine	histamine receptor antagonist	HRH1, S100A1, S100A12, S100A13, S100A2, S100B	Launched
olprinone	phosphodiesterase inhibitor	PDE3A	Launched
olsalazine	cyclooxygenase inhibitor	IFNG, TPMT	Launched
oltipraz	nuclear factor erythroid derived, like (NRF2) activator	ANG	Phase 3
olvanil	TRPV agonist	CNR1, GPR119, TRPV1	Preclinical
omadacycline	bacterial 30S ribosomal subunit inhibitor		Phase 3
omarigliptin	dipeptidyl peptidase inhibitor	DPP4	Launched
ombitasvir	HCV inhibitor		Launched
OMDM-2	FAAH inhibitor	GPR119	Preclinical
omecamtiv-mecarbil	cardiac myosin activator	MYBPC3	Phase 2
omega-(4-Iodophenyl)pentadecanoic acid			Preclinical
omega-3-acid-esters	cholesterol inhibitor		Launched
omeprazole	ATPase inhibitor	ATP4A, CLCN2	Launched
omeprazole-magnesium	proton pump inhibitor	ATP4A, ATP4B	Launched
omeprazole-sulfide	ATPase inhibitor		Phase 1
ON-01500	apoptosis stimulant		Preclinical
oncrasin-1	apoptosis stimulant		Preclinical
ONC201	AKT inhibitor, MAP kinase inhibitor	TNFSF10	Phase 2
ondansetron	serotonin receptor antagonist	HTR1A, HTR1B, HTR3A, HTR3B, HTR4, OPRM1	Launched
ONO-AE3-208	prostanoid receptor antagonist	PTGER4	Preclinical
ONO-4059	Bruton's tyrosine kinase (BTK) inhibitor	BTK	Phase 1
ONO-4817	matrix metalloprotease inhibitor	MMP8	Phase 1
ONO-8130	prostanoid receptor antagonist	PTGER1	Preclinical
ONX-0914	proteasome inhibitor		Preclinical
ON123300	CDK inhibitor	CDK4, NUAK1, PDGFRB	Preclinical
OPC-21268	vasopressin receptor antagonist	AVPR1A, AVPR2, OXTR	Phase 1
opicapone	catechol O methyltransferase inhibitor	COMT	Phase 3
opipramol	sigma receptor agonist		Launched
oprozomib	proteasome inhibitor		Phase 1/Phase 2
OR-486	catechol O methyltransferase inhibitor	COMT	Preclinical
orantinib	FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	AURKA, AURKB, EGFR, FGFR1, FGFR2, KDR, PDGFRA, PDGFRB	Phase 3
orbifloxacin	bacterial DNA gyrase inhibitor		Launched
ORE1001	angiotensin converting enzyme inhibitor	ACE2	Phase 1/Phase 2
Org-12962	serotonin receptor agonist	HTR2A, HTR2B, HTR2C	Phase 2
Org-25543	glycine transporter inhibitor	GLRB, SLC6A5	Preclinical
org-26576	glutamate receptor modulator		Phase 2
org-27569	cannabinoid receptor modulator	CNR1	Preclinical
org-9768	adrenergic receptor antagonist	ADRA2A	Phase 1
oridonin	BCL inhibitor	BCL2	Preclinical
oritavancin	bacterial cell wall synthesis inhibitor		Launched
orlistat	lipase inhibitor	CNR1, DAGLA, DAGLB, FASN, LIPF, PNLIP	Launched
ornidazole	antiprotozoal agent		Launched
ornithine	NFkB pathway modulator	ARG1, ARG2, GATM, GPRC6A, OAT, OAZ1, OAZ2, OAZ3, OTC, SLC25A15, SLC25A2, SLC7A1, SLC7A2, SLC7A3, SLC7A4	Launched
orotic-acid		DHODH	Phase 2
orphanin-fq	opioid receptor agonist	OPRL1, OPRM1	Phase 1
orphenadrine	acetylcholine receptor antagonist	GRIN1, GRIN2D, GRIN3A, GRIN3B, HRH1, SCN10A, SLC6A2	Launched
orteronel	androgen biosynthesis inhibitor, androgen receptor antagonist, cytochrome P450 inhibitor	CYP17A1	Phase 3
ORY-1001	histone lysine demethylase inhibitor	KDM1A	Phase 1/Phase 2
oseltamivir-carboxylate	neuraminidase inhibitor		Launched
oseltamivir-phosphate	neuraminidase inhibitor	CES1, NEU1, NEU2	Launched
osemozotan	serotonin receptor agonist	HTR1A	Phase 2/Phase 3
OSI-027	mTOR inhibitor	MTOR	Phase 1
OSI-420	EGFR inhibitor	EGFR	Preclinical
OSI-930	KIT inhibitor, VEGFR inhibitor	KDR, KIT	Phase 1
osimertinib	EGFR inhibitor	EGFR	Launched
ospemifene	selective estrogen receptor modulator (SERM)	ESR1, ESR2	Launched
ostarine	androgen receptor modulator	AR	Phase 3
osthol	calcium channel blocker		Preclinical
OT-R-antagonist-1	oxytocin receptor antagonist	AVPR1A, OXTR	Preclinical
otamixaban	coagulation factor inhibitor	F10	Phase 3
otenzepad	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Phase 3
otilonium	acetylcholine receptor antagonist	CACNA1C	Launched
OTS167	maternal embryonic leucine zipper kinase inhibitor	MELK	Phase 1
OTS514	TOPK inhibitor		Preclinical
OTX015	bromodomain inhibitor	BRD2, BRD3, BRD4	Phase 1/Phase 2
ouabain	ATPase inhibitor	ATP1A1	Launched
OXA-06	rho associated kinase inhibitor	ROCK1, ROCK2	Preclinical
oxacillin	bacterial cell wall synthesis inhibitor		Launched
oxacyclohexadecan-2-one	protein kinase inhibitor		Preclinical
oxaliplatin	DNA inhibitor		Launched
oxaloacetate	glutamate release inhibitor	CS, SPR	Phase 2/Phase 3
oxandrolone	androgen receptor agonist	AR	Launched
oxantel	anthelmintic agent		Phase 3
oxaprozin	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
oxatomide	histamine receptor antagonist	HRH1	Launched
oxazepam	GABA benzodiazepine site receptor agonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3	Launched
oxcarbazepine	sodium channel blocker	SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	Launched
oxelaidin	antitussive		Launched
oxethazaine	local anesthetic		Launched
OXF-BD-02	bromodomain inhibitor	BRD4	Preclinical
oxfendazole	anthelmintic agent		Launched
oxfenicine	carnitine palmitoyltransferase inhibitor	CPT1A, CPT1B	Phase 1
oxibendazole	tubulin polymerization inhibitor	TUBB, TUBB4B	Launched
oxiconazole	bacterial cell wall synthesis inhibitor		Launched
oxidopamine	neurotoxin		Preclinical
oxiniacic-acid			Preclinical
oxiperomide	dopamine receptor antagonist		Phase 2
oxiracetam	acetylcholine receptor agonist		Launched
oxolamine	antitussive		Launched
oxolinic-acid	bacterial DNA gyrase inhibitor		Preclinical
oxonic-acid	uricase inhibitor		Preclinical
oxotremorine-m	acetylcholine receptor agonist	CHRM1, CHRM2, CHRM3, CHRM4	Preclinical
oxotremorine-sesquifumarate	cholinergic receptor agonist	CHRM1, CHRM2, CHRM3, CHRM4	Preclinical
oxprenolol	adrenergic receptor antagonist	ADRB1, ADRB2	Launched
oxtriphylline	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3, HDAC2, PDE3A, PDE4A, PDE4B, PDE5A	Launched
oxybenzone	lipase inhibitor	LIPE	Launched
oxybuprocaine	local anesthetic	SCN10A	Launched
oxybutynin	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3	Launched
oxyclozanide			Launched
oxyfedrine	adrenergic receptor agonist		Launched
oxymatrine			Launched
oxymetazoline	adrenergic receptor agonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, HTR1B, HTR1D, HTR2C	Launched
oxymetholone	androgen receptor agonist	AR	Launched
oxyphenbutazone	cyclooxygenase inhibitor	PLA2G2E, PTGS1, PTGS2	Withdrawn
oxyphencyclimine	cholinergic receptor antagonist	CHRM1, CHRM2, CHRM3	Launched
oxyphenonium	cholinergic receptor antagonist	CHRM1	Launched
oxypurinol	xanthine oxidase inhibitor	XDH	Phase 2/Phase 3
oxyquinoline	chelating agent	METAP2	Launched
oxytetracycline	bacterial 30S ribosomal subunit inhibitor		Launched
oxytocin	oxytocin receptor agonist	AVPR1A, AVPR1B, AVPR2, OXTR	Launched
ozagrel	thromboxane synthase inhibitor	TBXAS1	Launched
ozanimod	sphingosine 1 phosphate receptor agonist	S1PR1	Phase 3
ozolinone	diuretic		Phase 3
O4I1	Oct inducer	POU5F1	Preclinical
O6-Benzylguanine	O6-alkylguanine-DNA alkyltransferase inhibitor	MGMT	Phase 3
p-dimethylinamyl-benzoate			Preclinical
PA-452	retinoid receptor antagonist	RXRA	Preclinical
PA-824	nitric oxide donor	FASN	Phase 3
PAC-1	caspase activator	CASP3	Phase 1
paclitaxel	tubulin polymerization inhibitor	BCL2, MAP2, MAP4, MAPT, NR1I2, TLR4, TUBB, TUBB1	Launched
PACOCF3	phospholipase inhibitor	PLA2G4A	Preclinical
pacritinib	FLT3 inhibitor, JAK inhibitor	FLT3, JAK1, JAK2, JAK3	Phase 3
paeoniflorin	anticonvulsant		Preclinical
paeonol	anti-inflammatory agent		Preclinical
pafuramidine	DNA synthesis inhibitor		Phase 3
palbociclib	CDK inhibitor	CDK4, CDK6	Launched
palifosfamide	DNA alkylating agent		Phase 3
paliperidone	dopamine receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CYP2D6, CYP3A4, CYP3A5, DRD1, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1D, HTR2A, HTR2C	Launched
palmatine-chloride	dopamine synthesis inhibitor	CYP3A4	Preclinical
palmitoleic-acid			Preclinical
palmitoylcarnitine	protein kinase inhibitor		Preclinical
palmitoylethanolamide	cannabinoid receptor agonist	CNR2, GPR119, GPR55	Launched
palomid-529	AKT inhibitor, mTOR inhibitor	MTOR	Phase 1
palonosetron	serotonin receptor antagonist	HTR3A	Launched
palosuran	urotensin receptor antagonist	UTS2R	Phase 2
palovarotene	retinoid receptor agonist	RARG	Phase 2
pamabrom	diuretic		Launched
pamidronate	bone resorption inhibitor	FDPS	Launched
pancuronium	acetylcholine receptor antagonist	CHRM2, CHRM3, CHRNA1, CHRNA2	Launched
panobinostat	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC4, HDAC6, HDAC7, HDAC8, HDAC9	Launched
pantethine	coenzyme A precursor		Launched
pantoprazole	ATPase inhibitor	ATP4A	Launched
pantothenic-acid	coenzyme A precursor		Launched
PAOPA	dopamine receptor modulator	DRD2	Preclinical
papaverine	phosphodiesterase inhibitor	PDE10A, PDE4B, PDE5A	Launched
para-toluenesulfonamide		CA12, CA2, CA6, CA9	Phase 3
paracetamol	cyclooxygenase inhibitor	FAAH, PTGS1, PTGS2, TRPV1	Launched
parachlorophenol	antiinfective drug		Launched
paramethadione	anticonvulsant	CACNA1G, CACNA1H, CACNA1I	Launched
paraxanthine	adenosine receptor antagonist		Phase 1
parbendazole	tubulin polymerization inhibitor	TUBB	Preclinical
pardoprunox	serotonin receptor agonist, dopamine receptor agonist	DRD2, DRD3, DRD4, HTR1A, HTR7	Phase 3
parecoxib	cyclooxygenase inhibitor	LTF	Launched
parethoxycaine	local anesthetic		Preclinical
pargyline	monoamine oxidase inhibitor	MAOA, MAOB	Launched
paricalcitol	vitamin D receptor agonist	VDR	Launched
paritaprevir	HCV inhibitor		Launched
paromomycin	bacterial 30S ribosomal subunit inhibitor		Launched
paroxetine	selective serotonin reuptake inhibitor (SSRI)	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HTR2A, SLC6A2, SLC6A4	Launched
paroxypropione	gonadotropin inhibitor		Launched
parthenolide	NFkB pathway inhibitor		Phase 1
parthenolide-(-)	NFkB pathway inhibitor	HDAC1	Preclinical
parthenolide-(alternate-stereo)	NFkB pathway inhibitor	IKBKB, RELA	Preclinical
pasiniazid	cyclooxygenase inhibitor		Launched
pasireotide	somatostatin receptor agonist	SSTR1, SSTR2, SSTR3, SSTR5	Launched
pazopanib	KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	CSF1R, FGF1, FGFR1, FGFR3, FLT1, FLT4, ITK, KDR, KIT, PDGFRA, PDGFRB, SH2B3	Launched
pazufloxacin	topoisomerase inhibitor		Launched
PCA-4248	platelet activating factor receptor antagonist	PTAFR	Phase 1
PCI-24781	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC6	Phase 1/Phase 2
PCI-29732	Bruton's tyrosine kinase (BTK) inhibitor	BTK	Preclinical
PCI-34051	HDAC inhibitor	HDAC1, HDAC10, HDAC6, HDAC8	Preclinical
PCO-400	potassium channel activator	KCNJ8	Phase 1
PD-0325901	MEK inhibitor	MAP2K1	Phase 2
PD-102807	acetylcholine receptor antagonist	CHRM4	Preclinical
PD-118057	potassium channel activator	KCNH2	Preclinical
PD-123319	angiotensin antagonist	AGTR2	Phase 1
PD-128907	dopamine receptor agonist	DRD2, DRD3	Preclinical
PD-153035	EGFR inhibitor	EGFR, KDR	Phase 1
PD-156707	endothelin receptor antagonist	EDNRA, EDNRB	Preclinical
PD-158780	EGFR inhibitor	EGFR	Preclinical
PD-160170	neuropeptide receptor antagonist	NPY1R	Preclinical
PD-161570	FGFR inhibitor	FGFR1	Preclinical
PD-166285	src inhibitor	EGFR, FGFR1, PDGFRB, PKMYT1, SRC, WEE1	Preclinical
PD-166793	collagenase inhibitor, metalloproteinase inhibitor	MMP13, MMP2, MMP3	Preclinical
PD-168077	dopamine receptor agonist	DRD2	Preclinical
PD-168393	EGFR inhibitor	EGFR, ERBB2, SRC	Preclinical
PD-168568	dopamine receptor antagonist	DRD2, DRD4	Preclinical
PD-173074	FGFR inhibitor, VEGFR inhibitor	FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB	Preclinical
PD-173212	calcium channel blocker	CACNA1B	Preclinical
PD-184352	MEK inhibitor	MAP2K1, MAP3K1, MAP3K2	Phase 2
PD-198306	MAP kinase inhibitor, MEK inhibitor	MAP2K1, MAP2K2	Preclinical
PD-318088	MEK inhibitor	MAP2K1	Preclinical
PD-407824	PKC inhibitor	WEE1	Preclinical
PD-81723	adenosine receptor agonist	ADORA1	Preclinical
PD-98059	MEK inhibitor	AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1	Preclinical
PDE10-IN-1	phosphodiesterase inhibitor	PDE10A	Preclinical
PDP-EA	FAAH activator	FAAH	Preclinical
PD1-PDL-inhibitor-1	programmed death ligand inhibitor	CD274	Preclinical
peficitinib	JAK inhibitor	JAK1, JAK2, JAK3	Phase 3
pefloxacin	bacterial DNA gyrase inhibitor	TOP2A	Launched
pelanserin	serotonin receptor antagonist	HTR2A	Phase 2
pelitinib	EGFR inhibitor	EGFR	Phase 2
pemetrexed	dihydrofolate reductase inhibitor, thymidylate synthase inhibitor	ATIC, DHFR, GART, TYMS	Launched
pemirolast	mediator release inhibitor	HRH1	Launched
pempidine	ganglionic blocker		Launched
penbutolol	adrenergic receptor antagonist	ADRB1, ADRB2, HTR1A, HTR1B	Launched
penciclovir	DNA directed DNA polymerase inhibitor		Launched
penfluridol	T-type calcium channel blocker	CACNA1G	Launched
penicillamine-(D)	chelating agent		Launched
penicillamine-(racemic)			Preclinical
penicillin-v-potassium	bacterial cell wall synthesis inhibitor		Launched
pentacosanoic-acid			Preclinical
pentagastrin	CCK receptor agonist	CCKBR	Launched
pentamidine	anti-pneumocystis agent	TRDMT1	Launched
pentetic-acid	chelating agent	PGD	Phase 2
pentobarbital	barbiturate antiepileptic, GABA receptor modulator	CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B	Withdrawn
pentolinium	cholinergic receptor antagonist	CHRNA10, CHRNA3, CHRNA4, CHRNB4	Launched
pentostatin	adenosine deaminase inhibitor, ribonucleotide reductase inhibitor	ADA	Launched
pentoxifylline	phosphodiesterase inhibitor	ADORA1, ADORA2A, ADORA2B, ADRA2B, NT5E, PDE10A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE6D, PDE6G, PDE6H, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, TNF	Launched
pentylenetetrazol	GABA receptor antagonist		Withdrawn
pepstatin	aspartic protease inhibitor	CTSB, CTSD, CTSL, REN	Preclinical
peramivir	neuraminidase inhibitor		Launched
perampanel	glutamate receptor antagonist	GRIA1, GRIA2, GRIA3, GRIA4	Launched
perchlozone			Launched
peretinoin	retinoid receptor agonist	RXRA	Phase 3
perfluamine			Launched
perflubron	contrast agent		Launched
perfluorodecalin			Launched
pergolide	dopamine receptor agonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C	Withdrawn
perhexiline	carnitine palmitoyltransferase inhibitor	CPT1A, CPT2	Launched
perifosine	AKT inhibitor	AKT1	Phase 3
perillyl-alcohol	apoptosis stimulant, farnesyltransferase inhibitor	FNTA	Phase 2
perindopril	angiotensin converting enzyme inhibitor	ACE	Launched
perindoprilat	angiotensin converting enzyme inhibitor	ACE	Phase 2
permethrin		SCN1A	Launched
perospirone	dopamine receptor antagonist, serotonin receptor antagonist	DRD2, DRD3, DRD4	Launched
perphenazine	dopamine receptor antagonist	CALM1, DRD1, DRD2, HRH1, HTR2A, HTR2C, HTR6, HTR7	Launched
peruvoside	cardiac glycoside		Phase 1
perzinfotel	glutamate receptor antagonist	GRIN1, GRIN2A, GRIN2B	Phase 2
PETCM	caspase activator	CASP3	Preclinical
pevonedistat	nedd activating enzyme inhibitor	NAE1, UBA3	Phase 2
pexidartinib	tyrosine kinase inhibitor	CSF1R, FLT3, KIT	Phase 3
pexmetinib	TIE tyrosine kinase inhibitor, MAP kinase inhibitor	MAPK14, TEK	Phase 1
PF-02545920	phosphodiesterase inhibitor	PDE10A	Phase 2
PF-03049423	phosphodiesterase inhibitor	PDE5A	Phase 2
PF-03084014	gamma secretase inhibitor		Phase 2
PF-03758309	p21 activated kinase inhibitor	PAK4	Phase 1
PF-03814735	Aurora kinase inhibitor	AURKA, AURKB	Phase 1
PF-03882845			Phase 1
PF-04136309	CC chemokine receptor antagonist		Phase 2
PF-04217903	c-Met inhibitor	MET	Phase 1
PF-04418948	prostaglandin inhibitor	PTGER2	Phase 1
PF-04447943	phosphodiesterase inhibitor	PDE9A	Phase 2
PF-04457845	FAAH inhibitor	FAAH	Phase 2
PF-04620110	diacylglycerol O acyltransferase inhibitor	DGAT1	Phase 1
PF-04691502	mTOR inhibitor, PI3K inhibitor	MTOR, PIK3CA	Phase 2
PF-04885614	voltage-gated sodium channel blocker	SCN10A	Preclinical
PF-04937319	glucokinase activator	GCK	Phase 2
PF-05190457	growth hormone secretagogue receptor inverse agonist	GHSR	Phase 2
PF-05212384	mTOR inhibitor, PI3K inhibitor	MTOR, PIK3CA	Phase 2
PF-06447475	serine/threonine kinase inhibitor	LRRK2	Preclinical
PF-06463922	ALK tyrosine kinase receptor inhibitor	ALK, FES, ROS1	Phase 2
PF-3274167	oxytocin receptor antagonist	AVPR1A, OXTR	Phase 2
PF-3845	FAAH inhibitor	FAAH	Preclinical
PF-429242	SREBP inhibitor	MBTPS1	Preclinical
PF-431396	focal adhesion kinase inhibitor	PTK2, PTK2B	Preclinical
PF-4708671	ribosomal protein inhibitor	RPS6KB1	Preclinical
PF-477736	CHK inhibitor	CHEK1, CHEK2	Phase 1
PF-4800567	casein kinase inhibitor	CSNK1D, CSNK1E	Preclinical
PF-4981517	cytochrome P450 inhibitor	CYP3A4	Preclinical
PF-5274857	smoothened receptor antagonist	SMO	Preclinical
PF-562271	focal adhesion kinase inhibitor	PTK2, PTK2B	Phase 1
PF-573228	focal adhesion kinase inhibitor	CDK1, CDK2, CDK7, GSK3B, IKBKB	Preclinical
PF-670462	casein kinase inhibitor	CSNK1D, CSNK1E	Preclinical
PF-750	FAAH inhibitor	FAAH	Preclinical
PF-8380	autotaxin inhibitor	ENPP2	Preclinical
PF-915275	11-beta hydroxysteroid dehydrogenase inhibitor	HSD11B1	Phase 1
PFI-1	bromodomain inhibitor	BRD4	Preclinical
PFI-3	bromodomain inhibitor	PBRM1, SMARCA4	Preclinical
PFI-4	bromodomain inhibitor	BRPF1	Preclinical
PFK-015	phosphofructokinase inhibitor	PFKFB3	Phase 1
PFK-158	phosphofructokinase inhibitor	PFKFB3	Phase 1
PG-9	acetylcholine receptor agonist		Preclinical
PGL5001	JNK inhibitor	MAPK10, MAPK8, MAPK9	Phase 2
PH-797804	p38 MAPK inhibitor	MAPK11, MAPK14	Phase 2
PHA-568487	nicotinic receptor agonist	CHRNA7	Preclinical
PHA-665752	c-Met inhibitor	MET	Preclinical
PHA-680632	Aurora kinase inhibitor	AURKA, AURKB, AURKC	Preclinical
PHA-767491	CDC inhibitor	CDK1, RPS6KB1	Preclinical
PHA-793887	CDK inhibitor	CDK1, CDK2, CDK4, CDK5, CDK7, CDK9	Phase 1
PHA-848125	CDK inhibitor, growth factor receptor inhibitor	CDK2, CDK4, CDK7, NTRK1	Phase 2
PHCCC	glutamate receptor agonist	GRM1, GRM4	Preclinical
phenacaine	local anesthetic		Launched
phenacemide	sodium channel blocker	SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	Launched
phenacetin	cyclooxygenase inhibitor	PTGS1	Withdrawn
phenazone	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
phenazopyridine	local anesthetic	SCN1A	Launched
phenelzine	monoamine oxidase inhibitor	ABAT, AOC3, GAD2, GPT, GPT2, MAOA, MAOB, SLC6A2, SLC6A3, SLC6A4	Launched
phenethicillin	bacterial cell wall synthesis inhibitor		Launched
phenethyl-isothiocyanate	anticancer agent	CYP2E1	Phase 2
phenformin	AMPK activator	KCNJ8, PRKAA1	Withdrawn
phenindamine	histamine receptor antagonist	HRH1	Launched
phenindione	vitamin K antagonist	VKORC1	Launched
pheniramine	histamine receptor antagonist	HRH1	Launched
phenol		CA1, CA12, CA14, CA2, CA4, CA9	Preclinical
phenolphthalein	indicator dye	UGT1A9	Withdrawn
phenolsulfonphthalein			Launched
phenothiazine	dopamine receptor antagonist		Preclinical
phenothrin			Launched
phenoxybenzamine	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB2, CALM1	Launched
phenprobamate	muscle relaxant		Launched
phenprocoumon	vitamin K antagonist	VKORC1	Launched
phenserine	acetylcholinesterase inhibitor, beta amyloid synthesis inhibitor	ACHE, BCHE	Phase 3
phensuximide	succinimide antiepileptic	CACNA1G, CACNA1H, CACNA1I	Launched
phentermine	dopamine uptake inhibitor, serotonin reuptake inhibitor	MAOA, MAOB, SLC6A2, SLC6A3, SLC6A4	Launched
phentolamine	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C	Launched
phenyl-aminosalicylate			Launched
phenyl-salicylate	antiseptic		Launched
phenylacetylglutamine	DNA methylase inhibitor, protein synthesis inhibitor		Phase 2
phenylbenzimidazole-sulfonic-acid			Launched
phenylbutazone	cyclooxygenase inhibitor, prostanoid receptor antagonist	PTGIS, PTGS1, PTGS2	Withdrawn
phenylbutyrate	HDAC inhibitor	HDAC1	Launched
phenylephrine	adrenergic receptor agonist	ADRA1A, ADRA1B, ADRA1D	Launched
phenylethyl-alcohol			Preclinical
phenylmercuric-acetate	other antifungal		Preclinical
phenylmethylsulfonyl-fluoride	serine protease inhibitor		Preclinical
phenylpiracetam	noradrenaline uptake inhibitor		Launched
phenytoin	hydantoin antiepileptic	SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	Launched
PhiKan-083	p53 stabilizing agent	TP53	Preclinical
phloretin	sodium/glucose cotransporter inhibitor	AQP9, CLCN3, SLC23A1	Launched
phlorizin	sodium/glucose cotransporter inhibitor	SLC5A1, SLC5A11, SLC5A2, SLC5A3	Preclinical
phloroglucin			Launched
phortress	aryl hydrocarbon receptor ligand	AHR	Phase 1
phosphatidylcholine		PCTP	Launched
PHP-501	GABA receptor antagonist	GABRA1, GABRB2, GABRG2	Preclinical
PHT-427	AKT inhibitor, pyruvate dehydrogenase inhibitor	AKT2, PDPK1	Preclinical
phthalylsulfacetamide			Preclinical
phthalylsulfathiazole	dihydropteroate synthetase inhibitor		Launched
PHTPP	estrogen receptor antagonist	ESR2	Preclinical
physostigmine	cholinesterase inhibitor	ACHE, BCHE	Launched
physostigmine-salicylate	acetylcholinesterase inhibitor		Phase 3
phytonadione		BGLAP, GGCX	Launched
phytosphingosine			Phase 1
PI-103	mTOR inhibitor, PI3K inhibitor	MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC	Preclinical
PI-828	PI3K inhibitor		Preclinical
pibenzimol	DNA inhibitor		Phase 2
piboserod	serotonin receptor antagonist	HTR2B, HTR4	Phase 2
picartamide	H+/K+-ATPase inhibitor	ATP4A	Phase 2
piceatannol	SYK inhibitor	ATP5A1, ATP5B, ATP5C1, IRF3	Preclinical
piclamilast	phosphodiesterase inhibitor	PDE4A, PDE4B, PDE4C, PDE4D	Phase 2
picolamine			Preclinical
picolinic-acid	chelating agent		Phase 2
piconol			Preclinical
picotamide	thromboxane receptor antagonist, thromboxane synthase inhibitor	TBXA2R	Launched
picrotin	GABA receptor antagonist	GABRA1, GABRR1, GLRA1, GLRA2, GLRA3, GLRB	Phase 2
picrotoxinin	GABA receptor antagonist	GLRA1, GLRA2, GLRA3, GLRB, HTR3A, HTR3B	Preclinical
pidolic-acid		ADAM28, AMY1A, AMY2A, AMY2B, ANG, CCL8, HCRT, IGLC1, KRTAP5-2, TFF2, VEGFA	Launched
pidotimod	interferon receptor agonist, interleukin receptor agonist		Launched
pifithrin-alpha	TP53 inhibitor	TP53	Preclinical
pifithrin-cyclic	TP53 inhibitor	TP53	Preclinical
pifithrin-mu	HSP inhibitor	HSPA1A, TP53	Preclinical
PIK-293	PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG	Preclinical
PIK-294	PI3K inhibitor	PIK3CB, PIK3CD, PIK3CG	Preclinical
PIK-75	DNA protein kinase inhibitor, PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC	Preclinical
PIK-93	PI3K inhibitor	PI4KB, PIK3C3, PIK3CG	Preclinical
pikamilone			Phase 1
piketoprofen	cyclooxygenase inhibitor		Launched
pilaralisib	PI3K inhibitor		Phase 2
pilocarpine	acetylcholine receptor agonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Launched
pilsicainide	sodium channel blocker	SCN5A	Launched
PIM-1-Inhibitor-2	Pim kinase inhibitor	PIM1	Preclinical
pimavanserin	serotonin receptor inverse agonist	DRD2, HTR2A	Launched
pimecrolimus	calcineurin inhibitor	FKBP1A, MTOR	Launched
pimethixene	antihistamine		Launched
pimobendan	calcium sensitizer, phosphodiesterase inhibitor	PDE3A	Launched
pimonidazole			Phase 3
pimozide	dopamine receptor antagonist	CACNA1I, CALM1, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR2A, KCNA10, KCNH2	Launched
pinacidil	ATP channel activator, potassium channel activator	ABCC8, ABCC9	Launched
pinanediol			Preclinical
pinaverium	T-type calcium channel blocker	CACNA1C	Launched
pincainide	antiarrhythmic		Phase 1
pindolol	adrenergic receptor antagonist	ADRB1, ADRB2, HTR1A, HTR1B, HTR2A, HTR2B	Launched
pindolol-(-)	adrenergic receptor antagonist, serotonin receptor antagonist	HTR1A	Preclinical
pinitol	gamma secretase inhibitor		Phase 2
pinocembrin	cytochrome P450 inhibitor	CYP1B1	Phase 2
pioglitazone	insulin sensitizer, PPAR receptor agonist	PPARG, TRPM3	Launched
pipamperone	dopamine receptor antagonist	DRD2, HRH1, HTR1A, HTR1B, HTR1D, HTR2A	Launched
pipecuronium	neuromuscular blocker	CHRM2, CHRM3, CHRNA2	Launched
pipemidic-acid	topoisomerase inhibitor		Launched
pipenzolate	cholinergic receptor antagonist	CHRM1	Launched
piperacetazine	dopamine receptor antagonist		Launched
piperacillin	bacterial cell wall synthesis inhibitor		Launched
piperaquine-phosphate	antimalarial agent		Launched
piperazine	benzodiazepine receptor agonist	GABRB3	Launched
piperazinedione	DNA synthesis inhibitor		Phase 2
piperidolate	acetylcholine receptor antagonist	CHRM1	Launched
piperine	monoamine oxidase inhibitor	MAOA, MAOB, TRPV1	Phase 1
piperonyl-butoxide	cytochrome P450 inhibitor		Launched
pipobroman	DNA alkylating agent		Launched
pipotiazine-palmitate	dopamine receptor antagonist, serotonin receptor antagonist	DRD1, DRD2, HTR1A, HTR2A	Launched
piracetam	acetylcholine receptor agonist	GRIA1, GRIA2, GRIA3, GRIA4	Launched
pirarubicin	topoisomerase inhibitor	TOP2A	Launched
pirenoxine	AGE inhibitor		Launched
pirenperone	serotonin receptor antagonist	HTR2A, HTR7	Preclinical
pirenzepine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Launched
piretanide	glucocorticoid receptor agonist	SLC12A1, SLC12A2	Launched
pirfenidone	TGF beta receptor inhibitor	FURIN, TNF	Launched
piribedil	dopamine receptor agonist	ADRA1A, ADRA2A, ADRA2C, DRD2, DRD3, DRD4, HTR1A, HTR2B	Launched
piricapiron	dopamine receptor antagonist, serotonin receptor antagonist	HTR2A	Phase 2
pirinixic-acid	PPAR receptor agonist	PPARA	Preclinical
pirlindole	monoamine oxidase inhibitor	MAOA	Launched
piroctone-olamine			Launched
pirodavir			Phase 2
piromidic-acid	bacterial DNA gyrase inhibitor		Phase 2
piroxicam	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
piroximone	phosphodiesterase inhibitor	PDE3A	Phase 2
pirquinozol	histamine release inhibitor		Phase 1
PIT	purinergic receptor antagonist	P2RY1	Preclinical
pitavastatin	HMGCR inhibitor	HMGCR	Launched
pivagabine	corticosteroid releasing factor receptor antagonist	CRHR1, CRHR2	Launched
pivampicillin	bacterial cell wall synthesis inhibitor		Launched
pivanex	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC8	Phase 2
pivmecillinam	bacterial cell wall synthesis inhibitor		Launched
pixantrone	topoisomerase inhibitor	TOP2A	Launched
pizotifen	serotonin receptor antagonist	HTR1A, HTR2A, HTR2C	Launched
PI3K-IN-2	PI3K inhibitor		Phase 2
PI4KIII-beta-inhibitor-1	PI4K inhibitor	PI4K2B	Preclinical
PJ-34	PARP inhibitor	EEF2, PARP1, PARP15, PARP3	Preclinical
PK-THPP	potassium channel blocker	KCNK9	Preclinical
PK-11195	benzodiazepine receptor antagonist	TSPO	Phase 1
PK-44	dipeptidyl peptidase inhibitor	DPP4	Preclinical
PKI-166	EGFR inhibitor	EGFR	Phase 1
PKI-179	mTOR inhibitor, PI3K inhibitor	MTOR	Phase 1
pleconaril			Phase 3
plerixafor	CC chemokine receptor antagonist	ACKR3, CCR4, CXCR4	Launched
plicamycin	alcohol dehydrogenase inhibitor		Launched
plinabulin	tubulin polymerization inhibitor		Phase 3
plovamer-acetate		TAT, TH, YARS, YARS2	Phase 2
plurisin-#1	stearoyl-CoA desaturase inhibitor	SCD	Preclinical
PLX-4720	RAF inhibitor	BRAF, KDR	Preclinical
PLX-647	receptor tyrosine protein kinase inhibitor	CSF1R, KIT	Preclinical
PLX8394	serine/threonine kinase inhibitor	BRAF	Phase 1/Phase 2
PMPA	glutamate receptor antagonist	FOLH1	Preclinical
PNU-120596	acetylcholine receptor agonist	CHRNA7	Preclinical
PNU-142633	serotonin receptor agonist	HTR1D	Phase 2
PNU-177864	dopamine receptor antagonist	DRD3	Preclinical
PNU-22394	serotonin receptor agonist	HTR2A, HTR2B, HTR2C, MAOA, MAOB	Phase 2
PNU-282987	cholinergic receptor agonist	CHRNA7	Preclinical
PNU-37883	ATP-sensitive potassium channel antagonist		Preclinical
PNU-74654	beta-catenin inhibitor	CTNNB1, TCF4	Preclinical
PNU-89843	benzodiazepine receptor agonist	GABBR1	Preclinical
podophyllotoxin	microtubule inhibitor, tubulin polymerization inhibitor	IGF1R, TOP2A, TUBA4A, TUBB	Launched
polidocanol	local anesthetic		Launched
polydatin	ICAM1 expression inhibitor	ICAM1	Phase 2
polyinosine	immunostimulant	ADSSL1, HPRT1, IMPDH2, PYGM	Preclinical
polymyxin-b-sulfate	bacterial permeability inducer		Launched
polythiazide	sodium/chloride cotransporter inhibitor	SLC12A3	Launched
pomalidomide	angiogenesis inhibitor, tumor necrosis factor production inhibitor	CRBN, PTGS2, TNF	Launched
ponatinib	Bcr-Abl kinase inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor	ABL1, BCR, FGFR1, FGFR2, FGFR3, FGFR4, FLT3, KDR, KIT, LCK, LYN, PDGFRA, RET, SRC, TEK	Launched
ponesimod	sphingosine 1 phosphate receptor agonist	S1PR1	Phase 3
posaconazole	sterol demethylase inhibitor	CYP3A4	Launched
potassium-canrenoate	mineralocorticoid receptor antagonist	NR3C2	Launched
potassium-iodide			Launched
potassium-p-aminobenzoate			Launched
pozanicline	acetylcholine receptor antagonist	CHRNA4, CHRNB2	Phase 2
poziotinib	EGFR inhibitor	EGFR, ERBB2, ERBB4	Phase 2
PP-1	src inhibitor	HCK, RET	Preclinical
PP-121	protein tyrosine kinase inhibitor	ABL1, EGFR, HCK, KDR, MTOR, PDGFRA, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC, SRC	Preclinical
PP-2	src inhibitor	ABL1, LCK, LYN, RIPK2, SRC	Preclinical
PPT	estrogen receptor agonist	ESR1	Preclinical
PPY-A	Abl kinase inhibitor	ABL1, BCR	Preclinical
PP242	mTOR inhibitor	MTOR, PASK	Preclinical
PQ-401	IGF-1 inhibitor	IGF1R	Preclinical
PR-619	DUB inhibitor		Preclinical
practolol	adrenergic receptor antagonist	ADRB1	Withdrawn
pralatrexate	dihydrofolate reductase inhibitor	DHFR, TYMS	Launched
pralidoxime	acetylcholinesterase inhibitor	ACHE, BCHE	Launched
pralidoxime-chloride	acetylcholinesterase inhibitor	ACHE, BCHE	Launched
pramipexole	dopamine receptor agonist	ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C	Launched
pramiracetam	acetylcholine receptor agonist		Launched
pramoxine	topical anesthetic		Launched
pranidipine	calcium channel blocker	CACNA1C	Phase 2
pranlukast	leukotriene receptor antagonist	CYSLTR1, CYSLTR2, IL5, MUC2, NFKB1, RNASE3, TNF	Launched
pranoprofen	cyclooxygenase inhibitor		Launched
prasterone-acetate			Preclinical
prasugrel	purinergic receptor antagonist	P2RY12	Launched
pravadoline	cyclooxygenase inhibitor	CNR1, CNR2	Preclinical
pravastatin	HMGCR inhibitor	HMGCR, SLCO1B1	Launched
praziquantel	anthelmintic agent		Launched
prazosin	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, KCNH2, KCNH6, KCNH7	Launched
PRE-084	sigma receptor agonist	SIGMAR1	Preclinical
preclamol	dopamine receptor agonist	DRD2	Phase 2
prednicarbate	phospholipase activator	NR3C1, PLA2G1B	Launched
prednisolone	glucocorticoid receptor agonist	NR3C1, NR3C2, SERPINA6	Launched
prednisolone-acetate	glucocorticoid receptor agonist	NR3C1	Launched
prednisolone-hemisuccinate	glucocorticoid receptor agonist	NR3C1	Preclinical
prednisolone-sodium-phosphate	glucocorticoid receptor agonist	NR3C1	Launched
prednisolone-tebutate	anti-inflammatory agent		Launched
prednisone	glucocorticoid receptor agonist	HSD11B1, NR3C1	Launched
pregabalin	voltage-gated calcium channel ligand	CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1E, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CACNG2, CACNG3, CACNG4, CACNG5, CACNG6, CACNG7, CACNG8	Launched
pregnanolone	GABA receptor positive allosteric modulator		Phase 2
pregnenolone	glutamate receptor modulator	CYP17A1, SULT2B1	Launched
pregnenolone-succinate	GABA receptor negative allosteric modulator		Preclinical
preladenant	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Phase 3
prenylamine	calcium channel blocker	CALM1, MYLK2	Withdrawn
presatovir	RSV fusion inhibitor		Phase 2
pridinol	muscle relaxant		Launched
prilocaine	local anesthetic	SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	Launched
primaquine	antimalarial agent, DNA inhibitor	KRT7, NQO2	Launched
PRIMA1	TP53 inhibitor	ACHE	Preclinical
primidone	GABA receptor antagonist	CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	Launched
prinaberel	estrogen receptor agonist	ESR2, NCOA1	Phase 2
priralfinamide	sodium channel blocker	CACNA1B	Phase 3
pritelivir	helicase primase inhibitor		Phase 2
proacipimox	cholesterol inhibitor		Phase 1
proadifen	nitric oxide synthase inhibitor	NOS1	Preclinical
probenecid	uricosuric blocker	PANX1, SLC22A11, SLC22A6, SLC22A8, SLCO1C1	Launched
probucol	atherogenesis inhibitor	ABCA1, ABCB11, CES1	Launched
procainamide	sodium channel blocker	DNMT1, SCN5A	Launched
procaine	HMGCR inhibitor	CHRNA2, GRIN3A, HTR3A, KCNMA1, KCNMB1, KCNMB2, KCNMB3, KCNMB4, KCNN1, KCNN2, KCNN3, KCNN4, MAOA, MAOB, RYR1, RYR2, SCN10A, SLC6A3	Launched
procarbazine	monoamine oxidase inhibitor		Launched
procaterol	adrenergic receptor agonist	ADRB2	Launched
prochlorperazine	dopamine receptor antagonist	DRD1, DRD2, DRD3, DRD4	Launched
procodazole	immunostimulant		Preclinical
procyanidin-b-2			Phase 2
procyclidine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4	Launched
procysteine	glutathione synthase stimulant		Phase 3
profenamine	butyrylcholinesterase inhibitor, cholinergic receptor antagonist	CHRM1, CHRM2, GRIN3A	Launched
proflavine-hemisulfate	topical anesthetic	F2	Phase 2
progesterone	progesterone receptor agonist	CATSPER1, CATSPER2, CATSPER3, CATSPER4, CYP17A1, ESR1, NR3C2, OPRK1, PGR, TRPC5	Launched
proglumetacin	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
proglumide	CCK receptor antagonist	CCKAR, CCKBR	Withdrawn
proguanil	dihydrofolate reductase inhibitor	DHFR	Launched
prolylleucylglycinamide	melanocyte-stimulating hormone release inhibitor		Phase 2
promazine	dopamine receptor antagonist	ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, HRH1, HTR2A, HTR2C	Launched
promestriene	estrogen receptor agonist	ESR1	Launched
promethazine	histamine receptor antagonist	ADRA1A, CALM1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A	Launched
pronethalol	adrenergic receptor antagonist		Withdrawn
propacetamol	cyclooxygenase inhibitor	PTGS2	Launched
propafenone	antiarrhythmic	ADRB1, ADRB2, KCNA5, KCNH2, SCN5A	Launched
propagermanium	interferon receptor agonist, CCR agonist	CCR2	Launched
propantheline	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4	Launched
propatylnitrate			Launched
propentofylline	adenosine reuptake inhibitor, phosphodiesterase inhibitor	PDE1A	Launched
propidium-iodide		ACHE	Preclinical
propiolactone			Launched
propiverine	acetylcholine receptor antagonist	CHRM1	Launched
propofol	benzodiazepine receptor agonist	FAAH, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, SCN2A, SCN4A	Launched
propoxur			Launched
propoxycaine	local anesthetic		Launched
propranolol	adrenergic receptor antagonist		Launched
propranolol-(R)	adrenergic receptor antagonist	ADRB2, ADRB3	Preclinical
propranolol-(S)	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3, HTR1A, HTR1B, HTR5A, SLC10A1	Preclinical
propyl-benzoate			Launched
propylene-glycol		F13A1	Launched
propylhexedrine	adrenergic receptor agonist	SLC18A2, TAAR1	Launched
propylparaben			Launched
propylthiouracil	thyroid peroxidase inhibitor	DIO1, TPO	Launched
proquazone	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
proscillaridin-a			Launched
protionamide			Launched
protirelin	thyrotropin releasing hormone receptor agonist	TRHR	Launched
protoporphyrin-ix	heme oxygenase inhibitor	HMOX1	Preclinical
protriptyline	tricyclic antidepressant	SLC6A2, SLC6A4	Launched
proxodolol	adrenergic receptor antagonist		Launched
proxyfan	histamine receptor modulator	HRH3	Preclinical
proxymetacaine	sodium channel blocker	SCN10A, SCN5A	Launched
proxyphylline			Launched
PRT062070	JAK inhibitor, syk inhibitor	SYK	Phase 1
PRT062607	syk inhibitor	FGR, MAP3K9, SYK	Phase 2
PRT4165	polycomb repressive complex inhibitor	PRC1	Preclinical
prucalopride	serotonin receptor agonist	HTR4	Launched
prulifloxacin	bacterial DNA gyrase inhibitor		Launched
pruvanserin	serotonin receptor antagonist	HTR2A, HTR2C	Phase 2
PRX-08066	serotonin receptor antagonist	HTR2B	Phase 2
PSB-06126	NTPDase inhibitor	ENTPD3	Preclinical
PSB-11	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA3	Preclinical
PSB-1115	adenosine receptor antagonist	ADORA1, ADORA2B, ADORA3	Preclinical
PSB-36	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Preclinical
PSB-603	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Preclinical
PSI-6130	RNA polymerase inhibitor		Phase 1
PSI-7976	HCV inhibitor		Preclinical
PSN-375963	glucose dependent insulinotropic receptor agonist	GPR119	Preclinical
PSNCBAM-1	cannabinoid receptor modulator	CNR1	Preclinical
psoralen		MAOA, MAOB	Launched
PS178990	androgen receptor modulator	AR	Phase 1
PT-2385	hypoxia inducible factor inhibitor	EPAS1	Phase 1
PTC-209	BMI-1 inhibitor		Preclinical
pterostilbene	cyclooxygenase inhibitor, PPAR receptor agonist	PTGS2	Phase 2/Phase 3
PU-H71	HSP inhibitor	HSP90AA1	Phase 1
puerarin	serotonin receptor antagonist		Phase 2
pumosetrag	serotonin receptor agonist	HTR3A, HTR4	Phase 2
purmorphamine	smoothened receptor agonist	SMO	Preclinical
puromycin	protein synthesis inhibitor	NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1	Preclinical
purvalanol-a	CDK inhibitor	CDK1, CDK2, CDK4, CDK5, CSNK1G3, RPS6KA1, SRC	Preclinical
purvalanol-b	tyrosine kinase inhibitor	CDK2, CDK4, CDK5, MAPK1, MAPK3, SRPK2	Preclinical
putrescine	tissue transglutaminase inhibitor	AMD1, KCNJ4, ODC1	Phase 2
PX-12	thioredoxin inhibitor	TXN, TXNRD1	Phase 2
PX-478	hypoxia inducible factor inhibitor		Phase 1
PYM50028	neurotrophic agent		Phase 2
PYR-41	ubiquitin activating enzyme inhibitor		Preclinical
pyrantel	nicotinic receptor agonist		Launched
pyrantel-pamoate	neuromuscular blocker		Launched
pyrantel-tartrate	acetylcholine receptor agonist	CHRNA1	Preclinical
pyrazinamide	fatty acid synthase inhibitor	FASN	Launched
pyrazinoylguanidine	diuretic		Phase 1
pyrazolanthrone	JNK inhibitor	MAPK10, MAPK8, MAPK8IP1, MAPK9, TTK	Preclinical
pyrazoloacridine	topoisomerase inhibitor	TOP1, TOP2A	Phase 2
pyrethrins			Launched
pyridoxal		PDXK	Launched
pyridoxal-isonicotinoyl-hydrazone	apoptosis stimulant		Phase 2
pyridoxamine	AGE inhibitor		Phase 3
pyridoxine	vitamin B	DDC, PDXK	Launched
pyrimethamine	dihydrofolate reductase inhibitor	DHFR, SLC47A1	Launched
pyrintegrin	integrin signaling activator		Preclinical
pyrithione-zinc	ATP synthase inhibitor	KCNQ1, KCNQ2, KCNQ4, KCNQ5	Launched
pyrithyldione	psychoactive drug		Withdrawn
pyritinol			Launched
pyronaridine	antimalarial agent		Phase 3
pyroxamide	HDAC inhibitor	HDAC1	Phase 1
pyrrolidine-dithiocarbamate	NFkB pathway inhibitor	HSD11B1, RELA	Preclinical
pyrvinium	androgen receptor antagonist		Launched
pyrvinium-pamoate	androgen receptor antagonist	AR	Launched
P22077	ubiquitin specific protease inhibitor	USP7	Preclinical
P276-00	CDK inhibitor	CDK1, CDK4, CDK9	Phase 2
P5091	ubiquitin specific protease inhibitor	USP7	Preclinical
P7C3	NAMPT inhibitor	NAMPT	Preclinical
Q-203	ATP synthase inhibitor		Phase 1
quazinone	phosphodiesterase inhibitor	PDE3A, PDE3B	Phase 2
quercetin	polar auxin transport inhibitor	ATP5A1, ATP5B, ATP5C1, HCK, HIBCH, PIK3CG, PIM1, STK17B, UGT3A1	Launched
quetiapine	dopamine receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2C, HTR3A, HTR6, HTR7, SLC6A2	Launched
quiflapon	leukotriene synthesis inhibitor	ALOX5, ALOX5AP	Phase 2
quinagolide	dopamine receptor agonist	DRD2	Launched
quinapril	angiotensin converting enzyme inhibitor	ACE	Launched
quinaprilat	angiotensin converting enzyme inhibitor	ACE	Launched
quinelorane	dopamine receptor agonist	DRD2, DRD3	Phase 3
quinestrol	estrogen receptor agonist	ESR1	Launched
quinethazone	thiazide diuretic	CA1, CA2, SLC12A1, SLC12A2, SLC12A3	Launched
quinidine	sodium channel blocker	KCNA5, KCNA7, KCNH1, KCNH2, KCNH5, KCNK1, KCNK6, SCN5A, SLC29A4	Launched
quinine	hemozoin biocrystallization inhibitor	GP9, KCNB2, KCNN4, SLC29A4	Launched
quinine-ethyl-carbonate			Launched
quinolinic-acid	glutamate receptor agonist		Preclinical
quinpirol-(-)	dopamine receptor agonist	DRD1, DRD2, DRD3, DRD4, HTR1A, HTR2A, HTR2B, HTR2C	Phase 2
quipazine	serotonin receptor agonist		Preclinical
quizartinib	FLT3 inhibitor	CSF1R, FLT3, KIT, PDGFRA, PDGFRB, RET	Phase 3
QX-222	sodium channel blocker		Preclinical
QX-314	sodium channel blocker	MAPK14, TGFBR1	Preclinical
r(-)-apomorphine	dopamine receptor agonist	DRD2, HTR5A	Launched
R-1479	HCV inhibitor		Phase 1
R-1485	serotonin receptor antagonist	HTR6	Phase 1
R-268712	serine/threonine kinase inhibitor	TGFBR1	Preclinical
R-428	AXL kinase inhibitor	AXL	Phase 1
R-59022	diacylglycerol kinase inhibitor, protein kinase inhibitor	DGKA	Preclinical
R-96544	serotonin receptor antagonist	HTR2A	Preclinical
rabeprazole	ATPase inhibitor, gastrin inhibitor	ATP4A	Launched
rac-BHFF	GABA receptor positive allosteric modulator	GABBR1	Preclinical
racecadotril	enkephalinase inhibitor	MME	Launched
raclopride	dopamine receptor antagonist	DRD2, DRD3, HTR1A	Launched
ractopamine	adrenergic receptor agonist		Launched
radafaxine	dopamine-norepinephrine reuptake inhibitor	SLC6A3	Phase 2
radezolid	bacterial 30S ribosomal subunit inhibitor, bacterial 50S ribosomal subunit inhibitor		Phase 2
RAF265	RAF inhibitor, VEGFR inhibitor	BRAF	Phase 2
raloxifene	estrogen receptor antagonist, selective estrogen receptor modulator (SERM)	ESR1, ESR2	Launched
raltegravir	HIV integrase inhibitor		Launched
raltitrexed	thymidylate synthase inhibitor	FPGS, TYMS	Launched
ramatroban	prostanoid receptor antagonist	PTGDR2, TBXA2R	Launched
ramelteon	melatonin receptor agonist	MTNR1A, MTNR1B	Launched
ramifenazone	cyclooxygenase inhibitor		Launched
ramipril	angiotensin converting enzyme inhibitor	ACE	Launched
ramosetron	serotonin receptor antagonist	HTR3A	Launched
ranirestat	aldose reductase inhibitor	AKR1B1	Phase 3
ranitidine	histamine receptor antagonist	HRH2	Launched
ranolazine	sodium channel blocker	SCN10A, SCN4A, SCN5A, SCN9A	Launched
rapastinel	glutamate receptor agonist		Phase 2
rasagiline	monoamine oxidase inhibitor	BCL2, MAOB	Launched
rauwolscine	adrenergic receptor antagonist	ADRA2A, ADRA2B, ADRA2C, HTR1B, HTR1D, HTR1E, HTR2B	Preclinical
ravoxertinib	ERK1 and ERK2 phosphorylation inhibitor	MAPK1, MAPK3	Phase 1
ravuconazole	sterol demethylase inhibitor		Phase 2
RBC8	Ral GTPase inhibitor	RALA, RALB	Preclinical
rebamipide	free radical scavenger	FPR1	Launched
rebastinib	Bcr-Abl kinase inhibitor, TIE tyrosine kinase inhibitor, VEGFR inhibitor	ABL1, BCR, FGR, FLT3, HCK, LYN, SRC	Phase 1
reboxetine	adrenergic receptor antagonist	SLC6A2	Launched
Rec-15/2615	adrenergic receptor antagonist	ADRA1A	Phase 2
refametinib	MEK inhibitor	MAP2K1, MAP2K2	Phase 2
regadenoson	adenosine receptor agonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Launched
regorafenib	FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RAF inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor	ABL1, BRAF, DDR2, EPHA2, FGFR1, FGFR2, FLT1, FLT4, FRK, KDR, KIT, MAPK11, NTRK1, PDGFRA, PDGFRB, RAF1, RET, TEK	Launched
relcovaptan	vasopressin receptor antagonist	AVPR1A, AVPR1B, AVPR2, OXTR	Phase 2
relebactam	beta lactamase inhibitor		Phase 3
remacemide	glutamate receptor antagonist	GRIN1	Phase 3
remimazolam	benzodiazepine receptor agonist	GABBR1	Phase 3
remodelin	transferase inhibitor	NAT10	Preclinical
remoxipride	dopamine receptor antagonist	DRD2, DRD3, DRD4, HTR2A, SIGMAR1	Withdrawn
repaglinide	insulin secretagogue	ABCC8, KCNJ11, PPARG	Launched
reparixin	CC chemokine receptor antagonist	CXCR1, CXCR2	Phase 3
repsox	TGF beta receptor inhibitor	TGFBR1	Preclinical
resatorvid	toll-like receptor antagonist	TLR4	Phase 3
reserpine	vesicular monoamine transporter inhibitor	SLC18A1, SLC18A2	Launched
resibufogenin	Na/K-ATPase inhibitor		Phase 2
resiquimod	toll-like receptor agonist	TLR7, TLR8	Phase 3
resminostat	HDAC inhibitor	HDAC1, HDAC3, HDAC6, HDAC8	Phase 2
resorcinol	phosphodiesterase inhibitor	CA12, CA14, CA2, PTGS1	Launched
resorcinol-monoacetate	antiseptic		Launched
resveratrol	cytochrome P450 inhibitor, SIRT activator	CSNK2A1, NQO2, PTGS1, PTGS2	Launched
retapamulin	protein synthesis inhibitor		Launched
retaspimycin	HSP inhibitor	HSP90AA1	Phase 3
retigabine	potassium channel activator	KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5	Launched
retinaldehyde			Launched
retinol	retinoid receptor ligand	ALDH1A1, ALDH1A2, ALDH1A3, DHRS3, DHRS4, LRAT, NR2C2, RBP1, RBP3, RDH11, RDH12, RDH13, RDH14, RDH5, RDH8, RETSAT, RHO, RLBP1, RXRA, RXRB, RXRG	Launched
retinyl-acetate			Launched
retinyl-palmitate			Launched
REV-5901	leukotriene receptor antagonist, lipoxygenase inhibitor	ALOX5	Phase 2
revaprazan	potassium-competitive acid antagonist	ATP4A	Launched
reversan	MRP inhibitor	ABCC1	Preclinical
reversine	Aurora kinase inhibitor	AURKB, INCENP, MAP2K1	Preclinical
RGB-286638	CDK inhibitor	CDK1, CDK2, CDK3, CDK4, CDK5, CDK6, CDK7, CDK9, FLT3, GSK3B, JAK2, MAP3K7, MAPK9	Phase 1
RGFP966	HDAC inhibitor	HDAC3	Preclinical
RG108	DNA methyltransferase inhibitor	DNMT1, DNMT3B	Preclinical
RG1530	FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	FGFR1, FGFR2	Phase 1
RG2833	HDAC inhibitor	HDAC1, HDAC3	Phase 1
RG4733	gamma secretase inhibitor	PSEN1	Phase 2
RG7112	MDM inhibitor	MDM2	Phase 1
RHC-80267	triacylglycerol lipase inhibitor	DAGLA, DAGLB	Preclinical
rhein		HSP90AA1	Phase 1
rheochrysidin	protein tyrosine kinase inhibitor	PTPN1	Preclinical
rhodamine-123			Phase 1
RI-1		RAD51	Preclinical
ribavirin	antiviral	ADK, ENPP1, IMPDH1, IMPDH2, NT5C2	Launched
ribitol			Preclinical
ribociclib	CDK inhibitor	CDK4, CDK6	Launched
riboflavin	vitamin B2	BLVRB, RFK	Launched
riboflavin-5-phosphate-sodium		BLVRB, DHODH, DPYD, HAO1, HAO2, MT-ND1, NOS1, PNPO, POR, PPCDC, RFK, RPS6KA4, SGK1	Launched
ribostamycin	bacterial 30S ribosomal subunit inhibitor		Launched
ribostamycin-sulfate	bacterial 30S ribosomal subunit inhibitor	P4HB	Launched
ricinoleic-acid	prostanoid receptor agonist	PTGER3	Launched
rifabutin	protein synthesis inhibitor	HSP90AA1, HSP90B1	Launched
rifampin	RNA polymerase inhibitor	NR1I2, SLCO1A2, SLCO1B1, SLCO1B3	Launched
rifamycin	DNA directed RNA polymerase inhibitor	SLCO1A2, SLCO1B1, SLCO1B3, SLCO2B1	Launched
rifamycin-sv	RNA synthesis inhibitor		Phase 3
rifapentine	RNA polymerase inhibitor	CYP2C8, CYP2C9, CYP3A4	Launched
rifaximin	RNA synthesis inhibitor	NR1I2	Launched
rigosertib	cell cycle inhibitor, PLK inhibitor	PLK1	Phase 3
rilmenidine	adrenergic receptor agonist, imidazoline receptor agonist	ADRA2A	Launched
rilpivirine	non-nucleoside reverse transcriptase inhibitor	NR1I2, SCN10A	Launched
riluzole	glutamate inhibitor	KCNK10, KCNK2, KCNK4, KCNN4, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A, SLC7A11	Launched
rimantadine	antiviral, RNA synthesis inhibitor		Launched
rimcazole	sigma receptor antagonist	SIGMAR1	Phase 1
rimexolone	glucocorticoid receptor agonist	NR3C1, SERPINA6	Launched
rimonabant	cannabinoid receptor antagonist	CNR1, GPR55	Withdrawn
riociguat	guanylate cyclase stimulant	GUCY1A2, GUCY1A3, GUCY1B2, GUCY1B3	Launched
riodipine	calcium channel blocker		Phase 2
riodoxol	other antibiotic		Launched
ripasudil	rho associated kinase inhibitor	ROCK1, ROCK2	Launched
ripazepam	benzodiazepine receptor agonist	GABRA1	Phase 2
risedronate	osteoclast inhibitor	FDPS	Launched
risperidone	dopamine receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2C, HTR6, HTR7	Launched
RITA	MDM inhibitor	MDM2	Preclinical
ritanserin	serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA1D, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7	Phase 3
ritodrine	adrenergic receptor agonist	ADRB2	Launched
ritonavir	HIV protease inhibitor	CYP1A2, CYP2B6, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP2E1, CYP3A4, CYP3A5, CYP3A7	Launched
rivanicline	acetylcholine receptor agonist	CHRNA4, CHRNB2, CXCL8	Phase 2
rivaroxaban	coagulation factor inhibitor	F10	Launched
rivastigmine	acetylcholinesterase inhibitor	ACHE, BCHE	Launched
rizatriptan	serotonin receptor agonist	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F	Launched
RKI-1447	rho associated kinase inhibitor	CDC42BPA, DMPK, LIMK1, MYLK, PAK1, PKN1, ROCK1, ROCK2	Preclinical
RLX			Preclinical
RN-1	histone demethylase inhibitor	KDM1A	Preclinical
RN-1734	TRPV antagonist	TRPV4	Preclinical
RN-1747	TRPV agonist	TRPV4	Preclinical
Ro-04-5595		GRIN2B	Preclinical
Ro-08-2750		NGF	Preclinical
Ro-10-5824	dopamine receptor agonist	DRD4	Preclinical
Ro-106-9920	NFkB pathway inhibitor		Preclinical
Ro-1138452	prostanoid receptor antagonist	PTGIR	Preclinical
Ro-15-4513		GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB2, GABRG2	Preclinical
Ro-19-4605		GABRA1, GABRA2, GABRA3, GABRA5	Preclinical
Ro-20-1724	phosphodiesterase inhibitor	PDE3A, PDE4A, PDE4B, PDE4C, PDE4D	Preclinical
Ro-25-6981		GRIN2B	Preclinical
Ro-28-1675	glucokinase activator	GCK	Preclinical
RO-3	purinergic receptor antagonist	P2RX3	Preclinical
Ro-3306	CDK inhibitor	CDK1	Preclinical
Ro-48-8071	oxidosqualene cyclase inhibitor	LSS	Preclinical
Ro-4987655	MEK inhibitor	MAP2K1	Phase 1
Ro-5126766	RAF inhibitor, MEK inhibitor	BRAF, MAP2K1, MAP2K2, RAF1	Phase 1
Ro-60-0175		HTR2A, HTR2B, HTR2C	Preclinical
Ro-61-8048	kynurenine 3-monooxygenase inhibitor	KMO	Preclinical
Ro-67-7476	glutamate receptor positive allosteric modulator	GRM1	Preclinical
Ro-90-7501		APP	Preclinical
Ro-9187	HCV inhibitor		Preclinical
robalzotan	serotonin receptor antagonist	HTR1A	Phase 2
rociletinib	EGFR inhibitor	EGFR	Phase 3
rocuronium	acetylcholine receptor antagonist	CHRM2, CHRNA2, HTR3A	Launched
rofecoxib	cyclooxygenase inhibitor	ELN, PTGS2	Withdrawn
roflumilast	phosphodiesterase inhibitor	PDE4A, PDE4B, PDE4C, PDE4D	Launched
rolipram	phosphodiesterase inhibitor		Phase 3
rolipram-R(-)	phosphodiesterase inhibitor	PDE4A, PDE4B, PDE4C, PDE4D, PDE5A	Preclinical
rolipram-S(+)	phosphodiesterase inhibitor		Preclinical
rolitetracycline	bacterial 30S ribosomal subunit inhibitor		Launched
rolziracetam			Phase 2
romidepsin	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9	Launched
ronidazole	antiprotozoal agent		Launched
ropinirole	dopamine receptor agonist	ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C	Launched
ropivacaine	sodium channel blocker	SCN10A	Launched
roquinimex	angiogenesis inhibitor, tumor necrosis factor production inhibitor		Phase 3
rosamicin	protein synthesis inhibitor		Phase 2
roscovitine	CDK inhibitor	CDK2, CDK9	Phase 2
rose-bengal	contrast agent		Launched
rose-bengal-lactone	coloring agent		Launched
rosiglitazone	insulin sensitizer, PPAR receptor agonist	ACSL4, FFAR1, PPARG, TRPC5, TRPM3	Withdrawn
rosmarinic-acid	GABA transaminase inhibitor	MCL1, TYR	Launched
rosoxacin	topoisomerase inhibitor		Launched
rostafuroxine	ATPase inhibitor	ATP1A1	Phase 2
rosuvastatin	HMGCR inhibitor	HMGCR	Launched
rotigotine	dopamine receptor agonist	ADRA2B, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A	Launched
rotundine	serotonin receptor agonist	DRD1, DRD2, DRD3, HTR1A	Launched
roxarsone	antiprotozoal agent		Launched
roxatidine-acetate	histamine receptor antagonist	HRH2	Launched
roxithromycin	bacterial 50S ribosomal subunit inhibitor	ABCB1, MLNR	Launched
RP-001	sphingosine 1 phosphate receptor agonist	S1PR1	Preclinical
RP67580			Preclinical
RQ-00203078	transient receptor potential channel antagonist	TRPM8	Preclinical
RRx-001	glucose 6-phosphate dehydrogenase inhibitor	G6PD	Phase 2
RS-0481	immunostimulant		Phase 2
RS-100329	adrenergic receptor antagonist	ADRA1A, ADRA1D	Preclinical
RS-102221	serotonin receptor antagonist	HTR2A, HTR2B, HTR2C	Preclinical
RS-102895	CCR antagonist	CCR2	Preclinical
RS-127445	serotonin receptor antagonist	HTR2A, HTR2B, HTR2C	Phase 1
RS-16566	serotonin receptor antagonist		Preclinical
RS-17053	adrenergic receptor antagonist	ADRA1A, ADRA1D	Preclinical
RS-23597-190	serotonin receptor antagonist	HTR4	Preclinical
RS-39604	serotonin receptor antagonist	HTR4	Preclinical
RS-45041-190	imidazoline receptor agonist		Preclinical
RS-504393	CC chemokine receptor antagonist	CCL2, CCR2	Preclinical
RS-56812	serotonin receptor partial agonist	HTR3A	Preclinical
RS-67333	serotonin receptor partial agonist	HTR4	Preclinical
RS-67506	serotonin receptor partial agonist	HTR4	Preclinical
RS-79948	adrenergic receptor antagonist	ADRA2A	Preclinical
RSV604	RSV replication inhibitor		Phase 2
RTA-408	nitric oxide production inhibitor	NFE2L2	Phase 2
RU-SKI-43	hedgehog pathway inhibitor	HHAT	Preclinical
RU-24969	serotonin receptor agonist	HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, HTR6	Phase 1
RU-28318	cytochrome P450 inhibitor	NR3C2	Phase 2
RU-42173	adrenergic receptor agonist	ADRB2	Phase 2
RU-58841	androgen receptor antagonist	AR	Phase 2
rubitecan	topoisomerase inhibitor	TOP1	Phase 3
rucaparib	PARP inhibitor	PARP1, PARP2	Phase 3
rucinol	tyrosinase inhibitor	TYR	Phase 1
rufinamide	voltage-gated sodium channel blocker	GRM5, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	Launched
rufloxacin	bacterial DNA gyrase inhibitor		Launched
rupatadine	histamine receptor antagonist, platelet activating factor receptor antagonist	HRH1, PTAFR	Launched
rutaecarpine	cyclooxygenase inhibitor	PTGS2	Preclinical
rutin	antioxidant, capillary stabilizing agent, nitric oxide scavenger	AKR1C3	Launched
ruxolitinib	JAK inhibitor	JAK1, JAK2, JAK3, TYK2	Launched
ruxolitinib-(S)	JAK inhibitor	JAK1, JAK2	Preclinical
RWJ-21757	toll-like receptor agonist	TLR7	Phase 1
RWJ-50271	integrin inhibitor	ICAM1	Preclinical
RWJ-67657	MAP kinase inhibitor	MAPK14, PTGS2	Phase 1
RX-3117	DNA synthesis inhibitor, CDK inhibitor	CDK2, DNMT1	Phase 1/Phase 2
RX-821002	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C	Preclinical
ryuvidine	histone lysine methyltransferase inhibitor	CDK2, CDK4	Preclinical
R112	syk inhibitor	SYK	Preclinical
R306465	HDAC inhibitor		Phase 1
R406	SYK inhibitor	RET, SYK	Phase 1
R547	CDK inhibitor	CDK1, CDK2, CDK4, CDK7	Phase 1
S-Isopropylisothiourea	nitric oxide synthase inhibitor	NOS3	Preclinical
S-methylcysteine		CTSD, MGMT	Phase 1
S-Nitrosoglutathione	nitric oxide stimulant	PTPN1	Phase 1
S-Sulfo-L-cysteine-sodium-salt	glutamate receptor agonist		Preclinical
S-Trityl-L-cysteine	mitotic kinesin inhibitor		Preclinical
S-07662	CAR antagonist	NR1I3	Preclinical
S-111	PARP inhibitor	PARP1	Phase 2
S-14506	serotonin receptor agonist	HTR1A	Preclinical
SA-47	FAAH inhibitor	FAAH	Preclinical
saccharin	DNA polymerase inhibitor	CA1, CA12, CA2, CA9	Launched
saclofen	GABA receptor antagonist	GABBR1, GABBR2, KCTD12, KCTD16, KCTD8	Preclinical
sacubitril	neprilysin inhibitor	MME	Launched
safflower-yellow	anti-inflammatory agent		Preclinical
safinamide	dopamine uptake inhibitor, glutamate inhibitor, monoamine oxidase inhibitor	MAOB	Launched
safingol	PKC inhibitor	TRPM3	Phase 1
safranal	benzodiazepine receptor agonist	GABBR1	Phase 2
SAG	smoothened receptor agonist	SMO, TRPC6	Preclinical
salazodine			Phase 2
salicin	anti-inflammatory agent		Phase 1
salicyl-alcohol			Preclinical
salicylamide	analgesic agent		Launched
salicylanilide	other antibiotic		Preclinical
salicylic-acid	cyclooxygenase inhibitor	AKR1C1, PTGS1, PTGS2	Launched
salidroside	beta amyloid protein neurotoxicity inhibitor	APP	Preclinical
salinomycin			Launched
salirasib	mTOR inhibitor	TRPA1	Phase 2
salmeterol	adrenergic receptor agonist	ADRB2	Launched
salsolinol-1-carboxylic-acid			Preclinical
salubrinal	eukaryotic translation initiation factor inhibitor	EIF2S1	Preclinical
salvianolic-acid-B	metalloproteinase inhibitor, EGFR inhibitor	MMP9	Phase 2
salvinorin-a	opioid receptor agonist	OPRD1, OPRK1, OPRM1	Phase 1
sal003	eukaryotic translation initiation factor inhibitor	EIF2A	Preclinical
sanazole			Phase 1
sangivamycin	DNA inhibitor		Phase 1
sanguinarium-chloride	apoptosis stimulant	CASP3	Phase 1
SANT-1	smoothened receptor antagonist	SHH, SMO	Preclinical
SANT-2	smoothened receptor antagonist	SHH, SMO	Preclinical
sapropterin	phenylalanine 4-hydroxylase stimulant	NOS3, PAH, TH, TPH1	Launched
saquinavir	HIV protease inhibitor	CYP3A4	Launched
SAR-245409	PI3K inhibitor	MTOR, PIK3CG	Phase 1/Phase 2
saracatinib	src inhibitor	ABL1, LCK, SRC, YES1	Phase 2/Phase 3
sarafloxacin	bacterial DNA gyrase inhibitor		Launched
sarcosine	Glycine transporter 1 inhibitor	SLC6A9	Phase 2
sari-59-801			Phase 1
saroglitazar	PPAR receptor agonist	PPARA, PPARG	Phase 3
sarpogrelate	serotonin receptor antagonist	HTR2A, HTR2B, HTR2C	Launched
SAR131675	VEGFR inhibitor	FLT4	Preclinical
SAR405	PI3K inhibitor	PIK3C3	Preclinical
SAR405838	MDM inhibitor	MDM2	Phase 1
SAR407899	rho associated kinase inhibitor	ROCK1	Phase 2
sasapyrine	NFkB pathway inhibitor	PTGS1, PTGS2	Launched
satraplatin	DNA alkylating agent		Phase 3
savolitinib	c-Met inhibitor	MET	Phase 2
saxagliptin	dipeptidyl peptidase inhibitor	DPP4	Launched
SB-200646	serotonin receptor antagonist	HTR2B, HTR2C	Preclinical
SB-202190	p38 MAPK inhibitor	AKT1, ALOX5, CHEK1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SGK1	Preclinical
SB-203186	serotonin receptor antagonist	HTR4	Preclinical
SB-203580	p38 MAPK inhibitor	AKT1, ALOX5, CHEK1, CYP2D6, CYP3A4, GAK, GSK3B, LCK, MAPK1, MAPK10, MAPK11, MAPK12, MAPK14, MAPK8, MAPK9, PRKCA, RAF1, RIPK2, ROCK1, RPS6KB1, SGK1, SRC, TNF	Preclinical
SB-205384	GABA receptor modulator	GABRA3, GABRA5, GABRA6	Preclinical
SB-206553	serotonin receptor antagonist	HTR2A, HTR2B, HTR2C	Preclinical
SB-216641	serotonin receptor antagonist	HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C	Preclinical
SB-216763	glycogen synthase kinase inhibitor	CCNA2, CDK2, GSK3A, GSK3B	Preclinical
SB-218078	CHK inhibitor	CHEK1	Preclinical
SB-218795	tachykinin antagonist	TACR3	Preclinical
SB-221284	serotonin receptor antagonist	HTR2A, HTR2B, HTR2C	Preclinical
SB-222200	tachykinin antagonist	TACR3	Preclinical
SB-225002	CC chemokine receptor antagonist	CXCR2	Preclinical
SB-228357	serotonin receptor antagonist	HTR2A, HTR2B, HTR2C	Preclinical
SB-2343	mTOR inhibitor, PI3K inhibitor	MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG	Phase 1
SB-239063	p38 MAPK inhibitor	MAPK11, MAPK14, PTGS2	Preclinical
SB-242235	p38 MAPK inhibitor	HSPB1, MAPK14	Phase 1
SB-243213	serotonin receptor inverse agonist	HTR2A, HTR2B, HTR2C, HTR6	Phase 1
SB-258585	serotonin receptor antagonist	HTR6	Preclinical
SB-268262	calcitonin antagonist	CALCA	Preclinical
SB-269970	serotonin receptor antagonist	HTR7	Preclinical
SB-271046	serotonin receptor antagonist	HTR6	Phase 1
SB-297006	CC chemokine receptor antagonist	CCR3	Preclinical
SB-328437	CCR antagonist		Preclinical
SB-334867	orexin receptor antagonist	HCRTR1, HCRTR2	Preclinical
SB-366791	TRPV antagonist	TRPV1	Preclinical
SB-399885	serotonin receptor antagonist	HTR6	Preclinical
SB-408124	orexin receptor antagonist	HCRTR1, HCRTR2	Preclinical
SB-415286	glycogen synthase kinase inhibitor	GSK3A, GSK3B, RPS6KB1	Preclinical
SB-431542	TGF beta receptor inhibitor	ACVR1C, TGFBR1	Preclinical
SB-452533	TRPV antagonist	TRPV1	Preclinical
SB-505124	ALK tyrosine kinase receptor inhibitor	TGFBR1	Preclinical
SB-525334	TGF beta receptor inhibitor	TGFBR1	Preclinical
SB-590885	RAF inhibitor	BRAF	Preclinical
SB-612111	nociceptin/orphanin FQ (NOP) receptor antagonist	OPRL1	Preclinical
SB-657510	urotensin receptor antagonist	UTS2R	Preclinical
SB-683698	integrin antagonist	ITGA4, ITGAV, ITGB1, ITGB7	Phase 1
SB-705498	TRPV antagonist	TRPV1	Phase 2
SB-706375	urotensin receptor antagonist	UTS2R	Preclinical
SB-742457	serotonin receptor antagonist	HTR6	Phase 3
SB-743921	kinesin-like spindle protein inhibitor	KIF11	Phase 1/Phase 2
SB-747651A	kinase inhibitor	AKT1, AKT3, ROCK1, RPS6KA5, RPS6KB1	Preclinical
SB-756050	G protein-coupled receptor agonist	GPBAR1	Phase 1
SB-772077B	rho associated kinase inhibitor	ROCK1, ROCK2	Preclinical
SB-939	HDAC inhibitor	HDAC1, HDAC10, HDAC3, HDAC4, HDAC5, HDAC9	Phase 2
SBE-13	PLK inhibitor	PLK1	Preclinical
SBHA	HDAC inhibitor	HDAC1, HDAC3	Preclinical
SC-10	protein kinase activator	PRKCA	Preclinical
SC-12267	dihydroorotate dehydrogenase inhibitor	IL17A	Phase 2
SC-144	P glycoprotein inhibitor		Preclinical
SC-19220	prostanoid receptor antagonist	PTGER1	Preclinical
SC-236	cyclooxygenase inhibitor	PTGS2	Preclinical
SC-51089	prostanoid receptor antagonist	PTGER1	Preclinical
SC-560	cyclooxygenase inhibitor	PTGS1	Preclinical
SC-9	protein tyrosine kinase activator	PRKCA	Preclinical
SCH-202676	G protein-coupled receptor modulator	CHRM1, CHRM2, DRD1, DRD2	Preclinical
SCH-221510	nociceptin/orphanin FQ (NOP) receptor agonist	OPRL1	Preclinical
SCH-23390	dopamine receptor antagonist	DRD1, DRD5, HTR2C, KCNJ4, KCNJ6	Preclinical
SCH-28080	ATPase inhibitor	ATP4A	Phase 1
SCH-51344	MTH1 inhibitor	NUDT1	Preclinical
SCH-58261	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Preclinical
SCH-900776	CHK inhibitor	CDK2, CHEK1	Phase 2
schisandrin-b	antioxidant	ATR	Preclinical
schisandrol-b	lipid peroxidase inhibitor		Phase 3
sclareol			Preclinical
sclareolide	other antifungal		Launched
SCMC-Lys	mucolytic agent	GSTP1	Launched
scopine			Launched
scopolamine	acetylcholine receptor antagonist		Launched
scopolamine-n-oxide	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, SI	Preclinical
SCP-1	analgesic agent		Phase 1
scriptaid	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9	Preclinical
SCS			Preclinical
SD-169	p38 MAPK inhibitor	MAPK14	Preclinical
SD-208	TGF beta receptor inhibitor	TGFBR1	Preclinical
SD-2590	matrix metalloprotease inhibitor	MMP1, MMP13, MMP2	Preclinical
SDM25N	opioid receptor antagonist	OPRD1	Preclinical
SDZ-NKT-343	tachykinin antagonist	TACR1	Phase 1
SDZ-SER-082	serotonin receptor antagonist	HTR2A, HTR2B, HTR2C	Preclinical
SDZ-WAG-994	adenosine receptor agonist	ADORA1	Phase 2
SDZ-205-557	serotonin receptor antagonist	HTR3A, HTR3B	Preclinical
SDZ-21009	adrenergic receptor antagonist, serotonin receptor antagonist	HTR1A, HTR1B	Preclinical
SDZ-220-040	glutamate receptor antagonist	GRIN1	Preclinical
SDZ-220-581	glutamate receptor antagonist	GRIN1	Preclinical
se-methylselenocysteine			Phase 2
secalciferol	vitamin D receptor agonist	VDR	Launched
seclazone	anti-inflammatory agent		Phase 1
secnidazole	acetylcholinesterase inhibitor, microtubule inhibitor		Launched
secoisolariciresinol-(-)			Preclinical
secoisolariciresinol-diglucoside	antioxidant		Phase 2
securinine	GABA receptor antagonist, TP53 activator	GABRA1	Preclinical
selamectin	nematocide		Launched
selegiline	monoamine oxidase inhibitor	MAOA, MAOB	Launched
selenomethionine			Launched
selexipag	platelet aggregation inhibitor, IP1 prostacyclin receptor agonist	PTGIR	Phase 3
selfotel	glutamate receptor antagonist	GRIN2A, GRIN2B, GRIN2C, GRIN2D	Phase 3
selinexor	exportin antagonist	XPO1	Phase 2/Phase 3
selumetinib	MEK inhibitor	MAP2K1	Phase 3
semagacestat	gamma secretase inhibitor	PSEN1	Phase 3
semapimod	cytokine production inhibitor, p38 MAPK inhibitor	MAPK14	Phase 2
semaxanib	VEGFR inhibitor	FGFR1, FLT1, KDR, KIT, PDGFRA, PDGFRB, RET	Phase 3
semustine	DNA alkylating agent		Phase 3
SEN-1269	beta amyloid inhibitor	APP	Preclinical
senicapoc	intermediate conductance potassium channel blocker	KCNN4	Phase 3
sennoside-a	glycoside agonist		Launched
sennoside-protonated			Preclinical
seocalcitol	vitamin D receptor agonist	VDR	Phase 3
SEP-227900	D-Amino Acid Oxidase Inhibitor	DAO	Phase 1
seratrodast	prostanoid receptor antagonist	TBXA2R	Launched
serdemetan	MDM inhibitor	MDM2	Phase 1
serotonin	growth factor receptor activator	DRD1, DRD5, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR3A, HTR3B, HTR4, HTR5A, HTR6, HTR7, SLC36A1	Launched
sertaconazole	sterol demethylase inhibitor		Launched
sertindole	dopamine receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2C, HTR6, KCNH2	Withdrawn
sertraline	selective serotonin reuptake inhibitor (SSRI)	SLC6A3, SLC6A4	Launched
sesamin	NFkB pathway inhibitor		Preclinical
setipiprant	prostaglandin inhibitor	PTGDR2	Phase 3
setiptiline	adrenergic receptor antagonist	HRH1, HTR2A, HTR2C	Launched
sevelamer	phosphate antagonist		Launched
sevoflurane	membrane integrity inhibitor	ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, KCNK10, KCNK18, KCNK2, KCNK3, KCNK9, MT-ND1	Launched
SEW-2871	lysophospholipid receptor agonist	S1PR1	Preclinical
SF-11	neuropeptide receptor antagonist	MCOLN3, NPY2R	Preclinical
SGC-CBP30	bromodomain inhibitor	CREBBP, EP300	Preclinical
SGC-0946	histone lysine methyltransferase inhibitor		Preclinical
SGC-707	protein arginine N-methyltransferase inhibitor	PRMT3	Preclinical
SGI-1027	DNA methyltransferase inhibitor	DNMT1, DNMT3A, DNMT3B	Preclinical
SGI-1776	Pim kinase inhibitor	FLT3, PIM1, PIM2, PIM3	Phase 1
SGX523	hepatocyte growth factor receptor inhibitor	MET	Phase 1
SHA-68	neuropeptide receptor antagonist	NPSR1	Preclinical
shikimic-acid			Preclinical
SHP099	protein tyrosine kinase inhibitor	PTPN11	Preclinical
SIB-1553A	acetylcholine receptor agonist	CHRNB4	Phase 2
SIB-1757	glutamate receptor antagonist	GRM5	Preclinical
SIB-1893	glutamate receptor antagonist	GRM4, GRM5	Preclinical
sibutramine	serotonin–norepinephrine reuptake inhibitor (SNRI)	SLC6A2, SLC6A3, SLC6A4	Withdrawn
SID-7969543	steroidogenic factor antagonist	NR5A1	Preclinical
siguazodan	phosphodiesterase inhibitor	PDE3A	Phase 1
sildenafil	phosphodiesterase inhibitor	PDE5A, PDE6G, PDE6H, SLCO1B1, SLCO1B3	Launched
silibinin	cytochrome P450 inhibitor	ALOX5	Launched
silodosin	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D	Launched
silver-sulfadiazine	PABA antagonist		Launched
silymarin			Launched
simeprevir	HCV inhibitor	CYP1A2, CYP3A4	Launched
simvastatin	HMGCR inhibitor	HMGCR, ITGB2	Launched
sinefungin	DNA methyltransferase inhibitor, RNA synthesis inhibitor	CARM1	Preclinical
sinomenine	angiogenesis inhibitor		Preclinical
sipatrigine	voltage-gated sodium channel blocker	CACNA1D, SCN10A, SCN1A, SCN3A, SCN4A, SCN5A, SCN9A	Phase 2
siponimod	sphingosine phosphate receptor modulator	S1PR1	Phase 3
siramesine	sigma receptor antagonist	ADRA1A, ADRA1B, ADRA1D	Phase 2
sirolimus	mTOR inhibitor	FGF2, FKBP1A, MTOR	Launched
SirReal-2	SIRT inhibitor	SIRT2	Preclinical
sirtinol	SIRT inhibitor	SIRT1, SIRT2	Preclinical
sisomicin	protein synthesis inhibitor		Launched
sisomicin-sulfate	bacterial 30S ribosomal subunit inhibitor		Launched
SIS3	serine/threonine kinase inhibitor	SMAD3, TGFBR1	Preclinical
sitafloxacin	bacterial DNA gyrase inhibitor		Launched
sitagliptin	dipeptidyl peptidase inhibitor	DPP4	Launched
sitaxentan	endothelin receptor antagonist	EDNRA	Withdrawn
sitosterol			Preclinical
sivelestat	elastase inhibitor	CELA1, ELANE	Launched
SJ-172550	MDM inhibitor	MDM4	Preclinical
SK&F-10047-(+)	sigma receptor agonist	SIGMAR1	Phase 1
SKA-31	potassium channel activator	KCNN4	Preclinical
skepinone-l	p38 MAPK inhibitor	MAPK14	Preclinical
SKF-38393	dopamine receptor agonist	CALY, DRD1, DRD5	Preclinical
SKF-77434	dopamine receptor agonist	DRD1	Preclinical
SKF-81297	dopamine receptor agonist	DRD1, DRD5	Preclinical
SKF-83566	dopamine receptor antagonist	DRD1, DRD5	Preclinical
SKF-86002	p38 MAPK inhibitor	ALOX5, MAPK14	Preclinical
SKF-89976A	GABA uptake inhibitor	SLC6A1	Preclinical
SKF-91488	histamine N-methyltransferase inhibitor	HNMT	Preclinical
SKF-96365	calcium channel blocker	CYP3A4, PKD2, TRPC1, TRPC3, TRPC4, TRPC5, TRPV2	Preclinical
SKI-II	sphingosine kinase inhibitor	SPHK1	Preclinical
SKLB1002	VEGFR inhibitor	KDR	Preclinical
SLV-319-(+/-)	cannabinoid receptor antagonist	CNR1, DRD2, HTR1A	Phase 2
SLV-320	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Phase 2
SM-108			Phase 2
SM-164	XIAP inhibitor	BIRC2, BIRC3, XIAP	Preclinical
SM-21	sigma receptor antagonist	PGRMC1	Preclinical
SMER-28	autophagy inducer	SNCA	Preclinical
SMI-4a	Pim kinase inhibitor	PIM1	Preclinical
SN-2	transient receptor potential channel agonist	MCOLN3	Preclinical
SN-38	topoisomerase inhibitor	TOP1	Launched
SN-6	sodium/calcium exchange inhibitor		Preclinical
SNAP	nitric oxide donor	PTPN1	Phase 2
SNAP-5089	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CACNA1C, CACNA1D	Preclinical
SNAP-94847		ADRA1A, DRD2	Preclinical
SNC-80		OPRD1	Preclinical
SNG-1153	selective estrogen receptor modulator (SERM)	ESR1	Preclinical
SNS-314	Aurora kinase inhibitor	AURKA, AURKB, AURKC	Phase 1
SNX-2112	HSP inhibitor		Phase 1
SNX-5422	HSP inhibitor	HSP90AA1	Phase 1/Phase 2
sobetirome	thyroid hormone receptor agonist	THRA, THRB	Phase 1
sobrepin	mucolytic agent		Launched
sodium-ascorbate			Launched
sodium-butyrate	HDAC inhibitor	BCHE, FFAR2, FFAR3, HDAC1, HDAC2, HDAC3, HDAC8	Phase 2
sodium-danshensu			Preclinical
sodium-dodecyl-sulfate		ALB, LYZ	Preclinical
sodium-glucoheptonate			Launched
sodium-gluconate			Launched
sodium-gualenate	antacid		Launched
sodium-monofluorophosphate		PYGM	Launched
sodium-nitrite	nitric oxide donor		Launched
sodium-nitroprusside	nitric oxide donor		Launched
sodium-orthovanadate			Preclinical
sodium-oxybate	benzodiazepine receptor agonist	GABRB1, HCAR1, SLC52A2	Launched
sodium-picosulfate			Launched
sodium-salicylate	prostanoid receptor antagonist	ASIC3, PTGS1, PTGS2	Launched
sodium-stibogluconate	tyrosine phosphatase inhibitor	PTPN6, TOP1	Launched
sodium-tanshinone-ii-a-sulfonate	potassium channel activator		Phase 2
sodium-tetradecyl-sulfate		PROC, PROS1	Launched
sofalcone	mucus protecting agent	CBR1	Launched
sofosbuvir	RNA polymerase inhibitor		Launched
solamargine	apoptosis inhibitor		Phase 3
solcitinib	JAK inhibitor	JAK1	Phase 1
solifenacin-succinate	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Launched
solithromycin	protein synthesis inhibitor		Phase 3
somantadine	antiviral		Phase 1
somatostatin	somatostatin receptor agonist	OPRD1, OPRM1, SSTR1, SSTR2, SSTR3, SSTR4, SSTR5	Launched
sonidegib	smoothened receptor antagonist	SMO	Launched
sophocarpine			Phase 3
sorafenib	FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RAF inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor	BRAF, DDR2, FGFR1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET	Launched
sorbic-acid			Preclinical
sorbinil	aldose reductase inhibitor	AKR1B1	Phase 3
sorbitan-monostearate			Preclinical
sorbitol	mucolytic agent		Launched
sotagliflozin	sodium/glucose cotransporter inhibitor	SLC5A1, SLC5A2	Phase 3
sotalol	adrenergic receptor antagonist	ADRB1, ADRB2, KCNH2	Launched
sotrastaurin	PKC inhibitor	PRKCA, PRKCB, PRKCD, PRKCE, PRKCH, PRKCQ	Phase 2
SP-100030	NFkB pathway inhibitor	JUN, NFKB1	Preclinical
SP-141	ubiquitin ligase inhibitor	MDM2	Preclinical
SP-420			Phase 1
spaglumic-acid	glutamate receptor antagonist	GRM3	Launched
sparfloxacin	bacterial DNA gyrase inhibitor	TOP2A	Withdrawn
sparfosate	aspartate carbamoyltransferase inhibitor	CA2, CA4, CAD	Phase 3
sparteine-sulfate			Launched
spautin-1	deubiquitinase inhibitor	USP10, USP13	Preclinical
spectinomycin	bacterial 30S ribosomal subunit inhibitor		Launched
spermidine	glutamate receptor modulator	KCNJ4, TXNRD1	Preclinical
spermine		CA14, CA4, CA6, CA9, CASR, GRIN1, GRIN2A, KCNJ4, ODC1, SMOX, SMS, TRPM4, TRPM5	Preclinical
sphingosylphosphorylcholine	gene expression stimulant	GPR12	Preclinical
spiperone	dopamine receptor antagonist	ADRA1A, ADRA1B, ADRA1D, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1D, HTR2A, HTR2B, HTR2C, HTR6, HTR7	Launched
spiradoline	opioid receptor agonist	OPRK1	Phase 2
spiramycin	bacterial 50S ribosomal subunit inhibitor		Launched
spirobromin			Phase 1
spironolactone	mineralocorticoid receptor antagonist	AR, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CYP11B2, NR3C1, NR3C2, PGR, SHBG	Launched
spiroxatrine	serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, HTR1A, HTR2B	Preclinical
spizofurone			Withdrawn
splitomycin	SIRT inhibitor	SIRT1	Preclinical
SPP-86	receptor tyrosine protein kinase inhibitor	RET	Preclinical
SPP301	endothelin receptor antagonist	EDNRA	Phase 3
SQ-109	bacterial cell wall synthesis inhibitor	FDFT1	Phase 3
SQ-22536	adenylyl cyclase inhibitor	ADCY1	Preclinical
SR-1078	retinoid receptor agonist	RORA, RORC	Preclinical
SR-11302			Preclinical
SR-140333	neurokinin receptor antagonist	TACR1	Phase 2
SR-1664	PPAR receptor ligand	PPARG	Preclinical
SR-2211	retinoid receptor inverse agonist	RORC	Preclinical
SR-2640	leukotriene receptor antagonist	CYSLTR1	Phase 2
SR-27897	CCK receptor antagonist	CCKAR	Phase 2
SR-3306	JNK inhibitor	MAPK10, MAPK8, MAPK9	Preclinical
SR-33805	calcium channel blocker		Phase 1
SR-3576	JNK inhibitor	MAPK10	Preclinical
SR-3677	rho associated kinase inhibitor	ROCK2	Preclinical
SR-57227A	serotonin receptor agonist	HTR3A	Phase 2
SR-59230A	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3	Preclinical
SR-95639A	acetylcholine receptor agonist	CHRM1	Preclinical
SRC-kinase-inhibitor-I	src inhibitor	CSK, LCK, RIPK2	Preclinical
SRPIN340	serine arginine protein kinase inhibitor	SRPK1, SRPK2	Preclinical
SRT1720	SIRT activator	SIRT1	Preclinical
SRT2104	SIRT activator	SIRT1	Phase 2
SSR-180711	acetylcholine receptor agonist	CHRNA7	Phase 2
SSR128129E			Preclinical
ST-1859	antiamyloidogenic agent		Phase 1
ST-2825	myeloid differentiation primary response inhibitor	MYD88	Preclinical
ST-91	adrenergic receptor agonist		Preclinical
STA-5326	interleukin synthesis inhibitor	IL12A	Phase 2
stanozolol	androgen receptor agonist	AR	Launched
stattic			Preclinical
STAT3-inhibitor-VI	STAT inhibitor	STAT3	Preclinical
stavudine	DNA directed DNA polymerase inhibitor, nucleoside reverse transcriptase inhibitor		Launched
stemregenin-1	aryl hydrocarbon receptor antagonist	AHR	Preclinical
stepronin	mucolytic agent		Launched
stetaderm			Launched
STF-083010	serine/threonine kinase inhibitor	ERN1	Preclinical
STF-118804	NAMPT inhibitor	NAMPT	Preclinical
STF-31	NAMPT inhibitor	NAMPT, SLC2A1	Preclinical
STF-62247	autophagy inducer		Preclinical
stigmasterol			Preclinical
stiripentol	GABA uptake inhibitor	GABRA3	Launched
stobadine	adrenergic receptor antagonist	ADRA1A	Phase 2
streptomycin	bacterial 30S ribosomal subunit inhibitor		Launched
streptozotocin	DNA alkylating agent	SLC2A2	Launched
strontium-ranelate	bone formation stimulant, bone resorption inhibitor	CASR	Launched
strychnine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA10, CHRNA9, GLRA1, GLRA2, GLRA3, GLRB	Preclinical
SU-11274	hepatocyte growth factor receptor inhibitor, tyrosine kinase inhibitor	MET	Preclinical
SU-16f	PDGFR tyrosine kinase receptor inhibitor	PDGFRB	Preclinical
SU-4312	PDGFR tyrosine kinase receptor inhibitor, tyrosine kinase inhibitor, VEGFR inhibitor	KDR, PDGFRB	Preclinical
substance-p	neurokinin receptor antagonist	TACR1, TACR2, TACR3	Phase 1
succinic-acid		ALDH5A1, ASPH, BBOX1, HSD17B6, OXCT1, OXCT2, P3H1, P3H2, P3H3, P4HA1, P4HA2, PLOD1, PLOD3, SDHA, SDHB, SDHC, SDHD, SLC13A1, SLC13A2, SLC13A3, SLC25A10, SUCLA2, SUCLG1, SUCLG2, SUCNR1, TMLHE	Launched
succinylcholine-chloride		CHRFAM7A, CHRM1, CHRM2, CHRM3, CHRNA1, CHRNA10	Launched
succinylsulfathiazole	dihydrofolate reductase inhibitor	DHFR	Phase 2
sucralfate	antacid	EGF, FGA, FGB, FGF2, FGG	Launched
sucralose			Launched
sucrose		ACTA1, ATOX1, C22orf28, LYZ	Launched
sucrose-octaacetate			Preclinical
sudan-iv			Preclinical
sufentanil	opioid receptor modulator	OPRD1, OPRK1, OPRM1	Launched
sulbactam	beta lactamase inhibitor		Launched
sulbactam-pivoxil	beta lactamase inhibitor		Launched
sulbentine	other antifungal		Preclinical
sulbutiamine	acetylcholine receptor antagonist		Launched
sulconazole	sterol demethylase inhibitor		Launched
sulfabenzamide	bacterial antifolate		Launched
sulfacarbamide			Withdrawn
sulfacetamide	PABA antagonist		Launched
sulfachlorpyridazine	bacterial antifolate		Launched
sulfadiazine	bacterial antifolate		Launched
sulfadoxine	dihydropteroate synthase inhibitor		Launched
sulfafurazole	bacterial antifolate		Launched
sulfaguanidine	bacterial antifolate		Launched
sulfamerazine	bacterial antifolate		Launched
sulfameter	dihydrofolate reductase inhibitor	DHFR	Launched
sulfamethazine	PABA antagonist		Launched
sulfamethizole	bacterial antifolate		Launched
sulfamethoxazole	PABA antagonist		Launched
sulfamethoxypyridazine	bacterial antifolate		Withdrawn
sulfametopyrazine	PABA antagonist		Launched
sulfamonomethoxine	bacterial antifolate		Launched
sulfamoxole	PABA antagonist		Launched
sulfanilamide	carbonic anhydrase inhibitor	CYP2C19, CYP2C9, CYP2D6, CYP2E1, CYP3A4	Launched
sulfanilate-zinc			Preclinical
sulfanitran			Launched
sulfaphenazole	dihydropteroate synthetase inhibitor	DHPS	Launched
sulfapyridine	PABA antagonist		Launched
sulfaquinoxaline	vitamin K antagonist		Launched
sulfasalazine	cyclooxygenase inhibitor	ACAT1, ALOX5, CHUK, IKBKB, PLA2G1B, PPARG, PTGS1, PTGS2, SLC46A1, SLC7A11, TBXAS1	Launched
sulfathiazole	dihydropteroate synthase inhibitor		Launched
sulfinpyrazone	uricosuric blocker	ABCC1, ABCC2, FPR1, SLC22A12	Launched
sulfisoxazole-acetyl	folic acid antagonist		Launched
sulforaphane	anticancer agent, aryl hydrocarbon receptor antagonist	NFE2L2	Phase 2
sulindac	cyclooxygenase inhibitor	AKR1B1, MAPK3, PPARD, PTGDR2, PTGS1, PTGS2	Launched
sulisobenzone			Launched
sulmazole	adenosine receptor antagonist		Phase 1
sulmetozine	gastrin inhibitor	GAST	Launched
suloctidil	adrenergic receptor antagonist		Withdrawn
sulphadimethoxine	dihydropteroate synthetase inhibitor		Launched
sulpiride	dopamine receptor antagonist		Launched
sumanirole	dopamine receptor agonist	DRD2	Phase 3
sumatriptan	serotonin receptor agonist	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR5A, HTR6, HTR7	Launched
SUN-B-8155	calcitonin agonist	CALCR	Preclinical
SUN-11602	fibroblast growth factor mimetic	FGFR1	Preclinical
sunitinib	FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor	CSF1R, FGFR1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET	Launched
suplatast	histamine release inhibitor, immunoglobulin inhibitor		Launched
suprofen	cyclooxygenase inhibitor	PTGS1, PTGS2	Withdrawn
suramin	DNA synthesis inhibitor	F2, FSHR, P2RY1, P2RY11, P2RY13, P2RY2, PLA2G2A, RYR1, RYR2, SIRT5	Launched
suritozole	GABA receptor inverse agonist	GABBR1	Phase 2
sutezolid	protein synthesis inhibitor		Phase 2
suvorexant	orexin receptor antagonist	HCRTR1, HCRTR2	Launched
suxibuzone	cyclooxygenase inhibitor		Launched
SU014813	PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	KDR	Phase 2
SU3327	JNK inhibitor	MAPK8	Preclinical
SU9516	CDK inhibitor	CDK1, CDK2, CDK4, CDK5	Preclinical
swainsonine	alpha mannosidase inhibitor	MAN2A1	Phase 2
SX-011	MAP kinase inhibitor	MAPK14	Preclinical
SYM-2081	kainate receptor antagonist	GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SLC1A2	Preclinical
SYM-2206	glutamate receptor antagonist	GRIA1, GRIA2, GRIA3, GRIA4	Preclinical
symclosene			Preclinical
synephrine	adrenergic receptor agonist	ADRA1A	Launched
S1P1-agonist-III	sphingosine kinase inhibitor	S1PR1	Preclinical
S18986	glutamate receptor modulator	GRIA1, GRIA2, GRIA3, GRIA4	Phase 2
S26948	PPAR receptor agonist	PPARG	Preclinical
S4	carbonic anhydrase inhibitor	CA12, CA9	Preclinical
T-0070907	PPAR receptor antagonist	PPARG	Preclinical
T-0156	phosphodiesterase inhibitor	PDE5A	Preclinical
T-0901317	LXR agonist	NCOA1, NCOA2, NR1H2, NR1H3, NR1I2, RXRB	Preclinical
T-5224	AP inhibitor	JUN	Phase 2
T-5601640	LIM kinase inhibitor	LIMK2	Preclinical
T-62	adenosine receptor modulator	ADORA2A	Phase 2
TA-01	casein kinase inhibitor, MAP kinase inhibitor	CSNK1D, CSNK1E, MAPK14	Preclinical
tabimorelin	growth hormone secretagogue receptor agonist	GHSR	Phase 2
tacalcitol	vitamin D receptor agonist	VDR	Launched
tacedinaline	HDAC inhibitor	HDAC1	Phase 3
tacrine	acetylcholinesterase inhibitor	ACHE, BCHE	Launched
tacrolimus	calcineurin inhibitor	FKBP1A	Launched
tadalafil	phosphodiesterase inhibitor	PDE11A, PDE5A	Launched
tafamidis-meglumine	transthyretin amyloid inhibitor	TTR	Launched
tafenoquine	antimalarial agent		Phase 3
tagatose	phosphorylase inhibitor	PYGL	Phase 3
TAK-063	phosphodiesterase inhibitor	PDE10A	Phase 2
TAK-220	CC chemokine receptor antagonist	CCR5	Phase 1
TAK-285	EGFR inhibitor	ERBB2	Phase 1
TAK-593	VEGFR inhibitor	PDGFRA	Phase 1
TAK-632	RAF inhibitor	BRAF	Preclinical
TAK-715	p38 MAPK inhibitor	MAPK14	Phase 2
TAK-733	MEK inhibitor	MAP2K1	Phase 1
TAK-875	insulin secretagogue	FFAR1	Phase 3
TAK-901	Aurora kinase inhibitor	AURKB	Phase 1
TAK-960	PLK inhibitor	PLK1	Phase 1
talabostat	dipeptidyl peptidase inhibitor, fibroblast activation protein inhibitor	DPP4	Phase 3
taladegib	smoothened receptor antagonist	DHH, IHH, SMO	Phase 2
talampanel	glutamate receptor antagonist	GRIA1, GRIA2, GRIA3, GRIA4	Phase 2
talarozole	cytochrome P450 inhibitor	CYP26A1	Phase 2
talazoparib	PARP inhibitor	PARP2	Phase 3
talc			Launched
talinolol	adrenergic receptor antagonist	ADRB1	Launched
talipexole	adrenergic receptor agonist, dopamine receptor agonist	ADRA2A, DRD2, HTR3A	Launched
talmapimod	p38 MAPK inhibitor	MAPK11, MAPK14	Phase 2
talnetant	tachykinin antagonist	TACR2, TACR3	Phase 2
talniflumate	cyclooxygenase inhibitor	CLCA1	Launched
talopram	adrenergic inhibitor	SLC6A2	Phase 2
taltirelin	thyrotropin releasing hormone receptor agonist	TRHR	Launched
taltobulin	tubulin polymerization inhibitor		Phase 1
TAME			Preclinical
tamibarotene	retinoid receptor agonist	RARA, RARB	Launched
tamoxifen	estrogen receptor antagonist, selective estrogen receptor modulator (SERM)	EBP, ESR1, ESR2, GPER1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCI, PRKCQ, PRKCZ	Launched
tamsulosin	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D	Launched
tanaproget	progesterone receptor agonist	PGR	Phase 2
tandospirone	serotonin receptor agonist	HTR1A	Launched
tandutinib	FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor	CSF1R, FLT3, KIT, PDGFD, PDGFRB	Phase 2
tanespimycin	HSP inhibitor	HSP90AA1	Phase 3
tangeritin	cell cycle inhibitor		Preclinical
tannic-acid	PARG inhibitor	ANO1	Launched
tanshinone-i	AP inhibitor	IFNG	Phase 2
tanshinone-iia	anti-inflammatory agent, interleukin inhibitor	IL1B, NR1I2, TNF	Phase 2/Phase 3
tapentadol	opioid receptor agonist	HTR3A, OPRD1, OPRK1, OPRM1, SLC6A2, SLC6A4	Launched
taprenepag	prostaglandin receptor agonist	PTGER2	Phase 2
tarafenacin	acetylcholine receptor antagonist	CHRM3	Phase 2
taranabant	cannabinoid receptor inverse agonist	CNR1	Phase 3
targinine	nitric oxide synthase inhibitor	NOS3	Phase 3
tariquidar	P glycoprotein inhibitor	ABCB1	Phase 3
tartaric-acid	antioxidant	ATP6V1C1, B3GAT1, DDX6, HIF1AN, TREM1	Launched
TAS-103	topoisomerase inhibitor	TOP1	Phase 1
taselisib	PI3K inhibitor	PIK3CA	Phase 3
tasimelteon	melatonin receptor agonist	MTNR1A, MTNR1B	Launched
tasisulam	apoptosis stimulant		Phase 3
tasquinimod	angiogenesis inhibitor, S100A9 inhibitor	HDAC4	Phase 3
tasuldine	mucolytic agent		Phase 3
taurine	antioxidant		Launched
taurocholate	G protein-coupled receptor agonist	CEL, FABP6, SLCO1C1	Phase 1
taurolidine	apoptosis stimulant		Launched
tavaborole	leucyl-tRNA synthetase inhibitor		Launched
taxifolin	opioid receptor antagonist	ADIPOR2	Phase 2
tazarotene	retinoid receptor agonist	RARA, RARB, RARG, RXRB	Launched
tazemetostat	histone lysine methyltransferase inhibitor	EZH2	Phase 2
tazobactam	beta lactamase inhibitor		Launched
TBA-354			Phase 1
TBOA-(DL)	excitatory amino acid transporter inhibitor	SLC1A1, SLC1A2, SLC1A3, SLC1A6, SLC1A7	Preclinical
TC-A-2317	Aurora kinase inhibitor	AURKA	Preclinical
TC-ASK-10	MAP kinase inhibitor	MAP3K5, MAP3K6	Preclinical
TC-E-5002	histone demethylase inhibitor	KDM2A, KDM4A, KDM4C, KDM5A, KDM6A, KDM7A, PHF8	Preclinical
TC-E-5006	gamma secretase modulator	APP	Preclinical
TC-F-2	FAAH inhibitor	FAAH	Preclinical
TC-FPR-43	formyl peptide receptor agonist	FPR2	Preclinical
TC-G-1000	adrenergic receptor agonist	ADRA2A, ADRA2B, ADRA2C	Preclinical
TC-G-1004	adenosine receptor antagonist	ADORA2A	Preclinical
TC-G-1005	G protein-coupled receptor agonist	GPBAR1	Preclinical
TC-G-1008	G protein-coupled receptor agonist	GPR39	Preclinical
TC-H-106	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC8	Preclinical
TC-I-15	integrin inhibitor	ITGA2, ITGB1	Preclinical
TC-I-2000	transient receptor potential channel antagonist	TRPM8	Preclinical
TC-I-2014	transient receptor potential channel antagonist	TRPM8	Preclinical
TC-LPA5-4	lysophosphatidic acid receptor antagonist	LPAR5	Preclinical
TC-Mps1-12	monopolar spindle 1 kinase inhibitor	TTK	Preclinical
TC-N-1752	sodium channel blocker	SCN9A	Preclinical
TC-NTR1-17	neurotensin agonist	NTSR1	Preclinical
TC-O-9311	G protein-coupled receptor agonist	GPR139	Preclinical
TC-OT-39	oxytocin receptor agonist, vasopressin receptor agonist	AVPR1A, OXT	Preclinical
TC-S-7003	src inhibitor	LCK	Preclinical
TC-S-7004	DYRK inhibitor	DYRK1A, DYRK1B	Preclinical
TC-S-7005	PLK inhibitor	PLK2	Preclinical
TC-S-7006	MAP kinase inhibitor	MAP3K8	Preclinical
TC-S-7009	hypoxia inducible factor inhibitor	EPAS1	Preclinical
TC-SP-14	sphingosine 1 phosphate receptor agonist	S1PR1	Preclinical
TCID			Preclinical
TCN-238	glutamate receptor positive allosteric modulator	GRM4	Preclinical
TCN201	glutamate receptor antagonist	GRIN2A	Preclinical
TCS-HDAC6-20b	HDAC inhibitor	HDAC6	Preclinical
TCS-OX2-29	orexin receptor antagonist	HCRTR2	Preclinical
TCS-PIM-1-1	Pim kinase inhibitor	PIM1	Preclinical
TCS-21311	JAK inhibitor	JAK3	Preclinical
TCS-2210	neural stem cell inducer		Preclinical
TCS-2314	integrin inhibitor	ITGA4, ITGB1	Preclinical
TCS-3035	G protein-coupled receptor agonist	GPR35	Preclinical
TCS-359	FLT3 inhibitor	FLT3	Preclinical
TCS-5861528	transient receptor potential channel antagonist	TRPA1	Preclinical
TCS2002	glycogen synthase kinase inhibitor	GSK3B	Preclinical
TC1	beta-secretase inhibitor	BACE1	Preclinical
TC2559	acetylcholine receptor agonist	CHRNA4	Preclinical
tebipenem	bacterial cell wall synthesis inhibitor	CNR1	Launched
tecalcet	calcium-sensing receptor agonist	CASR	Phase 2
tecastemizole	histamine receptor antagonist	KCNH2	Phase 3
tecovirimat	orthopoxvirus egress inhibitor		Phase 3
tedizolid	bacterial 50S ribosomal subunit inhibitor		Launched
tedizolid-phosphate	protein synthesis inhibitor		Launched
tegaserod	serotonin receptor partial agonist	HTR2A, HTR2B, HTR2C, HTR4	Withdrawn
tegobuvir	HCV inhibitor, protease inhibitor		Phase 3
teicoplanin	bacterial cell wall synthesis inhibitor		Launched
teicoplanin-A2-1	bacterial cell wall synthesis inhibitor		Launched
teicoplanin-a2-3	bacterial cell wall synthesis inhibitor		Launched
Teijin-compound-1	CC chemokine receptor antagonist	CCR2	Preclinical
telaprevir	HCV inhibitor	CTSA, PGR	Launched
telatinib	KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	KDR	Phase 2
telbivudine	DNA polymerase inhibitor	TK2	Launched
telcagepant	calcitonin antagonist	CALCRL, RAMP1	Phase 3
telenzepine	acetylcholine receptor antagonist	CHRM1	Phase 3
telithromycin	bacterial 30S ribosomal subunit inhibitor, bacterial 50S ribosomal subunit inhibitor	CYP1A2, CYP2D6, CYP3A4, CYP3A5, CYP3A7	Launched
telmesteine	mucolytic agent		Launched
telmisartan	angiotensin receptor antagonist	AGTR1, PPARG	Launched
telotristat	tryptophan hydroxylase inhibitor	TPH1	Launched
telotristat-ethyl	tryptophan hydroxylase inhibitor	TPH1	Launched
temazepam	benzodiazepine receptor agonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, TSPO	Withdrawn
temefos	cholinesterase inhibitor		Launched
temocapril	angiotensin converting enzyme inhibitor	ACE	Launched
temoporfin	radical formation stimulant		Launched
temozolomide	DNA alkylating agent	MGMT	Launched
tempol	free radical scavenger		Phase 2
temsirolimus	mTOR inhibitor	MTOR	Launched
tenatoprazole	ATPase inhibitor	IDO1	Phase 2
teneligliptin	dipeptidyl peptidase inhibitor	DPP4	Launched
tenidap	cyclooxygenase inhibitor	KCNJ4, PTGS1	Phase 3
tenilsetam	AGE inhibitor		Phase 3
teniposide	topoisomerase inhibitor	TOP2A, TOP2B	Launched
tenofovir	HIV integrase inhibitor, nucleoside reverse transcriptase inhibitor		Launched
tenofovir-alafenamide	nucleoside reverse transcriptase inhibitor		Preclinical
tenofovir-disoproxil	nucleoside reverse transcriptase inhibitor	CYP1A2	Launched
tenovin-1	SIRT inhibitor, TP53 activator	SIRT1	Preclinical
tenovin-6	SIRT inhibitor	SIRT1, SIRT2, SIRT3	Preclinical
tenoxicam	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
tenylidone			Preclinical
tepoxalin	cyclooxygenase inhibitor, lipoxygenase inhibitor	ALOX5	Launched
TEPP-46	pyruvate kinase isozyme activator	PKM	Preclinical
teprenone	mucus protecting agent		Launched
terameprocol	lipoxygenase inhibitor	BIRC5, CDK1	Phase 1/Phase 2
terazosin	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, KCNH2, KCNH6, KCNH7	Launched
terbinafine	fungal squalene epoxidase inhibitor	SQLE	Launched
terbutaline	adrenergic receptor agonist	ADRB2	Launched
terciprazine			Phase 1
terconazole	sterol demethylase inhibitor		Launched
terfenadine	histamine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, KCNH1, KCNH2	Withdrawn
terguride	dopamine receptor agonist, serotonin receptor antagonist	ADRA1A, ADRA2A, ADRA2B, ADRA2C, DRD2, DRD3, DRD4, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C	Launched
teriflunomide	dihydroorotate dehydrogenase inhibitor	DHODH	Launched
terlipressin	vasopressin receptor agonist	AVPR1A, AVPR1B, AVPR2	Launched
terodiline	cholinergic receptor antagonist		Phase 3
teroxirone	DNA inhibitor		Phase 1
terpene			Preclinical
terreic-acid-(-)	Bruton's tyrosine kinase (BTK) inhibitor	BTK	Preclinical
terutroban	prostanoid receptor antagonist	TBXA2R	Phase 3
tesaglitazar	insulin sensitizer, PPAR receptor agonist	PPARA, PPARG	Phase 3
testolactone	aromatase inhibitor	CYP19A1	Launched
testosterone	androgen receptor agonist	AR	Launched
testosterone-enanthate	androgen receptor agonist	AR	Launched
testosterone-propionate	androgen receptor agonist	AR	Launched
testosterone-undecanoate	androgen receptor agonist	AR	Launched
tetrabenazine	vesicular monoamine transporter inhibitor	DRD2, SLC18A1, SLC18A2	Launched
tetracaine	membrane integrity inhibitor	SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	Launched
tetracycline	bacterial 30S ribosomal subunit inhibitor	PRNP	Launched
tetradecylthioacetic-acid	lipid peroxidase inhibitor		Phase 2
tetraethylenepentamine	superoxide dismutase inhibitor	SOD1, SOD2	Phase 2/Phase 3
tetrahydrofolic-acid		ALDH1L1, AMT, ATIC, FOLR2, FTCD, MTFMT, MTHFD1, MTHFD2, MTHFR, MTR, SHMT1, SHMT2	Launched
tetrahydropapaverine			Preclinical
tetrahydrouridine	cytidine deaminase inhibitor	CDA	Phase 2
tetrahydrozoline	adrenergic receptor agonist		Launched
tetramethylthiuram-monosulfide			Preclinical
tetramisole	immunostimulant		Launched
tetrandrine	calcium channel blocker	SLC6A3	Preclinical
tetrazol-5-yl-glycine-(RS)	glutamate receptor agonist	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D	Preclinical
tetrindole	monoamine oxidase inhibitor	MAOA	Phase 3
tetroquinone			Preclinical
tezacaftor	CFTR channel agonist		Launched
TFC-007	prostaglandin inhibitor	HPGDS	Preclinical
TG-003	CLK inhibitor	CLK1, CLK4, DYRK1A, DYRK1B	Preclinical
TG-02	CDK inhibitor, FLT3 inhibitor, JAK inhibitor	CDK1, CDK2, CDK7, CDK9, FLT3, JAK2	Phase 1
TG-100572	src inhibitor, VEGFR inhibitor	KDR, SRC	Preclinical
TG-100713	PI3K inhibitor		Preclinical
TG-100801	src inhibitor, VEGFR inhibitor	FGFR1, FLT1, KDR, SRC	Phase 2
TG-101209	JAK inhibitor	JAK2, JAK3	Preclinical
TG-101348	FLT3 inhibitor, JAK inhibitor	BRD4, JAK1, JAK2, JAK3, TYK2	Phase 3
TGR-1202	PI3K inhibitor		Phase 3
TGX-221	PI3K inhibitor	PIK3CB, PIK3CD	Preclinical
TG100-115	PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG	Phase 1/Phase 2
TH-302	DNA alkylating agent		Phase 3
thaliblastine	DNA inhibitor		Phase 2
thalidomide	tumor necrosis factor production inhibitor	CRBN, FGFR2, NFKB1, ORM1, ORM2, PTGS2, TNF	Launched
theobromine	phosphodiesterase inhibitor	ADORA1, ADORA2A, PDE4B	Launched
theophylline	adenosine receptor antagonist		Launched
thiamet-g	GLCNAC phosphotransferase inhibitor	MGEA5	Preclinical
thiamine	vitamin B	SLC19A2, SLC19A3, TPK1	Launched
thiamine-pyrophosphate			Launched
thiamphenicol	bacterial 50S ribosomal subunit inhibitor		Launched
thiamylal	glutamate receptor antagonist	GABRA1, KCNJ11, KCNJ8	Launched
thiazovivin	rho associated kinase inhibitor		Preclinical
thiethylperazine	dopamine receptor antagonist	DRD1, DRD2, DRD4	Launched
thiocolchicoside	GABA receptor antagonist	GABRA1, GABRB2, GABRG2, GLRA1, GLRB	Launched
thioctic-acid	reducing agent	ACHE, LIAS, LIPT1, PTGS2, SLC5A6	Launched
thiodiglycol			Preclinical
thioguanine	purine antagonist	IMPDH1, IMPDH2	Launched
thiomersal	other antibiotic	OXCT1	Launched
thiopental	GABA receptor antagonist	CHRNA4, CHRNA7, FAAH, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GRIA2, GRIK2	Launched
thioperamide	histamine receptor antagonist	HRH3, HRH4	Preclinical
thiophanate			Preclinical
thioproperazine	dopamine receptor antagonist	ADRA1A, ADRA1B, DRD1, DRD2, HTR1A, HTR2A	Launched
thioridazine	dopamine receptor antagonist	ADRA1A, ADRA1B, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR2A, HTR2C, HTR6, HTR7, KCNH2	Withdrawn
thiorphan	membrane metalloendopeptidase inhibitor	MME	Phase 1
thiostrepton	FOXM1 inhibitor, protein synthesis inhibitor	FOXM1	Launched
thiotepa	cytochrome P450 inhibitor	CYP2B6, CYP3A4	Launched
thiothixene	dopamine receptor antagonist	DRD1, DRD2, HRH1, HTR2A	Launched
thiram		JAK2	Launched
thonzonium	ATPase inhibitor		Launched
thonzylamine	antihistamine		Launched
threo-2-methylisocitrate-(DL)	isocitrate lyase substrate		Preclinical
thymol	GABA receptor positive allosteric modulator	TRPA1	Launched
thymol-iodide			Preclinical
THZ1	CDK inhibitor	CDK7	Preclinical
THZ1-R	CDK inhibitor	CDK7	Preclinical
THZ2	CDK inhibitor	CDK7	Preclinical
TH588	MTH1 inhibitor	NUDT1	Preclinical
tiabendazole	angiogenesis inhibitor		Launched
tiagabine	GABA uptake inhibitor	SLC6A1	Launched
tianeptine	selective serotonin reuptake enhancer (SSRE)	OPRD1, OPRK1, OPRM1	Launched
tiapride	dopamine receptor antagonist	DRD2, DRD3	Launched
tiaprofenic-acid	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
tiaramide	anti-inflammatory agent		Launched
tibolone	androgen receptor agonist, estrogen receptor agonist, progesterone receptor agonist	ESR1	Launched
ticagrelor	purinergic receptor antagonist	P2RY12	Launched
ticarcillin	lactamase inhibitor		Launched
ticlopidine	purinergic receptor antagonist	P2RY12	Launched
TIC10	AKT inhibitor, TRAIL modulator	AKT1, MAPK1	Phase 2
tideglusib	glycogen synthase kinase inhibitor	GSK3B	Phase 2
tienilic-acid	sodium/potassium/chloride transporter inhibitor, cytochrome P450 inhibitor	CYP2C9, SLC12A1	Withdrawn
tie2-kinase-inhibitor	TIE tyrosine kinase inhibitor	KDR, MAPK14	Preclinical
tifenazoxide	ATP-sensitive potassium channel agonist	ABCC8, KCNJ11	Phase 1
tigecycline	bacterial 30S ribosomal subunit inhibitor		Launched
tiletamine	glutamate receptor antagonist		Launched
tilmicosin	bacterial 50S ribosomal subunit inhibitor		Launched
tilorone	interferon inducer		Launched
tiludronate	bone resorption inhibitor, osteoclast inhibitor	ATP6V1A, MMP2, PTPN1	Launched
timofibrate	cholesterol inhibitor, lipase clearing factor inhibitor	LPL	Phase 2
timolol	adrenergic receptor antagonist	ADRB1, ADRB2	Launched
timonacic	antioxidant	ANXA5	Launched
tinidazole	antiprotozoal agent		Launched
tioconazole	sterol demethylase inhibitor	CYP51A1	Launched
tioguanine	purine antagonist		Phase 2
tiopronin	chelating agent, reducing agent		Launched
tiotidine	histamine receptor antagonist	HRH2	Phase 2
tiotropium	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3	Launched
tioxolone	carbonic anhydrase inhibitor	CA2	Preclinical
tipifarnib	farnesyltransferase inhibitor	FNTA, FNTB	Phase 3
tipiracil	thymidine phosphorylase inhibitor	TYMP	Launched
tiplaxtinin	plasminogen activator inhibitor	SERPINE1	Phase 1
tipranavir	HIV protease inhibitor		Launched
tiprenolol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3	Phase 2
tiquizium	acetylcholine receptor antagonist		Launched
tiracizine	sodium channel blocker	SCN5A	Withdrawn
tirapazamine	DNA inhibitor		Phase 3
tirasemtiv	troponin activator		Phase 2
tiratricol	thyroid hormone stimulant	THRA, THRB	Launched
tirofiban	platelet aggregation inhibitor, structural glycoprotein antagonist	ITGA2B, ITGB3	Launched
titanocene-dichloride	apoptosis stimulant		Phase 2
tivantinib	tyrosine kinase inhibitor	MET	Phase 3
tivozanib	VEGFR inhibitor	FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB	Phase 3
tizanidine	adrenergic receptor agonist	ADRA2A, ADRA2B, ADRA2C, NISCH	Launched
TMC-353121	RSV fusion inhibitor		Phase 2
TMC647055	RNA polymerase inhibitor		Phase 2
TMN-355	cyclophilin inhibitor	PPIA	Preclinical
TMPH			Preclinical
TMS			Preclinical
TNP-470	methionine aminopeptidase inhibitor		Phase 2
tobramycin	bacterial 30S ribosomal subunit inhibitor		Launched
tocainide	sodium channel blocker	SCN5A	Launched
toceranib	protein tyrosine kinase inhibitor	FLT1, FLT3, KDR, PDGFRA, PDGFRB	Launched
tocofersolan	antioxidant		Launched
todralazine	antihypertensive agent		Launched
tofacitinib	JAK inhibitor	JAK1, JAK2, JAK3, TYK2	Launched
tofisopam	phosphodiesterase inhibitor, cytochrome P450 inhibitor	CYP3A4, PDE10A, PDE2A, PDE3A, PDE4A	Launched
tofogliflozin	sodium/glucose cotransporter inhibitor	GCK	Launched
tolamolol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3	Phase 3
tolazamide	ATP channel blocker	ABCC8, KCNJ1, KCNJ10, KCNJ11	Launched
tolazoline	adrenergic receptor antagonist	ADRA1A, ADRA2A, ADRA2B, ADRA2C, HRH1, HRH2	Launched
tolbutamide	ATP channel blocker	ABCC8, KCNJ1, KCNJ11, KCNJ8	Launched
tolcapone	catechol O methyltransferase inhibitor	COMT	Withdrawn
tolfenamic-acid	cyclooxygenase inhibitor, prostanoid receptor antagonist		Launched
tolimidone	src activator	LYN, SRC	Phase 2
tolmetin	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
tolnaftate	fungal squalene epoxidase inhibitor		Launched
tolonidine	adrenergic receptor antagonist	ADRA2A	Launched
tolonium			Launched
toloxatone	monoamine oxidase inhibitor	MAOA, MAOB	Launched
tolperisone	voltage-gated sodium channel blocker	CYP2C19, CYP2D6	Launched
tolrestat	aldose reductase inhibitor	AKR1A1, AKR1B1, AKR1B10	Withdrawn
tolterodine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Launched
toltrazuril	antiprotozoal agent		Launched
tolvaptan	vasopressin receptor antagonist	AVPR1A, AVPR2	Launched
tomelukast	leukotriene receptor antagonist	CYSLTR1	Phase 3
tonabersat	gap junction modulator, nitric oxide production inhibitor		Phase 2
topiramate	carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist	CA1, CA12, CA2, CA4, CA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	Launched
topiroxostat	xanthine oxidase inhibitor	XDH	Launched
topotecan	topoisomerase inhibitor	TOP1, TOP1MT	Launched
torasemide	electrolyte reabsorption inhibitor, thromboxane receptor antagonist	SLC12A1	Launched
torcetrapib	cholesteryl ester transfer protein inhibitor	CETP	Phase 3
torcitabine	DNA polymerase inhibitor	DCK, TK2	Phase 2
toremifene	estrogen receptor antagonist, selective estrogen receptor modulator (SERM)	ESR1	Launched
torin-1	mTOR inhibitor	MTOR	Preclinical
torin-2	mTOR inhibitor	MTOR	Preclinical
tosedostat	peptidase inhibitor	ANPEP, LAP3, NPEPPS	Phase 2
tosufloxacin	bacterial DNA gyrase inhibitor		Launched
toyocamycin	serine/threonine kinase inhibitor	ERN1	Phase 1
tozadenant	adenosine receptor antagonist	ADORA2A	Phase 3
tozasertib	Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor	AURKA, AURKB, AURKC, LCK	Phase 2
TP-003	GABA receptor inverse agonist	GABRA1, GABRA2, GABRA3, GABRA5	Preclinical
TP-0903	AXL kinase inhibitor	AXL	Preclinical
TPCA-1	IKK inhibitor	IKBKB	Preclinical
TPPS4			Phase 1
tracazolate	GABA receptor modulator	GABRA1	Phase 2
TRAM-34	potassium channel antagonist	KCNN4	Preclinical
TRAM-39	calcium-activated potassium channel activator	KCNN4	Preclinical
tramadol	norepinephrine reputake inhibitor, opioid receptor agonist, serotonin reuptake inhibitor	CHRFAM7A, CHRM3, GRIN3A, HTR2C, OPRD1, OPRK1, OPRM1, SLC6A2, SLC6A4	Launched
trametinib	MEK inhibitor	MAP2K1, MAP2K2	Launched
tramiprosate	beta amyloid protein neurotoxicity inhibitor	APP	Phase 3
trandolapril	angiotensin converting enzyme inhibitor	ACE	Launched
tranexamic-acid	antifibrinolytic, plasminogen activator inhibitor	PLG	Launched
tranilast	angiogenesis inhibitor	HPGDS, HRH1	Launched
trans-10,cis-12-Conjugated-linoleic-acid			Launched
trans-2-Undecenoic-acid			Preclinical
trans-4-[8-(3-Fluorophenyl)-1,7-naphthyridin-6-yl]cyclohexanecarboxylic-acid			Preclinical
trans-4-Hydroxycrotonic-acid	gamma hydroxybutyric acid ligand		Preclinical
trans-4-Methoxycinnamic-acid			Preclinical
tranylcypromine	monoamine oxidase inhibitor	KDM1A, MAOA, MAOB	Launched
trap-101	nociceptin/orphanin FQ receptor antagonist, opioid receptor antagonist	OPRL1	Preclinical
trapidil	PDGFR tyrosine kinase receptor inhibitor	PDGFRA	Launched
travoprost	prostanoid receptor agonist	PTGFR	Launched
traxoprodil	glutamate receptor antagonist	GRIN2B	Phase 2
trazodone	adrenergic receptor antagonist, serotonin receptor antagonist, serotonin reuptake inhibitor	ADRA1A, ADRA2A, HRH1, HTR1A, HTR2A, HTR2B, HTR2C, SLC6A4	Launched
trebenzomine			Phase 2
trelagliptin	dipeptidyl peptidase inhibitor	DPP4	Launched
tremorine	acetylcholine receptor agonist		Preclinical
treosulfan	DNA synthesis inhibitor		Launched
trepibutone	cholinergic receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4	Launched
trequinsin	phosphodiesterase inhibitor	PDE5A	Phase 1
tretazicar	DNA replication inhibitor	NQO2	Phase 2
tretinoin	retinoid receptor agonist, retinoid receptor ligand	ALDH1A1, ALDH1A2, GPRC5A, NR0B1, NR2C2, PPARD, RARA, RARB, RARG, RARRES1, RORB, RORC, RXRB, RXRG	Launched
triacetin			Launched
triamcinolone	glucocorticoid receptor agonist	NR3C1, SERPINA6	Launched
triamcinolone-acetonide	glucocorticoid receptor agonist, immunosuppressant	NR3C1	Launched
triamterene	sodium channel blocker	SCNN1A, SCNN1B, SCNN1D, SCNN1G	Launched
triapine	ribonucleotide reductase inhibitor	RRM1, RRM2	Phase 2
triazolam	GABA benzodiazepine site receptor agonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, TSPO	Withdrawn
tribenoside	anti-inflammatory agent, capillary stabilizing agent		Launched
tribomsalan			Preclinical
tribromoethanol	analgesic agent		Preclinical
tributyrin	HDAC inhibitor		Phase 1
tricaprylin			Launched
trichlormethiazide	chloride channel blocker	ATP1A1, CA1, CA2, CA4, SLC12A1, SLC12A3	Launched
trichlormethine	DNA alkylating agent		Preclinical
trichloroacetic-acid			Launched
trichloroethylene			Preclinical
trichostatin-a	HDAC inhibitor	HDAC1, HDAC10, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9	Preclinical
triciribine	AKT inhibitor	AKT1, AKT2, AKT3	Phase 1/Phase 2
triclabendazole	microtubule inhibitor	DNMT1	Launched
triclocarban	other antibiotic		Launched
triclosan	antibacterial agent	DNMT1	Launched
tridihexethyl	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3	Launched
trientine	chelating agent	CA14	Launched
trifluoperazine	dopamine receptor antagonist	ADRA1A, CALM1, CALY, DRD2, DRD4, HRH1, HTR2A, HTR2C, S100A4, TNNC1	Launched
triflupromazine	dopamine receptor antagonist	CHRM1, CHRM2, DRD1, DRD2, HTR2B	Launched
trifluridine	DNA directed DNA polymerase inhibitor, thymidylate synthase inhibitor	TYMS	Launched
triflusal	cyclooxygenase inhibitor, platelet aggregation inhibitor, thromboxane synthase inhibitor	NFKB1, NOS2, PDE10A, PTGS1	Launched
trigonelline			Phase 1
trihexyphenidyl	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Launched
trilostane	3beta-hydroxy-delta5-steroid dehydrogenase inhibitor	ESR1, ESR2, HSD3B1, HSD3B2	Launched
TRIM			Preclinical
trimebutine	opioid receptor agonist	OPRD1, OPRK1, OPRM1	Launched
trimeprazine	histamine receptor ligand, histamine receptor antagonist	HRH1	Launched
trimetazidine	3-ketoacyl CoA thiolase inhibitor	ACAA2	Launched
trimethadione	oxazolidine antiepileptic	CACNA1G, CACNA1H, CACNA1I	Launched
trimethobenzamide	histamine receptor antagonist	DRD2	Launched
trimethoprim	dihydrofolate reductase inhibitor	DHFR, TYMS	Launched
trimethoquinol	adrenergic receptor antagonist	ADRB2, ADRB3	Launched
trimethylolpropane-triacrylate			Preclinical
trimetozine	sedative		Launched
trimipramine	norepinephrine reputake inhibitor, tricyclic antidepressant	ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD5, HRH1, HTR1A, HTR1D, HTR2A, HTR2C, HTR3A, SLC6A2, SLC6A3, SLC6A4	Launched
trioxsalen	DNA synthesis inhibitor		Launched
tripelennamine	histamine receptor antagonist	HRH1	Launched
triprolidine	histamine receptor antagonist	HRH1	Launched
triptan	serotonin receptor agonist	HTR1B, HTR1D	Phase 1
triptolide	RNA polymerase inhibitor	RELA	Phase 3
triptorelin	gonadotropin releasing factor hormone receptor agonist	GNRHR	Launched
troclosene			Launched
trofinetide	cytokine production inhibitor	IFNG, IL6, TNF	Phase 2
troglitazone	insulin sensitizer, PPAR receptor agonist	ACSL4, ESRRA, ESRRG, PPARG, SERPINE1, SLC29A1, TRPM3	Withdrawn
troleandomycin	protein synthesis inhibitor		Launched
trolox	antioxidant		Launched
tromaril	prostanoid receptor antagonist		Launched
trometamol		AMD1, CANT1, DCN, NEIL1, VEGFA	Launched
tropanyl-3,5-dimethylbenzoate	serotonin receptor antagonist	HTR3A, HTR3B	Preclinical
tropesin	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
tropicamide	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4	Launched
tropisetron	serotonin receptor antagonist	GLRA1, GLRA2, GLRB, HTR3A, HTR4	Launched
trospium	acetylcholine receptor antagonist	CHRM1	Launched
trovafloxacin	bacterial DNA gyrase inhibitor	TOP2A	Withdrawn
troventol			Phase 1
trovirdine	non-nucleoside reverse transcriptase inhibitor		Phase 1
troxerutin	antioxidant		Launched
troxipide	glucosamine synthetase stimulant		Launched
TRV130	opioid receptor agonist	OPRM1	Phase 3
tryptanthrin	cyclooxygenase inhibitor	IDO1	Preclinical
tryptophan	serotonin receptor partial agonist	CASR, IDO1, SLC36A1, WARS, WARS2	Launched
TTNPB	retinoid receptor agonist	RARA, RARB, RARG	Phase 1
TTP-22	casein kinase inhibitor	CSNK2A1	Preclinical
TU-2100			Phase 2
tuaminoheptane			Launched
tubastatin-a	HDAC inhibitor	HDAC6	Preclinical
tubocurarine	acetylcholine receptor antagonist	ACHE, CHRNA2, HTR3A, HTR3B, KCNN1, KCNN2, KCNN3, ZACN	Launched
tucatinib	EGFR inhibitor	ERBB2	Phase 2
TUG-770	free fatty acid receptor agonist	FFAR1	Preclinical
TUG-891	free fatty acid receptor agonist	FFAR4	Preclinical
tulobuterol	adrenergic receptor agonist	ADRB2	Launched
TW-37	BCL inhibitor	BCL2, BCL2L1, MCL1	Preclinical
TWS-119	glycogen synthase kinase inhibitor	GSK3B, JUN, MYC	Preclinical
TXA127	angiotensin receptor agonist		Phase 2
TY-52156	sphingosine 1-phosphate receptor antagonist	S1PR3	Preclinical
tylosin	protein synthesis inhibitor		Launched
tyloxapol	NFkB pathway inhibitor	LPL, NFKB2	Launched
tymazoline			Launched
tyrphostin-AG-1296	FLT3 inhibitor	FLT3	Preclinical
tyrphostin-AG-1478	EGFR inhibitor	EGFR, MAPK14	Preclinical
tyrphostin-AG-18	EGFR inhibitor, tyrosine kinase inhibitor	EGFR	Preclinical
tyrphostin-AG-494	EGFR inhibitor	EGFR	Preclinical
tyrphostin-AG-825	protein tyrosine kinase inhibitor	ERBB2	Preclinical
tyrphostin-AG-835	protein tyrosine kinase inhibitor	EGFR	Preclinical
tyrphostin-AG-879	tyrosine kinase inhibitor	ERBB2, KDR, NTRK1	Preclinical
tyrphostin-AG-99	tyrosine kinase inhibitor	EGFR	Preclinical
tyrphostin-A9	protein tyrosine kinase inhibitor, tyrosine kinase inhibitor		Preclinical
U-0124	MEK inhibitor		Preclinical
U-0126	MEK inhibitor	AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAP2K2, MAP2K7, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1	Preclinical
U-0521	catechol O methyltransferase inhibitor	COMT	Preclinical
U-104	carbonic anhydrase inhibitor	CA1, CA12, CA2, CA9	Preclinical
U-18666A	oxidosqualene cyclase inhibitor		Preclinical
U-50488-(-)	opioid receptor agonist	OPRK1	Preclinical
U-54494A	opioid receptor agonist	OPRK1	Preclinical
U-75799E	growth hormone releasing factor agonist	GHSR	Phase 1
U-99194	dopamine receptor antagonist	DRD3	Preclinical
UAMC-00039	dipeptidyl peptidase inhibitor	DPP4, DPP7	Preclinical
UB-165	acetylcholine receptor agonist	CHRNA3, CHRNA4, CHRNB2	Preclinical
ubenimex	leukotriene synthesis inhibitor	LTA4H, RNPEP	Launched
UBP-296	glutamate receptor antagonist	GRIK1	Preclinical
UBP-302	glutamate receptor antagonist	GRIK1	Preclinical
UBP-310	glutamate receptor antagonist	GRIK1, GRIK5	Preclinical
UC-112	XIAP inhibitor	XIAP	Preclinical
UCL-2077	slow afterhyperpolarization channel blocker		Preclinical
UF-010	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC8	Preclinical
ufenamate	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
UH-232-(+)	dopamine receptor antagonist	DRD2, DRD3, DRD4, HTR1A	Preclinical
UK-356618	metalloproteinase inhibitor	MMP13, MMP14, MMP2, MMP3, MMP9	Preclinical
UK-383367	Procollagen C-Endopeptidase Inhibitors	BMP1	Phase 1
UK-5099	monocarboxylate transporter inhibitor	SLC16A1	Preclinical
ulifloxacin			Launched
ulipristal	progesterone receptor antagonist	PGR	Launched
umeclidinium	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3	Launched
UNBS-5162	CC chemokine receptor antagonist		Phase 1
UNC-2327	protein arginine N-methyltransferase inhibitor	PRMT3	Preclinical
UNC-3230	phosphatidyl-inositol activator	PIP5K1C	Preclinical
UNC-926	MBT inhibitor	L3MBTL1	Preclinical
UNC0224	histone lysine methyltransferase inhibitor	EHMT1, EHMT2	Preclinical
UNC0321	histone lysine methyltransferase inhibitor	EHMT2	Preclinical
UNC0631	histone lysine methyltransferase inhibitor	EHMT2	Preclinical
UNC0638	histone lysine methyltransferase inhibitor	EHMT1, EHMT2	Preclinical
UNC0642	histone lysine methyltransferase inhibitor	EHMT1, EHMT2	Preclinical
UNC0646	histone lysine methyltransferase inhibitor	EHMT2	Preclinical
UNC0737	histone lysine methyltransferase inhibitor	EHMT1, EHMT2	Preclinical
UNC1215	L3MBTL antagonist	L3MBTL3	Preclinical
UNC1999	histone lysine methyltransferase inhibitor	EZH2	Preclinical
UNC2025	MER tyrosine kinase inhibitor, FLT3 inhibitor	FLT3, MERTK	Preclinical
UNC2250	MER tyrosine kinase inhibitor	MERTK	Preclinical
UNC669	L3MBTL antagonist	L3MBTL1	Preclinical
undecylenic-acid	other antifungal		Launched
UPF-1069	PARP inhibitor	PARP2	Preclinical
uprosertib	AKT inhibitor	AKT1, AKT2, AKT3	Phase 2
uracil		DPYD, UCKL1	Launched
uracil-mustard	DNA synthesis inhibitor		Launched
urapidil	adrenergic receptor antagonist	HTR1A	Launched
URB597	FAAH inhibitor	FAAH, FAAH2, TRPA1	Phase 1
urea	hydroxy radical formation stimulant	ARG1, CA2, CTNNB1	Launched
urethane	local anesthetic		Preclinical
uric-acid		PYGL	Phase 3
uridine	dopamine receptor agonist	LSM6, TYMP	Phase 2
uridine-triacetate			Launched
uridine-5'-triphosphate	purinergic receptor activator	P2RY11, P2RY2, P2RY4, P2RY6, UCK2	Launched
URMC-099	mixed lineage kinase inhibitor	CDKL2, DAPK3, FLT3, LRRK2, MAP3K10, MAP3K11, MAP3K2, MAP3K9, SRPK2	Preclinical
ursodeoxycholyltaurine	cholesterol inhibitor		Phase 2
ursodiol	nuclear factor erythroid derived, like (NRF2) activator	NR1H4	Launched
ursolic-acid	ATPase inhibitor, NFkB pathway inhibitor, STAT inhibitor	HSD11B1, PLA2G1B, PTPN1, PYGM	Phase 1
usniacin-(+)	MAP kinase activator	PTPN1	Preclinical
V-51	adrenergic receptor antagonist		Phase 1
val		BCAT1, PCCB, VARS	Phase 2
valaciclovir	DNA polymerase inhibitor		Launched
valdecoxib	cyclooxygenase inhibitor	CA12, PTGS2	Withdrawn
valethamate	acetylcholine receptor antagonist	CHRM1, CHRM4, CHRM5	Launched
valganciclovir	DNA synthesis inhibitor		Launched
valnemulin	bacterial 50S ribosomal subunit inhibitor		Launched
valnoctamide	arachidonic acid acylation inhibitor, benzodiazepine receptor agonist		Phase 3
valproic-acid	HDAC inhibitor	ABAT, ACADSB, ALDH5A1, HDAC1, HDAC2, HDAC9, OGDH, SCN10A, SCN11A, SCN1A, SCN1B, SCN2A, SCN2B, SCN3A, SCN3B, SCN4A, SCN4B, SCN5A, SCN7A, SCN8A, SCN9A	Launched
valpromide	epoxide hydolase inhibitor		Launched
valrocemide			Phase 2
valrubicin	DNA inhibitor, topoisomerase inhibitor	TOP2A	Launched
valsartan	angiotensin receptor antagonist	AGTR1	Launched
valspodar	P glycoprotein inhibitor	ABCB1	Phase 3
vancomycin	bacterial cell wall synthesis inhibitor		Launched
vandetanib	EGFR inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor	EGFR, EPHA1, EPHA10, EPHA2, EPHA3, EPHA4, EPHA5, EPHA6, EPHA7, EPHA8, EPHB1, EPHB2, EPHB3, EPHB4, EPHB6, ERBB2, ERBB3, ERBB4, FLT1, FLT4, KDR, PTK6, RET, SRC, TEK, VEGFA	Launched
vanillin		ABAT, ALDH5A1	Preclinical
vanillylacetone			Preclinical
vanitiolide			Preclinical
vanoxerine	dopamine uptake inhibitor	SLC6A3	Phase 3
vardenafil	phosphodiesterase inhibitor	PDE5A, PDE6G, PDE6H	Launched
varenicline	acetylcholine receptor agonist	CHRNA3, CHRNA4, CHRNA6, CHRNA7	Launched
varespladib	secretory phospholipase inhibitor	PLA2G2A	Phase 3
vasopressin	vasopressin receptor agonist	AVPR1A, AVPR1B, AVPR2, OXTR	Launched
vatalanib	KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	EGFR, FLT1, FLT4, KDR, PDGFRB	Phase 3
VBY-825	cathepsin inhibitor	CTSB, CTSL, CTSS	Preclinical
VCH-916	HCV inhibitor		Phase 1
VE-821	ATR kinase inhibitor	ATR	Preclinical
VE-822	ATR kinase inhibitor	ATM, ATR, MTOR, PIK3CG	Phase 2
vecuronium	acetylcholine receptor antagonist	CHRNA2	Launched
veliflapon	leukotriene synthesis inhibitor	ALOX5AP	Phase 3
veliparib	PARP inhibitor	PARP1, PARP2	Phase 3
velneperit	neuropeptide receptor antagonist	NPY5R	Phase 2
vemurafenib	RAF inhibitor	BRAF, RAF1	Launched
venetoclax	BCL inhibitor	BCL2	Launched
venlafaxine	adrenergic inhibitor, norepinephrine reuptake inhibitor, serotonin–norepinephrine reuptake inhibitor (SNRI)	SLC6A2, SLC6A3, SLC6A4	Launched
VER-155008	HSP inhibitor	HSPA1A	Preclinical
VER-49009	HSP inhibitor	HSP90AA1	Preclinical
verapamil	calcium channel blocker	CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1I, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CYP3A4, KCNA10, KCNA7, KCNH2, KCNJ11, NALCN, SCN5A, SLC29A4, SLC6A4	Launched
verbascoside	PKC inhibitor, NFkB pathway inhibitor		Phase 2/Phase 3
vercirnon	CC chemokine receptor antagonist	CCR9	Phase 3
verinurad	urate transporter inhibitor	SLC22A12	Phase 2
vernakalant	potassium channel blocker	KCNA5	Launched
verteporfin	photosensitizing agent		Launched
verubulin	tubulin polymerization inhibitor	TUBB	Phase 2
vesamicol	acetylcholinesterase inhibitor	SLC18A3	Preclinical
vesnarinone	phosphodiesterase inhibitor	KCNH2, PDE3A	Launched
VGX-1027	tumor necrosis factor receptor antagonist	TLR4	Phase 1
vicriviroc	CC chemokine receptor antagonist	CCR5	Phase 3
vidarabine	antiviral	ADA	Launched
vigabatrin	GABA aminotransferase inhibitor	ABAT, GABBR1, SLC32A1	Launched
vilanterol	adrenergic receptor agonist	ADRB2	Launched
vilazodone	serotonin reuptake inhibitor	DRD2, DRD3, HRH1, HTR1A, HTR4, SLC6A4	Launched
vildagliptin	dipeptidyl peptidase inhibitor	DPP4	Launched
viloxazine	norepinephrine reuptake inhibitor	SLC6A2	Launched
vinblastine	microtubule inhibitor, tubulin polymerization inhibitor	JUN, TUBA1A, TUBB, TUBD1, TUBE1, TUBG1	Launched
vinburnine	adrenergic receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4	Launched
vincamine	adrenergic receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4	Withdrawn
vincristine	tubulin polymerization inhibitor	TUBA4A, TUBB	Launched
vindesine	tubulin polymerization inhibitor	TUBB, TUBB1	Launched
vinflunine	microtubule inhibitor		Launched
vinorelbine	tubulin polymerization inhibitor	TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8	Launched
vinpocetine	phosphodiesterase inhibitor, sodium channel blocker	PDE1A, PDE1C	Launched
viomycin	protein synthesis inhibitor		Launched
vipadenant	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Phase 1
vismodegib	hedgehog pathway inhibitor, smoothened receptor antagonist	SMO	Launched
vitamin-b12			Launched
vitamin-E	PKC inhibitor, LDL oxidation inhibitor	ALOX5, DGKA, NR1I2, PPP2CA, PPP2CB, PRKCA, PRKCB, SEC14L2, SEC14L3, SEC14L4	Phase 2/Phase 3
VLX-600	antitumor agent	TP53	Phase 1
VLX600	ubiquitin C-terminal hydrolase inhibitor	USP14	Phase 1
voglibose	glucosidase inhibitor	MGAM	Launched
volasertib	PLK inhibitor	PLK1	Phase 3
volinanserin	serotonin receptor antagonist	HTR2A, HTR2B, HTR2C, KCNH2	Phase 3
vonoprazan	potassium-competitive acid antagonist	ATP4A	Launched
vorapaxar	thrombin receptor antagonist	F2R	Launched
voreloxin	topoisomerase inhibitor	TOP2A	Phase 3
voriconazole	cytochrome P450 inhibitor	CYP2C19, CYP2C9, CYP3A4, CYP3A5, PTGS1	Launched
vorinostat	HDAC inhibitor	HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC5, HDAC6, HDAC8, HDAC9	Launched
vortioxetine	serotonin receptor agonist, serotonin receptor antagonist	HTR1A, HTR1B, HTR2A, HTR2C, HTR3A, HTR5A, HTR6, HTR7, SLC6A4	Launched
voxtalisib	mTOR inhibitor, PI3K inhibitor	MTOR, PIK3CA	Phase 2
VP-20629	beta amyloid antagonist	PLA2G2E, SLC36A1	Phase 1
VS-4718	focal adhesion kinase inhibitor		Phase 1
VT-464	cytochrome P450 inhibitor	CYP17A1	Phase 2
VTP-27999	renin inhibitor	REN	Phase 1
VU-0240551	potassium/chloride cotransporter inhibitor	SLC12A5	Preclinical
VU-0364739	phospholipase inhibitor	PLD2	Preclinical
VU-0422288	glutamate receptor allosteric modulator	GRM3	Preclinical
VU-152100	acetylcholine receptor allosteric modulator	CHRM4	Preclinical
VUF10166	serotonin receptor antagonist	HTR3A, HTR3B	Preclinical
VUF10460	histamine receptor agonist	HRH4	Preclinical
VUF11207	CC chemokine receptor agonist	ACKR3	Preclinical
VU0155069	phospholipase inhibitor	PLD1	Preclinical
VU0238429	acetylcholine receptor allosteric modulator	CHRM5	Preclinical
VU0357121	glutamate receptor positive allosteric modulator	GRM5	Preclinical
VU0360172	glutamate receptor positive allosteric modulator	GRM5	Preclinical
VU0361737	glutamate receptor positive allosteric modulator	GRM4	Preclinical
VU0364439	glutamate receptor positive allosteric modulator	GRM4	Preclinical
VU0364770	glutamate receptor positive allosteric modulator	GRM4	Preclinical
VU10010	acetylcholine receptor allosteric modulator	CHRM4	Preclinical
VU1545	glutamate receptor positive allosteric modulator	GRM5	Preclinical
VU29	glutamate receptor potentiator	GRM5	Preclinical
VU591	potassium channel blocker	KCNJ1	Preclinical
VX-11e	MAP kinase inhibitor	MAPK1	Preclinical
VX-222	HCV inhibitor		Phase 2
VX-702	p38 MAPK inhibitor	MAPK11, MAPK12, MAPK14	Phase 2
VX-745	p38 MAPK inhibitor	MAPK11, MAPK12, MAPK14	Phase 2
VX-765	caspase inhibitor	CASP1	Phase 2
W-54011	anaphylatoxin chemotactic receptor antagonist	C5AR1	Preclinical
walrycin-b	transcriptional regulatory protein WalR		Preclinical
warfarin	vitamin K antagonist	VKORC1	Launched
WAY-100635	serotonin receptor antagonist	HTR1A	Phase 1
WAY-161503	serotonin receptor agonist	HTR2C	Preclinical
WAY-170523	metalloproteinase inhibitor	MMP13	Preclinical
WAY-200070	estrogen receptor agonist	ERBB2, ERBB3, ERBB4, ESR2	Preclinical
WAY-207024	gonadotropin releasing factor hormone receptor antagonist	GNRHR, HRH2, TACR2	Preclinical
WAY-208466	serotonin receptor agonist	DRD2, HTR2A, HTR2C, HTR6, HTR7	Preclinical
WAY-213613	glutamate inhibitor	SLC1A2	Preclinical
WAY-316606	secreted frizzled related protein inhibitor	SFRP1	Preclinical
WAY-362450	FXR agonist	NR1H4	Phase 1
WAY-600	mTOR inhibitor	MTOR	Preclinical
WAY-629	serotonin receptor agonist	HTR2C	Preclinical
WB-4101	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, HTR1A	Preclinical
WDR5-0103	histone lysine methyltransferase inhibitor	WDR5	Preclinical
WEHI-345-analog	src inhibitor		Preclinical
WH-4-023	src inhibitor	LCK, SRC	Preclinical
WHI-P154	JAK inhibitor	EGFR, JAK1, JAK2, JAK3	Preclinical
WIKI4	Wnt pathway inhibitor, tankyrase inhibitor	TNKS2	Preclinical
WIN-18446	aldehyde dehydrogenase inhibitor	ALDH1A2	Preclinical
WIN-64338	bradykinin receptor antagonist	BDKRB2	Preclinical
wiskostatin	neural Wiskott-Aldrich syndrome protein inhibitor, actin related protein inhibitor	WAS, WASL	Preclinical
wnt-c59	porcupine inhibitor	PORCN	Preclinical
wortmannin	PI3K inhibitor	PI4KA, PI4KB, PIK3CA, PIK3CD, PIK3CG, PIK3R1, PLK1, PRKDC	Preclinical
WP1066	STAT inhibitor	STAT3	Phase 1
WP1130	deubiquitinase inhibitor	JAK2, UCHL5, USP14, USP9X	Preclinical
WR99210	dihydrofolate reductase inhibitor	TYMS	Preclinical
WWL-113	carboxylesterase inhibitor	CES3	Preclinical
WWL-123	monoacylglycerol lipase inhibitor	ABHD6	Preclinical
Wy-16922	histamine release inhibitor		Phase 1
WYE-125132	mTOR inhibitor	MTOR	Preclinical
WYE-354	mTOR inhibitor	MTOR	Preclinical
WYE-687	mTOR inhibitor	MTOR	Preclinical
WZ-3146	EGFR inhibitor	EGFR	Preclinical
WZ-4002	EGFR inhibitor	EGFR, ERBB2	Preclinical
WZ4003	AMPK inhibitor	NUAK1, NUAK2	Preclinical
WZ8040	EGFR inhibitor	EGFR	Preclinical
WZ811	CC chemokine receptor antagonist	CXCR4	Preclinical
xaliproden	serotonin receptor agonist	HTR1A	Phase 3
xamoterol	adrenergic receptor agonist	ADRB1	Phase 3
xanomeline	acetylcholine receptor agonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR6, HTR7	Phase 3
xanthone	antimalarial agent		Preclinical
XAV-939	tankyrase inhibitor	TNKS, TNKS2	Preclinical
XBD173	benzodiazepine receptor ligand	TSPO	Phase 2
XD-14	bromodomain inhibitor	BRD2, BRD3, BRD4, BRDT	Preclinical
XE-991	potassium channel blocker	KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5	Preclinical
xenalipin			Phase 2
xibenolol	adrenergic receptor antagonist		Phase 3
xilobam			Phase 1
xipamide	carbonic anhydrase inhibitor	SLC12A3	Launched
XL-147	PI3K inhibitor	PIK3CA, PIK3CD, PIK3CG	Phase 2
XL-647	EGFR inhibitor, VEGFR inhibitor	EGFR, EPHB4, ERBB2, FLT4, KDR	Phase 3
XL019	JAK inhibitor	JAK1, JAK2, JAK3	Phase 1
XL228	Abl kinase inhibitor, insulin growth factor receptor inhibitor, src inhibitor	IGF1R, SRC	Phase 1
XL388	mTOR inhibitor	MTOR	Preclinical
XL888	HSP inhibitor		Phase 1
XMD17-109	MAP kinase inhibitor	MAPK7	Preclinical
XMD8-92	MAP kinase inhibitor	DCLK2, MAPK7, PLK4, TNK1	Preclinical
xylazine	adrenergic receptor agonist	ADRA2A, ADRA2B, ADRA2C	Launched
xylometazoline	adrenergic receptor agonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C	Launched
xylose			Launched
Y-11	focal adhesion kinase inhibitor	PTK2	Preclinical
Y-134	estrogen receptor antagonist	ESR1, ESR2	Preclinical
Y-26763	potassium channel activator	KCNJ8	Phase 1
Y-27152	potassium channel activator	KCNJ8	Phase 1
Y-27632	rho associated kinase inhibitor	PKIA, PKN2, PRKACA, PRKCE, ROCK1, ROCK2	Preclinical
Y-29794	prolyl endopeptidase inhibitor	PREP	Preclinical
Y-320	interleukin inhibitor	IL17A	Preclinical
Y-39983	rho associated kinase inhibitor	ROCK1, ROCK2	Phase 2
YC-1	guanylyl cyclase activator	GUCY1A2, GUCY1A3, GUCY1B3, HIF1A	Preclinical
YIL-781	ghrelin receptor antagonist	GHSR	Preclinical
YK-4-279	apoptosis inhibitor	EWSR1, FLI1	Preclinical
YM-155	survivin inhibitor	BIRC5	Phase 2
YM-201636	PI3K inhibitor		Preclinical
YM-244769	sodium/calcium exchange inhibitor		Preclinical
YM-298198	glutamate receptor antagonist	GRM1	Preclinical
YM-511	aromatase inhibitor	CYP19A1	Phase 2
YM-58483	calcium channel blocker	TRPC3, TRPC5, TRPM4	Preclinical
YM-750	ACAT inhibitor	SOAT1	Phase 1
YM-90709	IL5 inhibitor	CSF2RB, IL5RA	Preclinical
YM-976	phosphodiesterase inhibitor	PDE4A	Phase 1
YM022	CCK receptor antagonist	CCKBR	Phase 2
YO-01027	gamma secretase inhibitor		Preclinical
yoda-1	piezo channel activator	PIEZO1	Preclinical
yohimbine	adrenergic receptor antagonist	ADRA2A, ADRA2B, ADRA2C, DRD2, DRD3, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, KCNJ1, KCNJ10, KCNJ11, KCNJ12, KCNJ14, KCNJ15, KCNJ8	Launched
YS-035	calcium channel blocker		Preclinical
YZ9	phosphofructokinase inhibitor	MIF, PFKFB3	Preclinical
Y16	rho associated kinase inhibitor	RHOA	Preclinical
zacopride	serotonin receptor antagonist	HTR3A, HTR3B, HTR4, HTR5A	Phase 2
zafirlukast	leukotriene receptor antagonist	CYSLTR1, CYSLTR2	Launched
zalcitabine	nucleoside reverse transcriptase inhibitor		Launched
zaldaride	calmodulin antagonist	CALM1	Phase 3
zaleplon	benzodiazepine receptor agonist	GABRA1, GABRB1, GABRG2, TSPO	Launched
zaltidine	histamine receptor antagonist	HRH2	Phase 3
zaltoprofen	cyclooxygenase inhibitor		Launched
ZAMI-633	urease inhibitor		Phase 3
zamifenacin	acetylcholine receptor antagonist	CHRM3	Phase 3
zanamivir	neuraminidase inhibitor	NEU2	Launched
ZAPA			Preclinical
zaprinast	phosphodiesterase inhibitor	GPR35, PDE1A, PDE4D, PDE5A, PDE9A	Phase 2
zardaverine	phosphodiesterase inhibitor	PDE4D	Phase 2
zatebradine	HCN channel blocker	HCN1, HCN2, HCN3, HCN4	Phase 3
ZCL-278	CDC inhibitor	CDC42	Preclinical
ZD-2079	adrenergic receptor agonist	ADRB3	Phase 2
ZD-7114	adrenergic receptor agonist	ADRB3	Phase 1
ZD-7155	angiotensin receptor antagonist	AGTR1	Preclinical
ZD-7288	HCN channel blocker	HCN1, HCN2, HCN3, HCN4	Phase 2
zeatin			Phase 1
zebularine	DNA methyltransferase inhibitor	CDA, DNMT1	Preclinical
zibotentan	endothelin receptor antagonist	EDNRA	Phase 3
zidovudine	nucleoside reverse transcriptase inhibitor	TERT	Launched
zileuton	leukotriene synthesis inhibitor, lipoxygenase inhibitor	ALOX5	Launched
zilpaterol	adrenergic receptor agonist	ADRB2	Launched
zimelidine	selective serotonin reuptake inhibitor (SSRI)	MAOA, MAOB, SLC6A4	Withdrawn
zinc-undecylenate	other antifungal		Launched
zindotrine	phosphodiesterase inhibitor		Phase 2
ziprasidone	dopamine receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR6, HTR7, SLC6A4	Launched
ZK-164015	estrogen receptor antagonist	ESR1, ESR2	Preclinical
ZK-200775	kainate receptor antagonist		Phase 2
ZK-93423	benzodiazepine receptor agonist	GABRA1, GABRA2, GABRA3, GABRA5, GABRB2, GABRG2	Phase 3
ZK-93426	benzodiazepine receptor antagonist	GABRA1, GABRA2, GABRA3, GABRA5	Phase 1
ZK811752	CC chemokine receptor antagonist	CCR1	Phase 2
ZLN-024	AMPK activator	PRKAA1, PRKAB1, PRKAG1	Preclinical
ZLN005			Preclinical
ZM-226600	Kir6 channel (KATP) activator		Preclinical
ZM-241385	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Preclinical
ZM-306416	Abl kinase inhibitor, src inhibitor, VEGFR inhibitor	EGFR, FLT1, FLT4, KDR	Preclinical
ZM-323881	VEGFR inhibitor	KDR	Preclinical
ZM-336372	RAF inhibitor	BRAF, LCK, MAPK14, RAF1	Preclinical
ZM-39923	JAK inhibitor	JAK1, JAK3	Preclinical
ZM-447439	Aurora kinase inhibitor	AURKA, AURKB	Preclinical
zofenopril-calcium	angiotensin converting enzyme inhibitor	ACE	Launched
zolantidine	histamine receptor antagonist		Preclinical
zoledronic-acid	bone resorption inhibitor	FDPS, GGPS1	Launched
zolimidine	mucus protecting agent		Launched
zolmitriptan	serotonin receptor agonist	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F	Launched
zolpidem	benzodiazepine receptor agonist	GABRA1, GABRA2, GABRA3	Launched
zomepirac	prostaglandin synthesis inhibitor	PTGDR2	Withdrawn
zometapine			Phase 2
zoniporide	sodium/hydrogen exchanger inhibitor	SLC9A1	Phase 3
zonisamide	sodium channel blocker, T-type calcium channel blocker	CA1, CA10, CA11, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9, CACNA1G, CACNA1H, CACNA1I, MAOA, MAOB, SCN10A, SCN11A, SCN1A, SCN1B, SCN2A, SCN2B, SCN3A, SCN3B, SCN4A, SCN4B, SCN5A, SCN7A, SCN8A, SCN9A	Launched
zopolrestat			Phase 2
zosuquidar	P glycoprotein inhibitor	ABCB1, ABCB4	Phase 3
zotarolimus	mTOR inhibitor	FKBP1A	Launched
zotepine	dopamine receptor antagonist, serotonin receptor antagonist	ADRA2B, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR6, HTR7, SLC6A2, SLC6A4	Launched
zoxazolamine	myorelaxant		Phase 2
ZSTK-474	PI3K inhibitor	PIK3CB, PIK3CD, PIK3CG	Phase 1/Phase 2
zuclopenthixol	dopamine receptor antagonist	ADRA1A, ADRA2A, DRD1, DRD2, DRD5, HRH1, HTR2A	Launched
Z160	N-type calcium channel blocker	CACNA2D1	Phase 2
1,12-Besm	polyamine biosynthesis inhibitor		Phase 2
1,2,3,4,5,6-hexabromocyclohexane	JAK inhibitor	JAK2	Preclinical
1,3-dipropyl-8-phenylxanthine	adenosine receptor antagonist		Preclinical
1,4-butanediol	benzodiazepine receptor agonist, gamma hydroxybutyric acid agonist	MAN1B1, PLA2G2A, PLA2G2E	Phase 1
1,5-dicaffeoylquinic-acid			Phase 1
1-((Z)-3-Chloroallyl)-1,3,5,7-tetraazaadamantan-1-ium			Preclinical
1-(1,2-Diphenylethyl)piperidine-(+/-)	glutamate receptor antagonist		Preclinical
1-(2-chloro-5-methylphenoxy)-3-(isopropylamino)-2-propanol			Preclinical
1-acetyl-4-methylpiperazine	acetylcholine receptor agonist		Preclinical
1-azakenpaullone	glycogen synthase kinase inhibitor	CCNB1, CDK1, CDK5, GSK3B	Preclinical
1-deoxymannojirimycin	alpha mannosidase inhibitor	MAN2A1	Preclinical
1-EBIO	potassium channel activator	KCNN1, KCNN2, KCNN3, KCNN4	Preclinical
1-ethyl-2-pyrrolidone	transdermal absorption-enhancing compound		Preclinical
1-hexadecanal	sphingosine 1 phosphate receptor substrate	DBI, RHO	Preclinical
1-hexadecanol			Launched
1-naphthyl-PP1	src inhibitor	SRC	Preclinical
1-octacosanol			Phase 2
1-octanol		GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1	Phase 2
1-phenylbiguanide	serotonin receptor agonist	HTR3A, HTR3B	Preclinical
1E-1-(2-hydroxy-5-methylphenyl)-1-dodecanone oxime			Preclinical
1s,2r-phenylpropanolamine	adrenergic receptor agonist	ADRA1A, ADRA2A, ADRB1, ADRB2, DRD1	Withdrawn
10-deacetylbaccatin	antitumor agent		Preclinical
10-DEBC	AKT inhibitor	PIM1	Preclinical
10-hydroxycamptothecin	topoisomerase inhibitor	TOP1	Preclinical
10058-F4	c-Myc inhibitor		Preclinical
12-O-tetradecanoylphorbol-13-acetate	PKC activator	KCNT2, TRPV4	Phase 2
1400W	nitric oxide synthase inhibitor	NOS1, NOS2, NOS3	Preclinical
16,16-dimethylprostaglandin-e2	prostanoid receptor agonist	HPGD	Phase 2
17-alpha-methyltestosterone	aromatase inhibitor	AR	Launched
17-hydroxyprogesterone-caproate	progesterone receptor agonist	AR, ESR1, ESR2, NR1H4, NR1I2, NR3C1, PGR	Launched
17-PA	glucocorticoid receptor agonist		Preclinical
2'-c-methylguanosine	HCV inhibitor		Preclinical
2'-MeCCPA	adenosine receptor agonist	ADORA1	Preclinical
2,3-cis/exo-camphanediol			Phase 1
2,3-cis/exo-pinanediol			Phase 1
2,3-DCPE	Bcl-XL downregulator	BCL2L1	Preclinical
2,4-dinitrochlorobenzene	thioredoxin inhibitor	TXN	Phase 2
2,4-dinitrophenol	ATP synthase inhibitor	APP	Preclinical
2,5-furandimethanol	hemoglobin modulator	HBB	Phase 2
2,6-dimethylpiperidine			Preclinical
2-(chloromethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one			Preclinical
2-(3-mercaptopropyl)pentanedioic acid	glutamate carboxypeptidase inhibitor	FOLH1	Phase 1
2-[1-(4-piperonyl)piperazinyl]benzothiazole	serotonin receptor agonist	HTR4	Preclinical
2-aminobenzenesulfonamide	carbonic anhydrase inhibitor	CA12, CA14, CA2, CA6, CA9	Preclinical
2-APB	1,4,5-trisphosphate inhibitor	TRPC1, TRPC3, TRPC4, TRPC5, TRPC6, TRPC7, TRPM2, TRPM3, TRPM6, TRPV1, TRPV6	Preclinical
2-BFI	imidazoline receptor ligand	ADRA2A, ADRA2B, ADRA2C, MAOA, MAOB	Preclinical
2-chloro-N6-cyclopentyladenosine	adenosine receptor agonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Preclinical
2-chloroadenosine	adenosine receptor agonist	ADORA1, ADORA2A, ADORA2B	Preclinical
2-Chloropyrazine			Preclinical
2-CMDO	dopamine receptor antagonist	DRD2, DRD4	Preclinical
2-cyanopyrimidine	cathepsin inhibitor		Preclinical
2-Deoxy-2-{[methyl(nitroso)carbamoyl]amino}hexose			Preclinical
2-deoxyglucose	glycolysis inhibitor	SLC2A1, SLC2A2, SLC2A3, SLC2A4	Phase 2
2-ethoxybenzoic-acid	analgesic agent		Phase 1
2-ethyl-1,3-hexanediol			Preclinical
2-fluoro-2-deoxy-D-galactose		LCT	Phase 1
2-hydroxy-4-((E)-3-(4-hydroxyphenyl)acryloyl)-2-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-6-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)cyclohexane-1,3,5-trione			Preclinical
2-hydroxyethyl-salicylate			Launched
2-hydroxyflutamide	androgen receptor antagonist	AR	Phase 1/Phase 2
2-hydroxysaclofen	GABA receptor antagonist	GABBR1, GABBR2	Preclinical
2-iminobiotin	nitric oxide synthase inhibitor	NOS1, NOS2	Phase 2
2-iodohippuric-acid			Preclinical
2-iodomelatonin	melatonin receptor agonist	MTNR1A, MTNR1B, NQO2	Preclinical
2-methoxyestradiol	hypoxia inducible factor inhibitor	COMT, CYP19A1, CYP1A1, CYP1B1, HIF1A, TUBB	Phase 2
2-methyl-5-hydroxytryptamine	serotonin receptor agonist	HTR1B, HTR1D, HTR1E, HTR1F, HTR3A, HTR3B, HTR6	Preclinical
2-methyl-5-nitrophenol			Preclinical
2-methylimidazole	cholesterol inhibitor		Preclinical
2-octyldodecan-1-ol			Preclinical
2-Oleoylglycerol	glucose dependent insulinotropic receptor ligand	GPR119	Phase 1
2-oxoglutaric-acid		OXGR1	Preclinical
2-oxopropanoate	pyruvate dehydrogenase kinase inhibitor	ABAT, AGXT2, PC, PDHB, PKLR, PKM, SLC16A1, SLC16A2, SLC16A3, SLC16A4, SLC16A5, SLC16A6, SLC16A7, SLC16A8	Preclinical
2-phenylmelatonin	melatonin receptor agonist	MTNR1A, MTNR1B	Preclinical
2-PMDQ	adrenergic receptor antagonist	ADRA1A	Preclinical
2-pyridylethylamine	histamine receptor agonist	HRH1	Preclinical
2-TEDC	lipoxygenase inhibitor	ALOX12	Preclinical
2-thiouracil			Preclinical
20-hydroxyecdysone	ecdysone receptor modulator		Preclinical
3'-fluorobenzylspiperone	dopamine receptor ligand	DRD2	Preclinical
3,3'-dichlorobenzaldazine	glutamate receptor allosteric ligand	GRM5	Preclinical
3,3'-diindolylmethane	CHK inhibitor, cytochrome P450 activator, indoleamine 2,3-dioxygenase inhibitor	AR, HIF1A, IFNG, PI3	Phase 3
3,4-DCPG-(+/-)	glutamate receptor agonist	GRM8	Preclinical
3,4-DCPG-(R)	glutamate receptor antagonist		Preclinical
3,4-DCPG-(S)	glutamate receptor agonist	GRM8	Preclinical
3,5-DHPG-(S)	glutamate receptor agonist	GRM1	Preclinical
3-(4-methylbenzylidene)camphor	endocrine disruptor		Launched
3-alpha-bis-(4-fluorophenyl)-methoxytropane	dopamine uptake inhibitor	CHRM1, SLC6A2, SLC6A3, SLC6A4	Preclinical
3-alpha-Hydroxy-5-beta-androstan-17-one			Preclinical
3-amino-benzamide	PARP inhibitor	PARP1	Phase 2
3-anilinopropan-1-ol			Preclinical
3-AQC	serotonin receptor agonist	HTR3A	Preclinical
3-bromo-7-nitroindazole	nitric oxide synthase inhibitor	NOS1, NOS2, NOS3	Preclinical
3-bromocamphor			Launched
3-bromopyruvate	hexokinase inhibitor	HK2	Preclinical
3-carboxy-4-hydroxyphenylglycine-(R)	glutamate receptor antagonist	GRIN1, GRIN2A, GRIN2B, GRIN2C	Preclinical
3-carboxy-4-hydroxyphenylglycine-(S)	glutamate receptor antagonist	GRM1, GRM5	Preclinical
3-CPMT	dopamine reuptake inhibitor		Preclinical
3-deazaadenosine	adenosylhomocysteinase inhibitor	AHCY	Phase 2
3-deazaneplanocin-A	histone lysine methyltransferase inhibitor	EZH2	Preclinical
3-deazauridine	cytidine deaminase inhibitor		Preclinical
3-hydroxy-3-phenylpentanamide	GABA receptor modulator		Phase 1
3-indolebutyric-acid		B2M, HLA-A, TRAC, TRBC1	Preclinical
3-MATIDA		GRM1	Preclinical
3-methyl-GABA	GABA aminotransferase activator	ABAT	Preclinical
3-methyladenine	PI3K inhibitor	PI3	Preclinical
3-MPPI	adrenergic receptor ligand	ADRA1A	Preclinical
3PO	phosphofructokinase inhibitor	PFKFB3	Preclinical
4,4'-DDT			Preclinical
4,4-pentamethylenepiperidine	M2 channel blocker		Preclinical
4,5,6,7-tetrabromobenzotriazole	casein kinase inhibitor	AKT1, CHEK1, CSNK2A1, GSK3B, LCK, MAP2K1, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SGK1	Preclinical
4-(4-fluorobenzoyl)-1-(4-phenylbutyl)-piperidine	serotonin receptor antagonist	HTR2A	Preclinical
4-acetyl-1,1-dimethylpiperazinium	acetylcholine receptor agonist		Preclinical
4-aminohippuric-acid		SLC22A6	Launched
4-carboxy-3-hydroxyphenylglycine-(RS)	glutamate receptor agonist, glutamate receptor antagonist	GRM1	Preclinical
4-carboxy-3-hydroxyphenylglycine-(S)	glutamate receptor agonist, glutamate receptor antagonist	GRM1, GRM2	Preclinical
4-chlorophenylguanidine	urokinase inhibitor	PLAUR	Preclinical
4-CMTB	free fatty acid receptor agonist	FFAR2	Preclinical
4-DAMP	cholinergic receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Preclinical
4-galactosyllactose		AMY2B	Preclinical
4-HQN	PARP inhibitor	PARP1	Preclinical
4-hydroxy-phenazone			Preclinical
4-IBP	sigma receptor agonist	SIGMAR1	Preclinical
4-iodo-L-phenylalanine		DPP4	Preclinical
4-iodo-6-phenylpyrimidine	macrophage migration inhibiting factor inhibitor	MIF	Preclinical
4-methylgenistein	protein tyrosine kinase inhibitor	CYP19A1, ESRRA, ESRRB, ESRRG, FASN	Preclinical
4-methylhistamine	histamine receptor agonist	HRH4	Preclinical
4-mu-8C	IRE1 inhibitor	ERN1	Preclinical
4-P-PDOT	melatonin receptor antagonist	MTNR1A, MTNR1B	Preclinical
4-phenolsulfonic-acid			Preclinical
4-phenyl-1,2,3,4-tetrahydroisoquinoline	dopamine release inhibitor		Preclinical
4-PPBP	sigma receptor ligand	SIGMAR1	Preclinical
4-propylbenzoic-acid			Preclinical
4-pyrimidinecarbonitrile			Preclinical
4-tert-butylphenol			Preclinical
4BP-TQS	nicotinic receptor agonist	CHRNA7	Preclinical
4EGI-1	protein synthesis inhibitor	EIF4E	Preclinical
4E1RCat	protein synthesis inhibitor	EIF4E, EIF4G1	Preclinical
4SC-202	HDAC inhibitor	HDAC1	Phase 1
5'-Chloro-5'-deoxy-ENBA-(+/-)	adenosine receptor agonist	ADORA1	Preclinical
5,7-dichlorokynurenic-acid	glutamate receptor antagonist	GLRA2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D	Preclinical
5,7-Dihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-2H-chromene-3,4-dione			Preclinical
5-(4chlorophenyl)-4-ethyl-2,4-dihydro-3H-1,2,4-triazol-3-one			Preclinical
5-Amino-3-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione			Preclinical
5-aminolevulinic-acid	oxidizing agent	ALAD	Launched
5-BDBD	purinergic receptor antagonist	P2RX4	Preclinical
5-carboxamidotryptamine	serotonin receptor agonist	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7	Preclinical
5-fluoro-3-pyridyl-methanol			Preclinical
5-fluorouracil	thymidylate synthase inhibitor	DPYD, TYMS	Launched
5-FP	thymidylate synthase inhibitor	TYMS	Phase 1
5-HMF			Phase 2
5-hydroxyectoine			Preclinical
5-hydroxymethyl-tolterodine	acetylcholine receptor antagonist	CHRM3	Phase 1
5-hydroxytryptophan	neurotransmitter	SLC36A1, SLC36A2	Launched
5-iodo-A-85380	acetylcholine receptor agonist		Phase 2
5-methylfurmethiodide	acetylcholine receptor agonist	CHRM1, CHRM2, CHRM3, CHRM4	Preclinical
5-methylhydantoin-(D)			Preclinical
5-methylhydantoin-(L)			Preclinical
6,_7-dehydro-17-acetoxy-progesterone	steroidal progestin		Preclinical
6-aminochrysene	transferase inhibitor		Phase 2
6-aminopenicillanic-acid			Preclinical
6-benzylaminopurine	purinergic receptor activator		Preclinical
6-chloromelatonin	melatonin receptor agonist	MTNR1A, MTNR1B	Preclinical
6-iodo-nordihydrocapsaicin	TRPV antagonist	TRPV1	Preclinical
7,8,9,10-tetrahydroazepino[2,1-b]quinazolin-12(6H)-one			Preclinical
7-aminocephalosporanic-acid	beta lactamase inhibitor		Preclinical
7-chlorokynurenic-acid	glutamate receptor antagonist	GRIN1, GRIN2A, GRIN2B, GRIN2C	Preclinical
7-hydroxy-DPAT	dopamine receptor agonist	DRD2, DRD3	Preclinical
7-hydroxy-PIPAT	dopamine receptor ligand	DRD3	Preclinical
7-hydroxystaurosporine	CDK inhibitor, CHK inhibitor, PKC inhibitor	CHEK1, MARK3, PDPK1	Phase 2
7-keto-DHEA	steroid		Launched
7-methoxytacrine	acetylcholinesterase inhibitor	ACHE	Phase 2
7-methylxanthine	adenosine receptor antagonist		Phase 2
7-nitroindazole	nitric oxide synthase inhibitor	NOS1, NOS2, NOS3	Preclinical
8-bromo-cAMP	PKA activator		Preclinical
8-bromo-cGMP	PKA activator	PRKG1	Preclinical
8-hydroxy-DPAT	serotonin receptor agonist	CDK1, CHEK1, CHEK2, GSK3B, HTR5A, HTR7, LCK, MAPK14, MARK1, PDPK1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG	Preclinical
8-hydroxy-PIPAT	dopamine receptor ligand	DRD2, DRD3	Preclinical
8-M-PDOT	melatonin receptor agonist	MTNR1A, MTNR1B	Preclinical
80841-78-7			Preclinical
9-aminoacridine			Preclinical
9-aminocamptothecin	topoisomerase inhibitor	TOP1	Phase 2
9-anthracenecarboxylic-acid		ANO1, CLCN1	Preclinical
